PK
pÂXÖ’|Z Z docProps/core.xml
PK
pÂXõ”¿w, , docProps/app.xml
SheetJSWorksheets1PK
pÂXÏÄ_
Vs Vs xl/worksheets/sheet1.xml
許å¯è‰å—號有效日期發è‰æ—¥æœŸè¨±å¯è‰ç¨®é¡žé€šé—œç°½å¯©æ–‡ä»¶ç·¨è™Ÿä¸æ–‡å“åé©æ‡‰ç—‡åŠ‘型包è£è—¥å“類別主æˆåˆ†ç•¥è¿°ç”³è«‹å•†å稱申請商地å€ç”³è«‹å•†çµ±ä¸€ç·¨è™Ÿè£½é€ 商åç¨±è£½é€ å» å» å€è£½é€ å» åœ‹åˆ¥ç•°å‹•æ—¥æœŸåŒ…è£èˆ‡åœ‹éš›æ¢ç¢¼è‹±æ–‡å“å用法用é‡èˆŠè‰å—號
罕èŒç–«è£½å—第000001號2018-08-012008-08-01èŒã€€ç–«DHY02300000102抗鎖éˆè›‡æ¯’血清å‡æ™¶æ³¨å°„劑å°éŽ–éˆè›‡å’¬å‚·å…·æœ‰ç‰¹ç•°æ€§çš„治療效果。注射劑瓶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨ANTIVENIN OF D.RUSSELLII衛生ç¦åˆ©éƒ¨ç–¾ç—…管制署å°åŒ—市昆陽街161號00970553衛生ç¦åˆ©éƒ¨ç–¾ç—…管制署å°åŒ—市å—港å€æ˜†é™½è¡—161號TAIWAN2014-06-11瓶è£Antivenin of D.russellii (Lyophilized)本å“1瓶用10毫å‡è¥¿å¸‚易溶解,以肌肉或éœè„ˆæ³¨å°„給藥。溶解後於2å°æ™‚內用完。æˆäººç”¨é‡æ™®é€šç‚º1瓶/1劑é‡ï¼Œåæ²ä»¥ä¸‹å°å©ç”¨é‡åŠ å€ã€‚
罕èŒç–«è¼¸å—第000001號2016-05-282001-05-28èŒã€€ç–«DHA02200000100立比扶注射劑 22 MCG復發型多發性硬化症。注射劑盒è£;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨INTERFERON BETA-1A臺ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2012-08-29ç›’è£;;注射é‡ç’REBIF 22 MICROGRAMS
罕èŒç–«è¼¸å—第000002號2016-11-262001-11-26èŒã€€ç–«DHA02200000202立比扶注射劑 44MCG復發型多發性硬化症。注射劑é å……å¼æ³¨å°„é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨INTERFERON BETA-1A臺ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2012-08-29é å……å¼æ³¨å°„é‡ç’;;ç›’è£REBIF 44 MICROGRAMS
罕èŒç–«è¼¸å—第000003號2018-05-062003-05-06èŒã€€ç–«DHA02200000304é©è«¾é€²å‡æ™¶æ³¨å°„劑 1.1毫克甲狀腺分化癌治療之輔助診斷製劑。é©ç”¨æ–¼å› 甲狀腺分化癌而接å—幾乎全部或全部甲狀腺切除ã€ä¸”沒有轉移性甲狀腺癌的跡象的病人,Thyrogen(thyrotropin alfa for injection)å¯ç”¨ä¾†ä½œç‚ºç”²ç‹€è…ºæ®˜ç•™çµ„織的放射碘去除之輔助療劑。å‰è¿°é©æ‡‰ç—‡åŒ…括下列4é …å¯èƒ½ç”¨æ³•ï¼š1.Thyrogen Tg測試å¯ç”¨æ–¼æŽ¥å—ç”²ç‹€è…ºæ¿€ç´ æŠ‘åˆ¶ç™‚æ³•å»ç„¡æ³•é 測Tg的病人以排除甲狀腺癌殘留或復發的診斷。2.å°æ²’有癌症轉移跡象的病人,在接å—幾乎全部甲狀腺切除術後,Thyrogen治療å¯èˆ‡æ”¾å°„碘(131I)åˆç”¨ä»¥åŽ»é™¤ç”²ç‹€è…ºç™Œæ®˜ç•™ç‰©ã€‚3.Thyrogen Tg測試å¯ç”¨æ–¼å¿…é ˆæŽ¥å—血清Tg測試åŠæ”¾å°„性碘æ”影,å»ä¸é¡˜æŽ¥å—ç”²ç‹€è…ºæ¿€ç´ åœç”¨æ¸¬è©¦çš„病人,且其測試醫師èªç‚ºä½¿ç”¨è¼ƒä¸æ•æ„Ÿçš„測試是æ£ç•¶çš„。4.Thyrogen治療åŠæ¸¬è©¦å¯ç”¨æ–¼å°åœç”¨ç”²ç‹€è…ºæ¿€ç´ 無法產生充份內生性TSHå應或åœè—¥ç‚ºé†«ç™‚ç¦å¿Œçš„病人。å‡æ™¶æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨THYROTROPIN ALFA賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356HOSPIRA INC.1776 NORTH CENTENNIAL DRIVE, MCPHERSON, KANSAS 67460, USAUNITED STATES2013-09-30å°ç“¶THYROGEN 1.1MG/VIAL
罕èŒç–«è¼¸å—第000003號2018-05-062003-05-06èŒã€€ç–«DHA02200000304é©è«¾é€²å‡æ™¶æ³¨å°„劑 1.1毫克甲狀腺分化癌治療之輔助診斷製劑。é©ç”¨æ–¼å› 甲狀腺分化癌而接å—幾乎全部或全部甲狀腺切除ã€ä¸”沒有轉移性甲狀腺癌的跡象的病人,Thyrogen(thyrotropin alfa for injection)å¯ç”¨ä¾†ä½œç‚ºç”²ç‹€è…ºæ®˜ç•™çµ„織的放射碘去除之輔助療劑。å‰è¿°é©æ‡‰ç—‡åŒ…括下列4é …å¯èƒ½ç”¨æ³•ï¼š1.Thyrogen Tg測試å¯ç”¨æ–¼æŽ¥å—ç”²ç‹€è…ºæ¿€ç´ æŠ‘åˆ¶ç™‚æ³•å»ç„¡æ³•é 測Tg的病人以排除甲狀腺癌殘留或復發的診斷。2.å°æ²’有癌症轉移跡象的病人,在接å—幾乎全部甲狀腺切除術後,Thyrogen治療å¯èˆ‡æ”¾å°„碘(131I)åˆç”¨ä»¥åŽ»é™¤ç”²ç‹€è…ºç™Œæ®˜ç•™ç‰©ã€‚3.Thyrogen Tg測試å¯ç”¨æ–¼å¿…é ˆæŽ¥å—血清Tg測試åŠæ”¾å°„性碘æ”影,å»ä¸é¡˜æŽ¥å—ç”²ç‹€è…ºæ¿€ç´ åœç”¨æ¸¬è©¦çš„病人,且其測試醫師èªç‚ºä½¿ç”¨è¼ƒä¸æ•æ„Ÿçš„測試是æ£ç•¶çš„。4.Thyrogen治療åŠæ¸¬è©¦å¯ç”¨æ–¼å°åœç”¨ç”²ç‹€è…ºæ¿€ç´ 無法產生充份內生性TSHå應或åœè—¥ç‚ºé†«ç™‚ç¦å¿Œçš„病人。å‡æ™¶æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨THYROTROPIN ALFA賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356GENZYME CORPORATIONBULK:51 NEW YORK AVE., FRAMINGHAM, MA, U.S.A.UNITED STATES2013-09-30å°ç“¶THYROGEN 1.1MG/VIAL
罕èŒç–«è¼¸å—第000003號2018-05-062003-05-06èŒã€€ç–«DHA02200000304é©è«¾é€²å‡æ™¶æ³¨å°„劑 1.1毫克甲狀腺分化癌治療之輔助診斷製劑。é©ç”¨æ–¼å› 甲狀腺分化癌而接å—幾乎全部或全部甲狀腺切除ã€ä¸”沒有轉移性甲狀腺癌的跡象的病人,Thyrogen(thyrotropin alfa for injection)å¯ç”¨ä¾†ä½œç‚ºç”²ç‹€è…ºæ®˜ç•™çµ„織的放射碘去除之輔助療劑。å‰è¿°é©æ‡‰ç—‡åŒ…括下列4é …å¯èƒ½ç”¨æ³•ï¼š1.Thyrogen Tg測試å¯ç”¨æ–¼æŽ¥å—ç”²ç‹€è…ºæ¿€ç´ æŠ‘åˆ¶ç™‚æ³•å»ç„¡æ³•é 測Tg的病人以排除甲狀腺癌殘留或復發的診斷。2.å°æ²’有癌症轉移跡象的病人,在接å—幾乎全部甲狀腺切除術後,Thyrogen治療å¯èˆ‡æ”¾å°„碘(131I)åˆç”¨ä»¥åŽ»é™¤ç”²ç‹€è…ºç™Œæ®˜ç•™ç‰©ã€‚3.Thyrogen Tg測試å¯ç”¨æ–¼å¿…é ˆæŽ¥å—血清Tg測試åŠæ”¾å°„性碘æ”影,å»ä¸é¡˜æŽ¥å—ç”²ç‹€è…ºæ¿€ç´ åœç”¨æ¸¬è©¦çš„病人,且其測試醫師èªç‚ºä½¿ç”¨è¼ƒä¸æ•æ„Ÿçš„測試是æ£ç•¶çš„。4.Thyrogen治療åŠæ¸¬è©¦å¯ç”¨æ–¼å°åœç”¨ç”²ç‹€è…ºæ¿€ç´ 無法產生充份內生性TSHå應或åœè—¥ç‚ºé†«ç™‚ç¦å¿Œçš„病人。å‡æ™¶æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨THYROTROPIN ALFA賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356GENZYME CORPORATION500 KENDALL STREET, CAMBRIDGE, MA 02142, U.S.AUNITED STATES2013-09-30å°ç“¶THYROGEN 1.1MG/VIAL
罕èŒç–«è¼¸å—第000003號2018-05-062003-05-06èŒã€€ç–«DHA02200000304é©è«¾é€²å‡æ™¶æ³¨å°„劑 1.1毫克甲狀腺分化癌治療之輔助診斷製劑。é©ç”¨æ–¼å› 甲狀腺分化癌而接å—幾乎全部或全部甲狀腺切除ã€ä¸”沒有轉移性甲狀腺癌的跡象的病人,Thyrogen(thyrotropin alfa for injection)å¯ç”¨ä¾†ä½œç‚ºç”²ç‹€è…ºæ®˜ç•™çµ„織的放射碘去除之輔助療劑。å‰è¿°é©æ‡‰ç—‡åŒ…括下列4é …å¯èƒ½ç”¨æ³•ï¼š1.Thyrogen Tg測試å¯ç”¨æ–¼æŽ¥å—ç”²ç‹€è…ºæ¿€ç´ æŠ‘åˆ¶ç™‚æ³•å»ç„¡æ³•é 測Tg的病人以排除甲狀腺癌殘留或復發的診斷。2.å°æ²’有癌症轉移跡象的病人,在接å—幾乎全部甲狀腺切除術後,Thyrogen治療å¯èˆ‡æ”¾å°„碘(131I)åˆç”¨ä»¥åŽ»é™¤ç”²ç‹€è…ºç™Œæ®˜ç•™ç‰©ã€‚3.Thyrogen Tg測試å¯ç”¨æ–¼å¿…é ˆæŽ¥å—血清Tg測試åŠæ”¾å°„性碘æ”影,å»ä¸é¡˜æŽ¥å—ç”²ç‹€è…ºæ¿€ç´ åœç”¨æ¸¬è©¦çš„病人,且其測試醫師èªç‚ºä½¿ç”¨è¼ƒä¸æ•æ„Ÿçš„測試是æ£ç•¶çš„。4.Thyrogen治療åŠæ¸¬è©¦å¯ç”¨æ–¼å°åœç”¨ç”²ç‹€è…ºæ¿€ç´ 無法產生充份內生性TSHå應或åœè—¥ç‚ºé†«ç™‚ç¦å¿Œçš„病人。å‡æ™¶æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨THYROTROPIN ALFA賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356Genzyme Corporation11 Forbes Road, Northborough, MA 01532, USAUNITED STATES2013-09-30å°ç“¶THYROGEN 1.1MG/VIAL
罕èŒç–«è¼¸å—第000004號2019-04-262004-04-26èŒã€€ç–«DHA02200000406åˆ©ç”«è“‹ç´ æ¿ƒç¸®æ³¨å°„æ¶²ï¼‘æ¯«å…‹ï¼¼å…¬æ’®ç”¨æ–¼æ²»ç™‚Î±-GALACTOSIDASE A缺ä¹æ‚£è€…(å³FABRY DISEASE),æä¾›é•·æœŸé…µç´ è£œå……æ²»ç™‚ã€‚æ³¨å°„åŠ‘å°ç“¶;;ç›’è£;;ç›’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨AGALSIDASE ALFA科懋生物科技股份有é™å…¬å¸å°åŒ—市å—港å€åœ’å€è¡—3號14樓之623024594DHL SUPPLY CHAIN B.V.BIJSTERHUIZEN 11-27, NL-6546 AR NIJMEGEN, THE NETHERLANDSNETHERLANDS2014-05-13å°ç“¶;;ç›’è£;;ç›’è£;;ç›’è£REPLAGAL 1MG/ML CONCENTRATION FOR SOLUTION FOR INFUSION
罕èŒç–«è¼¸å—第000004號2019-04-262004-04-26èŒã€€ç–«DHA02200000406åˆ©ç”«è“‹ç´ æ¿ƒç¸®æ³¨å°„æ¶²ï¼‘æ¯«å…‹ï¼¼å…¬æ’®ç”¨æ–¼æ²»ç™‚Î±-GALACTOSIDASE A缺ä¹æ‚£è€…(å³FABRY DISEASE),æä¾›é•·æœŸé…µç´ è£œå……æ²»ç™‚ã€‚æ³¨å°„åŠ‘å°ç“¶;;ç›’è£;;ç›’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨AGALSIDASE ALFA科懋生物科技股份有é™å…¬å¸å°åŒ—市å—港å€åœ’å€è¡—3號14樓之623024594SHIRE HUMAN GENETIC THERAPIES ABSVARDVAGEN 11D, 182 33 DANDERYD, SWEDENSWEDEN2014-05-13å°ç“¶;;ç›’è£;;ç›’è£;;ç›’è£REPLAGAL 1MG/ML CONCENTRATION FOR SOLUTION FOR INFUSION
罕èŒç–«è¼¸å—第000004號2019-04-262004-04-26èŒã€€ç–«DHA02200000406åˆ©ç”«è“‹ç´ æ¿ƒç¸®æ³¨å°„æ¶²ï¼‘æ¯«å…‹ï¼¼å…¬æ’®ç”¨æ–¼æ²»ç™‚Î±-GALACTOSIDASE A缺ä¹æ‚£è€…(å³FABRY DISEASE),æä¾›é•·æœŸé…µç´ è£œå……æ²»ç™‚ã€‚æ³¨å°„åŠ‘å°ç“¶;;ç›’è£;;ç›’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨AGALSIDASE ALFA科懋生物科技股份有é™å…¬å¸å°åŒ—市å—港å€åœ’å€è¡—3號14樓之623024594Cangene BioPharma Inc. (CBI)CAMDEN INDUSTRIAL PARK, 1111 SOUTH PACA STREET, BALTIMORE MD, 21230-2591, U.S.A.UNITED STATES2014-05-13å°ç“¶;;ç›’è£;;ç›’è£;;ç›’è£REPLAGAL 1MG/ML CONCENTRATION FOR SOLUTION FOR INFUSION
罕èŒç–«è¼¸å—第000004號2019-04-262004-04-26èŒã€€ç–«DHA02200000406åˆ©ç”«è“‹ç´ æ¿ƒç¸®æ³¨å°„æ¶²ï¼‘æ¯«å…‹ï¼¼å…¬æ’®ç”¨æ–¼æ²»ç™‚Î±-GALACTOSIDASE A缺ä¹æ‚£è€…(å³FABRY DISEASE),æä¾›é•·æœŸé…µç´ è£œå……æ²»ç™‚ã€‚æ³¨å°„åŠ‘å°ç“¶;;ç›’è£;;ç›’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨AGALSIDASE ALFA科懋生物科技股份有é™å…¬å¸å°åŒ—市å—港å€åœ’å€è¡—3號14樓之623024594SHIRE HUMAN GENETIC THERAPIES, Inc.205 ALEWIFE BROOK PARKWAY, CAMBRIDGE, MA 02138, USAUNITED STATES2014-05-13å°ç“¶;;ç›’è£;;ç›’è£;;ç›’è£REPLAGAL 1MG/ML CONCENTRATION FOR SOLUTION FOR INFUSION
罕èŒç–«è¼¸å—第000004號2019-04-262004-04-26èŒã€€ç–«DHA02200000406åˆ©ç”«è“‹ç´ æ¿ƒç¸®æ³¨å°„æ¶²ï¼‘æ¯«å…‹ï¼¼å…¬æ’®ç”¨æ–¼æ²»ç™‚Î±-GALACTOSIDASE A缺ä¹æ‚£è€…(å³FABRY DISEASE),æä¾›é•·æœŸé…µç´ è£œå……æ²»ç™‚ã€‚æ³¨å°„åŠ‘å°ç“¶;;ç›’è£;;ç›’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨AGALSIDASE ALFA科懋生物科技股份有é™å…¬å¸å°åŒ—市å—港å€åœ’å€è¡—3號14樓之623024594SHIRE HUMAN GENETIC THERAPIES, INC.400 SHIRE WAY LEXINGTON, MA 02421, USAUNITED STATES2014-05-13å°ç“¶;;ç›’è£;;ç›’è£;;ç›’è£REPLAGAL 1MG/ML CONCENTRATION FOR SOLUTION FOR INFUSION
罕èŒç–«è¼¸å—第000005號2019-04-262004-04-26èŒã€€ç–«DHA02200000508法布瑞酶å‡æ™¶æ³¨å°„劑35毫克/å°ç“¶ç”¨æ–¼æ²»Î±-GALACTOSIDASE A缺ä¹æ‚£è€…(å³FABRY DISEASE), æä¾›é•·æœŸé…µç´ è£œå……æ²»ç™‚ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨AGALSIDASE BETA賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356HOSPIRA INC.1776 NORTH CENTENNIAL DRIVE, MCPHERSON, KANSAS 67460, USAUNITED STATES2014-01-17å°ç“¶;;ç›’è£FABRAZYME INJECTION 35MG/VIAL
罕èŒç–«è¼¸å—第000005號2019-04-262004-04-26èŒã€€ç–«DHA02200000508法布瑞酶å‡æ™¶æ³¨å°„劑35毫克/å°ç“¶ç”¨æ–¼æ²»Î±-GALACTOSIDASE A缺ä¹æ‚£è€…(å³FABRY DISEASE), æä¾›é•·æœŸé…µç´ è£œå……æ²»ç™‚ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨AGALSIDASE BETA賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356Genzyme Corporation74 New York Avenue, Framingham, MA 01701, USAUNITED STATES2014-01-17å°ç“¶;;ç›’è£FABRAZYME INJECTION 35MG/VIAL
罕èŒç–«è¼¸å—第000005號2019-04-262004-04-26èŒã€€ç–«DHA02200000508法布瑞酶å‡æ™¶æ³¨å°„劑35毫克/å°ç“¶ç”¨æ–¼æ²»Î±-GALACTOSIDASE A缺ä¹æ‚£è€…(å³FABRY DISEASE), æä¾›é•·æœŸé…µç´ è£œå……æ²»ç™‚ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨AGALSIDASE BETA賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356Genzyme Corporation76 New York Avenue, Framingham, MA 01701, USAUNITED STATES2014-01-17å°ç“¶;;ç›’è£FABRAZYME INJECTION 35MG/VIAL
罕èŒç–«è¼¸å—第000005號2019-04-262004-04-26èŒã€€ç–«DHA02200000508法布瑞酶å‡æ™¶æ³¨å°„劑35毫克/å°ç“¶ç”¨æ–¼æ²»Î±-GALACTOSIDASE A缺ä¹æ‚£è€…(å³FABRY DISEASE), æä¾›é•·æœŸé…µç´ è£œå……æ²»ç™‚ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨AGALSIDASE BETA賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356Genzyme Corporation11 Forbes Road, Northborough, MA 01532, USAUNITED STATES2014-01-17å°ç“¶;;ç›’è£FABRAZYME INJECTION 35MG/VIAL
罕èŒç–«è¼¸å—第000006號2015-11-032005-11-03èŒã€€ç–«DHA02200000600é›ªç‘žç´ 200 UNITS第一型高雪æ°ç—‡ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨IMIGLUCERASE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356GENZYME CORPORATION, (ALLSTON LANDING GACILITY)500 SOLDIERS FIELD RD, ALLSTON, MA 02134, U.S.A.UNITED STATES2012-12-10å°ç“¶Cerezyme 200 UNITS60 U/KG/2 weekä¾ç—…情調整劑é‡
罕èŒç–«è¼¸å—第000007號2016-09-132006-09-13èŒã€€ç–«DHA02200000702艾德酶éœè„ˆæ³¨å°„用溶液用於治療患有é»å¤šé†£ç—‡ç¬¬ä¸€åž‹è³€å‹’æ°ç—‡èˆ‡è³€å‹’-施艾æ°ç—‡ä¹‹ç—…患以åŠä¸åº¦è‡³é‡åº¦ä¹‹æ–½è‰¾æ°ç—‡ç—…患。注射劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨LARONIDASE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356BIOMARIN PHARMACEUTICAL INC.46 GALLI DRIVE, NOVATO, CA 94949, USAUNITED STATES2014-03-10å°ç“¶Aldurazyme Concentrated SolutionALDURAZYME 的建è°èª¿é…劑é‡ç‚ºæ ¹æ“šé«”é‡0.58mg/kg æ¯é€±æŠ•äºˆä¸€æ¬¡ï¼Œä»¥éœè„ˆè¼¸å…¥é€²è¡Œã€‚輸注之總體ç©ç”±ç—…患之體é‡æ±ºå®šï¼Œè€Œä¸”應以約3至4å°æ™‚輸é€ã€‚é«”é‡20公斤或以下的病患應接å—總體ç©100mL,體é‡20公斤以上的病患應接å—總體ç©250ml。如果å¯ä»¥å¿å—,第一å°æ™‚之起輸注速率10mcg/kg/hrå¯ä»¥æ¯15分é˜é€æ¼¸å¢žåŠ ,直到é”到最大輸注速率為200mcg/kg/hr。剩餘之輸注å¯ä»¥ä»¥æ¤æœ€å¤§è¼¸æ³¨é€ŸçŽ‡æŒçºŒé€²è¡Œ(2-3å°æ™‚)。
罕èŒç–«è¼¸å—第000007號2016-09-132006-09-13èŒã€€ç–«DHA02200000702艾德酶éœè„ˆæ³¨å°„用溶液用於治療患有é»å¤šé†£ç—‡ç¬¬ä¸€åž‹è³€å‹’æ°ç—‡èˆ‡è³€å‹’-施艾æ°ç—‡ä¹‹ç—…患以åŠä¸åº¦è‡³é‡åº¦ä¹‹æ–½è‰¾æ°ç—‡ç—…患。注射劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨LARONIDASE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356Genzyme Corporation11 Forbes Road, Northborough, MA 01532, USAUNITED STATES2014-03-10å°ç“¶Aldurazyme Concentrated SolutionALDURAZYME 的建è°èª¿é…劑é‡ç‚ºæ ¹æ“šé«”é‡0.58mg/kg æ¯é€±æŠ•äºˆä¸€æ¬¡ï¼Œä»¥éœè„ˆè¼¸å…¥é€²è¡Œã€‚輸注之總體ç©ç”±ç—…患之體é‡æ±ºå®šï¼Œè€Œä¸”應以約3至4å°æ™‚輸é€ã€‚é«”é‡20公斤或以下的病患應接å—總體ç©100mL,體é‡20公斤以上的病患應接å—總體ç©250ml。如果å¯ä»¥å¿å—,第一å°æ™‚之起輸注速率10mcg/kg/hrå¯ä»¥æ¯15分é˜é€æ¼¸å¢žåŠ ,直到é”到最大輸注速率為200mcg/kg/hr。剩餘之輸注å¯ä»¥ä»¥æ¤æœ€å¤§è¼¸æ³¨é€ŸçŽ‡æŒçºŒé€²è¡Œ(2-3å°æ™‚)。
罕èŒç–«è¼¸å—第000007號2016-09-132006-09-13èŒã€€ç–«DHA02200000702艾德酶éœè„ˆæ³¨å°„用溶液用於治療患有é»å¤šé†£ç—‡ç¬¬ä¸€åž‹è³€å‹’æ°ç—‡èˆ‡è³€å‹’-施艾æ°ç—‡ä¹‹ç—…患以åŠä¸åº¦è‡³é‡åº¦ä¹‹æ–½è‰¾æ°ç—‡ç—…患。注射劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨LARONIDASE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356VETTER PHARMA-FERTIGUNG GMBH & CO. KGEISENBAHNSTRASSE 2-4, 88085 LANGENARGEN GERMANYGERMANY2014-03-10å°ç“¶Aldurazyme Concentrated SolutionALDURAZYME 的建è°èª¿é…劑é‡ç‚ºæ ¹æ“šé«”é‡0.58mg/kg æ¯é€±æŠ•äºˆä¸€æ¬¡ï¼Œä»¥éœè„ˆè¼¸å…¥é€²è¡Œã€‚輸注之總體ç©ç”±ç—…患之體é‡æ±ºå®šï¼Œè€Œä¸”應以約3至4å°æ™‚輸é€ã€‚é«”é‡20公斤或以下的病患應接å—總體ç©100mL,體é‡20公斤以上的病患應接å—總體ç©250ml。如果å¯ä»¥å¿å—,第一å°æ™‚之起輸注速率10mcg/kg/hrå¯ä»¥æ¯15分é˜é€æ¼¸å¢žåŠ ,直到é”到最大輸注速率為200mcg/kg/hr。剩餘之輸注å¯ä»¥ä»¥æ¤æœ€å¤§è¼¸æ³¨é€ŸçŽ‡æŒçºŒé€²è¡Œ(2-3å°æ™‚)。
衛部èŒç–«è¼¸å—第000959號2019-08-122014-08-12èŒã€€ç–«DHA06000095909"愛瑞"人類血清白蛋白20%注射液低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射液劑玻璃å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN ALBUMINå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING AGWANKDORFSTRASSE 10, 3014 BERN, SWITZERLANDSWITZERLAND2014-11-12玻璃å°ç“¶è£AlbuRx TM 20詳見仿單
罕èŒç–«è¼¸å—第000008號2016-09-132006-09-13èŒã€€ç–«DHA02200000801艾德酶éœè„ˆæ³¨å°„劑用於治療患有é»å¤šé†£ç—‡ç¬¬ä¸€åž‹è³€å‹’æ°ç—‡èˆ‡è³€å‹’-施艾æ°ç—‡ä¹‹ç—…患以åŠä¸åº¦è‡³é‡åº¦ä¹‹æ–½è‰¾æ°ç—‡ç—…患。注射劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨LARONIDASE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356GENZYME CORPORATION500 KENDALL STREET, CAMBRIDGE, MA 02142, U.S.A.UNITED STATES2014-03-10å°ç“¶Aldurazyme Concentrated SolutionALDURAZYME 的建è°èª¿é…劑é‡ç‚ºæ ¹æ“šé«”é‡0.58mg/kg æ¯é€±æŠ•äºˆä¸€æ¬¡ï¼Œä»¥éœè„ˆè¼¸å…¥é€²è¡Œã€‚輸注之總體ç©ç”±ç—…患之體é‡æ±ºå®šï¼Œè€Œä¸”應以約3至4å°æ™‚輸é€ã€‚é«”é‡20公斤或以下的病患應接å—總體ç©100mL,體é‡20公斤以上的病患應接å—總體ç©250ml。如果å¯ä»¥å¿å—,第一å°æ™‚之起輸注速率10mcg/kg/hrå¯ä»¥æ¯15分é˜é€æ¼¸å¢žåŠ ,直到é”到最大輸注速率為200mcg/kg/hr。剩餘之輸注å¯ä»¥ä»¥æ¤æœ€å¤§è¼¸æ³¨é€ŸçŽ‡æŒçºŒé€²è¡Œ(2-3å°æ™‚)。
罕èŒç–«è¼¸å—第000008號2016-09-132006-09-13èŒã€€ç–«DHA02200000801艾德酶éœè„ˆæ³¨å°„劑用於治療患有é»å¤šé†£ç—‡ç¬¬ä¸€åž‹è³€å‹’æ°ç—‡èˆ‡è³€å‹’-施艾æ°ç—‡ä¹‹ç—…患以åŠä¸åº¦è‡³é‡åº¦ä¹‹æ–½è‰¾æ°ç—‡ç—…患。注射劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨LARONIDASE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356BIOMARIN PHARMACEUTICAL INC.46 GALLI DRIVE, NOVATO, CA 94949, USAUNITED STATES2014-03-10å°ç“¶Aldurazyme Concentrated SolutionALDURAZYME 的建è°èª¿é…劑é‡ç‚ºæ ¹æ“šé«”é‡0.58mg/kg æ¯é€±æŠ•äºˆä¸€æ¬¡ï¼Œä»¥éœè„ˆè¼¸å…¥é€²è¡Œã€‚輸注之總體ç©ç”±ç—…患之體é‡æ±ºå®šï¼Œè€Œä¸”應以約3至4å°æ™‚輸é€ã€‚é«”é‡20公斤或以下的病患應接å—總體ç©100mL,體é‡20公斤以上的病患應接å—總體ç©250ml。如果å¯ä»¥å¿å—,第一å°æ™‚之起輸注速率10mcg/kg/hrå¯ä»¥æ¯15分é˜é€æ¼¸å¢žåŠ ,直到é”到最大輸注速率為200mcg/kg/hr。剩餘之輸注å¯ä»¥ä»¥æ¤æœ€å¤§è¼¸æ³¨é€ŸçŽ‡æŒçºŒé€²è¡Œ(2-3å°æ™‚)。
罕èŒç–«è¼¸å—第000008號2016-09-132006-09-13èŒã€€ç–«DHA02200000801艾德酶éœè„ˆæ³¨å°„劑用於治療患有é»å¤šé†£ç—‡ç¬¬ä¸€åž‹è³€å‹’æ°ç—‡èˆ‡è³€å‹’-施艾æ°ç—‡ä¹‹ç—…患以åŠä¸åº¦è‡³é‡åº¦ä¹‹æ–½è‰¾æ°ç—‡ç—…患。注射劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨LARONIDASE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356Jubilant HollisterStier LLC3525 NORTH REGAL STREET SPOKANE, WA 99207, USAUNITED STATES2014-03-10å°ç“¶Aldurazyme Concentrated SolutionALDURAZYME 的建è°èª¿é…劑é‡ç‚ºæ ¹æ“šé«”é‡0.58mg/kg æ¯é€±æŠ•äºˆä¸€æ¬¡ï¼Œä»¥éœè„ˆè¼¸å…¥é€²è¡Œã€‚輸注之總體ç©ç”±ç—…患之體é‡æ±ºå®šï¼Œè€Œä¸”應以約3至4å°æ™‚輸é€ã€‚é«”é‡20公斤或以下的病患應接å—總體ç©100mL,體é‡20公斤以上的病患應接å—總體ç©250ml。如果å¯ä»¥å¿å—,第一å°æ™‚之起輸注速率10mcg/kg/hrå¯ä»¥æ¯15分é˜é€æ¼¸å¢žåŠ ,直到é”到最大輸注速率為200mcg/kg/hr。剩餘之輸注å¯ä»¥ä»¥æ¤æœ€å¤§è¼¸æ³¨é€ŸçŽ‡æŒçºŒé€²è¡Œ(2-3å°æ™‚)。
罕èŒç–«è¼¸å—第000008號2016-09-132006-09-13èŒã€€ç–«DHA02200000801艾德酶éœè„ˆæ³¨å°„劑用於治療患有é»å¤šé†£ç—‡ç¬¬ä¸€åž‹è³€å‹’æ°ç—‡èˆ‡è³€å‹’-施艾æ°ç—‡ä¹‹ç—…患以åŠä¸åº¦è‡³é‡åº¦ä¹‹æ–½è‰¾æ°ç—‡ç—…患。注射劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨LARONIDASE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356Genzyme Corporation11 Forbes Road, Northborough, MA 01532, USAUNITED STATES2014-03-10å°ç“¶Aldurazyme Concentrated SolutionALDURAZYME 的建è°èª¿é…劑é‡ç‚ºæ ¹æ“šé«”é‡0.58mg/kg æ¯é€±æŠ•äºˆä¸€æ¬¡ï¼Œä»¥éœè„ˆè¼¸å…¥é€²è¡Œã€‚輸注之總體ç©ç”±ç—…患之體é‡æ±ºå®šï¼Œè€Œä¸”應以約3至4å°æ™‚輸é€ã€‚é«”é‡20公斤或以下的病患應接å—總體ç©100mL,體é‡20公斤以上的病患應接å—總體ç©250ml。如果å¯ä»¥å¿å—,第一å°æ™‚之起輸注速率10mcg/kg/hrå¯ä»¥æ¯15分é˜é€æ¼¸å¢žåŠ ,直到é”到最大輸注速率為200mcg/kg/hr。剩餘之輸注å¯ä»¥ä»¥æ¤æœ€å¤§è¼¸æ³¨é€ŸçŽ‡æŒçºŒé€²è¡Œ(2-3å°æ™‚)。
罕èŒç–«è¼¸å—第000009號2018-03-172008-03-17èŒã€€ç–«DHA02200000903æ®·å…‹é›·æ–¯ 注射劑é©ç”¨æ–¼é•·æœŸæ²»ç™‚é‡åº¦åŽŸç™¼æ€§é¡žèƒ°å³¶ç´ ç”Ÿé•·å› å第1型缺陷 (原發性IGFD) 的生長é²ç·©ï¼Œæˆ–æ˜¯å› ç‚ºç”Ÿé•·æ¿€ç´ åŸºå› ç¼ºå¤±è€Œå°ç”Ÿé•·æ¿€ç´ 產生ä¸å’Œæ€§æŠ—體的å©ç«¥ã€‚注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨MECASERMINå‰å¸è—¥å“股份有é™å…¬å¸å°ä¸å¸‚北屯å€ç¶é 路二段216之5號6樓16647167HOSPIRA INC.1776 NORTH CENTENNIAL DRIVE, MCPHERSON, KANSAS 67460, USAUNITED STATES2013-07-25å°ç“¶è£Increlex Injection建è°èµ·å§‹åŠ‘é‡ç‚º0.04到0.08毫克/公斤 (40到80 微公克/公斤) 一天兩次皮下注射。若è€å—良好至少一週以上,æ¯æ¬¡åŠ‘é‡å¯å¢žåŠ 0.04毫克/公斤,最大劑é‡ç‚ºä¸€å¤©å…©æ¬¡0.12毫克/公斤。
罕èŒç–«è¼¸å—第000009號2018-03-172008-03-17èŒã€€ç–«DHA02200000903æ®·å…‹é›·æ–¯ 注射劑é©ç”¨æ–¼é•·æœŸæ²»ç™‚é‡åº¦åŽŸç™¼æ€§é¡žèƒ°å³¶ç´ ç”Ÿé•·å› å第1型缺陷 (原發性IGFD) 的生長é²ç·©ï¼Œæˆ–æ˜¯å› ç‚ºç”Ÿé•·æ¿€ç´ åŸºå› ç¼ºå¤±è€Œå°ç”Ÿé•·æ¿€ç´ 產生ä¸å’Œæ€§æŠ—體的å©ç«¥ã€‚注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨MECASERMINå‰å¸è—¥å“股份有é™å…¬å¸å°ä¸å¸‚北屯å€ç¶é 路二段216之5號6樓16647167LONZA BALTIMORE, INC.5901 EAST LOMBARD STREET, BALTIMORE, MD 21224, USAUNITED STATES2013-07-25å°ç“¶è£Increlex Injection建è°èµ·å§‹åŠ‘é‡ç‚º0.04到0.08毫克/公斤 (40到80 微公克/公斤) 一天兩次皮下注射。若è€å—良好至少一週以上,æ¯æ¬¡åŠ‘é‡å¯å¢žåŠ 0.04毫克/公斤,最大劑é‡ç‚ºä¸€å¤©å…©æ¬¡0.12毫克/公斤。
罕èŒç–«è¼¸å—第000009號2018-03-172008-03-17èŒã€€ç–«DHA02200000903æ®·å…‹é›·æ–¯ 注射劑é©ç”¨æ–¼é•·æœŸæ²»ç™‚é‡åº¦åŽŸç™¼æ€§é¡žèƒ°å³¶ç´ ç”Ÿé•·å› å第1型缺陷 (原發性IGFD) 的生長é²ç·©ï¼Œæˆ–æ˜¯å› ç‚ºç”Ÿé•·æ¿€ç´ åŸºå› ç¼ºå¤±è€Œå°ç”Ÿé•·æ¿€ç´ 產生ä¸å’Œæ€§æŠ—體的å©ç«¥ã€‚注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨MECASERMINå‰å¸è—¥å“股份有é™å…¬å¸å°ä¸å¸‚北屯å€ç¶é 路二段216之5號6樓16647167IPSEN BIOPHARMACEUTICALS, INC.106 Allen Road, Basking Ridge, NJ 07920 USA.UNITED STATES2013-07-25å°ç“¶è£Increlex Injection建è°èµ·å§‹åŠ‘é‡ç‚º0.04到0.08毫克/公斤 (40到80 微公克/公斤) 一天兩次皮下注射。若è€å—良好至少一週以上,æ¯æ¬¡åŠ‘é‡å¯å¢žåŠ 0.04毫克/公斤,最大劑é‡ç‚ºä¸€å¤©å…©æ¬¡0.12毫克/公斤。
罕èŒç–«è¼¸å—第000010號2021-05-272011-05-27èŒã€€ç–«DHA02200001001血基賞濃縮輸注液 25 毫克/毫å‡æ²»ç™‚è‚臟型紫質症(急性間æ‡æ€§ç´«è³ªç—‡ã€ç•°ä½åž‹ç´«è³ªç—‡ã€éºå‚³æ€§ç´«è³ªç—‡)之急性發作。注射劑安瓿;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Human Hemin科懋生物科技股份有é™å…¬å¸å°åŒ—市å—港å€åœ’å€è¡—3號14樓之623024594ORPHAN EUROPEImmeuble Le Wilson, 70 avenue du General de Gaulle, F-92800, Puteaux, FranceFRANCE2013-02-19安瓿;;ç›’è£Normosang 25 mg/mL Concentrate for Solution for Infusion如仿單。
罕èŒç–«è¼¸å—第000010號2021-05-272011-05-27èŒã€€ç–«DHA02200001001血基賞濃縮輸注液 25 毫克/毫å‡æ²»ç™‚è‚臟型紫質症(急性間æ‡æ€§ç´«è³ªç—‡ã€ç•°ä½åž‹ç´«è³ªç—‡ã€éºå‚³æ€§ç´«è³ªç—‡)之急性發作。注射劑安瓿;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Human Hemin科懋生物科技股份有é™å…¬å¸å°åŒ—市å—港å€åœ’å€è¡—3號14樓之623024594EVER PHARMA JENA GMBHD-07745 JENA OTTO SCHOTT-STRASSE 15, GERMANYGERMANY2013-02-19安瓿;;ç›’è£Normosang 25 mg/mL Concentrate for Solution for Infusion如仿單。
罕èŒç–«è¼¸å—第000011號2022-08-092012-08-09èŒã€€ç–«DHA02200001103移é»å¯¶é…¶éœè„ˆè¼¸æ¶²æ²»ç™‚韓特æ°ç—‡(é»å¤šé†£ç—‡ç¬¬äºŒåž‹ï¼ŒMPS II)。注射劑玻璃å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨IDURSULFASE;;IDURSULFASE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356GENZYME CORPORATION500 KENDALL ST., CAMBRIDGE, MASSACHUSETTS, 02142, USAUNITED STATES2014-03-10玻璃å°ç“¶è£ELAPRASE (idursulfase) Injectioné»å¤šå¯¶酶的建è°åŠ‘é‡ç‚ºæ¯é€±éœè„ˆè¼¸æ³¨æ¯å…¬æ–¤é«”é‡0.5毫克。(詳見仿單)
罕èŒç–«è¼¸å—第000011號2022-08-092012-08-09èŒã€€ç–«DHA02200001103移é»å¯¶é…¶éœè„ˆè¼¸æ¶²æ²»ç™‚韓特æ°ç—‡(é»å¤šé†£ç—‡ç¬¬äºŒåž‹ï¼ŒMPS II)。注射劑玻璃å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨IDURSULFASE;;IDURSULFASE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356Cangene BioPharma Inc. (CBI)1111 SOUTH PACA STREET, BALTIMORE, MARYLAND 21230-2591, USAUNITED STATES2014-03-10玻璃å°ç“¶è£ELAPRASE (idursulfase) Injectioné»å¤šå¯¶酶的建è°åŠ‘é‡ç‚ºæ¯é€±éœè„ˆè¼¸æ³¨æ¯å…¬æ–¤é«”é‡0.5毫克。(詳見仿單)
罕èŒç–«è¼¸å—第000011號2022-08-092012-08-09èŒã€€ç–«DHA02200001103移é»å¯¶é…¶éœè„ˆè¼¸æ¶²æ²»ç™‚韓特æ°ç—‡(é»å¤šé†£ç—‡ç¬¬äºŒåž‹ï¼ŒMPS II)。注射劑玻璃å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨IDURSULFASE;;IDURSULFASE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SHIRE HUMAN GENETIC THERAPIES, Inc.205 ALEWIFE BROOK PARKWAY, CAMBRIDGE, MA 02138, USAUNITED STATES2014-03-10玻璃å°ç“¶è£ELAPRASE (idursulfase) Injectioné»å¤šå¯¶酶的建è°åŠ‘é‡ç‚ºæ¯é€±éœè„ˆè¼¸æ³¨æ¯å…¬æ–¤é«”é‡0.5毫克。(詳見仿單)
罕èŒç–«è¼¸å—第000011號2022-08-092012-08-09èŒã€€ç–«DHA02200001103移é»å¯¶é…¶éœè„ˆè¼¸æ¶²æ²»ç™‚韓特æ°ç—‡(é»å¤šé†£ç—‡ç¬¬äºŒåž‹ï¼ŒMPS II)。注射劑玻璃å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨IDURSULFASE;;IDURSULFASE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356Genzyme Corporation11 Forbes Road, Northborough, MA 01532, USAUNITED STATES2014-03-10玻璃å°ç“¶è£ELAPRASE (idursulfase) Injectioné»å¤šå¯¶酶的建è°åŠ‘é‡ç‚ºæ¯é€±éœè„ˆè¼¸æ³¨æ¯å…¬æ–¤é«”é‡0.5毫克。(詳見仿單)
罕èŒç–«è¼¸å—第000012號2022-08-202012-08-20èŒã€€ç–«DHA02200001205立比扶注射劑 66 mcg復發型多發性硬化症注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨INTERFERON BETA-1A臺ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-03-10ç›’è£Rebif solution for injection 66 micrograms詳如仿單
罕èŒç–«è¼¸å—第000012號2022-08-202012-08-20èŒã€€ç–«DHA02200001205立比扶注射劑 66 mcg復發型多發性硬化症注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨INTERFERON BETA-1A臺ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.A.-CORSIER-SUR-VEVEYROUTE DE FENIL, 25 ZONE INDUSTRIELLE B, 1804 CORSIER-SUR-VEVEY, SWITZERLANDSWITZERLAND2014-03-10ç›’è£Rebif solution for injection 66 micrograms詳如仿單
罕èŒç–«è¼¸å—第000013號2022-08-202012-08-20èŒã€€ç–«DHA02200001307立比扶注射劑 132 mcg復發型多發性硬化症注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨INTERFERON BETA-1A臺ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-03-10ç›’è£Rebif solution for injection 132 micrograms請詳見仿單
罕èŒç–«è¼¸å—第000013號2022-08-202012-08-20èŒã€€ç–«DHA02200001307立比扶注射劑 132 mcg復發型多發性硬化症注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨INTERFERON BETA-1A臺ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.A.-CORSIER-SUR-VEVEYROUTE DE FENIL, 25 ZONE INDUSTRIELLE B, 1804 CORSIER-SUR-VEVEY, SWITZERLANDSWITZERLAND2014-03-10ç›’è£Rebif solution for injection 132 micrograms請詳見仿單
罕èŒç–«è¼¸å—第000014號2022-08-272012-08-27èŒã€€ç–«DHA02200001409æ³°å‰åˆ©æ¿ƒç¸®éœè„ˆè¼¸æ³¨æ¶² 300 毫克單一藥物治療å覆發作型多發性硬化症,其病患群為下列18æ²ä»¥ä¸Šä¹‹æˆäººæ‚£è€…:(1)已使用β-interferon治療,但是無法有效控制病情的å覆發作型多發性硬化症病患或(2)病情急速惡化的å覆發作型多發性硬化症患者。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨Natalizumabè¯å®‡è—¥å“股份有é™å…¬å¸å°åŒ—市ä¸å±±åŒ—路二段115å··43號8樓70680851BIOGEN IDEC DENMARK MANUFACTURING APSBIOGEN IDEC ALLE 1, DK-3400 HILLEROD, DENMARKDENMARK2014-03-10å°ç“¶Tysabri concentrate for solution for infusion 300mg(詳見仿單)
罕èŒç–«è¼¸å—第000014號2022-08-272012-08-27èŒã€€ç–«DHA02200001409æ³°å‰åˆ©æ¿ƒç¸®éœè„ˆè¼¸æ³¨æ¶² 300 毫克單一藥物治療å覆發作型多發性硬化症,其病患群為下列18æ²ä»¥ä¸Šä¹‹æˆäººæ‚£è€…:(1)已使用β-interferon治療,但是無法有效控制病情的å覆發作型多發性硬化症病患或(2)病情急速惡化的å覆發作型多發性硬化症患者。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨Natalizumabè¯å®‡è—¥å“股份有é™å…¬å¸å°åŒ—市ä¸å±±åŒ—路二段115å··43號8樓70680851BIOGEN IDEC INTERNATIONAL GMBHLANDIS & GYR STRASSE 3 6300 ZUG - SWITZERLANDSWITZERLAND2014-03-10å°ç“¶Tysabri concentrate for solution for infusion 300mg(詳見仿單)
罕èŒç–«è¼¸å—第000014號2022-08-272012-08-27èŒã€€ç–«DHA02200001409æ³°å‰åˆ©æ¿ƒç¸®éœè„ˆè¼¸æ³¨æ¶² 300 毫克單一藥物治療å覆發作型多發性硬化症,其病患群為下列18æ²ä»¥ä¸Šä¹‹æˆäººæ‚£è€…:(1)已使用β-interferon治療,但是無法有效控制病情的å覆發作型多發性硬化症病患或(2)病情急速惡化的å覆發作型多發性硬化症患者。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨Natalizumabè¯å®‡è—¥å“股份有é™å…¬å¸å°åŒ—市ä¸å±±åŒ—路二段115å··43號8樓70680851BIOGEN IDEC U.S. LIMITED PARTNERSHIP5000 DAVIS DRIVE, RESEARCH TRIANGLE PARK, NORTH CAROLINA 27709, USAUNITED STATES2014-03-10å°ç“¶Tysabri concentrate for solution for infusion 300mg(詳見仿單)
罕èŒç–«è¼¸å—第000014號2022-08-272012-08-27èŒã€€ç–«DHA02200001409æ³°å‰åˆ©æ¿ƒç¸®éœè„ˆè¼¸æ³¨æ¶² 300 毫克單一藥物治療å覆發作型多發性硬化症,其病患群為下列18æ²ä»¥ä¸Šä¹‹æˆäººæ‚£è€…:(1)已使用β-interferon治療,但是無法有效控制病情的å覆發作型多發性硬化症病患或(2)病情急速惡化的å覆發作型多發性硬化症患者。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨Natalizumabè¯å®‡è—¥å“股份有é™å…¬å¸å°åŒ—市ä¸å±±åŒ—路二段115å··43號8樓70680851VETTER PHARMA-FERTIGUNG GMBH & CO KGMOOSWIESEN 2, 88214 RAVENSBURG, GERMANYGERMANY2014-03-10å°ç“¶Tysabri concentrate for solution for infusion 300mg(詳見仿單)
衛部èŒç–«è£½å—第000136號2019-07-152014-07-15èŒã€€ç–«DHY05900013606"安定ä¼"ä½åŠ‘åž‹æµæ„Ÿç–«è‹—(仿病毒體)é 防æµæ„Ÿæ³¨å°„液劑SYRINGEè£;;瓶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/Strain H1N1;;A/Strain H3N2;;B/STRAIN國光生物科技股份有é™å…¬å¸å°ä¸å¸‚æ½åå€æ½èˆˆè·¯ä¸€æ®µä¸‰è™Ÿ33259508國光生物科技股份有é™å…¬å¸å°ä¸å¸‚æ½åå€æ½èˆˆè·¯ä¸€æ®µä¸‰è™ŸTAIWAN2014-11-12SYRINGEè£;;瓶è£AdimFlu-V詳如仿單
衛部èŒç–«è¼¸å—第000945號2018-08-052013-08-05èŒã€€ç–«DHA06000094501æ©ç‘žèˆ’é‡ç’è£çš®ä¸‹æ³¨å°„劑125毫克æˆäººé¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žï¼šOrencia與methotrexate併用,用於治療罹患有ä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æº¼æ€§é—œç¯€ç‚Žä¸”å°å…¶ä»–疾病修飾抗風濕病藥物[包括methotrexate(MTX)或一種腫瘤壞æ»å› å(TNF)抑制劑]å應ä¸è‰¯æˆ–è€å—性ä¸ä½³çš„æˆäººæ‚£è€…。é‡è¦ç”¨è—¥é™åˆ¶ï¼šOrenciaä¸å¯èˆ‡å…¶ä»–治療類風濕性關節炎(RA)的生物製劑å«è‡³è…«ç˜¤å£žæ»å› å(TNF)抑制劑åŒæ™‚使用。ä¾ç›®å‰è‡¨åºŠè³‡æ–™ä¸å»ºè°è‚炎或其帶原者使用本藥å“。注射劑盒è£;;é 充填注射é‡ç’è£å«å®‰å…¨è·å¥— é™ç”±é†«å¸«ä½¿ç”¨ABATACEPT臺ç£å¿…治妥施貴寶股份有é™å…¬å¸å°åŒ—市æ¾å±±å€å¥åº·è·¯156號4樓ã€5樓11922609LONZA BIOLOGICS, INC.101 INTERNATIONAL DRIVE PEASE INTERNATIONAL TRADEPORT PORTSMOUTH, NEW HAMPSHIRE, U.S. 03801UNITED STATES2014-12-09ç›’è£;;é 充填注射é‡ç’è£å«å®‰å…¨è·å¥— Orencia (abatacept) Injection for subcutaneous use 125mg per syringe(125mg/ml)詳如仿單所列。
衛部èŒç–«è¼¸å—第000946號2018-09-042013-09-04èŒã€€ç–«DHA06000094600克癌平 å‡æ™¶æ³¨å°„劑440毫克Herclon應使用於下列HER2éŽåº¦è¡¨ç¾æˆ–HER2åŸºå› amplification之早期乳癌ã€è½‰ç§»æ€§ä¹³ç™Œæ‚£è€…說明:1.早期乳癌(EBC):(1)經外科手術ã€åŒ–å¸ç™‚法(è¡“å‰æˆ–術後)之輔助療法。(2)以doxorubicin與cyclophosphamide治療,å†åˆä½µpactlitaxel或docetaxel之輔助療法。(3)與docetaxelåŠcarboplatin併用之輔助療法。(4)è¡“å‰èˆ‡åŒ–å¸ç™‚法併用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2 厘米)2.轉移性乳癌(MBC):(1)å–®ç¨ä½¿ç”¨æ–¼æ›¾æŽ¥å—éŽä¸€æ¬¡(å«)以上化å¸ç™‚法之轉移性乳癌;除éžæ‚£è€…ä¸é©åˆä½¿ç”¨anthracyclin或taxane,å¦å‰‡å…ˆå‰ä¹‹åŒ–å¸æ²»ç™‚應至少包括anthracyclin或taxane。使用於è·çˆ¾è’™ç™‚法失敗之è·çˆ¾è’™å—體陽性之患者,除éžæ‚£è€…ä¸é©ç”¨è·çˆ¾è’™ç™‚法。(2)與pactlitaxel或docetaxel併用於未曾接å—éŽåŒ–å¸ç™‚法之轉移性乳癌。(3)與芳香環酶抑制劑併用於è·çˆ¾è’™å—體陽性之轉移性乳癌。3.轉移性胃癌(MGC):Herclonåˆä½µcapecitabine(或5-f1uorouracil)åŠcisplatiné©ç”¨æ–¼æœªæ›¾æŽ¥å—éŽåŒ–å¸æ²»ç™‚之HER2éŽåº¦è¡¨ç¾è½‰ç§»æ€§èƒƒè…ºç™Œ(或胃食é“接åˆè™•è…ºç™Œ)的治療。å‡æ™¶æ³¨å°„劑盒è£é™ç”±é†«å¸«ä½¿ç”¨TRASTUZUMABå°ç£ç¾…æ°é†«ç™‚診斷è¨å‚™è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸å±±å€æ°‘權æ±è·¯3段2號10樓23932173GENENTECH INC.1 DNA WAY SOUTH SAN FRANCISCO CA 94080-4990, U.S.A.UNITED STATES2014-03-10ç›’è£Herclon 440mg請見仿單
衛部èŒç–«è¼¸å—第000945號2018-08-052013-08-05èŒã€€ç–«DHA06000094501æ©ç‘žèˆ’é‡ç’è£çš®ä¸‹æ³¨å°„劑125毫克æˆäººé¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žï¼šOrencia與methotrexate併用,用於治療罹患有ä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æº¼æ€§é—œç¯€ç‚Žä¸”å°å…¶ä»–疾病修飾抗風濕病藥物[包括methotrexate(MTX)或一種腫瘤壞æ»å› å(TNF)抑制劑]å應ä¸è‰¯æˆ–è€å—性ä¸ä½³çš„æˆäººæ‚£è€…。é‡è¦ç”¨è—¥é™åˆ¶ï¼šOrenciaä¸å¯èˆ‡å…¶ä»–治療類風濕性關節炎(RA)的生物製劑å«è‡³è…«ç˜¤å£žæ»å› å(TNF)抑制劑åŒæ™‚使用。ä¾ç›®å‰è‡¨åºŠè³‡æ–™ä¸å»ºè°è‚炎或其帶原者使用本藥å“。注射劑盒è£;;é 充填注射é‡ç’è£å«å®‰å…¨è·å¥— é™ç”±é†«å¸«ä½¿ç”¨ABATACEPT臺ç£å¿…治妥施貴寶股份有é™å…¬å¸å°åŒ—市æ¾å±±å€å¥åº·è·¯156號4樓ã€5樓11922609BRISTOL-MYERS SQUIBB HOLDINGS PHARMA, LTD., LIABILITY COMPANYBO TIERRAS NUEVAS, ROUTE 686, KM. 2.3, MANATI, PUERTO RICO 00674, USAUNITED STATES2014-12-09ç›’è£;;é 充填注射é‡ç’è£å«å®‰å…¨è·å¥— Orencia (abatacept) Injection for subcutaneous use 125mg per syringe(125mg/ml)詳如仿單所列。
衛部èŒç–«è¼¸å—第000945號2018-08-052013-08-05èŒã€€ç–«DHA06000094501æ©ç‘žèˆ’é‡ç’è£çš®ä¸‹æ³¨å°„劑125毫克æˆäººé¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žï¼šOrencia與methotrexate併用,用於治療罹患有ä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æº¼æ€§é—œç¯€ç‚Žä¸”å°å…¶ä»–疾病修飾抗風濕病藥物[包括methotrexate(MTX)或一種腫瘤壞æ»å› å(TNF)抑制劑]å應ä¸è‰¯æˆ–è€å—性ä¸ä½³çš„æˆäººæ‚£è€…。é‡è¦ç”¨è—¥é™åˆ¶ï¼šOrenciaä¸å¯èˆ‡å…¶ä»–治療類風濕性關節炎(RA)的生物製劑å«è‡³è…«ç˜¤å£žæ»å› å(TNF)抑制劑åŒæ™‚使用。ä¾ç›®å‰è‡¨åºŠè³‡æ–™ä¸å»ºè°è‚炎或其帶原者使用本藥å“。注射劑盒è£;;é 充填注射é‡ç’è£å«å®‰å…¨è·å¥— é™ç”±é†«å¸«ä½¿ç”¨ABATACEPT臺ç£å¿…治妥施貴寶股份有é™å…¬å¸å°åŒ—市æ¾å±±å€å¥åº·è·¯156號4樓ã€5樓11922609BRISTOL-MYERS SQUIBB COMPANY8 JACKSON ROAD, DEVENS,MASSACHUSETTS 01434 ,USAUNITED STATES2014-12-09ç›’è£;;é 充填注射é‡ç’è£å«å®‰å…¨è·å¥— Orencia (abatacept) Injection for subcutaneous use 125mg per syringe(125mg/ml)詳如仿單所列。
衛部èŒç–«è¼¸å—第000946號2018-09-042013-09-04èŒã€€ç–«DHA06000094600克癌平 å‡æ™¶æ³¨å°„劑440毫克Herclon應使用於下列HER2éŽåº¦è¡¨ç¾æˆ–HER2åŸºå› amplification之早期乳癌ã€è½‰ç§»æ€§ä¹³ç™Œæ‚£è€…說明:1.早期乳癌(EBC):(1)經外科手術ã€åŒ–å¸ç™‚法(è¡“å‰æˆ–術後)之輔助療法。(2)以doxorubicin與cyclophosphamide治療,å†åˆä½µpactlitaxel或docetaxel之輔助療法。(3)與docetaxelåŠcarboplatin併用之輔助療法。(4)è¡“å‰èˆ‡åŒ–å¸ç™‚法併用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2 厘米)2.轉移性乳癌(MBC):(1)å–®ç¨ä½¿ç”¨æ–¼æ›¾æŽ¥å—éŽä¸€æ¬¡(å«)以上化å¸ç™‚法之轉移性乳癌;除éžæ‚£è€…ä¸é©åˆä½¿ç”¨anthracyclin或taxane,å¦å‰‡å…ˆå‰ä¹‹åŒ–å¸æ²»ç™‚應至少包括anthracyclin或taxane。使用於è·çˆ¾è’™ç™‚法失敗之è·çˆ¾è’™å—體陽性之患者,除éžæ‚£è€…ä¸é©ç”¨è·çˆ¾è’™ç™‚法。(2)與pactlitaxel或docetaxel併用於未曾接å—éŽåŒ–å¸ç™‚法之轉移性乳癌。(3)與芳香環酶抑制劑併用於è·çˆ¾è’™å—體陽性之轉移性乳癌。3.轉移性胃癌(MGC):Herclonåˆä½µcapecitabine(或5-f1uorouracil)åŠcisplatiné©ç”¨æ–¼æœªæ›¾æŽ¥å—éŽåŒ–å¸æ²»ç™‚之HER2éŽåº¦è¡¨ç¾è½‰ç§»æ€§èƒƒè…ºç™Œ(或胃食é“接åˆè™•è…ºç™Œ)的治療。å‡æ™¶æ³¨å°„劑盒è£é™ç”±é†«å¸«ä½¿ç”¨TRASTUZUMABå°ç£ç¾…æ°é†«ç™‚診斷è¨å‚™è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸å±±å€æ°‘權æ±è·¯3段2號10樓23932173F.HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303 KAISERAUGST, SWITZERLANDSWITZERLAND2014-03-10ç›’è£Herclon 440mg請見仿單
衛部èŒç–«è¼¸å—第000946號2018-09-042013-09-04èŒã€€ç–«DHA06000094600克癌平 å‡æ™¶æ³¨å°„劑440毫克Herclon應使用於下列HER2éŽåº¦è¡¨ç¾æˆ–HER2åŸºå› amplification之早期乳癌ã€è½‰ç§»æ€§ä¹³ç™Œæ‚£è€…說明:1.早期乳癌(EBC):(1)經外科手術ã€åŒ–å¸ç™‚法(è¡“å‰æˆ–術後)之輔助療法。(2)以doxorubicin與cyclophosphamide治療,å†åˆä½µpactlitaxel或docetaxel之輔助療法。(3)與docetaxelåŠcarboplatin併用之輔助療法。(4)è¡“å‰èˆ‡åŒ–å¸ç™‚法併用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2 厘米)2.轉移性乳癌(MBC):(1)å–®ç¨ä½¿ç”¨æ–¼æ›¾æŽ¥å—éŽä¸€æ¬¡(å«)以上化å¸ç™‚法之轉移性乳癌;除éžæ‚£è€…ä¸é©åˆä½¿ç”¨anthracyclin或taxane,å¦å‰‡å…ˆå‰ä¹‹åŒ–å¸æ²»ç™‚應至少包括anthracyclin或taxane。使用於è·çˆ¾è’™ç™‚法失敗之è·çˆ¾è’™å—體陽性之患者,除éžæ‚£è€…ä¸é©ç”¨è·çˆ¾è’™ç™‚法。(2)與pactlitaxel或docetaxel併用於未曾接å—éŽåŒ–å¸ç™‚法之轉移性乳癌。(3)與芳香環酶抑制劑併用於è·çˆ¾è’™å—體陽性之轉移性乳癌。3.轉移性胃癌(MGC):Herclonåˆä½µcapecitabine(或5-f1uorouracil)åŠcisplatiné©ç”¨æ–¼æœªæ›¾æŽ¥å—éŽåŒ–å¸æ²»ç™‚之HER2éŽåº¦è¡¨ç¾è½‰ç§»æ€§èƒƒè…ºç™Œ(或胃食é“接åˆè™•è…ºç™Œ)的治療。å‡æ™¶æ³¨å°„劑盒è£é™ç”±é†«å¸«ä½¿ç”¨TRASTUZUMABå°ç£ç¾…æ°é†«ç™‚診斷è¨å‚™è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸å±±å€æ°‘權æ±è·¯3段2號10樓23932173GENENTECH, INC.1000 NEW HORIZONS WAY, VACAVILLE, CA 95688, USAUNITED STATES2014-03-10ç›’è£Herclon 440mg請見仿單
衛部èŒç–«è¼¸å—第000947號2018-10-212013-10-21èŒã€€ç–«DHA06000094702克癌平 å‡æ™¶æ³¨å°„劑150毫克Herclon應使用於下列HER2éŽåº¦è¡¨ç¾æˆ–HER2åŸºå› amplification之早期乳癌ã€è½‰ç§»æ€§ä¹³ç™Œæ‚£è€…說明:1.早期乳癌(EBC):(1)經外科手術ã€åŒ–å¸ç™‚法(è¡“å‰æˆ–術後)之輔助療法。(2)以doxorubicin與cyclophosphamide治療,å†åˆä½µpactlitaxel或docetaxel之輔助療法。(3)與docetaxelåŠcarboplatin併用之輔助療法。(4)è¡“å‰èˆ‡åŒ–å¸ç™‚法並用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2 厘米)2.轉移性乳癌(MBC):(1)å–®ç¨ä½¿ç”¨æ–¼æ›¾æŽ¥å—éŽä¸€æ¬¡(å«)以上化å¸ç™‚法之轉移性乳癌;除éžæ‚£è€…ä¸é©åˆä½¿ç”¨anthracyclin或taxane,å¦å‰‡å…ˆå‰ä¹‹åŒ–å¸æ²»ç™‚應至少包括anthracyclin或taxane。使用於è·çˆ¾è’™ç™‚法失敗之è·çˆ¾è’™å—體陽性之患者,除éžæ‚£è€…ä¸é©ç”¨è·çˆ¾è’™ç™‚法。(2)與pactlitaxel或docetaxel併用於未曾接å—éŽåŒ–å¸ç™‚法之轉移性乳癌。(3)與芳香環酶抑制劑併用於è·çˆ¾è’™å—體陽性之轉移性乳癌。3.轉移性胃癌(MGC):Herceptinåˆä½µcapecitabine(或5-f1uorouracil)åŠcisplatiné©ç”¨æ–¼æœªæ›¾æŽ¥å—éŽåŒ–å¸æ²»ç™‚之HER2éŽåº¦è¡¨ç¾è½‰ç§»æ€§èƒƒè…ºç™Œ(或胃食é“接åˆè™•è…ºç™Œ)的治療。å‡æ™¶æ³¨å°„劑玻璃å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨TRASTUZUMABå°ç£ç¾…æ°é†«ç™‚診斷è¨å‚™è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸å±±å€æ°‘權æ±è·¯3段2號10樓23932173F.HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303 KAISERAUGST, SWITZERLANDSWITZERLAND2014-03-10玻璃å°ç“¶è£;;ç›’è£Herclon vial 150mg請見仿單
衛部èŒç–«è¼¸å—第000947號2018-10-212013-10-21èŒã€€ç–«DHA06000094702克癌平 å‡æ™¶æ³¨å°„劑150毫克Herclon應使用於下列HER2éŽåº¦è¡¨ç¾æˆ–HER2åŸºå› amplification之早期乳癌ã€è½‰ç§»æ€§ä¹³ç™Œæ‚£è€…說明:1.早期乳癌(EBC):(1)經外科手術ã€åŒ–å¸ç™‚法(è¡“å‰æˆ–術後)之輔助療法。(2)以doxorubicin與cyclophosphamide治療,å†åˆä½µpactlitaxel或docetaxel之輔助療法。(3)與docetaxelåŠcarboplatin併用之輔助療法。(4)è¡“å‰èˆ‡åŒ–å¸ç™‚法並用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2 厘米)2.轉移性乳癌(MBC):(1)å–®ç¨ä½¿ç”¨æ–¼æ›¾æŽ¥å—éŽä¸€æ¬¡(å«)以上化å¸ç™‚法之轉移性乳癌;除éžæ‚£è€…ä¸é©åˆä½¿ç”¨anthracyclin或taxane,å¦å‰‡å…ˆå‰ä¹‹åŒ–å¸æ²»ç™‚應至少包括anthracyclin或taxane。使用於è·çˆ¾è’™ç™‚法失敗之è·çˆ¾è’™å—體陽性之患者,除éžæ‚£è€…ä¸é©ç”¨è·çˆ¾è’™ç™‚法。(2)與pactlitaxel或docetaxel併用於未曾接å—éŽåŒ–å¸ç™‚法之轉移性乳癌。(3)與芳香環酶抑制劑併用於è·çˆ¾è’™å—體陽性之轉移性乳癌。3.轉移性胃癌(MGC):Herceptinåˆä½µcapecitabine(或5-f1uorouracil)åŠcisplatiné©ç”¨æ–¼æœªæ›¾æŽ¥å—éŽåŒ–å¸æ²»ç™‚之HER2éŽåº¦è¡¨ç¾è½‰ç§»æ€§èƒƒè…ºç™Œ(或胃食é“接åˆè™•è…ºç™Œ)的治療。å‡æ™¶æ³¨å°„劑玻璃å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨TRASTUZUMABå°ç£ç¾…æ°é†«ç™‚診斷è¨å‚™è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸å±±å€æ°‘權æ±è·¯3段2號10樓23932173ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-03-10玻璃å°ç“¶è£;;ç›’è£Herclon vial 150mg請見仿單
衛部èŒç–«è¼¸å—第000959號2019-08-122014-08-12èŒã€€ç–«DHA06000095909"愛瑞"人類血清白蛋白20%注射液低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射液劑玻璃å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN ALBUMINå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING AGWANKDORFSTRASSE 10 CH-3000 BERN 22, SWITZERLANDSWITZERLAND2014-11-12玻璃å°ç“¶è£AlbuRx TM 20詳見仿單
衛部èŒç–«è¼¸å—第000947號2018-10-212013-10-21èŒã€€ç–«DHA06000094702克癌平 å‡æ™¶æ³¨å°„劑150毫克Herclon應使用於下列HER2éŽåº¦è¡¨ç¾æˆ–HER2åŸºå› amplification之早期乳癌ã€è½‰ç§»æ€§ä¹³ç™Œæ‚£è€…說明:1.早期乳癌(EBC):(1)經外科手術ã€åŒ–å¸ç™‚法(è¡“å‰æˆ–術後)之輔助療法。(2)以doxorubicin與cyclophosphamide治療,å†åˆä½µpactlitaxel或docetaxel之輔助療法。(3)與docetaxelåŠcarboplatin併用之輔助療法。(4)è¡“å‰èˆ‡åŒ–å¸ç™‚法並用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2 厘米)2.轉移性乳癌(MBC):(1)å–®ç¨ä½¿ç”¨æ–¼æ›¾æŽ¥å—éŽä¸€æ¬¡(å«)以上化å¸ç™‚法之轉移性乳癌;除éžæ‚£è€…ä¸é©åˆä½¿ç”¨anthracyclin或taxane,å¦å‰‡å…ˆå‰ä¹‹åŒ–å¸æ²»ç™‚應至少包括anthracyclin或taxane。使用於è·çˆ¾è’™ç™‚法失敗之è·çˆ¾è’™å—體陽性之患者,除éžæ‚£è€…ä¸é©ç”¨è·çˆ¾è’™ç™‚法。(2)與pactlitaxel或docetaxel併用於未曾接å—éŽåŒ–å¸ç™‚法之轉移性乳癌。(3)與芳香環酶抑制劑併用於è·çˆ¾è’™å—體陽性之轉移性乳癌。3.轉移性胃癌(MGC):Herceptinåˆä½µcapecitabine(或5-f1uorouracil)åŠcisplatiné©ç”¨æ–¼æœªæ›¾æŽ¥å—éŽåŒ–å¸æ²»ç™‚之HER2éŽåº¦è¡¨ç¾è½‰ç§»æ€§èƒƒè…ºç™Œ(或胃食é“接åˆè™•è…ºç™Œ)的治療。å‡æ™¶æ³¨å°„劑玻璃å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨TRASTUZUMABå°ç£ç¾…æ°é†«ç™‚診斷è¨å‚™è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸å±±å€æ°‘權æ±è·¯3段2號10樓23932173ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-03-10玻璃å°ç“¶è£;;ç›’è£Herclon vial 150mg請見仿單
衛部èŒç–«è¼¸å—第000948號2018-10-252013-10-25èŒã€€ç–«DHA06000094804瑞樂é¶æ³¨å°„劑éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ç”¨æ–¼å¾©ç™¼æˆ–å°åŒ–å¸ç™‚法有抗性之低惡度B-細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚併用CVP化å¸ç™‚法用於未經治療之和緩性(組織型態為濾泡型)B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤çš„病人。併用CHOP或其他化å¸ç™‚法用於CD20抗原陽性之瀰漫性大型B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚用於åšç‚ºæ¿¾æ³¡æ€§æ·‹å·´ç˜¤æ‚£è€…å°èª˜å°Žç™‚法產生å應之後的ç¶æŒæ²»ç™‚用藥。類風濕性關節炎:與methotrexate併用,é©ç”¨æ–¼æ²»ç™‚曾接å—一種(å«)以上之腫瘤壞æ»å› å(TNF)抑制療法治療但效果ä¸å½°ï¼Œæˆ–無法è€å—的活動性類風濕性關節炎æˆäººæ‚£è€…。瑞樂é¶ï¼ˆRistova)與methotrexate併用,經X光檢查已è‰å¯¦å¯æ¸›ç·©é—œç¯€çµæ§‹å—æ的進展。慢性淋巴çƒæ€§ç™½è¡€ç—…瑞樂é¶ï¼ˆRistova)é©ç”¨æ–¼èˆ‡fludarabineåŠcyclophosphamide併用,åšç‚ºCD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…(CLL)患者的第一線用藥。瑞樂é¶ï¼ˆRistova)é©ç”¨æ–¼èˆ‡åŒ–å¸ç™‚法併用,åšç‚ºå¾©ç™¼/é ‘å›ºæ€§çš„CD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…病患的治療用藥。肉芽腫性血管炎( Granulomatosis with Polyangiitis, Granulomatosis with Polyangiitis, GPA)(Wegener’s肉芽腫症)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(Microscopic Polyangiitis, MPA): 瑞樂é¶ï¼ˆRistova)與葡è„ç³–çš®è³ªç´ (glucocorticoids)併用,é©ç”¨æ–¼æ²»ç™‚æˆäººä¹‹è‚‰èŠ½è…«æ€§è¡€ç®¡ç‚Ž(GPAï¼Œäº¦ç¨±ç‚ºéŸ‹æ ¼ç´è‚‰èŠ½è…«ç—‡)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(MPA)。注射劑å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Rituximabå°ç£ç¾…æ°é†«ç™‚診斷è¨å‚™è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸å±±å€æ°‘權æ±è·¯3段2號10樓23932173F.HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303 KAISERAUGST, SWITZERLANDSWITZERLAND2014-03-10å°ç“¶è£;;ç›’è£Ristova Solution for IV infusion請詳見仿單。
衛部èŒç–«è¼¸å—第000948號2018-10-252013-10-25èŒã€€ç–«DHA06000094804瑞樂é¶æ³¨å°„劑éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ç”¨æ–¼å¾©ç™¼æˆ–å°åŒ–å¸ç™‚法有抗性之低惡度B-細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚併用CVP化å¸ç™‚法用於未經治療之和緩性(組織型態為濾泡型)B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤çš„病人。併用CHOP或其他化å¸ç™‚法用於CD20抗原陽性之瀰漫性大型B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚用於åšç‚ºæ¿¾æ³¡æ€§æ·‹å·´ç˜¤æ‚£è€…å°èª˜å°Žç™‚法產生å應之後的ç¶æŒæ²»ç™‚用藥。類風濕性關節炎:與methotrexate併用,é©ç”¨æ–¼æ²»ç™‚曾接å—一種(å«)以上之腫瘤壞æ»å› å(TNF)抑制療法治療但效果ä¸å½°ï¼Œæˆ–無法è€å—的活動性類風濕性關節炎æˆäººæ‚£è€…。瑞樂é¶ï¼ˆRistova)與methotrexate併用,經X光檢查已è‰å¯¦å¯æ¸›ç·©é—œç¯€çµæ§‹å—æ的進展。慢性淋巴çƒæ€§ç™½è¡€ç—…瑞樂é¶ï¼ˆRistova)é©ç”¨æ–¼èˆ‡fludarabineåŠcyclophosphamide併用,åšç‚ºCD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…(CLL)患者的第一線用藥。瑞樂é¶ï¼ˆRistova)é©ç”¨æ–¼èˆ‡åŒ–å¸ç™‚法併用,åšç‚ºå¾©ç™¼/é ‘å›ºæ€§çš„CD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…病患的治療用藥。肉芽腫性血管炎( Granulomatosis with Polyangiitis, Granulomatosis with Polyangiitis, GPA)(Wegener’s肉芽腫症)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(Microscopic Polyangiitis, MPA): 瑞樂é¶ï¼ˆRistova)與葡è„ç³–çš®è³ªç´ (glucocorticoids)併用,é©ç”¨æ–¼æ²»ç™‚æˆäººä¹‹è‚‰èŠ½è…«æ€§è¡€ç®¡ç‚Ž(GPAï¼Œäº¦ç¨±ç‚ºéŸ‹æ ¼ç´è‚‰èŠ½è…«ç—‡)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(MPA)。注射劑å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Rituximabå°ç£ç¾…æ°é†«ç™‚診斷è¨å‚™è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸å±±å€æ°‘權æ±è·¯3段2號10樓23932173GENENTECH, INC.1000 NEW HORIZONS WAY, VACAVILLE, CA 95688, USAUNITED STATES2014-03-10å°ç“¶è£;;ç›’è£Ristova Solution for IV infusion請詳見仿單。
衛部èŒç–«è¼¸å—第000948號2018-10-252013-10-25èŒã€€ç–«DHA06000094804瑞樂é¶æ³¨å°„劑éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ç”¨æ–¼å¾©ç™¼æˆ–å°åŒ–å¸ç™‚法有抗性之低惡度B-細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚併用CVP化å¸ç™‚法用於未經治療之和緩性(組織型態為濾泡型)B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤çš„病人。併用CHOP或其他化å¸ç™‚法用於CD20抗原陽性之瀰漫性大型B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚用於åšç‚ºæ¿¾æ³¡æ€§æ·‹å·´ç˜¤æ‚£è€…å°èª˜å°Žç™‚法產生å應之後的ç¶æŒæ²»ç™‚用藥。類風濕性關節炎:與methotrexate併用,é©ç”¨æ–¼æ²»ç™‚曾接å—一種(å«)以上之腫瘤壞æ»å› å(TNF)抑制療法治療但效果ä¸å½°ï¼Œæˆ–無法è€å—的活動性類風濕性關節炎æˆäººæ‚£è€…。瑞樂é¶ï¼ˆRistova)與methotrexate併用,經X光檢查已è‰å¯¦å¯æ¸›ç·©é—œç¯€çµæ§‹å—æ的進展。慢性淋巴çƒæ€§ç™½è¡€ç—…瑞樂é¶ï¼ˆRistova)é©ç”¨æ–¼èˆ‡fludarabineåŠcyclophosphamide併用,åšç‚ºCD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…(CLL)患者的第一線用藥。瑞樂é¶ï¼ˆRistova)é©ç”¨æ–¼èˆ‡åŒ–å¸ç™‚法併用,åšç‚ºå¾©ç™¼/é ‘å›ºæ€§çš„CD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…病患的治療用藥。肉芽腫性血管炎( Granulomatosis with Polyangiitis, Granulomatosis with Polyangiitis, GPA)(Wegener’s肉芽腫症)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(Microscopic Polyangiitis, MPA): 瑞樂é¶ï¼ˆRistova)與葡è„ç³–çš®è³ªç´ (glucocorticoids)併用,é©ç”¨æ–¼æ²»ç™‚æˆäººä¹‹è‚‰èŠ½è…«æ€§è¡€ç®¡ç‚Ž(GPAï¼Œäº¦ç¨±ç‚ºéŸ‹æ ¼ç´è‚‰èŠ½è…«ç—‡)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(MPA)。注射劑å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Rituximabå°ç£ç¾…æ°é†«ç™‚診斷è¨å‚™è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸å±±å€æ°‘權æ±è·¯3段2號10樓23932173GENENTECH, INC.1 ANTIBODY WAY, OCEANSIDE, CA 92056, USAUNITED STATES2014-03-10å°ç“¶è£;;ç›’è£Ristova Solution for IV infusion請詳見仿單。
衛部èŒç–«è¼¸å—第000948號2018-10-252013-10-25èŒã€€ç–«DHA06000094804瑞樂é¶æ³¨å°„劑éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ç”¨æ–¼å¾©ç™¼æˆ–å°åŒ–å¸ç™‚法有抗性之低惡度B-細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚併用CVP化å¸ç™‚法用於未經治療之和緩性(組織型態為濾泡型)B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤çš„病人。併用CHOP或其他化å¸ç™‚法用於CD20抗原陽性之瀰漫性大型B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚用於åšç‚ºæ¿¾æ³¡æ€§æ·‹å·´ç˜¤æ‚£è€…å°èª˜å°Žç™‚法產生å應之後的ç¶æŒæ²»ç™‚用藥。類風濕性關節炎:與methotrexate併用,é©ç”¨æ–¼æ²»ç™‚曾接å—一種(å«)以上之腫瘤壞æ»å› å(TNF)抑制療法治療但效果ä¸å½°ï¼Œæˆ–無法è€å—的活動性類風濕性關節炎æˆäººæ‚£è€…。瑞樂é¶ï¼ˆRistova)與methotrexate併用,經X光檢查已è‰å¯¦å¯æ¸›ç·©é—œç¯€çµæ§‹å—æ的進展。慢性淋巴çƒæ€§ç™½è¡€ç—…瑞樂é¶ï¼ˆRistova)é©ç”¨æ–¼èˆ‡fludarabineåŠcyclophosphamide併用,åšç‚ºCD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…(CLL)患者的第一線用藥。瑞樂é¶ï¼ˆRistova)é©ç”¨æ–¼èˆ‡åŒ–å¸ç™‚法併用,åšç‚ºå¾©ç™¼/é ‘å›ºæ€§çš„CD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…病患的治療用藥。肉芽腫性血管炎( Granulomatosis with Polyangiitis, Granulomatosis with Polyangiitis, GPA)(Wegener’s肉芽腫症)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(Microscopic Polyangiitis, MPA): 瑞樂é¶ï¼ˆRistova)與葡è„ç³–çš®è³ªç´ (glucocorticoids)併用,é©ç”¨æ–¼æ²»ç™‚æˆäººä¹‹è‚‰èŠ½è…«æ€§è¡€ç®¡ç‚Ž(GPAï¼Œäº¦ç¨±ç‚ºéŸ‹æ ¼ç´è‚‰èŠ½è…«ç—‡)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(MPA)。注射劑å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Rituximabå°ç£ç¾…æ°é†«ç™‚診斷è¨å‚™è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸å±±å€æ°‘權æ±è·¯3段2號10樓23932173ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-03-10å°ç“¶è£;;ç›’è£Ristova Solution for IV infusion請詳見仿單。
衛部èŒç–«è¼¸å—第000949號2018-11-062013-11-06èŒã€€ç–«DHA06000094906賀癌寧å‡æ™¶æ³¨å°„劑KADCYLAå–®ç¨ä½¿ç”¨æ™‚èƒ½å¤ æ²»ç™‚HER2陽性ã€ä¹‹å‰åˆ†åˆ¥æŽ¥å—éŽtrastuzumab與一種taxane藥物治療或其åˆä½µç™‚法的轉移性乳癌病患。說明:病患應符åˆä¸‹åˆ—æ¢ä»¶ï¼šä¹‹å‰å·²ç¶“接å—éŽè½‰ç§»æ€§ç™Œç—‡æ²»ç™‚,或在輔助療法治療期間或完æˆæ²»ç™‚後6個月內癌症復發。å‡æ™¶æ³¨å°„劑盒è£;;å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨Trastuzumab Emtansineç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303 KAISERAUGST, SWITZERLANDSWITZERLAND2014-05-06ç›’è£;;å°ç“¶è£Kadcyla完整用法用é‡æ•˜è¿°ï¼Œè©³å¦‚仿單。
衛部èŒç–«è¼¸å—第000949號2018-11-062013-11-06èŒã€€ç–«DHA06000094906賀癌寧å‡æ™¶æ³¨å°„劑KADCYLAå–®ç¨ä½¿ç”¨æ™‚èƒ½å¤ æ²»ç™‚HER2陽性ã€ä¹‹å‰åˆ†åˆ¥æŽ¥å—éŽtrastuzumab與一種taxane藥物治療或其åˆä½µç™‚法的轉移性乳癌病患。說明:病患應符åˆä¸‹åˆ—æ¢ä»¶ï¼šä¹‹å‰å·²ç¶“接å—éŽè½‰ç§»æ€§ç™Œç—‡æ²»ç™‚,或在輔助療法治療期間或完æˆæ²»ç™‚後6個月內癌症復發。å‡æ™¶æ³¨å°„劑盒è£;;å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨Trastuzumab Emtansineç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467LONZA LTD.CHEMIE, LONZASTRASSE, 3930 VISP, SWITERLANDSWITZERLAND2014-05-06ç›’è£;;å°ç“¶è£Kadcyla完整用法用é‡æ•˜è¿°ï¼Œè©³å¦‚仿單。
衛部èŒç–«è¼¸å—第000949號2018-11-062013-11-06èŒã€€ç–«DHA06000094906賀癌寧å‡æ™¶æ³¨å°„劑KADCYLAå–®ç¨ä½¿ç”¨æ™‚èƒ½å¤ æ²»ç™‚HER2陽性ã€ä¹‹å‰åˆ†åˆ¥æŽ¥å—éŽtrastuzumab與一種taxane藥物治療或其åˆä½µç™‚法的轉移性乳癌病患。說明:病患應符åˆä¸‹åˆ—æ¢ä»¶ï¼šä¹‹å‰å·²ç¶“接å—éŽè½‰ç§»æ€§ç™Œç—‡æ²»ç™‚,或在輔助療法治療期間或完æˆæ²»ç™‚後6個月內癌症復發。å‡æ™¶æ³¨å°„劑盒è£;;å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨Trastuzumab Emtansineç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467DSM Pharmaceuticals,Inc.5900 Martin Luther King Jr. Highway,Greenville,NC27834,USAUNITED STATES2014-05-06ç›’è£;;å°ç“¶è£Kadcyla完整用法用é‡æ•˜è¿°ï¼Œè©³å¦‚仿單。
衛部èŒç–«è¼¸å—第000957號2019-01-112014-01-11èŒã€€ç–«DHA06000095705"瑞士"å–œé”諾TM注射液1.乾癬(Ps):Stelaraé©ç”¨æ–¼æ²»ç™‚é©åˆæŽ¥å—光療法或全身性治療的ä¸è‡³é‡åº¦æ–‘塊性乾癬æˆäººæ‚£è€…(18æ²(å«)以上)。2.乾癬性關節炎(PsA):Stelaraé©ç”¨æ–¼æ²»ç™‚å°ç–¾ç—…緩解型抗風濕性藥物(DMARDs)療效ä¸ä½³ä¹‹æˆäºº(18æ²åŠä»¥ä¸Š)活動性乾癬性關節炎。Stelaraå¯å–®ç¨ä½¿ç”¨ï¼Œäº¦å¯èˆ‡Methotrexate(MTX)併用。é å……å¡«å¼æ³¨å°„劑玻璃é å……å¡«å¼é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨Ustekinumab嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854JANSSEN BIOLOGICS B.V.EINSTEINWEG 101, 2333 CB LEIDEN, THE NETHERLANDSNETHERLANDS2014-12-11玻璃é å……å¡«å¼é‡ç’è£Stelara TM Solution for Injection詳見仿單
衛部èŒç–«è¼¸å—第000957號2019-01-112014-01-11èŒã€€ç–«DHA06000095705"瑞士"å–œé”諾TM注射液1.乾癬(Ps):Stelaraé©ç”¨æ–¼æ²»ç™‚é©åˆæŽ¥å—光療法或全身性治療的ä¸è‡³é‡åº¦æ–‘塊性乾癬æˆäººæ‚£è€…(18æ²(å«)以上)。2.乾癬性關節炎(PsA):Stelaraé©ç”¨æ–¼æ²»ç™‚å°ç–¾ç—…緩解型抗風濕性藥物(DMARDs)療效ä¸ä½³ä¹‹æˆäºº(18æ²åŠä»¥ä¸Š)活動性乾癬性關節炎。Stelaraå¯å–®ç¨ä½¿ç”¨ï¼Œäº¦å¯èˆ‡Methotrexate(MTX)併用。é å……å¡«å¼æ³¨å°„劑玻璃é å……å¡«å¼é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨Ustekinumab嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854JANSSEN BIOLOGICS (IRELAND)BARNAHELY, RINGASKIDDY, CO.CORK, IRELANDIRELAND2014-12-11玻璃é å……å¡«å¼é‡ç’è£Stelara TM Solution for Injection詳見仿單
衛部èŒç–«è¼¸å—第000957號2019-01-112014-01-11èŒã€€ç–«DHA06000095705"瑞士"å–œé”諾TM注射液1.乾癬(Ps):Stelaraé©ç”¨æ–¼æ²»ç™‚é©åˆæŽ¥å—光療法或全身性治療的ä¸è‡³é‡åº¦æ–‘塊性乾癬æˆäººæ‚£è€…(18æ²(å«)以上)。2.乾癬性關節炎(PsA):Stelaraé©ç”¨æ–¼æ²»ç™‚å°ç–¾ç—…緩解型抗風濕性藥物(DMARDs)療效ä¸ä½³ä¹‹æˆäºº(18æ²åŠä»¥ä¸Š)活動性乾癬性關節炎。Stelaraå¯å–®ç¨ä½¿ç”¨ï¼Œäº¦å¯èˆ‡Methotrexate(MTX)併用。é å……å¡«å¼æ³¨å°„劑玻璃é å……å¡«å¼é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨Ustekinumab嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854CILAG AGHOCHSTRASSE 201, CH-8205 SCHAFFAUSEN, SWITZERLANDSWITZERLAND2014-12-11玻璃é å……å¡«å¼é‡ç’è£Stelara TM Solution for Injection詳見仿單
衛部èŒç–«è¼¸å—第000958號2019-08-182014-08-18èŒã€€ç–«DHA06000095807益ä¼æ³¨å°„劑 5毫克/毫å‡YERVOY(ipilimumab)é©ç”¨æ–¼æ²»ç™‚æˆäººæ›¾æŽ¥å—å…¶ä»–ç™‚æ³•ä¹‹ç„¡æ³•åˆ‡é™¤æˆ–è½‰ç§»æ€§é»‘è‰²ç´ ç˜¤ã€‚æ³¨å°„æ¶²åŠ‘å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Ipilimumab臺ç£å¿…治妥施貴寶股份有é™å…¬å¸å°åŒ—市æ¾å±±å€å¥åº·è·¯156號4樓ã€5樓11922609BRISTOL-MYERS SQUIBB S.R.L.LOCALIT'A FONTANA DEL CERASO 03012 ANAGNI ITALYITALY2014-12-09å°ç“¶è£;;ç›’è£YERVOY (ipilimumab) Injection 5mg/mL詳如仿單。
衛部èŒç–«è¼¸å—第000958號2019-08-182014-08-18èŒã€€ç–«DHA06000095807益ä¼æ³¨å°„劑 5毫克/毫å‡YERVOY(ipilimumab)é©ç”¨æ–¼æ²»ç™‚æˆäººæ›¾æŽ¥å—å…¶ä»–ç™‚æ³•ä¹‹ç„¡æ³•åˆ‡é™¤æˆ–è½‰ç§»æ€§é»‘è‰²ç´ ç˜¤ã€‚æ³¨å°„æ¶²åŠ‘å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Ipilimumab臺ç£å¿…治妥施貴寶股份有é™å…¬å¸å°åŒ—市æ¾å±±å€å¥åº·è·¯156號4樓ã€5樓11922609LONZA BIOLOGICS, INC.101 INTERNATIONAL DRIVE PEASE INTERNATIONAL TRADEPORT PORTSMOUTH, NEW HAMPSHIRE, U.S. 03801UNITED STATES2014-12-09å°ç“¶è£;;ç›’è£YERVOY (ipilimumab) Injection 5mg/mL詳如仿單。
衛部èŒç–«è¼¸å—第000958號2019-08-182014-08-18èŒã€€ç–«DHA06000095807益ä¼æ³¨å°„劑 5毫克/毫å‡YERVOY(ipilimumab)é©ç”¨æ–¼æ²»ç™‚æˆäººæ›¾æŽ¥å—å…¶ä»–ç™‚æ³•ä¹‹ç„¡æ³•åˆ‡é™¤æˆ–è½‰ç§»æ€§é»‘è‰²ç´ ç˜¤ã€‚æ³¨å°„æ¶²åŠ‘å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Ipilimumab臺ç£å¿…治妥施貴寶股份有é™å…¬å¸å°åŒ—市æ¾å±±å€å¥åº·è·¯156號4樓ã€5樓11922609BAXTER PHARMACEUTICAL SOLUTIONS LLC927 SOUTH CURRY PIKE, BLOOMINGTON, INDIANA 47403-2624UNITED STATES2014-12-09å°ç“¶è£;;ç›’è£YERVOY (ipilimumab) Injection 5mg/mL詳如仿單。
衛部èŒç–«è¼¸å—第000962號2019-09-192014-09-19èŒã€€ç–«DHA06000096201努特徹500國際單ä½æ³¨å°„液劑使用於移æ¤å‰è¡›Båž‹è‚炎病毒DNAé™°æ€§ï¼Œå› Båž‹è‚炎所引發è‚功能衰ç«è€Œé€²è¡Œè‚臟移æ¤è¶…éŽ6個月後之Båž‹è‚炎病毒DNA陰性患者,以é 防å†åº¦è®Šåˆ°Båž‹è‚炎病毒的感染。說明:Zutectraåªä½¿ç”¨æ–¼æˆäººã€‚如果åˆé©çš„話,應考慮併用é©ç•¶çš„病毒抑制劑,åšç‚ºé 防å†åº¦æ„ŸæŸ“Båž‹è‚炎的標準方法。é å……å¡«å¼æ³¨å°„劑盒è£;;é 充填注射é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨HBs ANTIBODY CONTENT禾利行股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路311號3樓03126405BIOTEST PHARMA GMBHLANDSTEINER STRABE 5,D-63303 DREIEICH, GERMANYGERMANY2014-10-20ç›’è£;;é 充填注射é‡ç’è£Zutectra 500IU solution for injection in pre-filled syringes詳如仿單
衛部èŒç–«è¼¸å—第000962號2019-09-192014-09-19èŒã€€ç–«DHA06000096201努特徹500國際單ä½æ³¨å°„液劑使用於移æ¤å‰è¡›Båž‹è‚炎病毒DNAé™°æ€§ï¼Œå› Båž‹è‚炎所引發è‚功能衰ç«è€Œé€²è¡Œè‚臟移æ¤è¶…éŽ6個月後之Båž‹è‚炎病毒DNA陰性患者,以é 防å†åº¦è®Šåˆ°Båž‹è‚炎病毒的感染。說明:Zutectraåªä½¿ç”¨æ–¼æˆäººã€‚如果åˆé©çš„話,應考慮併用é©ç•¶çš„病毒抑制劑,åšç‚ºé 防å†åº¦æ„ŸæŸ“Båž‹è‚炎的標準方法。é å……å¡«å¼æ³¨å°„劑盒è£;;é 充填注射é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨HBs ANTIBODY CONTENT禾利行股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路311號3樓03126405VETTER PHARMA-FERTIGUNG GMBH & CO. KGSCHUTZENSTRASSE 87 D-88212 RAVENSBURG GERMANYGERMANY2014-10-20ç›’è£;;é 充填注射é‡ç’è£Zutectra 500IU solution for injection in pre-filled syringes詳如仿單
衛部èŒç–«è¼¸å—第000963號2019-09-012014-09-01èŒã€€ç–«DHA06000096300亞èˆæ‹‰æ³¨å°„劑治療å°å«fludarabine治療無效的CD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…(CLL)患者注射劑盒è£;;100mg/5mLåŠ1000mg/50mLå°ç“¶è£é™„輸注éŽæ¿¾çµ„é™ç”±é†«å¸«ä½¿ç”¨Ofatumumabè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXO OPERATIONS UK LIMITEDHARMIRE ROAD, BARNARD CASTLE, COUNTY DURHAM, UNITED KINGDOM, DL12 8DT U.K.UNITED KINGDOM2014-10-09ç›’è£;;100mg/5mLåŠ1000mg/50mLå°ç“¶è£é™„輸注éŽæ¿¾çµ„Arzerra concentrate for solution for Infusion詳見仿單
衛部èŒç–«è¼¸å—第000963號2019-09-012014-09-01èŒã€€ç–«DHA06000096300亞èˆæ‹‰æ³¨å°„劑治療å°å«fludarabine治療無效的CD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…(CLL)患者注射劑盒è£;;100mg/5mLåŠ1000mg/50mLå°ç“¶è£é™„輸注éŽæ¿¾çµ„é™ç”±é†«å¸«ä½¿ç”¨Ofatumumabè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438LONZA BIOLOGICS, INC.101 INTERNATIONAL DRIVE PEASE INTERNATIONAL TRADEPORT PORTSMOUTH, NEW HAMPSHIRE, U.S. 03801UNITED STATES2014-10-09ç›’è£;;100mg/5mLåŠ1000mg/50mLå°ç“¶è£é™„輸注éŽæ¿¾çµ„Arzerra concentrate for solution for Infusion詳見仿單
衛部èŒç–«è¼¸å—第000964號2019-09-092014-09-09èŒã€€ç–«DHA06000096402雅詩力 å‡æ™¶æ³¨å°„劑 50毫克1.ADCETRISæ ¸å‡†ç”¨æ–¼æˆäººæ‚£è€…ï¼Œæ²»ç™‚å¾©ç™¼æˆ–é ‘å›ºåž‹cd30+何æ°é‡‘æ°æ·‹å·´ç˜¤(HL):(1)已接å—自體幹細胞移æ¤(ASCT),或(2)無法使用ASCT或多é‡è—¥ç‰©åŒ–療,且先å‰è‡³å°‘已接å—兩種治療。2.ADCETRISæ ¸å‡†ç”¨æ–¼æˆäººæ‚£è€…ï¼Œæ²»ç™‚å¾©ç™¼æˆ–é ‘å›ºåž‹å…¨èº«æ€§é€€è¡Œåˆ†åŒ–åž‹å¤§ç´°èƒžæ·‹å·´ç˜¤(systemic anaplastic large cell lymphomaï¼›sALCL)。å‡æ™¶æ³¨å°„劑玻璃å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Brentuximab vedotin臺ç£æ¦ç”°è—¥å“å·¥æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市å—京æ±è·¯ä¸‰æ®µï¼’17號7F03564609TAKEDA ITALIA S.P.A.VIA CROSA 86, 28065 CERANO (NOVARA), ITALYITALY2014-10-20玻璃å°ç“¶è£;;ç›’è£ADCETRIS 50 mg powder for concentrate for solution for infusionè«‹åƒç…§ä¸æ–‡ä»¿å–®ä¹‹å…§å®¹ã€‚
衛部èŒç–«è¼¸å—第000964號2019-09-092014-09-09èŒã€€ç–«DHA06000096402雅詩力 å‡æ™¶æ³¨å°„劑 50毫克1.ADCETRISæ ¸å‡†ç”¨æ–¼æˆäººæ‚£è€…ï¼Œæ²»ç™‚å¾©ç™¼æˆ–é ‘å›ºåž‹cd30+何æ°é‡‘æ°æ·‹å·´ç˜¤(HL):(1)已接å—自體幹細胞移æ¤(ASCT),或(2)無法使用ASCT或多é‡è—¥ç‰©åŒ–療,且先å‰è‡³å°‘已接å—兩種治療。2.ADCETRISæ ¸å‡†ç”¨æ–¼æˆäººæ‚£è€…ï¼Œæ²»ç™‚å¾©ç™¼æˆ–é ‘å›ºåž‹å…¨èº«æ€§é€€è¡Œåˆ†åŒ–åž‹å¤§ç´°èƒžæ·‹å·´ç˜¤(systemic anaplastic large cell lymphomaï¼›sALCL)。å‡æ™¶æ³¨å°„劑玻璃å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Brentuximab vedotin臺ç£æ¦ç”°è—¥å“å·¥æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市å—京æ±è·¯ä¸‰æ®µï¼’17號7F03564609BSP PHARMACEUTICALS S.R.LVIA APPIA KM 65,561, LATINA SCALO(LT), 04013, ITALYITALY2014-10-20玻璃å°ç“¶è£;;ç›’è£ADCETRIS 50 mg powder for concentrate for solution for infusionè«‹åƒç…§ä¸æ–‡ä»¿å–®ä¹‹å…§å®¹ã€‚
衛署èŒç–«è¼¸å—第000380號2018-07-172013-04-17èŒã€€ç–«DHA01000038009"百åˆ" 人白蛋白2ï¼ï¼…低蛋白血症ã€ä¼‘å…‹ã€å‚·å‚·æ³¨å°„劑安瓿;;注射瓶é™ç”±é†«å¸«ä½¿ç”¨HUMAN PLASMA PROTEINS禾利行股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路311號3樓03126405Biotest AGLANDSTEINER STRABE 5, D-63303 DREIEICH, GERMANYGERMANY2014-11-20安瓿;;注射瓶ALBIOMIN 20%02005802
衛署èŒç–«è¼¸å—第000466號2012-09-181997-09-18èŒã€€ç–«DHA01000046606"百åˆ" å‡è¡€å®šæ³¨å°„劑先天åŠå¾Œå¤©æ€§ç¬¬å…«å‡è¡€å› å缺ä¹ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨FACTOR VIII禾利行股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路311號3樓03126405BIOTEST PHARMA GMBHLANDSTEINER STRABE 5,D-63303 DREIEICH, GERMANYGERMANY2010-07-26å°ç“¶HAEMOCTIN SDH "BIOTEST"
衛署èŒç–«è£½å—第000057號2009-05-251994-06-27èŒã€€ç–«DHY00900005704日本腦炎疫苗é 防日本腦炎滅èŒæ‡¸æ¶²æ³¨å°„劑瓶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨JAPANESE ENCEPHALITIS INACTIVE SUSPENSION;;THIMEROSAL (EQ TO SODIUM ETHYLMERCURITHIOSALICYLATE)行政院衛生署疾病管制局å°åŒ—市昆陽街161號00970553行政院衛生署疾病管制局å°åŒ—市昆陽街161號TAIWAN2014-06-11瓶è£JAPANESE ENCEPHALITIS VACCINE
衛署èŒç–«è¼¸å—第000471號2018-06-211997-10-29èŒã€€ç–«DHA01000047102æ„›æ›¿æ²»æ³¨å°„åŠ‘å™¨å®˜æ ˜æ¤æŽ’æ–¥å±éšªä¹‹é 防åŠæ²»ç™‚。注射劑/vialé™ç”±é†«å¸«ä½¿ç”¨RABBIT IMMUNOGLOBULIN海喬國際股份有é™å…¬å¸å°åŒ—市大åŒå€é‡æ…¶åŒ—路三段276號9樓23436809FRESENIUS BIOTECH GMBHAM HAAG 6-7, D-82166 GRAFELFING, GERMANYGERMANY2013-01-30/vialATG-FRESENIUS S
衛署èŒç–«è£½å—第000082號2017-04-271992-04-27èŒã€€ç–«DHY00900008203"國光" 日本腦炎疫苗é 防日本腦炎。注射劑瓶è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨JAPANESE ENCEPHALITIS INACTIVE VIRUS PROTEIN (NAKAYAMA STRAIN)國光生物科技股份有é™å…¬å¸å°ä¸å¸‚æ½åå€æ½èˆˆè·¯ä¸€æ®µä¸‰è™Ÿ33259508國光生物科技股份有é™å…¬å¸å°ä¸å¸‚æ½åå€æ½èˆˆè·¯ä¸€æ®µä¸‰è™ŸTAIWAN2012-12-17瓶è£;;ç›’è£JAPANESE ENCEPHALITIS VACCINE "KUO KWANG"
衛署èŒç–«è£½å—第000006號2019-05-251994-06-27èŒã€€ç–«DHY00900000600抗龜殼花åŠèµ¤å°¾é®è›‡æ¯’血清å‡æ™¶æ³¨å°„劑å°é¾œæ®¼èŠ±åŠèµ¤å°¾é®æ¯’蛇咬傷有特異性之治療效果å‡æ™¶æ³¨å°„劑瓶è£é™„溶液é™ç”±é†«å¸«ä½¿ç”¨TR. MUCROSQUAMATUS ANTIVENIN;;TR. GRAMINEUS ANTIVENIN衛生ç¦åˆ©éƒ¨ç–¾ç—…管制署å°åŒ—市昆陽街161號00970553衛生ç¦åˆ©éƒ¨ç–¾ç—…管制署å°åŒ—市昆陽街161號TAIWAN2014-06-11瓶è£é™„溶液ANTIVENIN OF TR. MUCROSQUAMATUS AND TR. GRAMINEUS (LYOPHILIZED)
衛署èŒç–«è£½å—第000009號2019-05-251994-06-27èŒã€€ç–«DHY00900000906抗雨傘節åŠé£¯åŒ™å€©è›‡æ¯’血清å‡æ™¶æ³¨å°„劑å°é›¨å‚˜ç¯€åŠé£¯åŒ™å€©æ¯’蛇咬傷有特異性之治療效果å‡æ™¶æ³¨å°„劑瓶è£é™„溶液é™ç”±é†«å¸«ä½¿ç”¨B. MULTICINCTUS ANTIVENIN BIVALENT;;N. NAJA ATRA ANTIVENIN衛生ç¦åˆ©éƒ¨ç–¾ç—…管制署å°åŒ—市昆陽街161號00970553衛生ç¦åˆ©éƒ¨ç–¾ç—…管制署å°åŒ—市昆陽街161號TAIWAN2014-06-11瓶è£é™„溶液BIVALENT ANTIVENIN OF B. MULTICINCTUS AND N. NAJA ATRA (LYOPHILIZED)
衛署èŒç–«è£½å—第000010號2019-05-251994-06-27èŒã€€ç–«DHY00900001004抗百æ¥è›‡æ¯’血清å‡æ™¶æ³¨å°„劑å°ç™¾æ¥è›‡å’¬å‚·æœ‰ç‰¹ç•°æ€§ä¹‹æ²»ç™‚效果å‡æ™¶æ³¨å°„劑瓶è£é™„溶液é™ç”±é†«å¸«ä½¿ç”¨A. ACUTUS ANTIVENIN衛生ç¦åˆ©éƒ¨ç–¾ç—…管制署å°åŒ—市昆陽街161號00970553衛生ç¦åˆ©éƒ¨ç–¾ç—…管制署å°åŒ—市昆陽街161號TAIWAN2014-06-11瓶è£é™„溶液ANTIVENIN OF D. ACUTUS (LYOPHILIZED)
衛署èŒç–«è£½å—第000017號1911-11-111911-11-11èŒã€€ç–«DHA00900001701é˜¿æ–¯å·´æ‹‰ç´ é€æžç”¨ç²‰åŠ‘é™ç”±é†«å¸«ä½¿ç”¨2001-12-30ASPALASE
衛署èŒç–«è£½å—第000020號2014-05-251994-06-27èŒã€€ç–«DHY00900002007å¸è‘—ç™½å–‰ç ´å‚·é¢¨æ··åˆé¡žæ¯’ç´ é é˜²ç ´å‚·é¢¨åŠç™½å–‰æ³¨å°„劑瓶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨DIPHTHERIA TOXOID;;TETANUS TOXOID行政院衛生署疾病管制局å°åŒ—市昆陽街161號00970553行政院衛生署疾病管制局å°åŒ—市昆陽街161號TAIWAN2014-06-11瓶è£DIPHTHERIA AND TETANUS TOXOIDS ADSORBED
衛署èŒç–«è£½å—第000048號2014-05-251994-06-27èŒã€€ç–«DHY00900004803æ˜Žç¤¬æ²ˆæ¾±ç ´å‚·é¢¨é¡žæ¯’ç´ é é˜²ç ´å‚·é¢¨æ»…èŒæ‡¸æ¶²æ³¨å°„劑瓶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨TETANUS TOXOID;;THIMEROSAL (EQ TO SODIUM ETHYLMERCURITHIOSALICYLATE)行政院衛生署疾病管制局å°åŒ—市昆陽街161號00970553行政院衛生署疾病管制局å°åŒ—市昆陽街161號TAIWAN2014-06-11瓶è£TETANUS TOXOID ALUM PRECIPITATED
衛署èŒç–«è£½å—第000053號2009-05-251994-06-27èŒã€€ç–«DHY00900005309ç™½å–‰æŠ—æ¯’ç´ å‡æ™¶æ³¨å°„劑5ï¼ï¼ï¼åœ‹éš›å–®ä½ç™½å–‰æ¡¿èŒæ„ŸæŸ“症注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨DIPHTHERIA ANTITOXIN;;THIMEROSAL (EQ TO SODIUM ETHYLMERCURITHIOSALICYLATE)行政院衛生署疾病管制局å°åŒ—市昆陽街161號00970553行政院衛生署疾病管制局å°åŒ—市昆陽街161號TAIWAN2014-06-11å°ç“¶LYOPHILIZED DIPHTHERIA ANTITOXIN 5000I.U.
衛署èŒç–«è£½å—第000054號2014-05-251994-06-27èŒã€€ç–«DHY00900005401éœäº‚ç–«è‹—é 防éœäº‚æ»…èŒæ‡¸æ¶²æ³¨å°„劑瓶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨CHOLERA INABA;;CHOLERA OGABA行政院衛生署疾病管制局å°åŒ—市昆陽街161號00970553行政院衛生署疾病管制局å°åŒ—市昆陽街161號TAIWAN2014-06-11瓶è£CHOLERA VACCINE
衛署èŒç–«è£½å—第000055號2009-05-251994-06-27èŒã€€ç–«DHY00900005500ç ´å‚·é¢¨æŠ—æ¯’ç´ å‡æ™¶æ³¨å°„劑15ï¼ï¼åœ‹éš›å–®ä½ç ´å‚·é¢¨æ¡¿èŒä¹‹æ„ŸæŸ“症注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨TETANUS ANTITOXIN;;THIMEROSAL (EQ TO SODIUM ETHYLMERCURITHIOSALICYLATE)行政院衛生署疾病管制局å°åŒ—市昆陽街161號00970553行政院衛生署疾病管制局å°åŒ—市昆陽街161號TAIWAN2014-06-11å°ç“¶LYOPHILIZED TETANUS ANTITOXIN 1500I.U.
衛署èŒç–«è£½å—第000056號2009-05-251994-06-27èŒã€€ç–«DHY00900005602ç ´å‚·é¢¨æŠ—æ¯’ç´ å‡æ™¶æ³¨å°„劑4ï¼ï¼ï¼åœ‹éš›å–®ä½ç ´å‚·é¢¨æ¡¿èŒä¹‹æ„ŸæŸ“症注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨TETANUS ANTITOXIN;;THIMEROSAL (EQ TO SODIUM ETHYLMERCURITHIOSALICYLATE)行政院衛生署疾病管制局å°åŒ—市昆陽街161號00970553行政院衛生署疾病管制局å°åŒ—市昆陽街161號TAIWAN2014-06-11å°ç“¶LYOPHILIZED TETANUS ANTITOXIN 4000I.U.
衛署èŒç–«è£½å—第000082號2017-04-271992-04-27èŒã€€ç–«DHY00900008203"國光" 日本腦炎疫苗é 防日本腦炎。注射劑瓶è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨JAPANESE ENCEPHALITIS INACTIVE VIRUS PROTEIN (NAKAYAMA STRAIN)國光生物科技股份有é™å…¬å¸å°ä¸å¸‚æ½åå€æ½èˆˆè·¯ä¸€æ®µä¸‰è™Ÿ33259508è¯äºžç”ŸæŠ€é–‹ç™¼è‚¡ä»½æœ‰é™å…¬å¸æ–°ç«¹äºŒå» 新竹縣湖å£é„‰ä¸èˆˆæ‘光復北路45號TAIWAN2012-12-17瓶è£;;ç›’è£JAPANESE ENCEPHALITIS VACCINE "KUO KWANG"
衛署èŒç–«è£½å—第000085號2019-05-252014-05-21èŒã€€ç–«DHY00900008509å‡çµä¹¾ç‡¥å¡ä»‹è‹—é 防çµæ ¸ç—…注射劑安瓿;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨B.C.G. VACCINE FREEZE-DRIED;;MONOSODIUM GLUTAMATE (SODIUM GLUTAMATE)衛生ç¦åˆ©éƒ¨ç–¾ç—…管制署å°åŒ—市昆陽街161號00970553衛生ç¦åˆ©éƒ¨ç–¾ç—…管制署å°åŒ—市昆陽街161號TAIWAN2014-06-11安瓿::,,;;ç›’è£::,,FREEZE-DRIED BCG VACCINE09000050
衛署èŒç–«è£½å—第000088號2013-11-301993-11-30èŒã€€ç–«DHY00900008802å¸è‘—ç ´å‚·é¢¨ç™½å–‰æ··åˆé¡žæ¯’ç´ ï¼ˆæˆäººç”¨ï¼‰é é˜²ç ´å‚·é¢¨ã€ç™½å–‰ã€‚注射劑瓶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨TETANUS TOXOID;;DIPHTHERIA TOXOID行政院衛生署疾病管制局å°åŒ—市昆陽街161號00970553行政院衛生署疾病管制局å°åŒ—市昆陽街161號TAIWAN2014-06-11瓶è£TETANUS & DIPHTHERIA TOXOID ADSORBED (ADULT USE)
衛署èŒç–«è£½å—第000089號2019-01-241994-01-24èŒã€€ç–«DHY00900008904"國光" æ˜Žç¤¬æ²ˆæ¾±ç ´å‚·é¢¨é¡žæ¯’ç´ é é˜²ç ´å‚·é¢¨ã€‚æ³¨å°„åŠ‘ç“¶è£;;ç›’è£;;é‡ç’è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨TETANUS TOXOID國光生物科技股份有é™å…¬å¸å°ä¸å¸‚æ½åå€æ½èˆˆè·¯ä¸€æ®µä¸‰è™Ÿ33259508國光生物科技股份有é™å…¬å¸å°ä¸å¸‚æ½åå€æ½èˆˆè·¯ä¸€æ®µä¸‰è™ŸTAIWAN2014-03-10瓶è£;;ç›’è£;;é‡ç’è£;;ç›’è£TETANUS TOXOID ALUM PRECIPITATED "KUO KWANG"
衛署èŒç–«è£½å—第000089號2019-01-241994-01-24èŒã€€ç–«DHY00900008904"國光" æ˜Žç¤¬æ²ˆæ¾±ç ´å‚·é¢¨é¡žæ¯’ç´ é é˜²ç ´å‚·é¢¨ã€‚æ³¨å°„åŠ‘ç“¶è£;;ç›’è£;;é‡ç’è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨TETANUS TOXOID國光生物科技股份有é™å…¬å¸å°ä¸å¸‚æ½åå€æ½èˆˆè·¯ä¸€æ®µä¸‰è™Ÿ33259508è¯äºžç”ŸæŠ€é–‹ç™¼è‚¡ä»½æœ‰é™å…¬å¸æ–°ç«¹äºŒå» 新竹縣湖å£é„‰ä¸èˆˆæ‘光復北路45號TAIWAN2014-03-10瓶è£;;ç›’è£;;é‡ç’è£;;ç›’è£TETANUS TOXOID ALUM PRECIPITATED "KUO KWANG"
衛署èŒç–«è£½å—第000113號2016-10-302010-09-20èŒã€€ç–«DHY00900011301"安定ä¼" 裂解型æµæ„Ÿç–«è‹—é 防æµæ„Ÿã€‚注射劑玻璃瓶è£;;玻璃瓶è£;;ç›’è£;;注射é‡ç’;;ç›’è£;;注射é‡ç’é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/California/7/2009(H1N1)-like virus;;A/Victoria/361/2011(H3N2);;B/Massachusetts/02/2012;;A/California/7/2009(H1N1)-like virus國光生物科技股份有é™å…¬å¸å°ä¸å¸‚æ½åå€æ½èˆˆè·¯ä¸€æ®µä¸‰è™Ÿ33259508國光生物科技股份有é™å…¬å¸å°ä¸å¸‚æ½åå€æ½èˆˆè·¯ä¸€æ®µä¸‰è™ŸTAIWAN2013-09-24玻璃瓶è£;;玻璃瓶è£;;ç›’è£;;注射é‡ç’;;ç›’è£;;注射é‡ç’AdimFlu-S通常採皮下或肌肉注射,æ¯æ¬¡æŽ¥ç¨®0.5ml。接種é‡ï¼š(1)1æ²ä»¥ä¸Šæœªæ»¿3æ²å…’童:一劑0.25mL。(2)3æ²ä»¥ä¸Šå…’ç«¥åŠæˆäººï¼šä¸€åŠ‘0.5mL。未滿9æ²å…’童,若先å‰æœªæ›¾æ³¨å°„éŽæµæ„Ÿç–«è‹—者,需接種2次,且間隔至少4週。
衛署èŒç–«è¼¸å—第000069號2018-12-081999-01-05èŒã€€ç–«DHA01000006909"百åˆ" 血漿蛋白低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑安瓿;;瓶è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN PLASMA PROTEINS禾利行股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路311號3樓03126405BIOTEST PHARMA GMBHLANDSTEINER STRABE 5,D-63303 DREIEICH, GERMANYGERMANY2014-11-20安瓿::,,;;瓶è£::,,BISEKO
衛署èŒç–«è¼¸å—第000069號2018-12-081999-01-05èŒã€€ç–«DHA01000006909"百åˆ" 血漿蛋白低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑安瓿;;瓶è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN PLASMA PROTEINS禾利行股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路311號3樓03126405Biotest AGLANDSTEINER STRABE 5, D-63303 DREIEICH, GERMANYGERMANY2014-11-20安瓿::,,;;瓶è£::,,BISEKO
衛署èŒç–«è¼¸å—第000079號2018-10-141998-10-08èŒã€€ç–«DHA01000007902低鹽白蛋白注射液5%白蛋白血症ã€ä¼‘å…‹ã€ç‡’傷注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN SERUM天行貿易股份有é™å…¬å¸å°åŒ—市ä¸å±±å€é•·å®‰æ±è·¯ä¸€æ®µ21號2樓11102308Grifols Therapeutics Inc.8368 US 70 BUS HWY WEST, CLAYTON, NC 27520, U.S.A.UNITED STATES2014-05-16瓶è£PLASBUMIN-5
衛署èŒç–«è¼¸å—第000101號2014-10-181981-07-02èŒã€€ç–«DHA01000010105"巴斯德" 白喉ã€ç™¾æ—¥å’³ã€ç ´å‚·é¢¨æ··åˆç–«è‹—é 防白喉ã€ç™¾æ—¥å’³ã€ç ´å‚·é¢¨æ»…èŒä¹¾ç²‰æ‡¸æ¶²æ³¨å°„劑安瓿;;å°ç“¶;;å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨DIPHTHERIA TOXOID PURIFIED;;TETANUS TOXOID PURIFIED;;PERTUSSIS賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR S.A.1541, AV. MARCEL-MERIEUX, 69280 MARCY L'ETOILE FRANCE58, AVENUE LECLERC, 69007 LYON, FRANCEFRANCE2014-11-03安瓿;;å°ç“¶;;å°ç“¶D.P.T. (D.T.COQ ADSORBE)10000088
衛署èŒç–«è¼¸å—第000112號2013-12-151998-11-19èŒã€€ç–«DHA01000011200ä¿å…’麻疹疫苗é 防麻疹å‡æ™¶æ³¨å°„劑盒è£;;å°ç“¶;;é‡ç’è£é™„æº¶åŠ‘é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨MUMPS VACCINE LIVE HYPERATTENUATED賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR S.A.1541, AV. MARCEL-MERIEUX, 69280 MARCY L'ETOILE FRANCE58, AVENUE LECLERC, 69007 LYON, FRANCEFRANCE2014-11-03ç›’è£;;å°ç“¶;;é‡ç’è£é™„溶劑ROUVAX10000104
衛署èŒç–«è¼¸å—第000166號2018-06-301998-07-15èŒã€€ç–«DHA01000016607å£æœå°å…’麻痺疫苗I+II+IIIé 防I+II+III型å°å…’麻痺液劑瓶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨POLIOMYELITIS TYPE I VACCINE;;POLIOMYELITIS TYPE II VACCINE;;POLIOMYELITIS TYPE III VACCINE;;NEOMYCIN SULFATEè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19瓶è£ORAL POLIOMYELITIS VACCINE POLIO SABIN (ORAL)10000152
衛署èŒç–«è¼¸å—第000197號2018-06-231998-09-30èŒã€€ç–«DHA01000019705白蛋白注射劑白蛋白血症ã€ä¼‘å…‹ã€ç‡’傷注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN天行貿易股份有é™å…¬å¸å°åŒ—市ä¸å±±å€é•·å®‰æ±è·¯ä¸€æ®µ21號2樓11102308Grifols Therapeutics Inc.8368 US 70 BUS HWY WEST, CLAYTON, NC 27520, U.S.A.UNITED STATES2014-12-10瓶è£NORMAL SERUM ALBUMIN (HUMAN) PLASBUMIN-2513003859
衛署èŒç–«è¼¸å—第000198號2018-06-231998-10-06èŒã€€ç–«DHA01000019807血漿注射劑急救輸血注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨PLASMA PROTEIN SELECTED天行貿易股份有é™å…¬å¸å°åŒ—市ä¸å±±å€é•·å®‰æ±è·¯ä¸€æ®µ21號2樓11102308Grifols Therapeutics Inc.8368 US 70 BUS HWY WEST, CLAYTON, NC 27520, U.S.A.UNITED STATES2013-07-10瓶è£PLASMANATE
衛署èŒç–«è¼¸å—第000242號2014-07-212009-04-30èŒã€€ç–«DHA01000024200"巴斯德" 麻疹ã€æµè¡Œæ€§è…®è…ºç‚Žã€å¾·åœ‹éº»ç–¹ä¸‰åˆç–«è‹—接種於一æ²ä»¥ä¸Šä¹‹å…’ç«¥ã€å¯å°éº»ç–¹ã€æµè¡Œæ€§è…®è…ºç‚ŽåŠå¾·åœ‹éº»ç–¹åŒæ™‚å…ç–«å‡æ™¶æ³¨å°„劑盒è£;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨MEASLES VACCINE, LIVE;;MUMPS VACCINE LIVE;;RUBELLA LIVE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR S.A.1541, AV. MARCEL-MERIEUX, 69280 MARCY L'ETOILE FRANCEFRANCE2014-11-03ç›’è£;;注射é‡ç’TRIMOVAX VACCINE
衛署èŒç–«è¼¸å—第000271號2018-04-061988-11-17èŒã€€ç–«DHA0100002710425%人體æ£å¸¸è¡€æ¸…白蛋白注射劑低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN NORMAL SERUM百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION BAXTER BIOSCIENCE4501 COLORADO BLVD. LOS ANGELES, CALIFORNIA 90039 USA.UNITED STATES2013-05-27瓶è£BUMINATE 25% ALBUMIN (HUMAN) USP, 25% SOLUTION "BAXTER"10000252
衛署èŒç–«è¼¸å—第000274號2018-11-282013-06-18èŒã€€ç–«DHA01000027400ç«‹ä¿ï¼¢åž‹è‚炎抗體注射液é 防B型è‚炎之感染注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨HBs ANTIBODY CONTENT禾利行股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路311號3樓03126405BIOTEST PHARMA GMBHLANDSTEINER STRABE 5,D-63303 DREIEICH, GERMANYGERMANY2014-11-20瓶è£HEPATECT CP INJECTION
衛署èŒç–«è¼¸å—第000274號2018-11-282013-06-18èŒã€€ç–«DHA01000027400ç«‹ä¿ï¼¢åž‹è‚炎抗體注射液é 防B型è‚炎之感染注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨HBs ANTIBODY CONTENT禾利行股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路311號3樓03126405Biotest AGLANDSTEINER STRABE 5, D-63303 DREIEICH, GERMANYGERMANY2014-11-20瓶è£HEPATECT CP INJECTION
衛署èŒç–«è¼¸å—第000380號2018-07-172013-04-17èŒã€€ç–«DHA01000038009"百åˆ" 人白蛋白2ï¼ï¼…低蛋白血症ã€ä¼‘å…‹ã€å‚·å‚·æ³¨å°„劑安瓿;;注射瓶é™ç”±é†«å¸«ä½¿ç”¨HUMAN PLASMA PROTEINS禾利行股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路311號3樓03126405BIOTEST PHARMA GMBHLANDSTEINER STRABE 5,D-63303 DREIEICH, GERMANYGERMANY2014-11-20安瓿;;注射瓶ALBIOMIN 20%02005802
衛署èŒç–«è¼¸å—第000285號2019-07-172014-06-25èŒã€€ç–«DHA01000028502"百åˆ" 施多特注射液移æ¤æˆ–用å…疫抑制劑治療時é 防巨細胞毒之感染注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN PLASMA PROTEIN THEREOF IMMUNOGLOBULIN G(IgG) ≧96% WITH ANTIBODIES TO CYTOMEGALOVIRUS 100U禾利行股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路311號3樓03126405Biotest AGLANDSTEINER STRABE 5, D-63303 DREIEICH, GERMANYGERMANY2014-07-08瓶è£CYTOTECT CP BIOTEST單一劑é‡ç‚ºæ¯å…¬æ–¤é«”é‡æŠ•èˆ‡1 毫å‡æœ¬ç”¢å“。在進行移æ¤ç•¶å¤©æ‡‰é–‹å§‹æŠ•èˆ‡æœ¬å“。å°éª¨é«“移æ¤æ‚£è€…,在移æ¤å‰10 天å¯é–‹å§‹æŠ•äºˆæœ¬å“作為é 防用途,特別是在CMV 血清陽性的病人。本å“應æ¯2 至3 週投予一次,共計投予至少6 個單一劑é‡ã€‚
衛署èŒç–«è¼¸å—第000285號2019-07-172014-06-25èŒã€€ç–«DHA01000028502"百åˆ" 施多特注射液移æ¤æˆ–用å…疫抑制劑治療時é 防巨細胞毒之感染注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN PLASMA PROTEIN THEREOF IMMUNOGLOBULIN G(IgG) ≧96% WITH ANTIBODIES TO CYTOMEGALOVIRUS 100U禾利行股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路311號3樓03126405BIOTEST PHARM GMBHLANDSTEINER STRABE 5, D-63303 DREIEICH,WEST GERMANYGERMANY2014-07-08瓶è£CYTOTECT CP BIOTEST單一劑é‡ç‚ºæ¯å…¬æ–¤é«”é‡æŠ•èˆ‡1 毫å‡æœ¬ç”¢å“。在進行移æ¤ç•¶å¤©æ‡‰é–‹å§‹æŠ•èˆ‡æœ¬å“。å°éª¨é«“移æ¤æ‚£è€…,在移æ¤å‰10 天å¯é–‹å§‹æŠ•äºˆæœ¬å“作為é 防用途,特別是在CMV 血清陽性的病人。本å“應æ¯2 至3 週投予一次,共計投予至少6 個單一劑é‡ã€‚
衛署èŒç–«è¼¸å—第000301號2019-12-202014-09-02èŒã€€ç–«DHA01000030100安在時B型è‚ç‚Žç–«è‹—é 防B型è‚炎懸液劑注射瓶;;é 充填型注射器附é‡é ;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨HEPATITIS B, ANTIGEN, SURFACEè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-09-25注射瓶::,,;;é 充填型注射器附é‡é ::,,;;ç›’è£::,,ENGERIX -B
衛署èŒç–«è¼¸å—第000301號2019-12-202014-09-02èŒã€€ç–«DHA01000030100安在時B型è‚ç‚Žç–«è‹—é 防B型è‚炎懸液劑注射瓶;;é 充填型注射器附é‡é ;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨HEPATITIS B, ANTIGEN, SURFACEè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.PARC DE LA NOIRE EPINE, RUE FLEMING 20, B-1300 WAVRE, BELGIUMBELGIUM2014-09-25注射瓶::,,;;é 充填型注射器附é‡é ::,,;;ç›’è£::,,ENGERIX -B
衛署èŒç–«è¼¸å—第000302號2013-04-242008-12-12èŒã€€ç–«DHA01000030202"愛默" 人體血清白蛋白5%注射液低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™„輸注器;;瓶è£æœªé™„輸注器é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN FRACTION Vå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING L.L.C.ROUTE 50 AND ARMOUR ROAD BRADLEY, IL 60915 USAUNITED STATES2014-04-28瓶è£é™„輸注器;;瓶è£æœªé™„輸注器ALBUMINAR-510000216
衛署èŒç–«è¼¸å—第000303號2018-04-241990-02-06èŒã€€ç–«DHA01000030304"愛默 " 人體血清白蛋白25%注射液低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™„輸注器;;瓶è£æœªé™„輸注器é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN FRACTION Vå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING L.L.C.ROUTE 50 NORTH, 1201 N. KINZIE, BRADLEY, IL 60915, USAUNITED STATES2014-04-28瓶è£é™„輸注器;;瓶è£æœªé™„輸注器ALBUMINAR-2510000217
衛署èŒç–«è¼¸å—第000308號2015-05-151990-05-15èŒã€€ç–«DHA01000030801兔抗胸腺細胞å…ç–«çƒè›‹ç™½é 防åŠæ²»ç™‚移æ¤ç‰©ä¹‹æŽ’斥(如腎臟移æ¤ã€å¿ƒè‡Ÿç§»æ¤åŠéª¨é«“移æ¤ï¼‰ï¼Œåš´é‡å†ç”Ÿä¸è‰¯æ€§è²§è¡€æ³¨å°„劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨IMMUNOGLOBULIN, RABBIT ANTI-HUMAN THYMOCYTE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356GENZYME LIMITED37 HOLLANDS ROAD, HAVERHILL, SUFFOLK, CB9 8PU, UNITED KINGDOMUNITED KINGDOM2014-11-03å°ç“¶è£THYMOGLOBULINE (ANTITHYMOCYTE IMMUNOGLOBULIN OF RABBIT ORIGIN)
衛署èŒç–«è¼¸å—第000308號2015-05-151990-05-15èŒã€€ç–«DHA01000030801兔抗胸腺細胞å…ç–«çƒè›‹ç™½é 防åŠæ²»ç™‚移æ¤ç‰©ä¹‹æŽ’斥(如腎臟移æ¤ã€å¿ƒè‡Ÿç§»æ¤åŠéª¨é«“移æ¤ï¼‰ï¼Œåš´é‡å†ç”Ÿä¸è‰¯æ€§è²§è¡€æ³¨å°„劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨IMMUNOGLOBULIN, RABBIT ANTI-HUMAN THYMOCYTE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356GENZYME POLYCLONALS S.A.S.1541 AVENUE MARCEL MERIEUX,BUILDINGS C4 & C5,69280 MARCY L'ETOILE, FRANCEFRANCE2014-11-03å°ç“¶è£THYMOGLOBULINE (ANTITHYMOCYTE IMMUNOGLOBULIN OF RABBIT ORIGIN)
衛署èŒç–«è¼¸å—第000308號2015-05-151990-05-15èŒã€€ç–«DHA01000030801兔抗胸腺細胞å…ç–«çƒè›‹ç™½é 防åŠæ²»ç™‚移æ¤ç‰©ä¹‹æŽ’斥(如腎臟移æ¤ã€å¿ƒè‡Ÿç§»æ¤åŠéª¨é«“移æ¤ï¼‰ï¼Œåš´é‡å†ç”Ÿä¸è‰¯æ€§è²§è¡€æ³¨å°„劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨IMMUNOGLOBULIN, RABBIT ANTI-HUMAN THYMOCYTE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356GENZYME IRELAND LIMITEDIDA INDUSTRIAL PARK, OLD KILMEADEN ROAD, WATERFORD, IRELANDIRELAND2014-11-03å°ç“¶è£THYMOGLOBULINE (ANTITHYMOCYTE IMMUNOGLOBULIN OF RABBIT ORIGIN)
衛署èŒç–«è¼¸å—第000309號2013-06-222008-07-29èŒã€€ç–«DHA01000030903"百特"抗血å‹ç—…å› å注射劑(單一åŒæºç´”化)A型血å‹ç—…(典型血å‹ç—…)注射劑瓶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨ANTIHEMOPHILIC FACTOR百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION911 N. DAVIS DRIVE CLEEVELAND, MISSISSIPPI 38732 U.S.A.UNITED STATES2008-11-26瓶è£"Baxter" HEMOFIL M, ANTIHEMOPHILIC FACTOR (HUMAN), METHOD M. "BAXTER"10000251
衛署èŒç–«è¼¸å—第000309號2013-06-222008-07-29èŒã€€ç–«DHA01000030903"百特"抗血å‹ç—…å› å注射劑(單一åŒæºç´”化)A型血å‹ç—…(典型血å‹ç—…)注射劑瓶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨ANTIHEMOPHILIC FACTOR百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION BAXTER BIOSCIENCE4501 COLORADO BLVD. LOS ANGELES, CALIFORNIA 90039 USA.UNITED STATES2008-11-26瓶è£"Baxter" HEMOFIL M, ANTIHEMOPHILIC FACTOR (HUMAN), METHOD M. "BAXTER"10000251
衛署èŒç–«è¼¸å—第000319號2015-12-101990-12-10èŒã€€ç–«DHA01000031906è¡€å‡ç´ ç¬¬å…«å› å注射劑(人類)5ï¼ï¼ï¼©ï¼µã€ï¼‘ï¼ï¼ï¼ï¼©ï¼µæ²»ç™‚åŠé 防血å‹ç—…Aå‡æ™¶æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨FACTOR VIII;;FACTOR VIII天行貿易股份有é™å…¬å¸å°åŒ—市ä¸å±±å€é•·å®‰æ±è·¯ä¸€æ®µ21號2樓11102308Grifols Therapeutics Inc.8368 US 70 BUS HWY WEST, CLAYTON, NC 27520, U.S.A.UNITED STATES2013-07-03å°ç“¶KOATE-DVI ANTIHEMOPHILIC FACTOR (HUMAN) 500IU,1000IU
衛署èŒç–«è¼¸å—第000320號2015-12-101990-12-10èŒã€€ç–«DHA01000032004è¡€å‡ç´ ç¬¬å…«å› å注射劑(人類)25ï¼ï¼©ï¼µæ²»ç™‚åŠé 防血å‹ç—…Aå‡æ™¶æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨FACTOR VIII天行貿易股份有é™å…¬å¸å°åŒ—市ä¸å±±å€é•·å®‰æ±è·¯ä¸€æ®µ21號2樓11102308Grifols Therapeutics Inc.8368 US 70 BUS HWY WEST, CLAYTON, NC 27520, U.S.A.UNITED STATES2013-07-03å°ç“¶KOATE-DVI ANTIHEMOPHILIC FACTOR (HUMAN) 250IU
衛署èŒç–«è¼¸å—第000334號2013-09-101991-07-22èŒã€€ç–«DHA01000033402“巴斯德â€æ²™è³“å°å…’麻痺å£æœç–«è‹—é 防å°å…’麻痺無èŒæ‡¸æ¶²åŠ‘å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨POLIOMYELITIS TYPE II VACCINE;;POLIOMYELITIS TYPE III VACCINE;;ALBUMIN HUMAN SERUM賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR S.A.1541, AV. MARCEL-MERIEUX, 69280 MARCY L'ETOILE FRANCE58, AVENUE LECLERC, 69007 LYON, FRANCEFRANCE2014-11-03å°ç“¶OPVERO10000138
衛署èŒç–«è¼¸å—第000351號2015-03-051992-06-25èŒã€€ç–«DHA01000035102ç„¡æ±žåŸºå› é‡çµ„B型è‚ç‚Žç–«è‹—é 防B型è‚炎注射劑盒è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨HEPATITIS B, ANTIGEN, SURFACE美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME B.V.WAARDERWEG 39,2031 BN,HAARLEM,THE NETHERLANDSNETHERLANDS2014-05-14ç›’è£;;ç›’è£H-B-VAX II INJECTION10000305
衛署èŒç–«è¼¸å—第000351號2015-03-051992-06-25èŒã€€ç–«DHA01000035102ç„¡æ±žåŸºå› é‡çµ„B型è‚ç‚Žç–«è‹—é 防B型è‚炎注射劑盒è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨HEPATITIS B, ANTIGEN, SURFACE美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME CORP.770 SUMNEYTOWN PIKE, WEST POINT, PA 19486 U.S.A.UNITED STATES2014-05-14ç›’è£;;ç›’è£H-B-VAX II INJECTION10000305
衛署èŒç–«è¼¸å—第000364號2019-07-102014-01-11èŒã€€ç–«DHA01000036401麻疹ã€è…®è…ºç‚ŽåŠå¾·åœ‹éº»ç–¹ä¸‰ç¨®æ··åˆç–«è‹—注射劑é 防麻疹ã€è…®è…ºç‚Žã€å¾·åœ‹éº»ç–¹å‡æ™¶æ³¨å°„劑å°ç“¶;;å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨MEASLES VACCINE, LIVE;;MUMPS VACCINE LIVE;;RUBELLA LIVE美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME B.V.WAARDERWEG 39,2031 BN,HAARLEM,THE NETHERLANDSNETHERLANDS2014-04-15å°ç“¶;;å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’M-M-R II (MEASLES, MUMPS AND RUBELLA VIRUS VACCINE, LIVE, MSD)10000132
衛署èŒç–«è¼¸å—第000364號2019-07-102014-01-11èŒã€€ç–«DHA01000036401麻疹ã€è…®è…ºç‚ŽåŠå¾·åœ‹éº»ç–¹ä¸‰ç¨®æ··åˆç–«è‹—注射劑é 防麻疹ã€è…®è…ºç‚Žã€å¾·åœ‹éº»ç–¹å‡æ™¶æ³¨å°„劑å°ç“¶;;å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨MEASLES VACCINE, LIVE;;MUMPS VACCINE LIVE;;RUBELLA LIVE美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME CORP.770 SUMNEYTOWN PIKE, WEST POINT, PA 19486 U.S.A.UNITED STATES2014-04-15å°ç“¶;;å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’M-M-R II (MEASLES, MUMPS AND RUBELLA VIRUS VACCINE, LIVE, MSD)10000132
衛署èŒç–«è¼¸å—第000369號2017-12-211992-12-11èŒã€€ç–«DHA01000036908巴斯德 BCG å…疫治療劑治療åŠé 防膀胱原發或復發性原ä½ç™Œæˆ–經尿é“切除後之表淺性乳é 瘤(TAåŠï¼´ï¼‘)注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨Bacillus Calmette-Guerin賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR LIMITED1755 STEELES AVENUE TORONTO ONTARIO CANADA M2R 3T4CANADA2014-11-03å°ç“¶BCG IMMUNOTHERAPEUTIC IMMUCYST
衛署èŒç–«è¼¸å—第000375號2019-09-112014-07-04èŒã€€ç–«DHA01000037503艾爾補定注射液25%低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN SERUM臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557INSTITUTO GRIFOLS S.A.POLIGONO LEVANTE C/CAN GUASCH 2, 08150 PARETS DEL VALLES BARCELONA SPAINSPAIN2014-07-22瓶è£ALBUTEIN 25% SOLUTION10000111
衛署èŒç–«è¼¸å—第000375號2019-09-112014-07-04èŒã€€ç–«DHA01000037503艾爾補定注射液25%低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN SERUM臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.5555 VALLEY BOULEVARD, LOS ANGELES, CALIFORNIA 90032UNITED STATES2014-07-22瓶è£ALBUTEIN 25% SOLUTION10000111
衛署èŒç–«è¼¸å—第000377號2019-11-042014-06-06èŒã€€ç–«DHA01000037707艾爾補定注射液5%低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN SERUM臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557INSTITUTO GRIFOLS S.A.POLIGONO LEVANTE C/CAN GUASCH 2, 08150 PARETS DEL VALLES BARCELONA SPAINSPAIN2014-06-27瓶è£::,,NORMAL SERUM ALBUMIN (HUMAN) ALBUTEIN 5% SOLUTION10000114
衛署èŒç–«è¼¸å—第000377號2019-11-042014-06-06èŒã€€ç–«DHA01000037707艾爾補定注射液5%低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN SERUM臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.5555 VALLEY BOULEVARD, LOS ANGELES, CALIFORNIA 90032UNITED STATES2014-06-27瓶è£::,,NORMAL SERUM ALBUMIN (HUMAN) ALBUTEIN 5% SOLUTION10000114
衛署èŒç–«è¼¸å—第000377號2019-11-042014-06-06èŒã€€ç–«DHA01000037707艾爾補定注射液5%低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN SERUM臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.13111 TEMPLE AVENUE, CITY OF INDUSTRY, CA 91746, USAUNITED STATES2014-06-27瓶è£::,,NORMAL SERUM ALBUMIN (HUMAN) ALBUTEIN 5% SOLUTION10000114
衛署èŒç–«è¼¸å—第000380號2018-07-172013-04-17èŒã€€ç–«DHA01000038009"百åˆ" 人白蛋白2ï¼ï¼…低蛋白血症ã€ä¼‘å…‹ã€å‚·å‚·æ³¨å°„劑安瓿;;注射瓶é™ç”±é†«å¸«ä½¿ç”¨HUMAN PLASMA PROTEINS禾利行股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路311號3樓03126405CAF-DCFDE TYRASLAAN, 109 BE-1120 BRUSSELS, BELGIUMBELGIUM2014-11-20安瓿;;注射瓶ALBIOMIN 20%02005802
衛署èŒç–«è¼¸å—第000400號2019-04-071994-12-13èŒã€€ç–«DHA01000040002"愛默" 人體血清白蛋白2ï¼ï¼…注射劑低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑玻璃瓶è£é™„輸注器é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMANå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING L.L.C.ROUTE 50 NORTH, 1201 N. KINZIE, BRADLEY, IL 60915, USAUNITED STATES2014-04-28玻璃瓶è£é™„輸注器ALBUMINAR-2010000382
衛署èŒç–«è¼¸å—第000422號2019-08-311996-12-09èŒã€€ç–«DHA01000042202"è²éˆ" 克療丙注射劑å…疫血清çƒè›‹ç™½ç¼ºä¹ç—‡ã€ï¼¡åž‹è‚ç‚Žçš„é 防ã€éº»ç–¹çš„é 防和治療注射液劑安瓿;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨IMMUNOGLOBULIN HUMANå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING GMBHEMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANYD-65925 FRANKFURT AM MAIN GERMANYGERMANY2014-06-04安瓿;;注射é‡ç’BERIGLOBIN P10000221
衛署èŒç–«è¼¸å—第000426號2014-12-041996-12-09èŒã€€ç–«DHA01000042607"è²éˆ"第八å‡è¡€å› å1ï¼ï¼ï¼åœ‹éš›å–®ä½æ³¨å°„劑先天åŠå¾Œå¤©ç¼ºä¹ç¬¬å…«å‡è¡€å› å注射劑å°ç“¶é™„溶液é™ç”±é†«å¸«ä½¿ç”¨vWF: RCO activity;;vWF ANTIGEN;;FACTOR VIIIå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING GMBHEMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANYD-65925 FRANKFURT AM MAIN GERMANYGERMANY2014-04-28å°ç“¶é™„溶液HAEMATE P 1000 I.U.10000291
衛署èŒç–«è¼¸å—第000427號2014-11-271996-12-09èŒã€€ç–«DHA01000042709"è²éˆ"第八å‡è¡€å› å5ï¼ï¼åœ‹éš›å–®ä½æ³¨å°„劑先天åŠå¾Œå¤©ç¼ºä¹ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液é™ç”±é†«å¸«ä½¿ç”¨FACTOR VIII;;vWF: RCO activity;;vWF ANTIGENå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING GMBHEMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANYD-65925 FRANKFURT AM MAIN GERMANYGERMANY2014-04-28å°ç“¶é™„溶液HAEMATE P 500I.U.10000292
衛署èŒç–«è¼¸å—第000428號2019-11-211996-12-04èŒã€€ç–«DHA01000042801å¿…å‡æ˜“得先天åŠå¾Œå¤©ç¼ºä¹ç¬¬å…«å‡è¡€å› åç—‡å‡æ™¶æ³¨å°„劑å°ç“¶;;å°ç“¶é™„溶液é™ç”±é†«å¸«ä½¿ç”¨HUMAN PLASMA FRACTION ENRICHED IN BLOOD COAGULATION FACTOR VIII AND HAVING A FACTOR VIII Cå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING GMBHEMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANYD-65925 FRANKFURT AM MAIN GERMANYGERMANY2014-07-30å°ç“¶;;å°ç“¶é™„溶液BERIATE10000393
衛署èŒç–«è¼¸å—第000430號2014-11-271996-12-04èŒã€€ç–«DHA01000043001"è²éˆ" 第八å‡è¡€å› å注射劑先天åŠå¾Œå¤©ç¼ºä¹ç¬¬å…«å‡è¡€å› å注射劑å°ç“¶é™„溶液é™ç”±é†«å¸«ä½¿ç”¨FACTOR VIII;;FACTOR VIIIå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING GMBHEMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANYD-65925 FRANKFURT AM MAIN GERMANYGERMANY2014-04-28å°ç“¶é™„溶液HAEMATE P10000293
衛署èŒç–«è¼¸å—第000439號2018-03-151997-02-03èŒã€€ç–«DHA01000043903å‡è¡€çº–ç¶è›‹ç™½åŽŸæ³¨å°„液出血症注射劑å°ç“¶é™„溶液é™ç”±é†«å¸«ä½¿ç”¨FIBRINOGEN HUMAN;;PLASMA PROTEIN HUMANå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING GMBHEMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANYD-65925 FRANKFURT AM MAIN GERMANYGERMANY2014-04-28å°ç“¶é™„溶液HAEMOCOMPLETTAN10000223
衛署èŒç–«è¼¸å—第000440號2017-02-131997-02-13èŒã€€ç–«DHA01000044001巴斯德å°å…’麻痺注射疫苗é 防å°å…’麻痺症。滅èŒæ‡¸æ¶²æ³¨å°„劑安瓿;;瓶è£;;瓶è£;;ç›’è£;;注射é‡ç’;;支è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨INACTIVATED POLIO VIRUS -TYPE 1;;INACTIVATED POLIO VIRUS - TYPE 2;;INACTIVATED POLIO VIRUS -TYPE 3賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR S.A.1541, AV. MARCEL-MERIEUX, 69280 MARCY L'ETOILE FRANCE58, AVENUE LECLERC, 69007 LYON, FRANCEFRANCE2014-11-03安瓿;;瓶è£;;瓶è£;;ç›’è£;;注射é‡ç’;;支è£IMOVAX POLIO
衛署èŒç–«è¼¸å—第000440號2017-02-131997-02-13èŒã€€ç–«DHA01000044001巴斯德å°å…’麻痺注射疫苗é 防å°å…’麻痺症。滅èŒæ‡¸æ¶²æ³¨å°„劑安瓿;;瓶è£;;瓶è£;;ç›’è£;;注射é‡ç’;;支è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨INACTIVATED POLIO VIRUS -TYPE 1;;INACTIVATED POLIO VIRUS - TYPE 2;;INACTIVATED POLIO VIRUS -TYPE 3賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR S.A.PARC INDUSTRIEL D'INCARVILLE, BP.101, 27101(OR 27100), VAL DE REUIL CEDEX, FRANCEFRANCE2014-11-03安瓿;;瓶è£;;瓶è£;;ç›’è£;;注射é‡ç’;;支è£IMOVAX POLIO
衛署èŒç–«è¼¸å—第000446號2012-03-141997-03-14èŒã€€ç–«DHA01000044600"百åˆ" çƒè›‹ç™½éœè„ˆæ³¨å°„液原發性體液性å…ç–«ä¸å…¨ã€åŽŸç™¼æ€§è¡€å°æ¿æ¸›å°‘ç´«æ–‘ç—…ã€éª¨é«“移æ¤ã€å°å…’HIV感染ã€å·å´Žç—‡ã€‚注射劑安瓿;;注射瓶é™ç”±é†«å¸«ä½¿ç”¨PROTEIN禾利行股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路311號3樓03126405BIOTEST PHARMA GMBHLANDSTEINER STRABE 5,D-63303 DREIEICH, GERMANYGERMANY2010-07-26安瓿;;注射瓶INTRAGLOBIN F "BIOTEST"
衛署èŒç–«è¼¸å—第000450號2017-05-071997-05-07èŒã€€ç–«DHA01000045004美瑞克水痘之主動å…疫。å‡æ™¶æ³¨å°„劑盒è£;;å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨LIVE ATTENUATED VARICELLA VIRUS VACCINE,OKA STRAINè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-12-04ç›’è£;;å°ç“¶VARILRIX
衛署èŒç–«è¼¸å—第000450號2017-05-071997-05-07èŒã€€ç–«DHA01000045004美瑞克水痘之主動å…疫。å‡æ™¶æ³¨å°„劑盒è£;;å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨LIVE ATTENUATED VARICELLA VIRUS VACCINE,OKA STRAINè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.PARC DE LA NOIRE EPINE, RUE FLEMING 20, B-1300 WAVRE, BELGIUMBELGIUM2014-12-04ç›’è£;;å°ç“¶VARILRIX
衛署èŒç–«è¼¸å—第000452號2018-10-141997-05-17èŒã€€ç–«DHA01000045208B型è‚ç‚Žå…疫人血çƒè›‹ç™½æ³¨å°„液é 防B型è‚炎之感染注射劑å°ç“¶;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨HEPATITIS B IMMUNOGLOBULIN天行貿易股份有é™å…¬å¸å°åŒ—市ä¸å±±å€é•·å®‰æ±è·¯ä¸€æ®µ21號2樓11102308Grifols Therapeutics Inc.8368 US 70 BUS HWY WEST, CLAYTON, NC 27520, U.S.A.UNITED STATES2014-07-02å°ç“¶;;注射é‡ç’HEPATITIS B IMMUNE GLOBULIN (HUMAN), HYPERHEP B S/D用法用é‡æ–°å¢žï¼š1.HBsAg陽性的病人接å—è‚臟移æ¤å¾Œï¼Œå…¶ç§»æ¤é«”å†åº¦æ„ŸæŸ“之é 防。2.HBsAg 陽性的病人接å—è‚臟移æ¤å¾Œï¼Œå…¶ç§»æ¤é«”å†åº¦æ„ŸæŸ“之é 防。手術後å‰ä¸ƒå¤©ï¼Œé ˆæ¯æ—¥è¼¸æ³¨2000IU,繼之,長期治療至少需6 個月,且治療期間應æ¯å€‹æœˆç›£è¦–並ç¶æŒè¡€æ¶²å…§B åž‹è‚炎抗體效價為100IU/L。本å“æ¯å°ç“¶æˆ–æ¯é‡åŠ‘å…§å«æœ‰çš„anti-HBs 抗體效價,ç‰æ–¼æˆ–大於æ¯æ¯«å‡220 個國際單ä½(≥220 IU/mL)。å‡ä½¿éœ€è¦ä½¿ç”¨è¼ƒå¤šåŠ‘量,建è°åˆ†æ•£ç‚ºå¹¾å€‹å°åŠ‘量於ä¸åŒéƒ¨ä½é€²è¡Œè‚Œè‚‰æ³¨å°„,æ¤é©ç”¨æ–¼éœ€æ³¨å°„2mL 以上劑量的å°å©ï¼ŒåŠéœ€æ³¨å°„5mL 以上劑量的æˆäººã€‚注射的部ä½å¿…é ˆè¦–æ³¨å°„çš„é‡å¤šå¯¡è€Œå®šï¼Œæœ€å¥½æ–¼ä¸Šè‡‚的三角肌或大腿外å´è‚Œè‚‰é€²è¡Œè‚Œè‚‰æ³¨å°„,臀部ä¸æ‡‰åšç‚ºä¾‹è¡Œçš„注射部ä½ï¼Œå› 為有傷到å骨神經的å±éšª(見注æ„äº‹é …)。10000078
衛署èŒç–«è¼¸å—第000453號2017-05-202006-09-15èŒã€€ç–«DHA01000045300巴斯德æµæ„Ÿç–«è‹—é 防æµæ„Ÿã€‚æ»…èŒæ‡¸æ¶²æ³¨å°„劑注射é‡ç’;;ç›’è£;;注射é‡ç’;;ç›’è£;;ç›’è£;;å°ç“¶è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/California/7/2009(H1N1);;A/Victoria/361/2011(H3N2);;B/Massachusetts/02/2012賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR S.A.PARC INDUSTRIEL D'INCARVILLE, BP.101, 27101(OR 27100), VAL DE REUIL CEDEX, FRANCEFRANCE2014-11-03注射é‡ç’;;ç›’è£;;注射é‡ç’;;ç›’è£;;ç›’è£;;å°ç“¶è£;;ç›’è£VAXIGRIP
衛署èŒç–«è¼¸å—第000456號2017-07-281997-07-28èŒã€€ç–«DHA01000045603新赫寶克A型è‚炎之主動å…疫。滅èŒæ‡¸æ¶²æ³¨å°„劑å°ç“¶;;注射é‡ç’é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨HEPATITIS Aè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19å°ç“¶;;注射é‡ç’HAVRIX 1440/720 JUNIOR
衛署èŒç–«è¼¸å—第000457號2017-07-301997-07-30èŒã€€ç–«DHA01000045705巴斯德傷寒疫苗é 防傷寒熱。注射劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PURE FOOD GLAZE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR S.A.1541, AV. MARCEL-MERIEUX, 69280 MARCY L'ETOILE FRANCE58, AVENUE LECLERC, 69007 LYON, FRANCEFRANCE2014-11-03å°ç“¶TYPHIM VI
衛署èŒç–«è¼¸å—第000461號2019-08-311997-08-20èŒã€€ç–«DHA01000046109ç ´å‚·é¢¨é 防注射劑 250 Unitsé é˜²ç ´å‚·é¢¨æ³¨å°„åŠ‘æ³¨å°„é‡ç’é™ç”±é†«å¸«ä½¿ç”¨Human immunoglobulin proteins with Tetanus potency天行貿易股份有é™å…¬å¸å°åŒ—市ä¸å±±å€é•·å®‰æ±è·¯ä¸€æ®µ21號2樓11102308Grifols Therapeutics Inc.8368 US 70 BUS HWY WEST, CLAYTON, NC 27520, U.S.A.UNITED STATES2014-05-15注射é‡ç’TETANUS IMMUNE GLOBULIN (HUMAN), HYPERTET S/D10000201
衛署èŒç–«è¼¸å—第000462號2019-01-051997-08-20èŒã€€ç–«DHA01000046201æŠ—ï¼²ï¼¨å› åçƒè›‹ç™½æ³¨å°„液é é˜²å› é…å¶é–“ï¼²ï¼¨å› åä¸åŒè€Œå°Žè‡´ä¹‹æµç”¢åŠåˆç”Ÿå…’å¤æŠ˜æ³¨å°„劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨GAMMA GLOBULIN, ANTI-RHO (D)天行貿易股份有é™å…¬å¸å°åŒ—市ä¸å±±å€é•·å®‰æ±è·¯ä¸€æ®µ21號2樓11102308Grifols Therapeutics Inc.8368 US 70 BUS HWY WEST, CLAYTON, NC 27520, U.S.A.UNITED STATES2013-11-27注射é‡ç’RHO (D) IMMUNE GLOBULIN (HUMAN), HYPERRHO S/D FULL DOSE10000087
衛署èŒç–«è¼¸å—第000480號2018-02-091998-02-09èŒã€€ç–«DHA01000048000ä¼ç—˜æ•ã€€æ´»æ€§æ°´ç—˜ç–«è‹—水痘之主動å…疫。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨OKA/MERCK VARICELLA VIRUS美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME B.V.WAARDERWEG 39,2031 BN,HAARLEM,THE NETHERLANDSNETHERLANDS2013-12-05ç›’è£;;å°ç“¶VARIVAX -VARICELLA VIRUS VACCINE
衛署èŒç–«è¼¸å—第000480號2018-02-091998-02-09èŒã€€ç–«DHA01000048000ä¼ç—˜æ•ã€€æ´»æ€§æ°´ç—˜ç–«è‹—水痘之主動å…疫。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨OKA/MERCK VARICELLA VIRUS美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME CORP.770 SUMNEYTOWN PIKE, WEST POINT, PA 19486 U.S.A.UNITED STATES2013-12-05ç›’è£;;å°ç“¶VARIVAX -VARICELLA VIRUS VACCINE
衛署èŒç–«è¼¸å—第000480號2018-02-091998-02-09èŒã€€ç–«DHA01000048000ä¼ç—˜æ•ã€€æ´»æ€§æ°´ç—˜ç–«è‹—水痘之主動å…疫。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨OKA/MERCK VARICELLA VIRUS美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720JUBILANT HOLLISTERSTIER LLC3525 NORTH REGAL STREET SPOKANE, WA 99207, USAUNITED STATES2013-12-05ç›’è£;;å°ç“¶VARIVAX -VARICELLA VIRUS VACCINE
衛署èŒç–«è¼¸å—第000481號2018-02-091998-02-09èŒã€€ç–«DHA01000048102嬰è·å¯§é 防白喉ã€ç™¾æ—¥å’³åŠç ´å•†é¢¨ã€‚æ»…èŒæ‡¸æ¶²æ³¨å°„劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PERTUSSIS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;PERTACTINE (OUTER MEMBRANE PROTEIN 69K);;DIPHTHERIA TOXOID;;TETANUS TOXOIDè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19å°ç“¶INFANRIX DTPOA
衛署èŒç–«è¼¸å—第000481號2018-02-091998-02-09èŒã€€ç–«DHA01000048102嬰è·å¯§é 防白喉ã€ç™¾æ—¥å’³åŠç ´å•†é¢¨ã€‚æ»…èŒæ‡¸æ¶²æ³¨å°„劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PERTUSSIS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;PERTACTINE (OUTER MEMBRANE PROTEIN 69K);;DIPHTHERIA TOXOID;;TETANUS TOXOIDè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.PARC DE LA NOIRE EPINE, RUE FLEMING 20, B-1300 WAVRE, BELGIUMBELGIUM2014-08-19å°ç“¶INFANRIX DTPOA
衛署èŒç–«è¼¸å—第000487號2018-03-101998-03-10èŒã€€ç–«DHA01000048701艾爾補定注射液2ï¼ï¼…低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN SERUM臺ç£ç¶ åå—股份有é™å…¬å¸è‡ºåŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557INSTITUTO GRIFOLS S.A.POLIGONO LEVANTE C/CAN GUASCH 2, 08150 PARETS DEL VALLES BARCELONA SPAINSPAIN2014-07-11瓶è£ALBUTEIN 20% SOLUTION
衛署èŒç–«è¼¸å—第000487號2018-03-101998-03-10èŒã€€ç–«DHA01000048701艾爾補定注射液2ï¼ï¼…低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN SERUM臺ç£ç¶ åå—股份有é™å…¬å¸è‡ºåŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.5555 VALLEY BOULEVARD, LOS ANGELES, CALIFORNIA 90032UNITED STATES2014-07-11瓶è£ALBUTEIN 20% SOLUTION
衛署èŒç–«è¼¸å—第000487號2018-03-101998-03-10èŒã€€ç–«DHA01000048701艾爾補定注射液2ï¼ï¼…低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN SERUM臺ç£ç¶ åå—股份有é™å…¬å¸è‡ºåŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.13111 TEMPLE AVENUE, CITY OF INDUSTRY, CA 91746, USAUNITED STATES2014-07-11瓶è£ALBUTEIN 20% SOLUTION
衛署èŒç–«è¼¸å—第000489號2018-04-041998-04-04èŒã€€ç–«DHA01000048905ç‘žåšæ³¨å°„液病患接å—ç¶“çš®ç®¡å…§å† ç‹€å‹•è„ˆè¡€ç®¡æˆå½¢è¡“(PTCA)ã€å† ç‹€å‹•è„ˆç²¥ç‹€ç¡¬åŒ–åˆ‡é™¤ï¼ˆï¼¤ï¼£ï¼¡ï¼‰æˆ–å› æ€¥éœ€æ”¾ç½®è¡€ç®¡æ”¯æž¶ã€ç”¨æ–¼é 防發生缺血性之心臟併發症時ã€æˆ–ç—…æ‚£å°å‚³çµ±ç™‚法無å應ã€å·²é å®šæ–½è¡Œç¶“çš®å† ç‹€å‹•è„ˆæˆå½¢è¡“之ä¸ç©©å®šç‹¹å¿ƒç—‡æ™‚ã€åšç‚ºï¼¨ï¼¥ï¼°ï¼¡ï¼²ï¼©ï¼®å’Œï¼¡ï¼³ï¼°ï¼©ï¼²ï¼©ï¼®çš„輔助療法。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨ABCIXIMAB (C7E3 FAB)臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803Janssen Biologics B.V.EINSTEINWEG 101, 2333 CB LEIDEN, THE NETHERLANDSNETHERLANDS2014-05-29å°ç“¶REOPRO(ABCIXIMAB 2MG/ML)
衛署èŒç–«è¼¸å—第000489號2018-04-041998-04-04èŒã€€ç–«DHA01000048905ç‘žåšæ³¨å°„液病患接å—ç¶“çš®ç®¡å…§å† ç‹€å‹•è„ˆè¡€ç®¡æˆå½¢è¡“(PTCA)ã€å† ç‹€å‹•è„ˆç²¥ç‹€ç¡¬åŒ–åˆ‡é™¤ï¼ˆï¼¤ï¼£ï¼¡ï¼‰æˆ–å› æ€¥éœ€æ”¾ç½®è¡€ç®¡æ”¯æž¶ã€ç”¨æ–¼é 防發生缺血性之心臟併發症時ã€æˆ–ç—…æ‚£å°å‚³çµ±ç™‚法無å應ã€å·²é å®šæ–½è¡Œç¶“çš®å† ç‹€å‹•è„ˆæˆå½¢è¡“之ä¸ç©©å®šç‹¹å¿ƒç—‡æ™‚ã€åšç‚ºï¼¨ï¼¥ï¼°ï¼¡ï¼²ï¼©ï¼®å’Œï¼¡ï¼³ï¼°ï¼©ï¼²ï¼©ï¼®çš„輔助療法。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨ABCIXIMAB (C7E3 FAB)臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803CILAG AG.HOCHSTRASSE 201 CH-8205 SCHAFFHAUSEN SWITZERLANDSWITZERLAND2014-05-29å°ç“¶REOPRO(ABCIXIMAB 2MG/ML)
衛署èŒç–«è¼¸å—第000489號2018-04-041998-04-04èŒã€€ç–«DHA01000048905ç‘žåšæ³¨å°„液病患接å—ç¶“çš®ç®¡å…§å† ç‹€å‹•è„ˆè¡€ç®¡æˆå½¢è¡“(PTCA)ã€å† ç‹€å‹•è„ˆç²¥ç‹€ç¡¬åŒ–åˆ‡é™¤ï¼ˆï¼¤ï¼£ï¼¡ï¼‰æˆ–å› æ€¥éœ€æ”¾ç½®è¡€ç®¡æ”¯æž¶ã€ç”¨æ–¼é 防發生缺血性之心臟併發症時ã€æˆ–ç—…æ‚£å°å‚³çµ±ç™‚法無å應ã€å·²é å®šæ–½è¡Œç¶“çš®å† ç‹€å‹•è„ˆæˆå½¢è¡“之ä¸ç©©å®šç‹¹å¿ƒç—‡æ™‚ã€åšç‚ºï¼¨ï¼¥ï¼°ï¼¡ï¼²ï¼©ï¼®å’Œï¼¡ï¼³ï¼°ï¼©ï¼²ï¼©ï¼®çš„輔助療法。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨ABCIXIMAB (C7E3 FAB)臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803HOSPIRA INC.1776 NORTH CENTENNIAL DRIVE, MCPHERSON, KANSAS 67460, USAUNITED STATES2014-05-29å°ç“¶REOPRO(ABCIXIMAB 2MG/ML)
衛署èŒç–«è¼¸å—第000491號2018-05-251998-04-22èŒã€€ç–«DHA01000049105"è²éˆ" 血清蛋白注射液2ï¼ï¼…低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£;;安瓿é™ç”±é†«å¸«ä½¿ç”¨HUMAN ALBUMINå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING AGWANKDORFSTRASSE 10 CH-3000 BERN 22, SWITZERLANDSWITZERLAND2014-04-28瓶è£;;安瓿HUMAN ALBUMIN 20% "BEHRING"10000429
衛署èŒç–«è¼¸å—第000491號2018-05-251998-04-22èŒã€€ç–«DHA01000049105"è²éˆ" 血清蛋白注射液2ï¼ï¼…低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£;;安瓿é™ç”±é†«å¸«ä½¿ç”¨HUMAN ALBUMINå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING L.L.C.ROUTE 50 NORTH AND ARMOUR ROAD, P.O.BOX 511, KANKAKEE IL 60901, U.S.A.UNITED STATES2014-04-28瓶è£;;安瓿HUMAN ALBUMIN 20% "BEHRING"10000429
衛署èŒç–«è¼¸å—第000491號2018-05-251998-04-22èŒã€€ç–«DHA01000049105"è²éˆ" 血清蛋白注射液2ï¼ï¼…低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£;;安瓿é™ç”±é†«å¸«ä½¿ç”¨HUMAN ALBUMINå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING GMBHEMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANYD-65925 FRANKFURT AM MAIN GERMANYGERMANY2014-04-28瓶è£;;安瓿HUMAN ALBUMIN 20% "BEHRING"10000429
衛署èŒç–«è¼¸å—第000492號2018-04-291998-04-29èŒã€€ç–«DHA01000049207ç´è’™è‚ºå¤šåƒ¹æ€§è‚ºç‚ŽéˆçƒèŒç–«è‹—é 防肺炎éˆçƒèŒæ€§è‚ºç‚ŽåŠè‚ºç‚ŽéˆçƒèŒæ€§èŒè¡€ç—‡ã€‚注射劑å°ç“¶;;ç›’è£;;å°ç“¶;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨CAPSULAR POLYSACCHARIDE PURIFIED美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME B.V.WAARDERWEG 39,2031 BN,HAARLEM,THE NETHERLANDSNETHERLANDS2013-10-28å°ç“¶;;ç›’è£;;å°ç“¶;;ç›’è£PNEUMOVAX 23 (PNEUMOCOCCAL VACCINE POLYVALENT)
衛署èŒç–«è¼¸å—第000492號2018-04-291998-04-29èŒã€€ç–«DHA01000049207ç´è’™è‚ºå¤šåƒ¹æ€§è‚ºç‚ŽéˆçƒèŒç–«è‹—é 防肺炎éˆçƒèŒæ€§è‚ºç‚ŽåŠè‚ºç‚ŽéˆçƒèŒæ€§èŒè¡€ç—‡ã€‚注射劑å°ç“¶;;ç›’è£;;å°ç“¶;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨CAPSULAR POLYSACCHARIDE PURIFIED美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME CORP.770 SUMNEYTOWN PIKE, WEST POINT, PA 19486 U.S.A.UNITED STATES2013-10-28å°ç“¶;;ç›’è£;;å°ç“¶;;ç›’è£PNEUMOVAX 23 (PNEUMOCOCCAL VACCINE POLYVALENT)
衛署èŒç–«è¼¸å—第000497號2018-05-201998-12-09èŒã€€ç–«DHA01000049704ã€åŸºç«‹ç¦ã€žä¹¾ç‡¥ç¬¬ä¹å‡è¡€å› å注射劑é 防åŠæ²»ç™‚乙型血å‹ç—…åŠç¼ºä¹ç¬¬ä¹å‡è¡€å› å。å‡æ™¶æ³¨å°„劑å°ç“¶;;安瓿é™ç”±é†«å¸«ä½¿ç”¨FACTOR IX臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.5555 VALLEY BOULEVARD, LOS ANGELES, CALIFORNIA 90032UNITED STATES2013-01-09å°ç“¶;;安瓿ALPHANINE SD COAGULATION FACTOR IX(HUMAN)10000497
衛署èŒç–«è¼¸å—第000497號2018-05-201998-12-09èŒã€€ç–«DHA01000049704ã€åŸºç«‹ç¦ã€žä¹¾ç‡¥ç¬¬ä¹å‡è¡€å› å注射劑é 防åŠæ²»ç™‚乙型血å‹ç—…åŠç¼ºä¹ç¬¬ä¹å‡è¡€å› å。å‡æ™¶æ³¨å°„劑å°ç“¶;;安瓿é™ç”±é†«å¸«ä½¿ç”¨FACTOR IX臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.13111 TEMPLE AVENUE, CITY OF INDUSTRY, CA 91746, USAUNITED STATES2013-01-09å°ç“¶;;安瓿ALPHANINE SD COAGULATION FACTOR IX(HUMAN)10000497
衛署èŒç–«è¼¸å—第000501號2018-06-291998-06-29èŒã€€ç–«DHA01000050108"唯德" ä¸æ´»åŒ–A型è‚ç‚Žç–«è‹—é 防A型è‚炎。注射劑å°ç“¶è£;;é‡ç’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨Hepatitis A Virus, Purified, Inactivated美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME B.V.WAARDERWEG 39,2031 BN,HAARLEM,THE NETHERLANDNETHERLANDS2014-02-10å°ç“¶è£;;é‡ç’è£VAQTA (HEPATITIS A VACCINE, INACTIVATED)
衛署èŒç–«è¼¸å—第000501號2018-06-291998-06-29èŒã€€ç–«DHA01000050108"唯德" ä¸æ´»åŒ–A型è‚ç‚Žç–«è‹—é 防A型è‚炎。注射劑å°ç“¶è£;;é‡ç’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨Hepatitis A Virus, Purified, Inactivated美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME CORP.770 SUMNEYTOWN PIKE, WEST POINT, PA 19486 U.S.A.UNITED STATES2014-02-10å°ç“¶è£;;é‡ç’è£VAQTA (HEPATITIS A VACCINE, INACTIVATED)
衛署èŒç–«è¼¸å—第000503號2013-07-071998-07-07èŒã€€ç–«DHA01000050302è«¾å’Œç¬¬ä¸ƒå› å注射劑A型åŠï¼¢åž‹è¡€å‹ç—…發生抗第八åŠç¬¬ä¹å› å抗體者ã€å¾Œå¤©æ€§è¡€å‹ç—…(發生抗第八åŠç¬¬ä¹å› å抗體者)ã€ç¼ºä¹ç¬¬ä¸ƒå› å者,GLANZMANNS THROMBASTHENIA。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SDK 2820 GENTOFTE.DENMARKDENMARK2013-01-17å°ç“¶é™„溶液NOVOSEVEN詳如ä¸æ–‡ä»¿å–®æ ¸å®šæœ¬ã€‚
衛署èŒç–«è¼¸å—第000509號2013-11-171998-11-17èŒã€€ç–«DHA01000050901巴斯德b型嗜血桿èŒæŽ¥åˆç–«è‹—é 防由b型æµè¡Œæ€§æ„Ÿå†’嗜血桿èŒé€ æˆä¹‹ä¾µå…¥æ€§ç–¾ç—…。å‡æ™¶æ³¨å°„劑å°ç“¶;;ç›’è£;;注射é‡ç’;;å°ç“¶;;ç›’è£;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨TETANUS賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR S.A.1541, AV. MARCEL-MERIEUX, 69280 MARCY L'ETOILE FRANCE58, AVENUE LECLERC, 69007 LYON, FRANCEFRANCE2014-11-03å°ç“¶;;ç›’è£;;注射é‡ç’;;å°ç“¶;;ç›’è£;;注射é‡ç’ACT-HIBå…月齡大之å‰ï¼šä»¥ä¸€åˆ°å…©å€‹æœˆé–“隔注射三劑 (æ¯åŠ‘0.5毫å‡)ï¼Œç¬¬ä¸‰åŠ‘æ³¨å°„ä¸€å¹´å¾Œï¼Œè¿½åŠ æ³¨å°„ä¸€åŠ‘ (0.5毫å‡)。
衛署èŒç–«è¼¸å—第000510號2018-12-041998-12-04èŒã€€ç–«DHA01000051009派立克麻疹ã€è…®è…ºç‚ŽåŠå¾·åœ‹éº»ç–¹ä¹‹ä¸»å‹•å…疫。å‡æ™¶æ³¨å°„劑注射é‡ç’é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨MUMPS VACCINE LIVE ATTENUATED;;RUBELLA VACCINE LIVE ATTENUATED;;MEASLES VACCINE, LIVE ATTENUATEDè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-12-09注射é‡ç’::,,PRIORIX
衛署èŒç–«è¼¸å—第000510號2018-12-041998-12-04èŒã€€ç–«DHA01000051009派立克麻疹ã€è…®è…ºç‚ŽåŠå¾·åœ‹éº»ç–¹ä¹‹ä¸»å‹•å…疫。å‡æ™¶æ³¨å°„劑注射é‡ç’é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨MUMPS VACCINE LIVE ATTENUATED;;RUBELLA VACCINE LIVE ATTENUATED;;MEASLES VACCINE, LIVE ATTENUATEDè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.PARC DE LA NOIRE EPINE, RUE FLEMING 20, B-1300 WAVRE, BELGIUMBELGIUM2014-12-09注射é‡ç’::,,PRIORIX
衛署èŒç–«è¼¸å—第000516號2014-02-091999-02-09èŒã€€ç–«DHA01000051608康諾å¸é™„白喉ã€ç ´å‚·é¢¨ã€ç„¡ç´°èƒžæ€§ç™¾æ—¥å’³ç–«è‹—é 防白喉ã€ç ´å‚·é¢¨å’Œç™¾æ—¥å’³ã€‚注射劑å°ç“¶;;支è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨è³½è«¾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356AVENTIS PASTER LIMITED1755 STEELES AVENUE TORONTO ONTARIO CANADA M2R 3T4CANADA2014-11-03å°ç“¶;;支è£;;ç›’è£TRIPACEL
衛署èŒç–«è¼¸å—第000520號2019-03-151999-03-15èŒã€€ç–«DHA01000052002第ä¹å‡è¡€å› å複åˆæ³¨å°„劑 25ï¼ï¼ï¼•ï¼ï¼é é˜²ä¸¦æ²»ç™‚å› å…ˆå¤©æ€§æˆ–å¾Œå¤©æ€§ç¼ºä¹ç¬¬äºŒã€ç¬¬ä¸ƒã€ç¬¬ä¹ã€ç¬¬åå‡è¡€å› åæ‰€é€ æˆçš„出血。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑玻璃å°ç“¶è£;;玻璃å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨FACTOR II;;FACTOR VII;;FACTOR IX;;FACTOR X;;Protein C;;Protein S Antigenå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING GMBHEMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANYD-65925 FRANKFURT AM MAIN GERMANYGERMANY2014-11-10玻璃å°ç“¶è£::,,;;玻璃å°ç“¶è£BERIPLEX P/N 250/500
衛署èŒç–«è¼¸å—第000523號2019-04-161999-04-16èŒã€€ç–«DHA01000052305ä¼æµæ„Ÿç–«è‹—é 防æµè¡Œæ€§æ„Ÿå†’。滅èŒæ‡¸æ¶²æ³¨å°„劑SYRINGEè£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/California/7/2009(H1N1)-like virus;;A/Perth/16/2009 (H3N2)-like virus;;B/Brisbane/60/2008-like virusè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS BRANCH OF SMITHKLINE BEECHAM PHARMA GmbH & CO. KGZIRKUSSTR 40 01069 DRESDEN GERMANYGERMANY2014-08-19SYRINGEè£;;ç›’è£FLUARIX
衛署èŒç–«è¼¸å—第000525號2019-04-201999-04-20èŒã€€ç–«DHA01000052509ã€æ„›åŠ›æ ¹ã€žä¿å¦¥é©ä¹¾ç²‰æ³¨å°„劑眼瞼痙攣ã€åŠé¢ç—™æ”£ã€å±€éƒ¨è‚Œè‚‰ç—™æ”£ç—‡ã€æ–œè¦–ã€ç—™æ”£æ€§æ–œé ¸ã€å°å…’腦性痲痹引起之肌肉痙攣。上臉部皺紋(皺眉紋ã€æŠ¬é ç´‹ã€éšå°¾ç´‹)ã€åŽŸç™¼æ€§è…‹çª©å¤šæ±—症。æˆäººä¸é¢¨å¾Œä¹‹æ‰‹è‡‚ç—™æ”£ã€‚å› è„Šéš¨ç—…è®Šæ‰€å¼•èµ·çš„é€¼å°¿è‚ŒéŽå‹•è€Œå°Žè‡´å°¿å¤±ç¦ä¹‹æˆäººç—…患,且經抗膽鹼類藥物治療無效或無法è€å—者。治療有尿失ç¦ã€å°¿æ€¥èˆ‡é »å°¿ç‰è†€èƒ±éŽå‹•ç—‡çš„æˆäººç—…患,經抗膽鹼類藥物治療å應ä¸ä½³æˆ–無法è€å—å¿…é ˆåœè—¥ï¼Œä¸”如有需è¦æ™‚,願æ„åŠèƒ½å¤ 於治療後進行乾淨間æ‡æ€§å°Žå°¿(Clean intermittent catheterization) 者。乾粉注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨BOTULINUM TOXIN TYPE Aå°ç£æ„›åŠ›æ ¹è—¥å“股份有é™å…¬å¸å°åŒ—市ä¸æ£å€ç¾…æ–¯ç¦è·¯2段102號9樓53529261ALLERGAN PHARMACEUTICALS IRELANDCASTLEBAR ROAD, WESTPORT COUNTY MAYO,IRELANDIRELAND2014-08-14å°ç“¶BOTOX (BOTULINUM TOXIN TYPE A) PURIFIED NEUROTOXIN COMPLEX "ALLERGAN"
衛署èŒç–«è¼¸å—第000526號2014-05-201999-05-20èŒã€€ç–«DHA01000052601æ–°ç¦æ¨‚å‡æ™¶æ³¨å°„劑用於新的腎臟移æ¤(DE NOVO RENAL TRANSPLANTATION)ã€é 防急性器官排斥ç¾è±¡ä¹‹ç™¼ç”Ÿï¼Œè€Œä¸”是伴隨以CYCLOSPORIN的微乳劑型(MICROEMULSION)和皮質固醇為基礎的å…疫抑制劑治療方å¼ä½µç”¨ï¼›æˆ–與CYCLOSPORIN的微乳劑型(MICROEMULSION)ã€çš®è³ªå›ºé†‡åŠ å…¥AZATHIOPRINE 或 MYCOPHENOLATE MOFETIL 的三é‡å…疫抑制劑為主的治療方å¼ä½µç”¨ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶;;安瓿é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589TAKEDA AUSTRIA GMBHST. PETER-STRASSE 25 A-4020 LINZ, AUSTRIAAUSTRIA2014-10-09å°ç“¶;;安瓿SIMULECT LYOPHILISATE FOR INJECTION 4MG/ML
衛署èŒç–«è¼¸å—第000526號2014-05-201999-05-20èŒã€€ç–«DHA01000052601æ–°ç¦æ¨‚å‡æ™¶æ³¨å°„劑用於新的腎臟移æ¤(DE NOVO RENAL TRANSPLANTATION)ã€é 防急性器官排斥ç¾è±¡ä¹‹ç™¼ç”Ÿï¼Œè€Œä¸”是伴隨以CYCLOSPORIN的微乳劑型(MICROEMULSION)和皮質固醇為基礎的å…疫抑制劑治療方å¼ä½µç”¨ï¼›æˆ–與CYCLOSPORIN的微乳劑型(MICROEMULSION)ã€çš®è³ªå›ºé†‡åŠ å…¥AZATHIOPRINE 或 MYCOPHENOLATE MOFETIL 的三é‡å…疫抑制劑為主的治療方å¼ä½µç”¨ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶;;安瓿é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS PHARMA AGLICHTSTRASSE 35, 4056 BASEL, SWITZERLANDSWITZERLAND2014-10-09å°ç“¶;;安瓿SIMULECT LYOPHILISATE FOR INJECTION 4MG/ML
衛署èŒç–«è¼¸å—第000526號2014-05-201999-05-20èŒã€€ç–«DHA01000052601æ–°ç¦æ¨‚å‡æ™¶æ³¨å°„劑用於新的腎臟移æ¤(DE NOVO RENAL TRANSPLANTATION)ã€é 防急性器官排斥ç¾è±¡ä¹‹ç™¼ç”Ÿï¼Œè€Œä¸”是伴隨以CYCLOSPORIN的微乳劑型(MICROEMULSION)和皮質固醇為基礎的å…疫抑制劑治療方å¼ä½µç”¨ï¼›æˆ–與CYCLOSPORIN的微乳劑型(MICROEMULSION)ã€çš®è³ªå›ºé†‡åŠ å…¥AZATHIOPRINE 或 MYCOPHENOLATE MOFETIL 的三é‡å…疫抑制劑為主的治療方å¼ä½µç”¨ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶;;安瓿é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS PHARMA STEIN AGSCHAFFHAUSERSTRASSE, 4332 STEIN, SWITZERLAND.SWITZERLAND2014-10-09å°ç“¶;;安瓿SIMULECT LYOPHILISATE FOR INJECTION 4MG/ML
衛署èŒç–«è¼¸å—第000552號2014-08-051999-08-05èŒã€€ç–«DHA01000055202é›™è‚克(A型åŠï¼¢åž‹è‚炎疫苗)é©ç”¨æ–¼æœ‰æ„ŸæŸ“A型åŠï¼¢åž‹è‚ç‚Žå±éšª ,但ä¸å…·å…疫力之æˆäººèˆ‡ä¸€æ²ä»¥ä¸Šä¹‹å…’童,用以é 防A型åŠï¼¢åž‹è‚炎。滅èŒæ‡¸æ¶²æ³¨å°„劑å°ç“¶;;注射é‡ç’;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨è·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19å°ç“¶;;注射é‡ç’;;ç›’è£TWINRIX
衛署èŒç–«è¼¸å—第000573號2014-10-191999-10-19èŒã€€ç–«DHA01000057307賀百克B型æµè¡Œæ„Ÿå†’嗜血桿èŒç–«è‹—é 防B型æµè¡Œæ€§æ„Ÿå†’嗜血桿èŒå¼•èµ·ä¹‹ç–¾ç—…。å‡æ™¶æ³¨å°„劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨TETANUS TOXOIDè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19å°ç“¶HIBERIX
衛署èŒç–«è¼¸å—第000578號2014-12-071999-12-07èŒã€€ç–«DHA01000057804人血清白蛋白2ï¼ï¼…注射液ã€å–œæ–¯æ‚…〞低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN世信生物科技股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路201之36號5樓16447082CSL LTD.189-209 CAMP ROAD BROADMEADOWS VICTORIA 3047 AUSTRALIA45 POPLAR ROAD PARKVILLE VICTORIA 3052,AUSTRALIAAUSTRALIA2009-12-16瓶è£ALBAPURE 20 "CSL"
衛署èŒç–«è¼¸å—第000580號2015-01-112000-01-11èŒã€€ç–«DHA01000058004ã€ç‘žå£«ã€žå®œä¿åˆ©è¡€æ³¨å°„液1ï¼ï¼ï¼ï¼å–®ä½/毫å‡æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€ä¹‹æ‚£è€…ã€æ²»ç™‚與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN ALFA嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854CILAG AGHOCHSTRASSE 201, CH-8200 SCHAFFHAUSEN, SWITZERLANDSWITZERLAND2014-12-11注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;ç›’è£EPREX INJECTION 10000IU/ML
衛署èŒç–«è¼¸å—第000601號2015-04-112000-04-11èŒã€€ç–«DHA01000060102è²ä»–費隆 注射劑é™ä½Žåè¦†ç™¼ä½œåž‹å¤šç™¼æ€§ç¡¬åŒ–ç—‡çš„ç™¼ä½œé »çŽ‡åŠåš´é‡åº¦ã€‚é™ä½ŽçºŒç™¼åž‹å¤šç™¼æ€§ç¡¬åŒ–ç—‡(secondary progressive multiple sclerosis)å¾©ç™¼çš„é »çŽ‡åŠåš´é‡åº¦ã€‚發生單一臨床症狀(Clinically Isolated Syndrome)疑似多發性硬化症的病患,å¯å»¶ç·©å…¶æƒ¡åŒ–æˆå¤šç™¼æ€§ç¡¬åŒ–症。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;注射é‡ç’;;å°ç“¶è£æº¶åŠ‘;;包è£;;包è£;;包è£;;å°ç“¶;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨INTERFERON BETA-1B臺ç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184BOEHRINGER INGELHEIM RCV GMBH & CO. KGDR. BOEHRINGER GASSE 5-11, 1121 VIENNA, AUSTRIAAUSTRIA2014-09-25å°ç“¶è£;;注射é‡ç’;;å°ç“¶è£æº¶åŠ‘;;包è£;;包è£;;包è£;;å°ç“¶;;注射é‡ç’BETAFERON (INTERFERON BETA-1B)
衛署èŒç–«è¼¸å—第000601號2015-04-112000-04-11èŒã€€ç–«DHA01000060102è²ä»–費隆 注射劑é™ä½Žåè¦†ç™¼ä½œåž‹å¤šç™¼æ€§ç¡¬åŒ–ç—‡çš„ç™¼ä½œé »çŽ‡åŠåš´é‡åº¦ã€‚é™ä½ŽçºŒç™¼åž‹å¤šç™¼æ€§ç¡¬åŒ–ç—‡(secondary progressive multiple sclerosis)å¾©ç™¼çš„é »çŽ‡åŠåš´é‡åº¦ã€‚發生單一臨床症狀(Clinically Isolated Syndrome)疑似多發性硬化症的病患,å¯å»¶ç·©å…¶æƒ¡åŒ–æˆå¤šç™¼æ€§ç¡¬åŒ–症。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;注射é‡ç’;;å°ç“¶è£æº¶åŠ‘;;包è£;;包è£;;包è£;;å°ç“¶;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨INTERFERON BETA-1B臺ç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184BOEHRINGER INGELHEIM Pharma GmbH & Co.KGBIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS. GERMANYGERMANY2014-09-25å°ç“¶è£;;注射é‡ç’;;å°ç“¶è£æº¶åŠ‘;;包è£;;包è£;;包è£;;å°ç“¶;;注射é‡ç’BETAFERON (INTERFERON BETA-1B)
衛署èŒç–«è¼¸å—第000608號2015-06-052000-06-05èŒã€€ç–«DHA01000060800賓å‡é©ç¬¬ä¹å‡è¡€å› åå‡æ™¶æ³¨å°„劑é©ç”¨æ–¼æŽ§åˆ¶èˆ‡é 防B型血å‹ç—…(先天性第ä¹å‡è¡€å› å缺ä¹ç—‡ï¼Œæˆ–稱è–誕節症)之出血,包括接å—外科手術時的出血控制與é 防出血。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;é‡ç’è£é™„溶劑é™ç”±é†«å¸«ä½¿ç”¨GAMMA-FIX(NONACOG ALFA);;GAMMA-FIX(NONACOG ALFA);;GAMMA-FIX(NONACOG ALFA)ç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH FARMA, S.A.AUTOVIA DEL NORTE A1 KM 23 DESVIO ALGETE KM1 SAN SEBASTIAN DE LOS REYES 28700 MADRID, SPAINSPAIN2012-06-18å°ç“¶è£;;é‡ç’è£é™„溶劑BENEFIX{RFIX} COAGULATION FACTOR IX (RECOMBINANT)
衛署èŒç–«è¼¸å—第000601號2015-04-112000-04-11èŒã€€ç–«DHA01000060102è²ä»–費隆 注射劑é™ä½Žåè¦†ç™¼ä½œåž‹å¤šç™¼æ€§ç¡¬åŒ–ç—‡çš„ç™¼ä½œé »çŽ‡åŠåš´é‡åº¦ã€‚é™ä½ŽçºŒç™¼åž‹å¤šç™¼æ€§ç¡¬åŒ–ç—‡(secondary progressive multiple sclerosis)å¾©ç™¼çš„é »çŽ‡åŠåš´é‡åº¦ã€‚發生單一臨床症狀(Clinically Isolated Syndrome)疑似多發性硬化症的病患,å¯å»¶ç·©å…¶æƒ¡åŒ–æˆå¤šç™¼æ€§ç¡¬åŒ–症。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;注射é‡ç’;;å°ç“¶è£æº¶åŠ‘;;包è£;;包è£;;包è£;;å°ç“¶;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨INTERFERON BETA-1B臺ç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184BAYER PHARMA AG(一)POSTAL ADDRESS:D-13342 BERLIN, GERMANY (二)STREET ADDRESS:MUELLERSTRASSE 178 D-13353 BERLIN, GERMANYGERMANY2014-09-25å°ç“¶è£;;注射é‡ç’;;å°ç“¶è£æº¶åŠ‘;;包è£;;包è£;;包è£;;å°ç“¶;;注射é‡ç’BETAFERON (INTERFERON BETA-1B)
衛署èŒç–«è¼¸å—第000604號2015-05-022000-05-02èŒã€€ç–«DHA01000060405"百特" 抗血å‹ç—…å› å 25ï¼ã€€åœ‹éš›å–®ä½æ³¨å°„劑治療A型血å‹ç—…。å‡æ™¶æ³¨å°„劑瓶è£é™„溶劑ã€?端é é‡åŠæ¿¾é‡é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION911 N. DAVIS DRIVE CLEEVELAND, MISSISSIPPI 38732 U.S.A.UNITED STATES2012-11-30瓶è£é™„溶劑ã€?端é é‡åŠæ¿¾é‡ANTIHEMOPHILIC FACTOR (RECOMBINANT) RECOMBINATE (250IU)"BAXTER"
衛署èŒç–«è¼¸å—第000604號2015-05-022000-05-02èŒã€€ç–«DHA01000060405"百特" 抗血å‹ç—…å› å 25ï¼ã€€åœ‹éš›å–®ä½æ³¨å°„劑治療A型血å‹ç—…。å‡æ™¶æ³¨å°„劑瓶è£é™„溶劑ã€?端é é‡åŠæ¿¾é‡é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION1700 RANCHO CONEJO BOULEVARD THOUSAND OAKS CALIFORNIA 91320 U.S.A.UNITED STATES2012-11-30瓶è£é™„溶劑ã€?端é é‡åŠæ¿¾é‡ANTIHEMOPHILIC FACTOR (RECOMBINANT) RECOMBINATE (250IU)"BAXTER"
衛署èŒç–«è¼¸å—第000605號2015-05-022000-05-02èŒã€€ç–«DHA01000060507"百特" 抗血å‹ç—…å› å 5ï¼ï¼ã€€åœ‹éš›å–®ä½æ³¨å°„劑治療A型血å‹ç—…。å‡æ™¶æ³¨å°„劑瓶è£é™„溶劑ã€?端é é‡åŠæ¿¾é‡é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION911 N. DAVIS DRIVE CLEEVELAND, MISSISSIPPI 38732 U.S.A.UNITED STATES2012-11-09瓶è£é™„溶劑ã€?端é é‡åŠæ¿¾é‡ANTIHEMOPHILIC FACTOR (RECOMBINANT) RECOMBINATE (500IU)"BAXTER"
衛署èŒç–«è¼¸å—第000605號2015-05-022000-05-02èŒã€€ç–«DHA01000060507"百特" 抗血å‹ç—…å› å 5ï¼ï¼ã€€åœ‹éš›å–®ä½æ³¨å°„劑治療A型血å‹ç—…。å‡æ™¶æ³¨å°„劑瓶è£é™„溶劑ã€?端é é‡åŠæ¿¾é‡é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION1700 RANCHO CONEJO BOULEVARD THOUSAND OAKS CALIFORNIA 91320 U.S.A.UNITED STATES2012-11-09瓶è£é™„溶劑ã€?端é é‡åŠæ¿¾é‡ANTIHEMOPHILIC FACTOR (RECOMBINANT) RECOMBINATE (500IU)"BAXTER"
衛署èŒç–«è¼¸å—第000606號2015-05-022000-05-02èŒã€€ç–«DHA01000060609"百特" 抗血å‹ç—…å› å 1ï¼ï¼ï¼ã€€åœ‹éš›å–®ä½æ³¨å°„劑治療A型血å‹ç—…。å‡æ™¶æ³¨å°„劑瓶è£é™„溶劑ã€?端é é‡åŠæ¿¾é‡é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION911 N. DAVIS DRIVE CLEEVELAND, MISSISSIPPI 38732 U.S.A.UNITED STATES2012-11-30瓶è£é™„溶劑ã€?端é é‡åŠæ¿¾é‡ANTIHEMOPHILIC FACTOR (RECOMBINANT) RECOMBINATE (1000IU)"BAXTER"
衛署èŒç–«è¼¸å—第000606號2015-05-022000-05-02èŒã€€ç–«DHA01000060609"百特" 抗血å‹ç—…å› å 1ï¼ï¼ï¼ã€€åœ‹éš›å–®ä½æ³¨å°„劑治療A型血å‹ç—…。å‡æ™¶æ³¨å°„劑瓶è£é™„溶劑ã€?端é é‡åŠæ¿¾é‡é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION1700 RANCHO CONEJO BOULEVARD THOUSAND OAKS CALIFORNIA 91320 U.S.A.UNITED STATES2012-11-30瓶è£é™„溶劑ã€?端é é‡åŠæ¿¾é‡ANTIHEMOPHILIC FACTOR (RECOMBINANT) RECOMBINATE (1000IU)"BAXTER"
衛署èŒç–«è¼¸å—第000608號2015-06-052000-06-05èŒã€€ç–«DHA01000060800賓å‡é©ç¬¬ä¹å‡è¡€å› åå‡æ™¶æ³¨å°„劑é©ç”¨æ–¼æŽ§åˆ¶èˆ‡é 防B型血å‹ç—…(先天性第ä¹å‡è¡€å› å缺ä¹ç—‡ï¼Œæˆ–稱è–誕節症)之出血,包括接å—外科手術時的出血控制與é 防出血。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;é‡ç’è£é™„溶劑é™ç”±é†«å¸«ä½¿ç”¨GAMMA-FIX(NONACOG ALFA);;GAMMA-FIX(NONACOG ALFA);;GAMMA-FIX(NONACOG ALFA)ç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH PHARMACEUTICAL INC.P.O. BOX 8299, PHILADELPHIA, PA 19010-8299 U.S.A.UNITED STATES2012-06-18å°ç“¶è£;;é‡ç’è£é™„溶劑BENEFIX{RFIX} COAGULATION FACTOR IX (RECOMBINANT)
衛署èŒç–«è¼¸å—第000608號2015-06-052000-06-05èŒã€€ç–«DHA01000060800賓å‡é©ç¬¬ä¹å‡è¡€å› åå‡æ™¶æ³¨å°„劑é©ç”¨æ–¼æŽ§åˆ¶èˆ‡é 防B型血å‹ç—…(先天性第ä¹å‡è¡€å› å缺ä¹ç—‡ï¼Œæˆ–稱è–誕節症)之出血,包括接å—外科手術時的出血控制與é 防出血。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;é‡ç’è£é™„溶劑é™ç”±é†«å¸«ä½¿ç”¨GAMMA-FIX(NONACOG ALFA);;GAMMA-FIX(NONACOG ALFA);;GAMMA-FIX(NONACOG ALFA)ç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410VETTER PHARMA-FERTIGUNG GMBH & CO. KGSCHUTZENSTRABE 87,99-101, 88212 RAVENSBURG, GERMANYGERMANY2012-06-18å°ç“¶è£;;é‡ç’è£é™„溶劑BENEFIX{RFIX} COAGULATION FACTOR IX (RECOMBINANT)
衛署èŒç–«è¼¸å—第000609號2010-07-142000-07-14èŒã€€ç–«DHA01000060902利潰å‡å‡è† 計劑 ï¼ï¼Žï¼ï¼‘%促進全層糖尿病潰ç˜å°æ–¼æˆ–ç‰æ–¼ï¼•ï¼£ï¼å‚·å£çš„ç™’åˆã€‚外用å‡è† 劑管è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨BECAPLERMIN嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854OMJ PHARMACEUTICALS INC.CARR 362 KM. 0.5, INDUSTRIAL PARK N., SAN GERMAN PUERTO RICOPUERTO RICO2013-03-19管è£REGRANEX GEL 0.01%
衛署èŒç–«è¼¸å—第000609號2010-07-142000-07-14èŒã€€ç–«DHA01000060902利潰å‡å‡è† 計劑 ï¼ï¼Žï¼ï¼‘%促進全層糖尿病潰ç˜å°æ–¼æˆ–ç‰æ–¼ï¼•ï¼£ï¼å‚·å£çš„ç™’åˆã€‚外用å‡è† 劑管è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨BECAPLERMIN嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854CILAG AGHOCHSTRASSE 201, 8200 SCHAFFHAUSEN, SWITZERLANDSWITZERLAND2013-03-19管è£REGRANEX GEL 0.01%
衛署èŒç–«è¼¸å—第000615號2015-09-202000-09-20èŒã€€ç–«DHA01000061500帥å¥æ³¨å°„劑8å…¬çµ²è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³ã€å…¶ä»–GONADOL DYSGENESIS(TURNER’S SYNDROï¼ï¼¥ï¼‰æ‰€å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€é’春期å‰å› 慢性腎臟衰ç«å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€‚æˆäººç”Ÿé•·æ¿€ç´ åš´é‡åˆ†æ³Œä¸è¶³ä¹‹è£œå……療法。低出生體é‡å…’(Small for Gestational Ageï¼›SGA)逾四æ²è€…之生長障礙。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶é™„溶液;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨SOMATOTROPIN (GROWTH HORMONE)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-11-13å°ç“¶é™„溶液;;ç›’è£SAIZEN 8MG CLICK EASY
衛署èŒç–«è¼¸å—第000615號2015-09-202000-09-20èŒã€€ç–«DHA01000061500帥å¥æ³¨å°„劑8å…¬çµ²è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³ã€å…¶ä»–GONADOL DYSGENESIS(TURNER’S SYNDROï¼ï¼¥ï¼‰æ‰€å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€é’春期å‰å› 慢性腎臟衰ç«å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€‚æˆäººç”Ÿé•·æ¿€ç´ åš´é‡åˆ†æ³Œä¸è¶³ä¹‹è£œå……療法。低出生體é‡å…’(Small for Gestational Ageï¼›SGA)逾四æ²è€…之生長障礙。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶é™„溶液;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨SOMATOTROPIN (GROWTH HORMONE)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2014-11-13å°ç“¶é™„溶液;;ç›’è£SAIZEN 8MG CLICK EASY
衛署èŒç–«è¼¸å—第000618號2015-10-232000-10-26èŒã€€ç–«DHA01000061803第ä¹å‡è¡€å› å注射劑é 防並治療B型血å‹ç—…åŠç¬¬ä¹å‡è¡€å› å缺ä¹æ‰€é€ æˆçš„其他疾病。注射劑å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨FACTOR IXå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING GMBHEMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANYD-65925 FRANKFURT AM MAIN GERMANYGERMANY2014-04-28å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨BERININ P (BLOOD COAGULATION FACTOR IX,HUMAN PASTEURIZED)
衛署èŒç–«è¼¸å—第000667號2016-06-112001-06-11èŒã€€ç–«DHA01000066703派樂能å‡æ™¶ä¹¾ç²‰æ³¨å°„劑 1ï¼ï¼ï¼ï¼£ï¼§/VIAL用於治療慢性C型è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶é™„溶液;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH LABO N.V.INDUSTRIEPARK,30,B-2220 HEIST-OP-DEN-BERG BELGIUMBELGIUM2012-11-28å°ç“¶é™„溶液;;ç›’è£PEG-INTRON POWDER FOR INJECTION 100MCG/VIAL
衛署èŒç–«è¼¸å—第000620號2012-06-132000-11-17èŒã€€ç–«DHA01000062003宜ä¿åˆ©è¡€æ³¨å°„液2ï¼ï¼ï¼å–®ä½/毫å‡æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的貧血。注射劑瓶è£;;ç›’è£;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨EPOETIN ALFA嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854CILAG AG.HOCHSTRASSE 201 CH-8205 SCHAFFHAUSEN SWITZERLANDHOCHSTRASSE 201,CH-8205 SCHAFFHAUSEN ,SWITZERLANDSWITZERLAND2014-12-11瓶è£;;ç›’è£;;注射é‡ç’EPREX INJECTION 2000 U/ML02019307
衛署èŒç–«è¼¸å—第000621號2015-09-252000-11-17èŒã€€ç–«DHA01000062105宜ä¿åˆ©è¡€æ³¨å°„液4ï¼ï¼ï¼å–®ä½/毫å‡æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的貧血。注射劑å°ç“¶;;注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN ALFA嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854CILAG AG.HOCHSTRASSE 201 CH-8205 SCHAFFHAUSEN SWITZERLANDHOCHSTRASSE 201,CH-8205 SCHAFFHAUSEN ,SWITZERLANDSWITZERLAND2014-12-11å°ç“¶;;注射é‡ç’;;ç›’è£EPREX INJECTION 4000U/ML02018284
衛署èŒç–«è¼¸å—第000622號2017-06-132000-11-17èŒã€€ç–«DHA01000062207宜ä¿åˆ©è¡€æ³¨å°„液1ï¼ï¼ï¼ï¼å–®ä½/毫å‡æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者ã€æ²»ç™‚與癌症化å¸æ²»ç™‚有關的貧血。注射劑å°ç“¶;;ç›’è£;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨EPOETIN ALFA嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854CILAG AG.HOCHSTRASSE 201 CH-8200 SCHAFFHAUSEN SWITZERLANDHOCHSTRASSE 201,CH-8205 SCHAFFHAUSEN ,SWITZERLANDSWITZERLAND2014-12-11å°ç“¶;;ç›’è£;;注射é‡ç’EPREX INJECTION 10000 U/ML02019306
衛署èŒç–«è¼¸å—第000623號2015-11-212000-11-21èŒã€€ç–«DHA01000062309åŸºå› é‡çµ„B型è‚ç‚Žç–«è‹—ï¼é€æžé…æ–¹é 防B型è‚ç‚Žï¼é©ç”¨æ–¼é€æžå‰ï¼ˆï¼°ï¼²ï¼¥ï¼¤ï¼©ï¼¡ï¼¬ï¼¹ï¼³ï¼©ï¼³ï¼‰åŠé€æžï¼ˆï¼¤ï¼©ï¼¡ï¼¬ï¼¹ï¼³ï¼©ï¼³ï¼‰æˆäººç—…患,用以é 防B型è‚炎病毒所有已知亞型所引起的感染症。注射劑å°ç“¶;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨HEPATITIS B, ANTIGEN, SURFACE美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME B.V.WAARDERWEG 39,2031 BN,HAARLEM,THE NETHERLANDSNETHERLANDS2013-09-06å°ç“¶;;ç›’è£H-B-VAX II-DIALYSIS FORMULATION
衛署èŒç–«è¼¸å—第000623號2015-11-212000-11-21èŒã€€ç–«DHA01000062309åŸºå› é‡çµ„B型è‚ç‚Žç–«è‹—ï¼é€æžé…æ–¹é 防B型è‚ç‚Žï¼é©ç”¨æ–¼é€æžå‰ï¼ˆï¼°ï¼²ï¼¥ï¼¤ï¼©ï¼¡ï¼¬ï¼¹ï¼³ï¼©ï¼³ï¼‰åŠé€æžï¼ˆï¼¤ï¼©ï¼¡ï¼¬ï¼¹ï¼³ï¼©ï¼³ï¼‰æˆäººç—…患,用以é 防B型è‚炎病毒所有已知亞型所引起的感染症。注射劑å°ç“¶;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨HEPATITIS B, ANTIGEN, SURFACE美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME CORP.770 SUMNEYTOWN PIKE, WEST POINT, PA 19486 U.S.A.UNITED STATES2013-09-06å°ç“¶;;ç›’è£H-B-VAX II-DIALYSIS FORMULATION
衛署èŒç–«è¼¸å—第000625號2015-12-182000-12-18èŒã€€ç–«DHA01000062500賀癌平å‡æ™¶æ³¨å°„劑44ï¼å…¬çµ²Herceptin應使用於下列HER2éŽåº¦è¡¨ç¾æˆ–HER2åŸºå› amplification之早期乳癌ã€è½‰ç§»æ€§ä¹³ç™Œæ‚£è€…:1.早期乳癌(EBC):(1)經外科手術ã€åŒ–å¸ç™‚法(è¡“å‰æˆ–術後)之輔助療法。(2)以doxorubicin與cyclophosphamide治療,å†åˆä½µpactlitaxel或docetaxel之輔助療法。(3)與docetaxelåŠcarboplatin併用之輔助療法。(4)è¡“å‰èˆ‡åŒ–å¸ç™‚法併用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2厘米)。2.轉移性乳癌(MBC):(1)å–®ç¨ä½¿ç”¨æ–¼æ›¾æŽ¥å—éŽä¸€æ¬¡(å«)以上化å¸ç™‚法之轉移性乳癌;除éžæ‚£è€…ä¸é©åˆä½¿ç”¨anthracyclin或taxane,å¦å‰‡å…ˆå‰ä¹‹åŒ–å¸æ²»ç™‚應至少包括anthracyclin或taxane。使用於è·çˆ¾è’™ç™‚法失敗之è·çˆ¾è’™å—體陽性之患者,除éžæ‚£è€…ä¸é©ç”¨è·çˆ¾è’™ç™‚法。(2)與pactlitaxel或docetaxel併用於未曾接å—éŽåŒ–å¸ç™‚法之轉移性乳癌。(3)與芳香環?抑制劑併用於è·çˆ¾è’™å—體陽性之轉移性乳癌。3.轉移性胃癌(MGC):Herceptinåˆä½µcapecitabine(或5-fluorouracil)åŠcisplatiné©ç”¨æ–¼æœªæ›¾æŽ¥å—éŽåŒ–å¸æ²»ç™‚之HER2éŽåº¦è¡¨ç¾è½‰ç§»æ€§èƒƒè…ºç™Œ(或胃食é“接åˆè™•è…ºç™Œ)的治療。說明:(1)HER2éŽåº¦è¡¨ç¾ä¹‹æª¢æ¸¬æ–¹æ³•é ˆç¶“è¡›ç”Ÿä¸»ç®¡æ©Ÿé—œæ ¸å‡†(用於胃癌之檢驗),請åƒç…§ç›¸é—œæª¢æ¸¬å¥—組仿單ä¸é©æ‡‰ç—‡ï¼Œç¢ºæ•ˆ(validation)åŠæ•ˆèƒ½(performance)之敘述,å¦è«‹åƒç…§æœ¬ä»¿å–®ã€Œ12.3轉移性胃癌ã€ä¹‹æ•˜è¿°ã€‚(2)樞ç´è©¦é©—確èªç™‚效僅顯ç¾æ–¼æœ‰è¼ƒé«˜HER2蛋白表ç¾(IHC2+/FISH+或IHC3+)之æ—群。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨TRASTUZUMABç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467MADE BY GENENTECH INC. MADE FOR F. HOFFMANN-LA ROCHE LTD.1 DNA WAY SOUTH SAN FRANCISCO U.S.A.UNITED STATES2014-05-06å°ç“¶é™„溶液;;ç›’è£HERCEPTIN VIAL 440MG
衛署èŒç–«è¼¸å—第000659號2009-05-082001-04-10èŒã€€ç–«DHA01000065904優泌林ï¼é•·æ•ˆåž‹æ³¨å°„液ã€ç¦®ä¾†ã€žç³–尿病。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨INSULIN HUMAN臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803ELI. LILLY & CO.INDIANAPOLIS INDIANA 46285UNITED STATES2014-05-29å°ç“¶HUMULIN L02017189
衛署èŒç–«è¼¸å—第000630號2016-01-022001-01-02èŒã€€ç–«DHA01000063006ã€åŸºç«‹ç¦ã€žä¹¾ç‡¥æŠ—è¡€å‹ç—…ç¬¬å…«å› å注射劑25ï¼åœ‹éš›å–®ä½ï¼¡åž‹è¡€å‹ç—…。DDAVP治療無效或ç¦å¿Œä¹‹vWD 病人在實施手術åŠ/或侵入性治療時使用,但ä¸é©åˆä½¿ç”¨æ–¼é€²è¡Œé‡åº¦æ‰‹è¡“çš„Type 3病患。å‡æ™¶æ³¨å°„劑å°ç“¶;;å°ç“¶é™„溶液;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR;;STERILE WATER FOR INJECTION臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.5555 VALLEY BOULEVARD, LOS ANGELES, CALIFORNIA 90032UNITED STATES2011-09-08å°ç“¶;;å°ç“¶é™„溶液;;ç›’è£ALPHANATE ®250IU
衛署èŒç–«è¼¸å—第000630號2016-01-022001-01-02èŒã€€ç–«DHA01000063006ã€åŸºç«‹ç¦ã€žä¹¾ç‡¥æŠ—è¡€å‹ç—…ç¬¬å…«å› å注射劑25ï¼åœ‹éš›å–®ä½ï¼¡åž‹è¡€å‹ç—…。DDAVP治療無效或ç¦å¿Œä¹‹vWD 病人在實施手術åŠ/或侵入性治療時使用,但ä¸é©åˆä½¿ç”¨æ–¼é€²è¡Œé‡åº¦æ‰‹è¡“çš„Type 3病患。å‡æ™¶æ³¨å°„劑å°ç“¶;;å°ç“¶é™„溶液;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR;;STERILE WATER FOR INJECTION臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.13111 TEMPLE AVENUE, CITY OF INDUSTRY, CA 91746, USAUNITED STATES2011-09-08å°ç“¶;;å°ç“¶é™„溶液;;ç›’è£ALPHANATE ®250IU
衛署èŒç–«è¼¸å—第000631號2016-01-022001-01-02èŒã€€ç–«DHA01000063108ã€åŸºç«‹ç¦ã€žä¹¾ç‡¥æŠ—è¡€å‹ç—…ç¬¬å…«å› å注射劑1ï¼ï¼ï¼åœ‹éš›å–®ä½ï¼¡åž‹è¡€å‹ç—…。DDAVP治療無效或ç¦å¿Œä¹‹vWD 病人在實施手術åŠ/或侵入性治療時使用, 但ä¸é©åˆä½¿ç”¨æ–¼é€²è¡Œé‡åº¦æ‰‹è¡“çš„type 3病患。å‡æ™¶æ³¨å°„劑å°ç“¶;;å°ç“¶é™„溶液;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR HUMAN;;STERILE WATER FOR INJECTION臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.5555 VALLEY BOULEVARD, LOS ANGELES, CALIFORNIA 90032UNITED STATES2011-09-13å°ç“¶;;å°ç“¶é™„溶液;;ç›’è£ALPHANATE ®1000IU
衛署èŒç–«è¼¸å—第000631號2016-01-022001-01-02èŒã€€ç–«DHA01000063108ã€åŸºç«‹ç¦ã€žä¹¾ç‡¥æŠ—è¡€å‹ç—…ç¬¬å…«å› å注射劑1ï¼ï¼ï¼åœ‹éš›å–®ä½ï¼¡åž‹è¡€å‹ç—…。DDAVP治療無效或ç¦å¿Œä¹‹vWD 病人在實施手術åŠ/或侵入性治療時使用, 但ä¸é©åˆä½¿ç”¨æ–¼é€²è¡Œé‡åº¦æ‰‹è¡“çš„type 3病患。å‡æ™¶æ³¨å°„劑å°ç“¶;;å°ç“¶é™„溶液;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR HUMAN;;STERILE WATER FOR INJECTION臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.13111 TEMPLE AVENUE, CITY OF INDUSTRY, CA 91746, USAUNITED STATES2011-09-13å°ç“¶;;å°ç“¶é™„溶液;;ç›’è£ALPHANATE ®1000IU
衛署èŒç–«è¼¸å—第000814號2015-10-072005-10-07èŒã€€ç–«DHA01000081403æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 150μg/Pen用於治療慢性Cåž‹è‚炎。盒è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MSD International GmbH (Singapore Branch)60, TUAS WEST DRIVE, SINGAPORE, 638413SINGAPORE2014-03-25ç›’è£;;ç›’è£Peg-Intron Redipen 150μg/Pen
衛署èŒç–«è¼¸å—第000635號2016-02-052001-02-05èŒã€€ç–«DHA01000063503ä¿å¦Šåº·æ³¨å°„劑15ï¼åœ‹éš›å–®ä½ï¼ˆï¼‘)無排åµç—‡ï¼ˆåŒ…括多囊性åµå·¢ç—‡å€™ç¾¤ï¼Œï¼°ï¼£ï¼¯S),且å°ï¼£ï¼¬ï¼¯ï¼ï¼©ï¼°ï¼¨ï¼¥ï¼®ï¼¥ï¼£ï¼©ï¼´ï¼²ï¼¡ï¼´ï¼¥ä¹‹æ²»ç™‚ç„¡å應之婦女。(2)å—控制下åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。男性方é¢ï¼Œå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANONKLOOSTERSTRAAT 6 5349 AB OSS,THE NETHERLANDSNETHERLANDS2014-10-21å°ç“¶;;ç›’è£PUREGON SOLUTION FOR INJECTION 150IU
衛署èŒç–«è¼¸å—第000635號2016-02-052001-02-05èŒã€€ç–«DHA01000063503ä¿å¦Šåº·æ³¨å°„劑15ï¼åœ‹éš›å–®ä½ï¼ˆï¼‘)無排åµç—‡ï¼ˆåŒ…括多囊性åµå·¢ç—‡å€™ç¾¤ï¼Œï¼°ï¼£ï¼¯S),且å°ï¼£ï¼¬ï¼¯ï¼ï¼©ï¼°ï¼¨ï¼¥ï¼®ï¼¥ï¼£ï¼©ï¼´ï¼²ï¼¡ï¼´ï¼¥ä¹‹æ²»ç™‚ç„¡å應之婦女。(2)å—控制下åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。男性方é¢ï¼Œå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANON-SITE DIOSITEVEERSEMEER 4, 5347 JN OSS, THE NETHERLANDSNETHERLANDS2014-10-21å°ç“¶;;ç›’è£PUREGON SOLUTION FOR INJECTION 150IU
衛署èŒç–«è¼¸å—第000637號2016-02-052001-02-05èŒã€€ç–«DHA01000063707ä¿å¦Šåº·æ³¨å°„劑1ï¼ï¼åœ‹éš›å–®ä½ï¼ˆï¼‘)無排åµç—‡ï¼ˆåŒ…括多囊性åµå·¢ç—‡å€™ç¾¤ã€ï¼°ï¼£ï¼¯S),且å°ï¼£ï¼¬ï¼¯ï¼ï¼©ï¼°ï¼¨ï¼¥ï¼®ï¼¥ CITRATE之治療無å應之婦女。(2)å—控制下åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。男性方é¢ï¼Œå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANONKLOOSTERSTRAAT 6 5349 AB OSS,THE NETHERLANDSNETHERLANDS2014-10-21å°ç“¶;;ç›’è£PUREGON SOLUTION FOR INJECTION 100IU
衛署èŒç–«è¼¸å—第000637號2016-02-052001-02-05èŒã€€ç–«DHA01000063707ä¿å¦Šåº·æ³¨å°„劑1ï¼ï¼åœ‹éš›å–®ä½ï¼ˆï¼‘)無排åµç—‡ï¼ˆåŒ…括多囊性åµå·¢ç—‡å€™ç¾¤ã€ï¼°ï¼£ï¼¯S),且å°ï¼£ï¼¬ï¼¯ï¼ï¼©ï¼°ï¼¨ï¼¥ï¼®ï¼¥ CITRATE之治療無å應之婦女。(2)å—控制下åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。男性方é¢ï¼Œå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANON-SITE DIOSITEVEERSEMEER 4, 5347 JN OSS, THE NETHERLANDSNETHERLANDS2014-10-21å°ç“¶;;ç›’è£PUREGON SOLUTION FOR INJECTION 100IU
衛署èŒç–«è¼¸å—第000638號2016-02-052001-02-05èŒã€€ç–«DHA01000063809ä¿å¦Šåº·æ³¨å°„劑5ï¼åœ‹éš›å–®ä½ï¼ˆï¼‘)無排åµç—‡ï¼ˆåŒ…括多囊性åµå·¢ç—‡å€™ç¾¤ã€ï¼°ï¼£ï¼¯S),且å°ï¼£ï¼¬ï¼¯ï¼ï¼©ï¼°ï¼¨ï¼¥ï¼®ï¼¥ CITRATE之治療無å應之婦女。(2)å—控制下åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。男性方é¢ï¼Œå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANONKLOOSTERSTRAAT 6 5349 AB OSS,THE NETHERLANDSNETHERLANDS2014-10-21å°ç“¶;;ç›’è£PUREGON SOLUTION FOR INJECTION 50IU
衛署èŒç–«è¼¸å—第000638號2016-02-052001-02-05èŒã€€ç–«DHA01000063809ä¿å¦Šåº·æ³¨å°„劑5ï¼åœ‹éš›å–®ä½ï¼ˆï¼‘)無排åµç—‡ï¼ˆåŒ…括多囊性åµå·¢ç—‡å€™ç¾¤ã€ï¼°ï¼£ï¼¯S),且å°ï¼£ï¼¬ï¼¯ï¼ï¼©ï¼°ï¼¨ï¼¥ï¼®ï¼¥ CITRATE之治療無å應之婦女。(2)å—控制下åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。男性方é¢ï¼Œå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANON-SITE DIOSITEVEERSEMEER 4, 5347 JN OSS, THE NETHERLANDSNETHERLANDS2014-10-21å°ç“¶;;ç›’è£PUREGON SOLUTION FOR INJECTION 50IU
衛署èŒç–«è¼¸å—第000641號2016-03-122001-03-12èŒã€€ç–«DHA01000064101"科基"è¡€å‡ç´ ç¬¬å…«å› å注射劑(é‡çµ„體)治療A型血å‹ç—…。無關節æ傷之Aåž‹è¡€å‹ç—…患童的常è¦é 防(é™åˆ¶ä½¿ç”¨è‡³12æ²ç‚ºæ¢)。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;注射用水é‡ç’è£;;瓶è£;;注射用水é‡ç’è£;;å°ç“¶è£;;瓶è£;;注射用水é‡ç’è£;;包è£;;注射用水é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR臺ç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184BAYER HEALTHCARE LLC800 DWIGHT WAY, BERKELEY, CA 94710 USAUNITED STATES2014-09-25å°ç“¶è£;;注射用水é‡ç’è£;;瓶è£;;注射用水é‡ç’è£;;å°ç“¶è£;;瓶è£;;注射用水é‡ç’è£;;包è£;;注射用水é‡ç’è£KOGENATE FS, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FORMULATED WITH SUCROSE
衛署èŒç–«è¼¸å—第000663號2019-02-032001-04-10èŒã€€ç–«DHA01000066308"禮來" 優泌林ï¼å¸¸è¦åž‹ï¼ˆå¸¸è¦åž‹äººé«”èƒ°å³¶ç´ ï¼ˆåŸºå› é‡çµ„)注射液)1ï¼ï¼å–®ç³–尿病注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨BIOSYNTHETIC HUMAN INSULIN臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803ELI. LILLY & CO.INDIANAPOLIS, INDIANA 46285 U.S.A.UNITED STATES2014-05-29å°ç“¶HUMULIN R (REGULAR HUMAN INSULIN,RECOMBINANT DNA ORIGIN INJECTION) 100 I.U./ML02015635
衛署èŒç–«è¼¸å—第000641號2016-03-122001-03-12èŒã€€ç–«DHA01000064101"科基"è¡€å‡ç´ ç¬¬å…«å› å注射劑(é‡çµ„體)治療A型血å‹ç—…。無關節æ傷之Aåž‹è¡€å‹ç—…患童的常è¦é 防(é™åˆ¶ä½¿ç”¨è‡³12æ²ç‚ºæ¢)。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;注射用水é‡ç’è£;;瓶è£;;注射用水é‡ç’è£;;å°ç“¶è£;;瓶è£;;注射用水é‡ç’è£;;包è£;;注射用水é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR臺ç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184BAYER PHARMA AGMUELLERSTRASSE 178, D-13353 BERLIN, GERMANYGERMANY2014-09-25å°ç“¶è£;;注射用水é‡ç’è£;;瓶è£;;注射用水é‡ç’è£;;å°ç“¶è£;;瓶è£;;注射用水é‡ç’è£;;包è£;;注射用水é‡ç’è£KOGENATE FS, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FORMULATED WITH SUCROSE
衛署èŒç–«è¼¸å—第000642號2016-03-122001-03-12èŒã€€ç–«DHA01000064200"科基" è¡€å‡ç´ ç¬¬å…«å› å注射劑(é‡çµ„體)5ï¼ï¼ã€€ï¼©ï¼µ/VIAL治療A型血å‹ç—…。無關節æ傷之Aåž‹è¡€å‹ç—…患童的常è¦é 防(é™åˆ¶ä½¿ç”¨è‡³12æ²ç‚ºæ¢)。å‡æ™¶æ³¨å°„劑å°ç“¶;;瓶è£;;注射用水é‡ç’è£;;包è£;;注射用水é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR臺ç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184BAYER HEALTHCARE LLC800 DWIGHT WAY, BERKELEY, CA 94710 USAUNITED STATES2014-09-25å°ç“¶;;瓶è£;;注射用水é‡ç’è£;;包è£;;注射用水é‡ç’è£KOGENATE FS, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FORMULATED WITH SUCROSE, 500 I
衛署èŒç–«è¼¸å—第000642號2016-03-122001-03-12èŒã€€ç–«DHA01000064200"科基" è¡€å‡ç´ ç¬¬å…«å› å注射劑(é‡çµ„體)5ï¼ï¼ã€€ï¼©ï¼µ/VIAL治療A型血å‹ç—…。無關節æ傷之Aåž‹è¡€å‹ç—…患童的常è¦é 防(é™åˆ¶ä½¿ç”¨è‡³12æ²ç‚ºæ¢)。å‡æ™¶æ³¨å°„劑å°ç“¶;;瓶è£;;注射用水é‡ç’è£;;包è£;;注射用水é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR臺ç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184BAYER PHARMA AGMUELLERSTRASSE 178, D-13353 BERLIN, GERMANYGERMANY2014-09-25å°ç“¶;;瓶è£;;注射用水é‡ç’è£;;包è£;;注射用水é‡ç’è£KOGENATE FS, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FORMULATED WITH SUCROSE, 500 I
衛署èŒç–«è¼¸å—第000643號2016-12-032001-12-03èŒã€€ç–«DHA01000064302ã€è²éˆã€žBåž‹è‚ç‚Žå…ç–«çƒè›‹ç™½æ³¨å°„液Båž‹è‚ç‚Žçš„å…ç–«é 防。注射劑安瓿;;ç›’è£;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨IMMUNOGLOBULIN HUMANå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING GMBHEMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANYGERMANY2014-04-28安瓿;;ç›’è£;;注射é‡ç’HEPATITIS B IMMUNOGLOBULIN P 〞BEHRING〞
衛署èŒç–«è¼¸å—第000644號2016-03-192001-03-19èŒã€€ç–«DHA01000064404ã€åŸºç«‹ç¦ã€žä¹¾ç‡¥æŠ—è¡€å‹ç—…ç¬¬å…«å› å注射劑5ï¼ï¼åœ‹éš›å–®ä½ï¼¡åž‹è¡€å‹ç—…æˆ–å¾Œå¤©æ€§ç¬¬å…«å› å缺ä¹å¼•èµ·ä¹‹å‡ºè¡€æ€§ç–¾ç—…。DDAVP治療無效或ç¦å¿Œä¹‹vWD 病人在實施手術åŠ/或侵入性治療時使用,但ä¸é©åˆä½¿ç”¨æ–¼é€²è¡Œé‡åº¦æ‰‹è¡“çš„type 3病患。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR HUMAN;;SOLVENT;;STERILE WATER FOR INJECTION臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.5555 VALLEY BOULEVARD, LOS ANGELES, CALIFORNIA 90032UNITED STATES2010-12-21å°ç“¶é™„溶液;;ç›’è£ALPHANATE ®500IU
衛署èŒç–«è¼¸å—第000644號2016-03-192001-03-19èŒã€€ç–«DHA01000064404ã€åŸºç«‹ç¦ã€žä¹¾ç‡¥æŠ—è¡€å‹ç—…ç¬¬å…«å› å注射劑5ï¼ï¼åœ‹éš›å–®ä½ï¼¡åž‹è¡€å‹ç—…æˆ–å¾Œå¤©æ€§ç¬¬å…«å› å缺ä¹å¼•èµ·ä¹‹å‡ºè¡€æ€§ç–¾ç—…。DDAVP治療無效或ç¦å¿Œä¹‹vWD 病人在實施手術åŠ/或侵入性治療時使用,但ä¸é©åˆä½¿ç”¨æ–¼é€²è¡Œé‡åº¦æ‰‹è¡“çš„type 3病患。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR HUMAN;;SOLVENT;;STERILE WATER FOR INJECTION臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.13111 TEMPLE AVENUE, CITY OF INDUSTRY, CA 91746, USAUNITED STATES2010-12-21å°ç“¶é™„溶液;;ç›’è£ALPHANATE ®500IU
衛署èŒç–«è¼¸å—第000645號2016-03-202001-03-20èŒã€€ç–«DHA01000064506容å¯æ›¼é‡ç’è£æ³¨å°„劑5ï¼ï¼ï¼åœ‹éš›å–®ä½æ²»ç™‚慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETA GENETICAL RECOMBINANTç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£RECORMON SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 5000IU
衛署èŒç–«è¼¸å—第000645號2016-03-202001-03-20èŒã€€ç–«DHA01000064506容å¯æ›¼é‡ç’è£æ³¨å°„劑5ï¼ï¼ï¼åœ‹éš›å–®ä½æ²»ç™‚慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETA GENETICAL RECOMBINANTç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£RECORMON SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 5000IU
衛署èŒç–«è¼¸å—第000646號2016-03-202001-03-20èŒã€€ç–«DHA01000064608容å¯æ›¼é‡ç’注射劑2ï¼ï¼ï¼åœ‹åŠ‘å–®ä½æ²»ç™‚慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETA GENETICAL RECOMBINANTç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£RECORMON SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 2000IU
衛署èŒç–«è¼¸å—第000646號2016-03-202001-03-20èŒã€€ç–«DHA01000064608容å¯æ›¼é‡ç’注射劑2ï¼ï¼ï¼åœ‹åŠ‘å–®ä½æ²»ç™‚慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETA GENETICAL RECOMBINANTç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£RECORMON SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 2000IU
衛署èŒç–«è¼¸å—第000647號2016-03-202001-03-20èŒã€€ç–«DHA01000064700容å¯æ›¼é‡ç’è£æ³¨å°„劑 1ï¼ï¼ï¼ï¼åœ‹éš›å–®ä½æ²»ç™‚慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETA GENETICAL RECOMBINANTç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£RECORMON SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 10000IU
衛署èŒç–«è¼¸å—第000663號2019-02-032001-04-10èŒã€€ç–«DHA01000066308"禮來" 優泌林ï¼å¸¸è¦åž‹ï¼ˆå¸¸è¦åž‹äººé«”èƒ°å³¶ç´ ï¼ˆåŸºå› é‡çµ„)注射液)1ï¼ï¼å–®ç³–尿病注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨BIOSYNTHETIC HUMAN INSULIN臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803ELI LILLY AND COMPANYINDIANAPOLIS, INDIANA 46285, U.S.A.UNITED STATES2014-05-29å°ç“¶HUMULIN R (REGULAR HUMAN INSULIN,RECOMBINANT DNA ORIGIN INJECTION) 100 I.U./ML02015635
衛署èŒç–«è¼¸å—第000647號2016-03-202001-03-20èŒã€€ç–«DHA01000064700容å¯æ›¼é‡ç’è£æ³¨å°„劑 1ï¼ï¼ï¼ï¼åœ‹éš›å–®ä½æ²»ç™‚慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETA GENETICAL RECOMBINANTç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£RECORMON SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 10000IU
衛署èŒç–«è¼¸å—第000648號2016-03-202001-03-20èŒã€€ç–«DHA01000064802容å¯æ›¼é‡ç’è£æ³¨å°„劑1ï¼ï¼ï¼åœ‹éš›å–®ä½æ²»ç™‚慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETA GENETICAL RECOMBINANTç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£RECORMON SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 1000IU
衛署èŒç–«è¼¸å—第000650號2016-03-302001-03-30èŒã€€ç–«DHA01000065002普留淨注射劑治療轉移性腎細胞癌åŠæƒ¡æ€§é»‘è‰²ç´ ç™Œã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨ALDESLEUKINå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS PHARMA. AGLICHTSTRASSE 35 CH-4056 BASEL SWITZERLANDSWITZERLAND2013-10-07å°ç“¶PROLEUKIN FOR INJECTION
衛署èŒç–«è¼¸å—第000650號2016-03-302001-03-30èŒã€€ç–«DHA01000065002普留淨注射劑治療轉移性腎細胞癌åŠæƒ¡æ€§é»‘è‰²ç´ ç™Œã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨ALDESLEUKINå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589BAYER HEALTH CARE PHARMACEUTICALS, INC.5650 HOLLIS STREET, EMERYVILLE, CA 94608, USAUNITED STATES2013-10-07å°ç“¶PROLEUKIN FOR INJECTION
衛署èŒç–«è¼¸å—第000653號2017-09-072001-04-04èŒã€€ç–«DHA01000065305優泌林ï¼æ··åˆåž‹ï¼ˆï¼—ï¼ï¼ï¼“ï¼ï¼‰ï¼‘ï¼ï¼å–®ä½ï¼æ¯«å‡ç³–尿病。滅èŒæ‡¸æ¶²æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨INSULIN HUMAN臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803ELI LILLY AND COMPANYINDIANAPOLIS, INDIANA 46285, U.S.A.UNITED STATES2014-10-28å°ç“¶HUMULIN 70/30 100 IU/ML02019469
衛署èŒç–«è¼¸å—第000653號2017-09-072001-04-04èŒã€€ç–«DHA01000065305優泌林ï¼æ··åˆåž‹ï¼ˆï¼—ï¼ï¼ï¼“ï¼ï¼‰ï¼‘ï¼ï¼å–®ä½ï¼æ¯«å‡ç³–尿病。滅èŒæ‡¸æ¶²æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨INSULIN HUMAN臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY PHARMA FERTIGUNG UND DISTRIBUTION GMBH & CO. KGTEICHWEG 3 D-35396 GIESSEN, GERMANYGERMANY2014-10-28å°ç“¶HUMULIN 70/30 100 IU/ML02019469
衛署èŒç–«è¼¸å—第000657號2019-03-102001-04-10èŒã€€ç–«DHA01000065700優泌林ï¼ä¸æ•ˆåž‹ï¼ˆï¼®ï¼°ï¼¨åž‹äººé«”èƒ°å³¶ç´ ï¼ˆåŸºå› é‡çµ„)懸液)100å–®ä½/公撮糖尿病。注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN HUMAN臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803ELI LILLY AND COMPANYINDIANAPOLIS, INDIANA 46285, U.S.A.UNITED STATES2014-06-20å°ç“¶è£::,,HUMULIN N (NPH HUMAN INSULIN RECOMBINANT DNA ORIGIN) ISOPHANE SUSPENSION) 100I.U./ML)02015735
衛署èŒç–«è¼¸å—第000657號2019-03-102001-04-10èŒã€€ç–«DHA01000065700優泌林ï¼ä¸æ•ˆåž‹ï¼ˆï¼®ï¼°ï¼¨åž‹äººé«”èƒ°å³¶ç´ ï¼ˆåŸºå› é‡çµ„)懸液)100å–®ä½/公撮糖尿病。注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN HUMAN臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY PHARMA FERTIGUNG UND DISTRIBUTION GMBH & CO. KGTEICHWEG 3 D-35396 GIESSEN, GERMANYGERMANY2014-06-20å°ç“¶è£::,,HUMULIN N (NPH HUMAN INSULIN RECOMBINANT DNA ORIGIN) ISOPHANE SUSPENSION) 100I.U./ML)02015735
衛署èŒç–«è¼¸å—第000663號2019-02-032001-04-10èŒã€€ç–«DHA01000066308"禮來" 優泌林ï¼å¸¸è¦åž‹ï¼ˆå¸¸è¦åž‹äººé«”èƒ°å³¶ç´ ï¼ˆåŸºå› é‡çµ„)注射液)1ï¼ï¼å–®ç³–尿病注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨BIOSYNTHETIC HUMAN INSULIN臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY PHARMA FERTIGUNG UND DISTRIBUTION GMBH & CO. KGTEICHWEG 3 D-35396 GIESSEN, GERMANYGERMANY2014-05-29å°ç“¶HUMULIN R (REGULAR HUMAN INSULIN,RECOMBINANT DNA ORIGIN INJECTION) 100 I.U./ML02015635
衛署èŒç–«è¼¸å—第000667號2016-06-112001-06-11èŒã€€ç–«DHA01000066703派樂能å‡æ™¶ä¹¾ç²‰æ³¨å°„劑 1ï¼ï¼ï¼ï¼£ï¼§/VIAL用於治療慢性C型è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶é™„溶液;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH (BRINNY) COMPANYINNISHANNON, CO. CORK,IRELAND2012-11-28å°ç“¶é™„溶液;;ç›’è£PEG-INTRON POWDER FOR INJECTION 100MCG/VIAL
衛署èŒç–«è¼¸å—第000668號2016-06-112001-06-11èŒã€€ç–«DHA01000066805派樂能å‡æ™¶ä¹¾ç²‰æ³¨å°„劑 15ï¼ï¼ï¼£ï¼§ï¼Ÿï¼¶ï¼©ï¼¡ï¼¬ç”¨æ–¼æ²»ç™‚慢性C型è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶é™„溶液;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨ç¾Žå•†é»˜æ²™æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH (BRINNY) COMPANYINNISHANNON, CO. CORK,IRELAND2012-08-27å°ç“¶é™„溶液;;ç›’è£PEG-INTRON POWDER FOR INJECTION 150MCG/VIAL
衛署èŒç–«è¼¸å—第000669號2016-06-112001-06-11èŒã€€ç–«DHA01000066907派樂能å‡æ™¶ä¹¾ç²‰æ³¨å°„劑 5ï¼ï¼ï¼£ï¼§/VIAL用於治療慢性C型è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH LABO N.V.INDUSTRIEPARK,30,B-2220 HEIST-OP-DEN-BERG BELGIUMBELGIUM2012-11-28å°ç“¶;;ç›’è£PEG-INTRON POWDER FOR INJECTION 50MCG/VIAL
衛署èŒç–«è¼¸å—第000669號2016-06-112001-06-11èŒã€€ç–«DHA01000066907派樂能å‡æ™¶ä¹¾ç²‰æ³¨å°„劑 5ï¼ï¼ï¼£ï¼§/VIAL用於治療慢性C型è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH (BRINNY) COMPANYINNISHANNON, CO. CORK,IRELAND2012-11-28å°ç“¶;;ç›’è£PEG-INTRON POWDER FOR INJECTION 50MCG/VIAL
衛署èŒç–«è¼¸å—第000670號2016-06-112001-06-11èŒã€€ç–«DHA01000067005æƒ çˆ¾è¡€æ·»ã€€ï¼ï¼“ï¼ï¼ï¼‘ï¼Žå‹•å“¡é€ è¡€å¹¹ç´°èƒžè‡³å‘¨é‚Šè¡€ä¸ã€ï¼’ï¼Žä¿ƒé€²é€ è¡€å¹¹ç´°èƒžç§»æ¤æ™‚å—œä¸æ€§ç™½è¡€çƒæ•¸çš„å¢žåŠ ã€ï¼“.癌症化å¸ç™‚法所引起之嗜ä¸æ€§ç™½è¡€çƒæ¸›å°‘ç—‡ã€ï¼”.骨髓發育ä¸è‰¯ç—‡å€™ç¾¤çš„å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€ï¼•ï¼Žå…ˆå¤©æ€§ã€ç‰¹ç•°æ€§å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚注射劑安瓿é™ç”±é†«å¸«ä½¿ç”¨FILGRASTIMå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO, LTD., TAKASAKI PLANT100-1, HAGIWARA-MACHI, TAKASAKI-SHI, GUNMA, JAPANJAPAN2014-12-02安瓿FILGRASTIM INJECTION M300,300MCG/0.7ML詳如仿單。
衛署èŒç–«è¼¸å—第000672號2016-06-262001-06-26èŒã€€ç–«DHA01000067209人å…ç–«çƒè›‹ç™½éœè„ˆæ³¨å°„液5%ã€åŸºç«‹ç¦ã€žå…ç–«çƒè›‹ç™½ç¼ºä¹ç—‡ã€åŽŸç™¼æ€§è¡€å°æ¿æ¸›å°‘紫瘢症。å·å´Žæ°ç—‡(KAWASAKI DISEASE)。注射劑瓶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨IMMUNOGLOBULIN HUMAN臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557INSTITUTO GRIFOLS S.A.POLIGONO LEVANTE C/CAN GUASCH 2, 08150 PARETS DEL VALLES BARCELONA SPAINSPAIN2011-04-28瓶è£;;ç›’è£FLEBOGAMMA 5%
衛署èŒç–«è¼¸å—第000673號2016-07-052001-07-05èŒã€€ç–«DHA01000067301æžœç´èŠ¬æ³¨å°„劑1050國際單ä½/1.75公撮(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD)。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT)ã€åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人ã€å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚(3)Gonal-F®ä½µç”¨äººé¡žçµ¨æ¯›è†œæ€§è…ºåˆºæ¿€ç´ (hCG)ï¼Œç”¨æ–¼æ²»ç™‚æ‚£æœ‰å…ˆå¤©æˆ–å¾Œå¤©æ€§è…ºåˆºæ¿€ç´ ä¸è¶³ä¹‹æ€§è…ºåŠŸèƒ½ä½Žä¸‹ç—‡ä¹‹ç”·æ€§æ‚£è€…,以刺激精å生æˆã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-11-13注射é‡ç’GONAL-F 1050IU/1.75ML
衛署èŒç–«è¼¸å—第000673號2016-07-052001-07-05èŒã€€ç–«DHA01000067301æžœç´èŠ¬æ³¨å°„劑1050國際單ä½/1.75公撮(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD)。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT)ã€åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人ã€å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚(3)Gonal-F®ä½µç”¨äººé¡žçµ¨æ¯›è†œæ€§è…ºåˆºæ¿€ç´ (hCG)ï¼Œç”¨æ–¼æ²»ç™‚æ‚£æœ‰å…ˆå¤©æˆ–å¾Œå¤©æ€§è…ºåˆºæ¿€ç´ ä¸è¶³ä¹‹æ€§è…ºåŠŸèƒ½ä½Žä¸‹ç—‡ä¹‹ç”·æ€§æ‚£è€…,以刺激精å生æˆã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2014-11-13注射é‡ç’GONAL-F 1050IU/1.75ML
衛署èŒç–«è¼¸å—第000674號2016-07-162001-07-16èŒã€€ç–«DHA01000067400派樂能å‡æ™¶ä¹¾ç²‰æ³¨å°„劑 8ï¼ï¼ï¼£ï¼§/VIAL用於治療慢性C型è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH LABO N.V.INDUSTRIEPARK,30,B-2220 HEIST-OP-DEN-BERG BELGIUMBELGIUM2013-01-07ç›’è£;;å°ç“¶PEG-INTRON POWDER FOR INJECTION 80MCG/VIAL
衛署èŒç–«è¼¸å—第000674號2016-07-162001-07-16èŒã€€ç–«DHA01000067400派樂能å‡æ™¶ä¹¾ç²‰æ³¨å°„劑 8ï¼ï¼ï¼£ï¼§/VIAL用於治療慢性C型è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH (BRINNY) COMPANYINNISHANNON, CO. CORK,IRELAND2013-01-07ç›’è£;;å°ç“¶PEG-INTRON POWDER FOR INJECTION 80MCG/VIAL
衛署èŒç–«è¼¸å—第000675號2016-07-162001-07-16èŒã€€ç–«DHA01000067502派樂能å‡æ™¶ä¹¾ç²‰æ³¨å°„劑 12ï¼ï¼ï¼£ï¼§/VIAL用於治療慢性C型è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH LABO N.V.INDUSTRIEPARK,30,B-2220 HEIST-OP-DEN-BERG BELGIUMBELGIUM2012-11-28ç›’è£;;å°ç“¶PEG-INTRON POWDER FOR INJECTION 120MCG/VIAL
衛署èŒç–«è¼¸å—第000675號2016-07-162001-07-16èŒã€€ç–«DHA01000067502派樂能å‡æ™¶ä¹¾ç²‰æ³¨å°„劑 12ï¼ï¼ï¼£ï¼§/VIAL用於治療慢性C型è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH (BRINNY) COMPANYINNISHANNON, CO. CORK,IRELANDIRELAND2012-11-28ç›’è£;;å°ç“¶PEG-INTRON POWDER FOR INJECTION 120MCG/VIAL
衛署èŒç–«è¼¸å—第000677號2016-08-012001-08-01èŒã€€ç–«DHA01000067706諾德欣注射液1ï¼å…¬çµ²ï¹¨ï¼‘.5公撮å°è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æˆ–功能ä¸å…¨é€ æˆçš„生長åœé “ã€Turner症候群。é’春期å‰ï¼Œå› 慢性腎病所致之生長é²æ»¯ã€æˆäººä¹‹è£œå……療法。低出生體é‡å…’Small for Grstational Age (SGA)逾四æ²è€…之生長é²ç·©ã€‚注射劑盒è£;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨SOMATOTROPIN (GROWTH HORMONE)臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SHAGEDORNSVEJ 1, DK-2820 GENTOFTE, DENMARKDENMARK2013-01-17ç›’è£;;å°ç“¶NORDITROPIN SIMPLEXX INJECTION 10MG/1.5ML
衛署èŒç–«è¼¸å—第000677號2016-08-012001-08-01èŒã€€ç–«DHA01000067706諾德欣注射液1ï¼å…¬çµ²ï¹¨ï¼‘.5公撮å°è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æˆ–功能ä¸å…¨é€ æˆçš„生長åœé “ã€Turner症候群。é’春期å‰ï¼Œå› 慢性腎病所致之生長é²æ»¯ã€æˆäººä¹‹è£œå……療法。低出生體é‡å…’Small for Grstational Age (SGA)逾四æ²è€…之生長é²ç·©ã€‚注射劑盒è£;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨SOMATOTROPIN (GROWTH HORMONE)臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SKIRKE VAERLOESEVEJ 30, DK-3500 VAERLOESE, DENMARKDENMARK2013-01-17ç›’è£;;å°ç“¶NORDITROPIN SIMPLEXX INJECTION 10MG/1.5ML
衛署èŒç–«è¼¸å—第000678號2016-08-012001-08-01èŒã€€ç–«DHA01000067808諾德欣注射液5公絲﹨1.5公撮å°è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æˆ–功能ä¸å…¨é€ æˆçš„生長åœé “ã€Turner症候群。é’春期å‰ï¼Œå› 慢性腎病所致之生長é²æ»¯ï¼Œæˆäººä¹‹è£œå……療法。低出生體é‡å…’Small for Grstational Age (SGA)逾四æ²è€…之生長é²ç·©ã€‚注射劑盒è£;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨SOMATOTROPIN (GROWTH HORMONE)臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SHAGEDORNSVEJ 1, DK-2820, GENTOFTE.DENMARKDENMARK2013-01-17ç›’è£;;å°ç“¶NORDITROPIN SIMPLEXX INJECTION 5MG/1.5ML
衛署èŒç–«è¼¸å—第000678號2016-08-012001-08-01èŒã€€ç–«DHA01000067808諾德欣注射液5公絲﹨1.5公撮å°è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æˆ–功能ä¸å…¨é€ æˆçš„生長åœé “ã€Turner症候群。é’春期å‰ï¼Œå› 慢性腎病所致之生長é²æ»¯ï¼Œæˆäººä¹‹è£œå……療法。低出生體é‡å…’Small for Grstational Age (SGA)逾四æ²è€…之生長é²ç·©ã€‚注射劑盒è£;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨SOMATOTROPIN (GROWTH HORMONE)臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SKIRKE VAERLOESEVEJ 30, DK-3500 VAERLOESE, DENMARKDENMARK2013-01-17ç›’è£;;å°ç“¶NORDITROPIN SIMPLEXX INJECTION 5MG/1.5ML
衛署èŒç–«è¼¸å—第000682號2016-08-122001-09-07èŒã€€ç–«DHA01000068202密斯它3ï¼èƒ°å³¶ç´ 注射液DIABETES ï¼ï¼¥ï¼¬ï¼¬ï¼©ï¼´ï¼µï¼³ï¼ˆç³–尿病)。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN MONOCOMPONENT ISOPHANE INSULIN;;HUMAN MONOCOMPONENT BIOSYNTHETIC REGULAR INSULIN臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SHALLAS ALL'E, DK-4400 KALUNDBORG, DENMARKDENMARK2013-01-17å°ç“¶;;ç›’è£MIXTARD 30
衛署èŒç–«è¼¸å—第000682號2016-08-122001-09-07èŒã€€ç–«DHA01000068202密斯它3ï¼èƒ°å³¶ç´ 注射液DIABETES ï¼ï¼¥ï¼¬ï¼¬ï¼©ï¼´ï¼µï¼³ï¼ˆç³–尿病)。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN MONOCOMPONENT ISOPHANE INSULIN;;HUMAN MONOCOMPONENT BIOSYNTHETIC REGULAR INSULIN臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SDK 2880 BAGSVAERD, DENMARKDENMARK2013-01-17å°ç“¶;;ç›’è£MIXTARD 30
衛署èŒç–«è¼¸å—第000683號2018-03-022001-09-10èŒã€€ç–«DHA01000068301增若托平注射劑5.3æ¯«å…‹è…¦ä¸‹åž‚é«”ä¹‹ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾ï¼›TURNER'S SYNDROME所導致之生長干擾;PRADER-WILLI SYNDROME所導致之生長干擾;慢性腎臟功能ä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾ï¼›æˆäººç”Ÿé•·æ¿€ç´ åš´é‡ç¼ºä¹ä¹‹è£œå……療法。低出生體é‡å…’Small for Gestational Age(SGA)逾四æ²è€…之生長障礙。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液é™ç”±é†«å¸«ä½¿ç”¨SOMATOTROPIN HUMANè¼ç‘žå¤§è—¥å» 股份有é™å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µï¼‘77號37199708PFIZER MANUFACTURING BELGIUM NVRIJKSWEG 12, 2870, PUURS, BELGIUMBELGIUM2013-02-22å°ç“¶é™„溶液GENOTROPIN 5.3MG02019807
衛署èŒç–«è¼¸å—第000683號2018-03-022001-09-10èŒã€€ç–«DHA01000068301增若托平注射劑5.3æ¯«å…‹è…¦ä¸‹åž‚é«”ä¹‹ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾ï¼›TURNER'S SYNDROME所導致之生長干擾;PRADER-WILLI SYNDROME所導致之生長干擾;慢性腎臟功能ä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾ï¼›æˆäººç”Ÿé•·æ¿€ç´ åš´é‡ç¼ºä¹ä¹‹è£œå……療法。低出生體é‡å…’Small for Gestational Age(SGA)逾四æ²è€…之生長障礙。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液é™ç”±é†«å¸«ä½¿ç”¨SOMATOTROPIN HUMANè¼ç‘žå¤§è—¥å» 股份有é™å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µï¼‘77號37199708VETTER PHARMA-FERTIGUNG GMBH & CO. KGEISENBAHNSTRASSE 2-4, 88085 LANGENARGEN GERMANYGERMANY2013-02-22å°ç“¶é™„溶液GENOTROPIN 5.3MG02019807
衛署èŒç–«è¼¸å—第000697號2016-07-042001-11-13èŒã€€ç–«DHA01000069702å› é€Ÿä¾†é”ç†åž‹èƒ°å³¶ç´ 注射劑糖尿病。注射劑盒è£;;ç†è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN MONOCOMPONENT ISOPHANE INSULIN臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SHALLAS ALLE, DK-4400 KALUNDBORG, DENMARKDENMARK2013-01-17ç›’è£;;ç†è£INSULATARD PENFILL02021282
衛署èŒç–«è¼¸å—第000731號2017-07-242002-09-25èŒã€€ç–«DHA01000073102è¹£éŽæ•æ²»ç™‚注射劑 (DF)è¹£éŽæ•ä¹‹æ²»ç™‚。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨STANDARDIZED MITE EXTRACT醫æä¼æ¥æœ‰é™å…¬å¸å°åŒ—市大安å€å¿ åæ±è·¯å››æ®µ299號9樓22733252ALLERMED LABORATORIES INC. PMF 01017203 CONVOY CT. SAN DIEGO CA 92111 U.S.A.UNITED STATES2012-12-05å°ç“¶STANDARDIZED ALLERGENIC EXTRACT, HOUSE DUST MITE, D. FARINAE; INJECTABLE SOLUTION
衛署èŒç–«è¼¸å—第000699號2016-12-102012-05-07èŒã€€ç–«DHA01000069903èŽ«é ˆç˜¤ 注射劑éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ï¼šç”¨æ–¼å¾©ç™¼æˆ–å°åŒ–å¸ç™‚法有抗性之低惡度B-細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚併用CVP化å¸ç™‚法用於未經治療之和緩性(組織型態為濾泡型)B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤çš„病人。併用CHOP或其他化å¸ç™‚法用於CD20抗原陽性之瀰漫性大型B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚用於åšç‚ºæ¿¾æ³¡æ€§æ·‹å·´ç˜¤æ‚£è€…å°èª˜å°Žç™‚法產生å應之後的ç¶æŒæ²»ç™‚用藥。類風濕性關節炎:與methotrexate併用,é©ç”¨æ–¼æ²»ç™‚曾接å—一種(å«)以上之腫瘤壞æ»å› å(TNF)抑制療法治療但效果ä¸å½°ï¼Œæˆ–無法è€å—的活動性類風濕性關節炎æˆäººæ‚£è€…ã€‚èŽ«é ˆç˜¤(MabThera)與methotrexate併用,經X光檢查已è‰å¯¦å¯æ¸›ç·©é—œç¯€çµæ§‹å—æ的進展。慢性淋巴çƒæ€§ç™½è¡€ç—…ï¼šèŽ«é ˆç˜¤(MabThera)é©ç”¨æ–¼èˆ‡fludarabineåŠcyclophosphamide併用,åšç‚ºCD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…(CLL)æ‚£è€…çš„ç¬¬ä¸€ç·šç”¨è—¥ã€‚èŽ«é ˆç˜¤(MabThera)é©ç”¨æ–¼èˆ‡åŒ–å¸ç™‚法併用,åšç‚ºå¾©ç™¼/é ‘å›ºæ€§çš„CD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…病患的治療用藥。肉芽腫性血管炎(GPA)(Wegener’s肉芽腫症)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(MPA): èŽ«é ˆç˜¤(MabThera)與葡è„ç³–çš®è³ªç´ (glucocorticoids)併用,é©ç”¨æ–¼æ²»ç™‚æˆäººä¹‹è‚‰èŠ½è…«æ€§è¡€ç®¡ç‚Ž(GPAï¼Œäº¦ç¨±ç‚ºéŸ‹æ ¼ç´è‚‰èŠ½è…«ç—‡)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(MPA)。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Rituximabç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.GRENZACHERSTRASSE 124 CH-4070 BASLE,SWITZERLANDSWITZERLAND2014-05-06å°ç“¶;;ç›’è£MABTHERA SOLUTION FOR IV INFUSIONèŽ«é ˆç˜¤ï¼ˆMabThera)應在備有å¯ç«‹å³å–用之完善復甦è¨å‚™çš„環境ä¸ï¼Œä¸¦ä¸”在有經驗的醫師嚴密監ç£ä¸‹ï¼Œç¶“由專用的注射管線éœè„ˆè¼¸æ³¨æŠ•äºˆã€‚ä¸å¯ä»¥éœè„ˆæŽ¨æ³¨ï¼ˆi.v. push or bolus)的方å¼æŠ•äºˆé…製好的輸注溶液 (見4.2 使用ã€æ“作åŠè™•ç½®ä¹‹ç‰¹æ®ŠæŒ‡ç¤º)。æ¯æ¬¡åœ¨è¼¸æ³¨èŽ«é ˆç˜¤ï¼ˆMabThera)å‰æ‡‰è©²çµ¦äºˆä¹‹å‰ç½®çµ¦è—¥(premedication),包括æ¢ç—›åŠ‘/解熱劑(例如paracetamol)åŠæŠ—組織胺劑(例如diphenhydramine)。在注射å‰ä¹Ÿæ‡‰è€ƒæ…®æŠ•äºˆç³–皮質類固醇(glucocorticoidsï¼‰ï¼Œç‰¹åˆ¥æ˜¯åœ¨æŠ•äºˆèŽ«é ˆç˜¤(MabThera)時未åˆä½µä½¿ç”¨å«é¡žå›ºé†‡åŒ–å¸ç™‚法的情æ³ä¸‹ï¼ˆè¦‹ä»¥ä¸‹æ¨™æº–劑é‡ï¼‰ã€‚(詳細用法用é‡è«‹è¦‹ä»¿å–®ï¼‰
衛署èŒç–«è¼¸å—第000700號2018-05-142001-12-14èŒã€€ç–«DHA01000070001羅飛é¾ï¼A注射劑å¡æ³¢è¥¿æ°è‚‰ç˜¤ã€å¤šæ¯›ç‹€ç´°èƒžç™½è¡€çƒéŽå¤šç—…ã€å°æ´»æ€§æ…¢æ€§Båž‹è‚ç‚Žå¯èƒ½æœ‰æ•ˆã€æ…¢æ€§éª¨é«“白血病ã€çš®è†šT細胞淋巴瘤ã€æ…¢æ€§Cåž‹è‚ç‚Žã€è…Žç´°èƒžç™Œã€éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€å°–é 濕疣。注射劑盒è£;;注射é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨INTERFERON ALPHA- 2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F. HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303 KAISERAUGST, SWITZERLANDSWITZERLAND2014-07-17ç›’è£;;注射é‡ç’è£ROFERON-A ( SOLUTION FOR INJECTION )02022178
衛署èŒç–«è¼¸å—第000700號2018-05-142001-12-14èŒã€€ç–«DHA01000070001羅飛é¾ï¼A注射劑å¡æ³¢è¥¿æ°è‚‰ç˜¤ã€å¤šæ¯›ç‹€ç´°èƒžç™½è¡€çƒéŽå¤šç—…ã€å°æ´»æ€§æ…¢æ€§Båž‹è‚ç‚Žå¯èƒ½æœ‰æ•ˆã€æ…¢æ€§éª¨é«“白血病ã€çš®è†šT細胞淋巴瘤ã€æ…¢æ€§Cåž‹è‚ç‚Žã€è…Žç´°èƒžç™Œã€éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€å°–é 濕疣。注射劑盒è£;;注射é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨INTERFERON ALPHA- 2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F. HOFFMANN-LA ROCHE LTD.GRENZACHERSTRASSE 124, CH-4070 BASEL, SWITZERLANDSWITZERLAND2014-07-17ç›’è£;;注射é‡ç’è£ROFERON-A ( SOLUTION FOR INJECTION )02022178
衛署èŒç–«è¼¸å—第000700號2018-05-142001-12-14èŒã€€ç–«DHA01000070001羅飛é¾ï¼A注射劑å¡æ³¢è¥¿æ°è‚‰ç˜¤ã€å¤šæ¯›ç‹€ç´°èƒžç™½è¡€çƒéŽå¤šç—…ã€å°æ´»æ€§æ…¢æ€§Båž‹è‚ç‚Žå¯èƒ½æœ‰æ•ˆã€æ…¢æ€§éª¨é«“白血病ã€çš®è†šT細胞淋巴瘤ã€æ…¢æ€§Cåž‹è‚ç‚Žã€è…Žç´°èƒžç™Œã€éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€å°–é 濕疣。注射劑盒è£;;注射é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨INTERFERON ALPHA- 2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-07-17ç›’è£;;注射é‡ç’è£ROFERON-A ( SOLUTION FOR INJECTION )02022178
衛署èŒç–«è¼¸å—第000702號2017-01-212002-01-21èŒã€€ç–«DHA01000070205嬰è·å¯§äº”åˆä¸€ç–«è‹—(白喉\ç ´å‚·é¢¨\無細胞性百日咳\去活性å°å…’麻痹\båž‹æµè¡Œæ€§æ„Ÿå†’嗜血桿èŒæ··åˆç–«è‹—)é‡å°äºŒå€‹æœˆä»¥ä¸Šå¬°å¹¼å…’白喉ã€ç™¾æ—¥å’³ã€ç ´å‚·é¢¨ã€å°å…’麻痺åŠBåž‹æµè¡Œæ€§æ„Ÿå†’嗜血桿èŒä¹‹ä¸»å‹•å…疫。å‡æ™¶æ³¨å°„劑å°ç“¶;;é å……å¼æ³¨å°„é‡ç’é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨CONJUGATED OF HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (PRP) AND TETANUS TOXOID (T), ADSORBED;;DIPHTHERIA TOXOID;;TETANUS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;PERTUSSIS TOXOID;;PERTACTIN;;ALUMINIUM (FROM ALUMINIUM HYDROXIDE AND ALUMINIUM PHOSPHATE);;INACTIVATED POLIO VIRUS -TYPE 1;;INACTIVATED POLIO VIRUS - TYPE 2;;INACTIVATED POLIO VIRUS -TYPE 3è·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19å°ç“¶;;é å……å¼æ³¨å°„é‡ç’INFANRIX-IPV + HIB
衛署èŒç–«è¼¸å—第000702號2017-01-212002-01-21èŒã€€ç–«DHA01000070205嬰è·å¯§äº”åˆä¸€ç–«è‹—(白喉\ç ´å‚·é¢¨\無細胞性百日咳\去活性å°å…’麻痹\båž‹æµè¡Œæ€§æ„Ÿå†’嗜血桿èŒæ··åˆç–«è‹—)é‡å°äºŒå€‹æœˆä»¥ä¸Šå¬°å¹¼å…’白喉ã€ç™¾æ—¥å’³ã€ç ´å‚·é¢¨ã€å°å…’麻痺åŠBåž‹æµè¡Œæ€§æ„Ÿå†’嗜血桿èŒä¹‹ä¸»å‹•å…疫。å‡æ™¶æ³¨å°„劑å°ç“¶;;é å……å¼æ³¨å°„é‡ç’é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨CONJUGATED OF HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (PRP) AND TETANUS TOXOID (T), ADSORBED;;DIPHTHERIA TOXOID;;TETANUS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;PERTUSSIS TOXOID;;PERTACTIN;;ALUMINIUM (FROM ALUMINIUM HYDROXIDE AND ALUMINIUM PHOSPHATE);;INACTIVATED POLIO VIRUS -TYPE 1;;INACTIVATED POLIO VIRUS - TYPE 2;;INACTIVATED POLIO VIRUS -TYPE 3è·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.PARC DE LA NOIRE EPINE, RUE FLEMING 20, B-1300 WAVRE, BELGIUMBELGIUM2014-08-19å°ç“¶;;é å……å¼æ³¨å°„é‡ç’INFANRIX-IPV + HIB
衛署èŒç–«è¼¸å—第000706號2012-02-262002-02-26èŒã€€ç–«DHA01000070600ä¼å¿…éˆæµè¡Œæ€§æ„Ÿå†’疫苗“英國â€é 防æµè¡Œæ€§æ„Ÿå†’。懸浮注射劑盒è£;;å°ç“¶è£;;SYRINGEè£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/MOSCOW/10/99 (H3N2)-LIKE STRAIN;;B/BEIJING/184/93-LIKE STRAIN;;A/NEW CALEDONIA/20/99 (H1N1)-LIKE STRAINå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS VACCINES AND DIAGNOSTICS LIMITEDSPEKE LIVERPOOL L24 9DJLANGHURST HORSHAM, WEST SUSSEX. RH134QD, ENGLANDUNITED KINGDOM2010-10-20ç›’è£;;å°ç“¶è£;;SYRINGEè£FLUVIRIN, SUSPENSION FOR INJECTION
衛署èŒç–«è¼¸å—第000707號2017-06-282002-04-09èŒã€€ç–«DHA01000070702帥å¥3.33å…¬çµ²è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€å…¶ä»– GONADOL DYSGENESIS(TURNER'S SYNDROME)所導致之生長é²æ»¯ã€é’春期å‰å› 慢性腎臟衰ç«å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯åŠæˆäººç”Ÿé•·æ¿€ç´ åš´é‡åˆ†æ³Œä¸è¶³ä¹‹è£œå……療法。低出生體é‡å…’(Small for Gestational Ageï¼›SGA)逾四æ²è€…之生長障礙。å‡æ™¶æ³¨å°„劑盒è£é™ç”±é†«å¸«ä½¿ç”¨SOMATROPIN (BIOSYNTHETIC HUMAN GROWTH HORMONE)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2014-11-13ç›’è£SAIZEN 3.33MG
衛署èŒç–«è¼¸å—第000707號2017-06-282002-04-09èŒã€€ç–«DHA01000070702帥å¥3.33å…¬çµ²è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€å…¶ä»– GONADOL DYSGENESIS(TURNER'S SYNDROME)所導致之生長é²æ»¯ã€é’春期å‰å› 慢性腎臟衰ç«å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯åŠæˆäººç”Ÿé•·æ¿€ç´ åš´é‡åˆ†æ³Œä¸è¶³ä¹‹è£œå……療法。低出生體é‡å…’(Small for Gestational Ageï¼›SGA)逾四æ²è€…之生長障礙。å‡æ™¶æ³¨å°„劑盒è£é™ç”±é†«å¸«ä½¿ç”¨SOMATROPIN (BIOSYNTHETIC HUMAN GROWTH HORMONE)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO SA, AUBONNE BRANCHZONE INDUSTRIELLE DE L'OURIETTAZ, 1170 AUBONNE SWITZERLANDSWITZERLAND2014-11-13ç›’è£SAIZEN 3.33MG
衛署èŒç–«è¼¸å—第000709號2017-04-162002-04-16èŒã€€ç–«DHA01000070906容å¯æ›¼å¤šåŠ‘é‡æ³¨å°„劑 50000 國際單ä½æ²»ç™‚慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。å‡æ™¶æ³¨å°„劑盒è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467MADE FOR F. HOFFMANN-LA ROCHE LTD, BASEL, SWITZERLAND BY ROCHE DIAGNOSTICS GMBH, MANNHEIM, GERMANYROCHE DIAGNOSTICS GMBH, SANDHOFER STRASSE 116, D-68305 MANNHEIM, GERMANYGERMANY2014-05-06ç›’è£RECORMON MULTIDOSE POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 50000IU
衛署èŒç–«è¼¸å—第000709號2017-04-162002-04-16èŒã€€ç–«DHA01000070906容å¯æ›¼å¤šåŠ‘é‡æ³¨å°„劑 50000 國際單ä½æ²»ç™‚慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。å‡æ™¶æ³¨å°„劑盒è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市民生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06ç›’è£RECORMON MULTIDOSE POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 50000IU
衛署èŒç–«è¼¸å—第000711號2017-08-242002-04-26èŒã€€ç–«DHA01000071106æƒ çˆ¾è¡€æ·»æ³¨å°„åŠ‘ 1501.å‹•å“¡é€ è¡€å¹¹ç´°èƒžè‡³å‘¨é‚Šè¡€ä¸2.ä¿ƒé€²é€ è¡€å¹¹ç´°èƒžç§»æ¤æ™‚å—œä¸æ€§ç™½è¡€çƒæ•¸çš„å¢žåŠ 3.癌症化å¸ç™‚法所引起之嗜ä¸æ€§ç™½è¡€çƒæ¸›å°‘ç—‡4.骨髓發育ä¸è‰¯ç—‡å€™ç¾¤çš„å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡5.先天性ã€ç‰¹ç•°æ€§å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚注射劑安瓿é™ç”±é†«å¸«ä½¿ç”¨FILGRASTIMå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO, LTD., TAKASAKI PLANT100-1, HAGIWARA-MACHI, TAKASAKI-SHI, GUNMA, JAPANJAPAN2014-12-02安瓿FILGRASTIM INJECTION 150 μG/0.6ML詳如仿單。
衛署èŒç–«è¼¸å—第000909號2016-01-122011-01-12èŒã€€ç–«DHA01000090901諾和密斯50諾芯管糖尿病注射劑支è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN ASPART臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SNOVO ALLE, DK-2880 BAGSVAERD, DENMARKDENMARK2014-04-25支è£NovoMix 50 Penfillè©³è¦‹ç¶“è¡›ç”Ÿç½²æ ¸å‡†ä¹‹ä»¿å–®
衛署èŒç–«è¼¸å—第000712號2017-08-242002-04-26èŒã€€ç–«DHA01000071208æƒ çˆ¾è¡€æ·»æ³¨å°„åŠ‘ 751.å‹•å“¡é€ è¡€å¹¹ç´°èƒžè‡³å‘¨é‚Šè¡€ä¸2.ä¿ƒé€²é€ è¡€å¹¹ç´°èƒžç§»æ¤æ™‚å—œä¸æ€§ç™½è¡€çƒæ•¸çš„å¢žåŠ 3.癌症化å¸ç™‚法所引起之嗜ä¸æ€§ç™½è¡€çƒæ¸›å°‘ç—‡4.骨髓發育ä¸è‰¯ç—‡å€™ç¾¤çš„å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡5.先天性ã€ç‰¹ç•°æ€§å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚注射劑安瓿é™ç”±é†«å¸«ä½¿ç”¨FILGRASTIMå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO, LTD., TAKASAKI PLANT100-1, HAGIWARA-MACHI, TAKASAKI-SHI, GUNMA, JAPANJAPAN2014-12-02安瓿FILGRASTIM INJECTION 75 μG/0.3ML詳如仿單。
衛署èŒç–«è¼¸å—第000713號2017-04-302002-04-30èŒã€€ç–«DHA01000071300æ©åšå‡æ™¶æ³¨å°„劑é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,例如methotrexate) ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。亦é©ç”¨æ–¼methotrexate治療無效或無法è€å—çš„2æ²ä»¥ä¸Šå…’ç«¥åŠé’少年的活動性多關節幼年型慢性關節炎。尚未å°ä¸è¶³2æ²çš„兒童進行試驗。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate 或光化療法(PUVA) )無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之6æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPT;;WATER FOR INJECTIONç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH PHARMACEUTICALSNEW LANE, HAVANT HAMPSHIRE P092NG, UK.UNITED KINGDOM2014-10-24å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;ç›’è£ENBREL (ETANERCEPT) 25MG詳如仿單。
衛署èŒç–«è¼¸å—第000713號2017-04-302002-04-30èŒã€€ç–«DHA01000071300æ©åšå‡æ™¶æ³¨å°„劑é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,例如methotrexate) ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。亦é©ç”¨æ–¼methotrexate治療無效或無法è€å—çš„2æ²ä»¥ä¸Šå…’ç«¥åŠé’少年的活動性多關節幼年型慢性關節炎。尚未å°ä¸è¶³2æ²çš„兒童進行試驗。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate 或光化療法(PUVA) )無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之6æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPT;;WATER FOR INJECTIONç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410Pfizer Ireland PharmaceuticalsGrange Castle Business Park, Clondalkin, Dublin 22, IrelandIRELAND2014-10-24å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;ç›’è£ENBREL (ETANERCEPT) 25MG詳如仿單。
衛署èŒç–«è¼¸å—第000713號2017-04-302002-04-30èŒã€€ç–«DHA01000071300æ©åšå‡æ™¶æ³¨å°„劑é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,例如methotrexate) ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。亦é©ç”¨æ–¼methotrexate治療無效或無法è€å—çš„2æ²ä»¥ä¸Šå…’ç«¥åŠé’少年的活動性多關節幼年型慢性關節炎。尚未å°ä¸è¶³2æ²çš„兒童進行試驗。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate 或光化療法(PUVA) )無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之6æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPT;;WATER FOR INJECTIONç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410BOEHRINGER INGELHEIM Pharma GmbH & Co.KGBIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS.GERMANYGERMANY2014-10-24å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;ç›’è£ENBREL (ETANERCEPT) 25MG詳如仿單。
衛署èŒç–«è¼¸å—第000714號2017-05-272002-05-27èŒã€€ç–«DHA01000071402æ “é«”æº¶æ³¨å°„åŠ‘ç”¨æ–¼æ€¥æ€§å¿ƒè‚Œæ¢—å¡žä¹‹è¡€æ “æº¶è§£æ²»ç™‚ã€‚æ³¨å°„åŠ‘å°ç“¶é™„溶液é™ç”±é†«å¸«ä½¿ç”¨TENECTEPLASE;;STERILE WATER FOR INJECTION;;TENECTEPLASE;;STERILE WATER FOR INJECTION臺ç£ç™¾éˆä½³æ®·æ ¼ç¿°è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼”ï¼™ã€ï¼•ï¼‘號12樓12469866BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGBIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS, GERMANYBINGER STRASSE 173, 55216 INGELHEIM AM RHEIN, GERMANY.GERMANY2014-05-05å°ç“¶é™„溶液METALYSE INJECTION
衛署èŒç–«è¼¸å—第000716號2018-11-242003-07-17èŒã€€ç–«DHA01000071603優秘樂 注射劑100å–®ä½/公撮(超çŸæ•ˆåž‹äººé«”èƒ°å³¶ç´ )糖尿病。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨INSULIN LISPRO臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803ELI. LILLY & CO.INDIANAPOLIS INDIANA 46285UNITED STATES2014-05-29å°ç“¶HUMALOG U-100
衛署èŒç–«è¼¸å—第000717號2017-07-222002-07-22èŒã€€ç–«DHA01000071705"è²éˆ" æ¢è¡€çº–ç¶è›‹ç™½è† 纖ç¶è›‹ç™½æ¢è¡€çµ„出血性胃ã€å二指腸的內視é¡é€²ä¸€æ¥æ²»ç™’。液劑玻璃瓶è£é™ç”±é†«å¸«ä½¿ç”¨FIBRINOGEN HUMAN;;FACTOR XIII FROM HUMAN PLASMA;;APROTININ FROM BOVINE LUNG;;HUMAN THROMBIN;;CALCIUM CHLORIDE DIHYDRATEå‰ç™¼ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市愛國西路9號2F之903178418CSL BEHRING GMBHEMIL-VON-BEHRING STRASSE 76,35041 MARBURG GERMANYD-65925 FRANKFURT AM MAIN GERMANYGERMANY2014-12-11玻璃瓶è£BERIPLAST P COMBI-SET
衛署èŒç–«è¼¸å—第000725號2017-09-132002-09-13èŒã€€ç–«DHA01000072504ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液300國際單ä½/0.36毫å‡(1)無排åµç—‡(包括多囊性åµå·¢ç—…æ‚£ã€PCOD),且å°CLOMIPHENE CITRATE之治療無å應之婦女。(2)å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。(3) 男性方é¢-å› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑注射匣;;ç›’è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANONKLOOSTERSTRAAT 6 5349 AB OSS,THE NETHERLANDSNETHERLANDS2014-11-11注射匣;;ç›’è£;;注射ç†PUREGON 300IU/0.36ML SOLUTION FOR INJECTION
衛署èŒç–«è¼¸å—第000725號2017-09-132002-09-13èŒã€€ç–«DHA01000072504ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液300國際單ä½/0.36毫å‡(1)無排åµç—‡(包括多囊性åµå·¢ç—…æ‚£ã€PCOD),且å°CLOMIPHENE CITRATE之治療無å應之婦女。(2)å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。(3) 男性方é¢-å› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑注射匣;;ç›’è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANON-SITE DIOSITEVEERSEMEER 4, 5347 JN OSS, THE NETHERLANDSNETHERLANDS2014-11-11注射匣;;ç›’è£;;注射ç†PUREGON 300IU/0.36ML SOLUTION FOR INJECTION
衛署èŒç–«è¼¸å—第000725號2017-09-132002-09-13èŒã€€ç–«DHA01000072504ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液300國際單ä½/0.36毫å‡(1)無排åµç—‡(包括多囊性åµå·¢ç—…æ‚£ã€PCOD),且å°CLOMIPHENE CITRATE之治療無å應之婦女。(2)å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。(3) 男性方é¢-å› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑注射匣;;ç›’è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720ORGANON (IRELAND) LTD.P.O. BOX 2857 DRYNAM ROAD SWORDS CO. DUBLIN IRELANDIRELAND2014-11-11注射匣;;ç›’è£;;注射ç†PUREGON 300IU/0.36ML SOLUTION FOR INJECTION
衛署èŒç–«è¼¸å—第000725號2017-09-132002-09-13èŒã€€ç–«DHA01000072504ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液300國際單ä½/0.36毫å‡(1)無排åµç—‡(包括多囊性åµå·¢ç—…æ‚£ã€PCOD),且å°CLOMIPHENE CITRATE之治療無å應之婦女。(2)å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。(3) 男性方é¢-å› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑注射匣;;ç›’è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720VETTER PHARMA-FERTIGUNG GMBH & CO. KGMOOSWIESEN 2, 88214 RAVENSBURG, GERMANYGERMANY2014-11-11注射匣;;ç›’è£;;注射ç†PUREGON 300IU/0.36ML SOLUTION FOR INJECTION
衛署èŒç–«è¼¸å—第000726號2017-09-162002-09-16èŒã€€ç–«DHA01000072606ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液600國際單ä½/0.72毫å‡(1)無排åµç—‡(包括多囊性åµå·¢ç—‡å€™ç¾¤ï¼ŒPCOS),且å°CLOMIPHENE CITRATE 之治療無å應之婦女。(2)å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。(3) 男性方é¢-å› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑注射匣;;ç›’è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANONKLOOSTERSTRAAT 6 5349 AB OSS,THE NETHERLANDSNETHERLANDS2014-11-11注射匣;;ç›’è£;;注射ç†PUREGON 600IU/0.72ML SOLUTION FOR INJECTION
衛署èŒç–«è¼¸å—第000726號2017-09-162002-09-16èŒã€€ç–«DHA01000072606ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液600國際單ä½/0.72毫å‡(1)無排åµç—‡(包括多囊性åµå·¢ç—‡å€™ç¾¤ï¼ŒPCOS),且å°CLOMIPHENE CITRATE 之治療無å應之婦女。(2)å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。(3) 男性方é¢-å› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑注射匣;;ç›’è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANON-SITE DIOSITEVEERSEMEER 4, 5347 JN OSS, THE NETHERLANDSNETHERLANDS2014-11-11注射匣;;ç›’è£;;注射ç†PUREGON 600IU/0.72ML SOLUTION FOR INJECTION
衛署èŒç–«è¼¸å—第000726號2017-09-162002-09-16èŒã€€ç–«DHA01000072606ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液600國際單ä½/0.72毫å‡(1)無排åµç—‡(包括多囊性åµå·¢ç—‡å€™ç¾¤ï¼ŒPCOS),且å°CLOMIPHENE CITRATE 之治療無å應之婦女。(2)å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。(3) 男性方é¢-å› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑注射匣;;ç›’è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720ORGANON (IRELAND) LTD.P.O. BOX 2857 DRYNAM ROAD SWORDS CO. DUBLIN IRELANDIRELAND2014-11-11注射匣;;ç›’è£;;注射ç†PUREGON 600IU/0.72ML SOLUTION FOR INJECTION
衛署èŒç–«è¼¸å—第000726號2017-09-162002-09-16èŒã€€ç–«DHA01000072606ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液600國際單ä½/0.72毫å‡(1)無排åµç—‡(包括多囊性åµå·¢ç—‡å€™ç¾¤ï¼ŒPCOS),且å°CLOMIPHENE CITRATE 之治療無å應之婦女。(2)å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。(3) 男性方é¢-å› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ç—‡ã€‚注射劑注射匣;;ç›’è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720VETTER PHARMA-FERTIGUNG GMBH & CO. KGMOOSWIESEN 2, 88214 RAVENSBURG, GERMANYGERMANY2014-11-11注射匣;;ç›’è£;;注射ç†PUREGON 600IU/0.72ML SOLUTION FOR INJECTION
衛署èŒç–«è¼¸å—第000727號2012-09-182002-09-18èŒã€€ç–«DHA01000072708克得諾å‡æ™¶æ³¨å°„劑 250MCG1.實施人工生殖å”助技術(ART),如體外å—ç²¾(IVF)的超誘導排åµ:投與OVIDRELå¯å¼•èµ·æœ€çµ‚濾泡æˆç†Ÿèˆ‡ç¶“刺激æˆé•·çš„濾泡黃體化。2.無排åµéŽå°‘婦女的誘導排åµ:投與OVIDRELå¯å¼•èµ·åˆºç¶“刺激濾泡æˆé•·çš„無排åµéŽå°‘婦女的排åµåŠé»ƒé«”化。å‡æ™¶æ³¨å°„劑盒è£é™ç”±é†«å¸«ä½¿ç”¨CHORIOGONADOTROPIN ALFA臺ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2012-08-29ç›’è£OVIDREL 250 MICROGRAMS
衛署èŒç–«è¼¸å—第000728號2017-09-202002-09-20èŒã€€ç–«DHA01000072800è˜å¾·ä»•æ³¨å°„劑糖尿病。注射劑注射匣;;注射ç†;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨INSULIN GLARGINE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI-AVENTIS DEUTSCHLAND GMBHD-65926 FRANKFURT AM MAIN,GERMANYGERMANY2014-11-03注射匣;;注射ç†;;注射ç†LANTUS 100 U/ML, SOLUTION FOR INJECTION
衛署èŒç–«è¼¸å—第000729號2017-09-202002-09-20èŒã€€ç–«DHA01000072902諾和瑞 諾芯管糖尿病。注射劑ç†è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN ASPART臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693Novo Nordisk Production SAS45, Avenue d’Orleans, F-28002 Chartres, FranceFRANCE2014-04-16ç†è£NOVORAPID PENFILL 3ML, 100 U/ML
衛署èŒç–«è¼¸å—第000730號2017-09-202002-09-20èŒã€€ç–«DHA01000073000è«¾å’Œç‘žèƒ°å³¶ç´ ç³–å°¿ç—…ã€‚æ³¨å°„åŠ‘å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨INSULIN ASPART臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SNOVO ALLE, DK 2880 BAGSVAERD, DENMARKDENMARK2013-05-08å°ç“¶NOVORAPID 100 U/ML, 10ML
衛署èŒç–«è¼¸å—第000732號2017-07-242002-09-25èŒã€€ç–«DHA01000073201è¹£éŽæ•æ²»ç™‚注射劑 (DP)è¹£éŽæ•ä¹‹æ²»ç™‚。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨STANDARDIZED MITE EXTRACT醫æä¼æ¥æœ‰é™å…¬å¸å°åŒ—市大安å€å¿ åæ±è·¯å››æ®µ299號9樓22733252ALLERMED LABORATORIES INC. PMF 01017203 CONVOY CT. SAN DIEGO CA 92111 U.S.A.UNITED STATES2012-12-05å°ç“¶Standardized Allergenic Extract, House Dust Mite, D. pteronyssinus; Injectable solution
衛署èŒç–«è¼¸å—第000733號2017-09-302002-09-30èŒã€€ç–«DHA01000073303ã€åŸºç«‹ç¦ã€ž 第ä¹å‡å›ºå› å複åˆé«”注射劑é 防åŠæ²»ç™‚乙型血å‹ç—…åŠç¼ºä¹ç¬¬ä¹å‡è¡€å› å。å‡æ™¶æ³¨å°„劑å°ç“¶;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨FACTOR II;;FACTOR VII;;FACTOR IX;;FACTOR X;;STERILE WATER FOR INJECTION臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.5555 VALLEY BOULEVARD, LOS ANGELES, CALIFORNIA 90032UNITED STATES2014-10-24å°ç“¶;;å°ç“¶PROFILNINE SD
衛署èŒç–«è¼¸å—第000733號2017-09-302002-09-30èŒã€€ç–«DHA01000073303ã€åŸºç«‹ç¦ã€ž 第ä¹å‡å›ºå› å複åˆé«”注射劑é 防åŠæ²»ç™‚乙型血å‹ç—…åŠç¼ºä¹ç¬¬ä¹å‡è¡€å› å。å‡æ™¶æ³¨å°„劑å°ç“¶;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨FACTOR II;;FACTOR VII;;FACTOR IX;;FACTOR X;;STERILE WATER FOR INJECTION臺ç£ç¶ åå—股份有é™å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯ä¸‰æ®µäºŒå››å››è™Ÿå…樓71621557GRIFOLS BIOLOGICALS INC.13111 TEMPLE AVENUE, CITY OF INDUSTRY, CA 91746, USAUNITED STATES2014-10-24å°ç“¶;;å°ç“¶PROFILNINE SD
衛署èŒç–«è¼¸å—第000734號2012-10-072002-10-07èŒã€€ç–«DHA01000073405沛兒肺炎çƒèŒä¸ƒåƒ¹æŽ¥åˆåž‹ç–«è‹—é 防莢膜血清型(4, 6B, 9V, 14, 18C, 19Få’Œ23F)的肺炎éˆçƒèŒæ‰€å¼•èµ·çš„侵入性疾病。注射劑å°ç“¶;;ç›’è£;;é å……å¼æ³¨å°„é‡ç’é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨POLYSACCHARIDE SEROTYPE;;POLYSACCHARIDE SEROTYPE;;POLYSACCHARIDE SEROTYPE;;POLYSACCHARIDE SEROTYPE;;OLIGOSACCHARIDE SEROTYPE 18C;;POLYSACCHARIDE SEROTYPE;;POLYSACCHARIDE SEROTYPE;;CRM197 CARRIER PROTEINç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH PHARMACEUTICALS DIVISION OF WYETH HOLDINGS CORPORATION401 NORTH MIDDLETOWN RD., PEARL RIVER, NY 10965, U.S.A.UNITED STATES2012-06-18å°ç“¶;;ç›’è£;;é å……å¼æ³¨å°„é‡ç’PREVENAR, PNEUMOCOCCAL 7-VALENT CONJUGATE VACCINE (DIPHTHERIA CRM197 PROTEIN)
衛署èŒç–«è¼¸å—第000735號2017-10-072002-10-07èŒã€€ç–«DHA01000073507昇糖精1.ç”¨æ–¼ä½¿ç”¨èƒ°å³¶ç´ æ²»ç™‚ç³–å°¿ç—…æ‚£æ‰€è‡´ä¹‹åš´é‡ä½Žè¡€ç³–。2.用於消化é“內視é¡æª¢åŠæ”¾å°„線顯影術。3.用於評估胰島βï¼ç´°èƒžåˆ†æ³ŒåŠŸèƒ½ã€‚注射劑å°ç“¶;;å°ç“¶é™„溶液é™ç”±é†«å¸«ä½¿ç”¨GLUCAGON;;WATER FOR INJECTION臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SHAGEDORNSVEJ 1, DK 2820 GENTOFTE, DENMARKDENMARK2013-01-17å°ç“¶;;å°ç“¶é™„溶液GLUCAGEN 1 MG
衛署èŒç–«è¼¸å—第000736號2017-10-142002-10-14èŒã€€ç–«DHA01000073609精製çµæ ¸èŒç´ RT23SSI試驗çµæ ¸èŒç´ å應。注射劑å°ç“¶;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨TUBERCULIN國光生物科技股份有é™å…¬å¸å°ä¸å¸‚æ½åå€æ½èˆˆè·¯ä¸€æ®µä¸‰è™Ÿ33259508STATENS SERUM INSTITUT5 ARTILLERIVEJ 2300 COPENHAGEN S, DENMARKDENMARK2012-11-30å°ç“¶;;ç›’è£TUBERCULIN PPD RT23 SSI
衛署èŒç–«è¼¸å—第000739號2017-12-212002-11-04èŒã€€ç–«DHA01000073902æ„›é€ŸåŸºå› äººé«”èƒ°å³¶ç´ ç³–å°¿ç—…ã€‚æ³¨å°„åŠ‘å°ç“¶;;ç›’è£;;é‡ç†é™ç”±é†«å¸«ä½¿ç”¨HUMAN MONOCOMPONENT INSULIN BIOSYNTHETIC臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SHALLAS ALLE, DK-4400 KALUNDBORG, DENMARKDENMARK2013-05-06å°ç“¶;;ç›’è£;;é‡ç†ACTRAPID 100 IU/ML
衛署èŒç–«è¼¸å—第000740號2017-11-072002-11-07èŒã€€ç–«DHA01000074000"科基" è¡€å‡ç´ ç¬¬å…«å› å注射劑(é‡çµ„體25ï¼IU\瓶治療Aåž‹è¡€å‹ç—…。無關節æ傷之Aåž‹è¡€å‹ç—…患童的常è¦é 防(é™åˆ¶ä½¿ç”¨è‡³12æ²ç‚ºæ¢)。å‡æ™¶æ³¨å°„劑å°ç“¶;;瓶è£;;注射用水é‡ç’è£;;包è£;;注射用水é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR RECOMBINANT FORMULATED WITH SUCROSE NOMINAL POTENCY臺ç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184BAYER HEALTHCARE LLC800 DWIGHT WAY, BERKELEY, CA 94710, U.S.A.UNITED STATES2014-09-25å°ç“¶;;瓶è£;;注射用水é‡ç’è£;;包è£;;注射用水é‡ç’è£KOGENATE FS, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FORMULATED WITH SUCROSE, 250 IU/VIAL
衛署èŒç–«è¼¸å—第000740號2017-11-072002-11-07èŒã€€ç–«DHA01000074000"科基" è¡€å‡ç´ ç¬¬å…«å› å注射劑(é‡çµ„體25ï¼IU\瓶治療Aåž‹è¡€å‹ç—…。無關節æ傷之Aåž‹è¡€å‹ç—…患童的常è¦é 防(é™åˆ¶ä½¿ç”¨è‡³12æ²ç‚ºæ¢)。å‡æ™¶æ³¨å°„劑å°ç“¶;;瓶è£;;注射用水é‡ç’è£;;包è£;;注射用水é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨ANTIHEMOPHILIC FACTOR RECOMBINANT FORMULATED WITH SUCROSE NOMINAL POTENCY臺ç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184BAYER PHARMA AGMUELLERSTRASSE 178, D-13353 BERLIN, GERMANYGERMANY2014-09-25å°ç“¶;;瓶è£;;注射用水é‡ç’è£;;包è£;;注射用水é‡ç’è£KOGENATE FS, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FORMULATED WITH SUCROSE, 250 IU/VIAL
衛署èŒç–«è¼¸å—第000743號2018-04-252002-11-15èŒã€€ç–«DHA01000074306æ “é«”èˆ’æ³¨å°„æ¶²æ€¥æ€§å† ç‹€å‹•è„ˆæ “å¡žä¹‹è¡€æ “æº¶è§£ã€æ€¥æ€§å¤§ç‰‡è‚ºæ “å¡žã€æ€¥æ€§ç¼ºè¡€æ€§ä¸é¢¨ä¹‹è¡€æ “溶解。注射劑å°ç“¶é™„溶液;;å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN ACTIVATOR;;PHOSPHORIC ACID;;L-ARGININE;;POLYSORBATE 80(TWEEN 80)(SORBIMACROGOL OLEATE300;;WATER FOR INJECTION臺ç£ç™¾éˆä½³æ®·æ ¼ç¿°è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼”ï¼™ã€ï¼•ï¼‘號12樓12469866BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGBIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS, GERMANYGERMANY2014-05-05å°ç“¶é™„溶液;;å°ç“¶;;ç›’è£ACTILYSE INJECTION
衛署èŒç–«è¼¸å—第000744號2015-05-092002-11-15èŒã€€ç–«DHA01000074408æ “é«”èˆ’æ³¨å°„æ¶²ï¼’ï¼å…¬çµ²æ€¥æ€§å† ç‹€å‹•è„ˆæ “å¡žä¹‹è¡€æ “æº¶è§£ã€æ€¥æ€§å¤§ç‰‡è‚ºæ “å¡žã€æ€¥æ€§ç¼ºè¡€æ€§ä¸é¢¨ä¹‹è¡€æ “溶解。å‡æ™¶æ³¨å°„劑瓶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN ACTIVATOR;;STERILE WATER FOR INJECTION臺ç£ç™¾éˆä½³æ®·æ ¼ç¿°è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼”ï¼™ã€ï¼•ï¼‘號12樓12469866BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGBIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS, GERMANYGERMANY2014-05-05瓶è£;;ç›’è£ACTILYSE INJECTION 20MG02017990
衛署èŒç–«è¼¸å—第000745號2017-12-092002-12-09èŒã€€ç–«DHA01000074500è˜å¾·ä»•10毫å‡å°ç“¶æ³¨å°„劑糖尿病。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨INSULIN GLARGINE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI-AVENTIS DEUTSCHLAND GMBHD-65926 FRANKFURT AM MAIN,GERMANYGERMANY2014-11-03å°ç“¶LANTUS 100 UNITS/ML SOLUTION FOR INJECTION, 10ML VIAL
衛署èŒç–«è¼¸å—第000746號2017-12-112002-12-11èŒã€€ç–«DHA01000074602"百特" å¨ä¿1000U抗抑制åå‡è¡€è¤‡åˆç‰©æ²»ç™‚Aåž‹åŠBåž‹è¡€å‹ç—…發生抗第八åŠç¬¬ä¹å› å抗體者,å«ç¬¬å…«ã€å一ã€åäºŒå› å抑制å之éžè¡€å‹ç—…患者。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨HUMAN PLASMA PROTEIN WITH FACTOR VIII INHIBITOR BY PASSING ACTIVITY百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER AGA-1220 VIENNA, INDUSTRIESTRASSES 67, AUSTRIA.AUSTRIA2012-09-20å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨â€œBAXTER†FEIBA 1000U
衛署èŒç–«è¼¸å—第000747號2017-12-112002-12-11èŒã€€ç–«DHA01000074701"百特" å¨ä¿500U 抗抑制åå‡è¡€è¤‡åˆç‰©æ²»ç™‚Aåž‹åŠBåž‹è¡€å‹ç—…發生抗第八åŠç¬¬ä¹å› å抗體者,å«ç¬¬å…«ã€å一ã€åäºŒå› å抑制å之éžè¡€å‹ç—…患者。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨HUMAN PLASMA PROTEIN WITH FACTOR VIII INHIBITOR BY PASSING ACTIVITY百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER AGA-1220 VIENNA, INDUSTRIESTRASSES 67, AUSTRIA.AUSTRIA2012-11-12å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨â€œBAXTERâ€FEIBA 500U
衛署èŒç–«è¼¸å—第000756號2016-04-222003-02-12èŒã€€ç–«DHA01000075602顆çƒè«¾å¾—25ï¼1.ä¿ƒé€²é€ è¡€å¹¹ç´°èƒžç§»æ¤æ™‚çš„å—œä¸æ€§ç™½è¡€çƒæ•¸çš„å¢žåŠ ã€‚2.癌症化å¸ç™‚法所引起之嗜ä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚3.伴隨著骨髓發育ä¸è‰¯ç—‡å€™ç¾¤çš„å—œä¸æ€§ç™½è¡€çƒæ¸›å°‘症。4.先天性ã€ç‰¹ç•°æ€§å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚5.å‹•å“¡é€ è¡€å¹¹ç´°èƒžè‡³é€±é‚Šè¡€æ¶²ä¸ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;ç›’è£;;安瓿附溶液é™ç”±é†«å¸«ä½¿ç”¨LENOGRASTIM (GENETICAL RECOMBINATION);;WATER FOR INJECTION臺ç£ä¸å¤–製藥股份有é™å…¬å¸å°åŒ—市內湖å€æ´²åè¡—73號3樓23060795CHUGAI PHARMACEUTICAL CO., LTD.5-1, UKIMA 5-CHOME, KITA-KU, TOKYO, JAPANJAPAN2012-10-19å°ç“¶;;ç›’è£;;安瓿附溶液GRANOCYTE 250
衛署èŒç–«è¼¸å—第000748號2017-12-112002-12-11èŒã€€ç–«DHA01000074803嬰è·å¯§å®‰ç—ºå¨ç–«è‹—(白喉/ç ´å‚·é¢¨/éžç´°èƒžæ€§ç™¾æ—¥å’³èˆ‡åŽ»æ´»åŒ–å°å…’麻痺混åˆç–«è‹—)INFANRIX-IPVé©ç”¨æ–¼ï¼’個月大以上之嬰幼兒å°ç™½å–‰ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³åŠå°å…’麻痺產生主動å…疫。先å‰å·²æŽ¥ç¨®éŽDTPåŠå°å…’麻痺抗原的兒童亦å¯ä½¿ç”¨INFANRIX-IPVä½œç‚ºè¿½åŠ åŠ‘ã€‚æ‡¸æµ®æ³¨å°„åŠ‘é 充填型注射器附é‡é é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PERTUSSIS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;PERTACTINE;;DIPHTHERIA TOXOID;;TETANUS TOXOID;;INACTIVATED POLIOVIRUS VACCINE TYPE I;;INACTIVATED POLIOVIRUS VACCINE TYPE II;;INACTIVATED POLIOVIRUS VACCINE TYPE IIIè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19é 充填型注射器附é‡é INFANRIX-IPV
衛署èŒç–«è¼¸å—第000748號2017-12-112002-12-11èŒã€€ç–«DHA01000074803嬰è·å¯§å®‰ç—ºå¨ç–«è‹—(白喉/ç ´å‚·é¢¨/éžç´°èƒžæ€§ç™¾æ—¥å’³èˆ‡åŽ»æ´»åŒ–å°å…’麻痺混åˆç–«è‹—)INFANRIX-IPVé©ç”¨æ–¼ï¼’個月大以上之嬰幼兒å°ç™½å–‰ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³åŠå°å…’麻痺產生主動å…疫。先å‰å·²æŽ¥ç¨®éŽDTPåŠå°å…’麻痺抗原的兒童亦å¯ä½¿ç”¨INFANRIX-IPVä½œç‚ºè¿½åŠ åŠ‘ã€‚æ‡¸æµ®æ³¨å°„åŠ‘é 充填型注射器附é‡é é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PERTUSSIS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;PERTACTINE;;DIPHTHERIA TOXOID;;TETANUS TOXOID;;INACTIVATED POLIOVIRUS VACCINE TYPE I;;INACTIVATED POLIOVIRUS VACCINE TYPE II;;INACTIVATED POLIOVIRUS VACCINE TYPE IIIè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.PARC DE LA NOIRE EPINE, RUE FLEMING 20, B-1300 WAVRE, BELGIUMBELGIUM2014-08-19é 充填型注射器附é‡é INFANRIX-IPV
衛署èŒç–«è¼¸å—第000751號2018-01-282003-01-28èŒã€€ç–«DHA01000075105補施追疫苗BOOSTRIXé©ç”¨æ–¼å››æ²ä»¥ä¸Šè€…ä¹‹è¿½åŠ ç–«è‹—æŽ¥ç¨®ï¼Œä»¥é 防白喉ã€ç ´å‚·é¢¨åŠç™¾æ—¥å’³ã€‚懸浮注射劑é å……å¼æ³¨å°„é‡ç’;;支è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PERTUSSIS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;PERTACTINE;;DIPHTHERIA TOXOID;;TETANUS TOXOIDè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19é å……å¼æ³¨å°„é‡ç’;;支è£BOOSTRIX
衛署èŒç–«è¼¸å—第000751號2018-01-282003-01-28èŒã€€ç–«DHA01000075105補施追疫苗BOOSTRIXé©ç”¨æ–¼å››æ²ä»¥ä¸Šè€…ä¹‹è¿½åŠ ç–«è‹—æŽ¥ç¨®ï¼Œä»¥é 防白喉ã€ç ´å‚·é¢¨åŠç™¾æ—¥å’³ã€‚懸浮注射劑é å……å¼æ³¨å°„é‡ç’;;支è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PERTUSSIS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;PERTACTINE;;DIPHTHERIA TOXOID;;TETANUS TOXOIDè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.PARC DE LA NOIRE EPINE, RUE FLEMING 20, B-1300 WAVRE, BELGIUMBELGIUM2014-08-19é å……å¼æ³¨å°„é‡ç’;;支è£BOOSTRIX
衛署èŒç–«è¼¸å—第000754號2013-01-282003-04-28èŒã€€ç–«DHA01000075401å› æ²»éš†ä¹¾ç²‰æ³¨å°„æ¶²æ…¢æ€§Båž‹è‚ç‚Žã€æ…¢æ€§Cåž‹è‚ç‚Žï¼éžAéžBåž‹è‚ç‚Žã€å¤šæ¯›ç‹€ç´°èƒžç™½è¡€çƒéŽå¤šç—…ã€æ…¢æ€§éª¨é«“性白血病ã€å¤šç™¼æ€§ç™½è¡€ç—…ã€éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€AIDS病患之å¡æ³¢è¥¿æ°è‚‰ç˜¤ã€å°–é æ¿•ç–£ã€æƒ¡æ€§é»‘è‰²ç´ ç´°èƒžç˜¤ã€‚å‡æ™¶ä¹¾ç²‰æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨INTERFERON ALPHA- 2B;;INTERFERON ALPHA- 2B;;INTERFERON ALPHA- 2B;;INTERFERON ALPHA- 2B美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH (BRINNY) COMPANYINNISHANNON, CO. CORK,IRELAND2012-08-27å°ç“¶INTRON A INJECTION
衛署èŒç–«è¼¸å—第000755號2016-04-222003-02-12èŒã€€ç–«DHA01000075500顆çƒè«¾å¾—5ï¼1.ä¿ƒé€²é€ è¡€å¹¹ç´°èƒžç§»æ¤æ™‚çš„å—œä¸æ€§ç™½è¡€çƒæ•¸çš„å¢žåŠ ã€‚2.癌症化å¸ç™‚法所引起之嗜ä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚3.伴隨著骨髓發育ä¸è‰¯ç—‡å€™ç¾¤çš„å—œä¸æ€§ç™½è¡€çƒæ¸›å°‘症。4.先天性ã€ç‰¹ç•°æ€§å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚5.å‹•å“¡é€ è¡€å¹¹ç´°èƒžè‡³é€±é‚Šè¡€æ¶²ä¸ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;ç›’è£;;安瓿附溶液é™ç”±é†«å¸«ä½¿ç”¨LENOGRASTIM (GENETICAL RECOMBINATION);;WATER FOR INJECTION臺ç£ä¸å¤–製藥股份有é™å…¬å¸å°åŒ—市內湖å€æ´²åè¡—73號3樓23060795UTSUNOMIYA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD.16-3 KIYOHARAKOUGYOUDANCHI,UTSUNOMIYA-CITY,TOCHIGI,JAPANJAPAN2012-10-19å°ç“¶;;ç›’è£;;安瓿附溶液GRANOCYTE 50
衛署èŒç–«è¼¸å—第000755號2016-04-222003-02-12èŒã€€ç–«DHA01000075500顆çƒè«¾å¾—5ï¼1.ä¿ƒé€²é€ è¡€å¹¹ç´°èƒžç§»æ¤æ™‚çš„å—œä¸æ€§ç™½è¡€çƒæ•¸çš„å¢žåŠ ã€‚2.癌症化å¸ç™‚法所引起之嗜ä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚3.伴隨著骨髓發育ä¸è‰¯ç—‡å€™ç¾¤çš„å—œä¸æ€§ç™½è¡€çƒæ¸›å°‘症。4.先天性ã€ç‰¹ç•°æ€§å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚5.å‹•å“¡é€ è¡€å¹¹ç´°èƒžè‡³é€±é‚Šè¡€æ¶²ä¸ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;ç›’è£;;安瓿附溶液é™ç”±é†«å¸«ä½¿ç”¨LENOGRASTIM (GENETICAL RECOMBINATION);;WATER FOR INJECTION臺ç£ä¸å¤–製藥股份有é™å…¬å¸å°åŒ—市內湖å€æ´²åè¡—73號3樓23060795CHUGAI PHARMACEUTICAL CO., LTD.5-1, UKIMA 5-CHOME, KITA-KU, TOKYO, JAPANJAPAN2012-10-19å°ç“¶;;ç›’è£;;安瓿附溶液GRANOCYTE 50
衛署èŒç–«è¼¸å—第000755號2016-04-222003-02-12èŒã€€ç–«DHA01000075500顆çƒè«¾å¾—5ï¼1.ä¿ƒé€²é€ è¡€å¹¹ç´°èƒžç§»æ¤æ™‚çš„å—œä¸æ€§ç™½è¡€çƒæ•¸çš„å¢žåŠ ã€‚2.癌症化å¸ç™‚法所引起之嗜ä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚3.伴隨著骨髓發育ä¸è‰¯ç—‡å€™ç¾¤çš„å—œä¸æ€§ç™½è¡€çƒæ¸›å°‘症。4.先天性ã€ç‰¹ç•°æ€§å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚5.å‹•å“¡é€ è¡€å¹¹ç´°èƒžè‡³é€±é‚Šè¡€æ¶²ä¸ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;ç›’è£;;安瓿附溶液é™ç”±é†«å¸«ä½¿ç”¨LENOGRASTIM (GENETICAL RECOMBINATION);;WATER FOR INJECTION臺ç£ä¸å¤–製藥股份有é™å…¬å¸å°åŒ—市內湖å€æ´²åè¡—73號3樓23060795UKIMA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD.5-1, UKIMA 5-CHOME, KITA-KU, TOKYO JAPANJAPAN2012-10-19å°ç“¶;;ç›’è£;;安瓿附溶液GRANOCYTE 50
衛署èŒç–«è¼¸å—第000756號2016-04-222003-02-12èŒã€€ç–«DHA01000075602顆çƒè«¾å¾—25ï¼1.ä¿ƒé€²é€ è¡€å¹¹ç´°èƒžç§»æ¤æ™‚çš„å—œä¸æ€§ç™½è¡€çƒæ•¸çš„å¢žåŠ ã€‚2.癌症化å¸ç™‚法所引起之嗜ä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚3.伴隨著骨髓發育ä¸è‰¯ç—‡å€™ç¾¤çš„å—œä¸æ€§ç™½è¡€çƒæ¸›å°‘症。4.先天性ã€ç‰¹ç•°æ€§å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚5.å‹•å“¡é€ è¡€å¹¹ç´°èƒžè‡³é€±é‚Šè¡€æ¶²ä¸ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;ç›’è£;;安瓿附溶液é™ç”±é†«å¸«ä½¿ç”¨LENOGRASTIM (GENETICAL RECOMBINATION);;WATER FOR INJECTION臺ç£ä¸å¤–製藥股份有é™å…¬å¸å°åŒ—市內湖å€æ´²åè¡—73號3樓23060795UTSUNOMIYA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD.16-3 KIYOHARAKOUGYOUDANCHI,UTSUNOMIYA-CITY,TOCHIGI,JAPANJAPAN2012-10-19å°ç“¶;;ç›’è£;;安瓿附溶液GRANOCYTE 250
衛署èŒç–«è¼¸å—第000756號2016-04-222003-02-12èŒã€€ç–«DHA01000075602顆çƒè«¾å¾—25ï¼1.ä¿ƒé€²é€ è¡€å¹¹ç´°èƒžç§»æ¤æ™‚çš„å—œä¸æ€§ç™½è¡€çƒæ•¸çš„å¢žåŠ ã€‚2.癌症化å¸ç™‚法所引起之嗜ä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚3.伴隨著骨髓發育ä¸è‰¯ç—‡å€™ç¾¤çš„å—œä¸æ€§ç™½è¡€çƒæ¸›å°‘症。4.先天性ã€ç‰¹ç•°æ€§å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚5.å‹•å“¡é€ è¡€å¹¹ç´°èƒžè‡³é€±é‚Šè¡€æ¶²ä¸ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;ç›’è£;;安瓿附溶液é™ç”±é†«å¸«ä½¿ç”¨LENOGRASTIM (GENETICAL RECOMBINATION);;WATER FOR INJECTION臺ç£ä¸å¤–製藥股份有é™å…¬å¸å°åŒ—市內湖å€æ´²åè¡—73號3樓23060795UKIMA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD.5-1, UKIMA 5-CHOME, KITA-KU, TOKYO JAPANJAPAN2012-10-19å°ç“¶;;ç›’è£;;安瓿附溶液GRANOCYTE 250
衛署èŒç–«è¼¸å—第000757號2016-04-222003-02-12èŒã€€ç–«DHA01000075704顆çƒè«¾å¾—1ï¼ï¼1.ä¿ƒé€²é€ è¡€å¹¹ç´°èƒžç§»æ¤æ™‚çš„å—œä¸æ€§ç™½è¡€çƒæ•¸çš„å¢žåŠ ã€‚2.癌症化å¸ç™‚法所引起之嗜ä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚3.伴隨著骨髓發育ä¸è‰¯ç—‡å€™ç¾¤çš„å—œä¸æ€§ç™½è¡€çƒæ¸›å°‘症。4.先天性ã€ç‰¹ç•°æ€§å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚5.å‹•å“¡é€ è¡€å¹¹ç´°èƒžè‡³é€±é‚Šè¡€æ¶²ä¸ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;ç›’è£;;安瓿附溶液é™ç”±é†«å¸«ä½¿ç”¨LENOGRASTIM (GENETICAL RECOMBINATION);;WATER FOR INJECTION臺ç£ä¸å¤–製藥股份有é™å…¬å¸å°åŒ—市內湖å€æ´²åè¡—73號3樓23060795UTSUNOMIYA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD.16-3 KIYOHARAKOUGYOUDANCHI,UTSUNOMIYA-CITY,TOCHIGI,JAPANJAPAN2012-10-19å°ç“¶;;ç›’è£;;安瓿附溶液GRANOCYTE 100
衛署èŒç–«è¼¸å—第000781號2013-11-252003-11-25èŒã€€ç–«DHA01000078101ä½¿è¡€ç´…æ˜‡æ³¨å°„åŠ‘ï¼’ï¼•æ²»ç™‚èˆ‡æ…¢æ€§è…ŽåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780AMGEN INC.ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 U.S.A.UNITED STATES2012-05-07å°ç“¶;;ç›’è£ARANESP 25MCG/ML
衛署èŒç–«è¼¸å—第000757號2016-04-222003-02-12èŒã€€ç–«DHA01000075704顆çƒè«¾å¾—1ï¼ï¼1.ä¿ƒé€²é€ è¡€å¹¹ç´°èƒžç§»æ¤æ™‚çš„å—œä¸æ€§ç™½è¡€çƒæ•¸çš„å¢žåŠ ã€‚2.癌症化å¸ç™‚法所引起之嗜ä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚3.伴隨著骨髓發育ä¸è‰¯ç—‡å€™ç¾¤çš„å—œä¸æ€§ç™½è¡€çƒæ¸›å°‘症。4.先天性ã€ç‰¹ç•°æ€§å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚5.å‹•å“¡é€ è¡€å¹¹ç´°èƒžè‡³é€±é‚Šè¡€æ¶²ä¸ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;ç›’è£;;安瓿附溶液é™ç”±é†«å¸«ä½¿ç”¨LENOGRASTIM (GENETICAL RECOMBINATION);;WATER FOR INJECTION臺ç£ä¸å¤–製藥股份有é™å…¬å¸å°åŒ—市內湖å€æ´²åè¡—73號3樓23060795CHUGAI PHARMACEUTICAL CO., LTD.5-1, UKIMA 5-CHOME, KITA-KU, TOKYO, JAPANJAPAN2012-10-19å°ç“¶;;ç›’è£;;安瓿附溶液GRANOCYTE 100
衛署èŒç–«è¼¸å—第000757號2016-04-222003-02-12èŒã€€ç–«DHA01000075704顆çƒè«¾å¾—1ï¼ï¼1.ä¿ƒé€²é€ è¡€å¹¹ç´°èƒžç§»æ¤æ™‚çš„å—œä¸æ€§ç™½è¡€çƒæ•¸çš„å¢žåŠ ã€‚2.癌症化å¸ç™‚法所引起之嗜ä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚3.伴隨著骨髓發育ä¸è‰¯ç—‡å€™ç¾¤çš„å—œä¸æ€§ç™½è¡€çƒæ¸›å°‘症。4.先天性ã€ç‰¹ç•°æ€§å—œä¸æ€§ç™½è¡€çƒç¼ºä¹ç—‡ã€‚5.å‹•å“¡é€ è¡€å¹¹ç´°èƒžè‡³é€±é‚Šè¡€æ¶²ä¸ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;ç›’è£;;安瓿附溶液é™ç”±é†«å¸«ä½¿ç”¨LENOGRASTIM (GENETICAL RECOMBINATION);;WATER FOR INJECTION臺ç£ä¸å¤–製藥股份有é™å…¬å¸å°åŒ—市內湖å€æ´²åè¡—73號3樓23060795UKIMA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD.5-1, UKIMA 5-CHOME, KITA-KU, TOKYO JAPANJAPAN2012-10-19å°ç“¶;;ç›’è£;;安瓿附溶液GRANOCYTE 100
衛署èŒç–«è¼¸å—第000760號2016-02-072003-03-05èŒã€€ç–«DHA01000076006å› é€Ÿä¾†é”èƒ°å³¶ç´ æ³¨å°„æ¶²ç³–å°¿ç—…ã€‚æ³¨å°„åŠ‘å°ç“¶;;å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN MONOCOMPONENT ISOPHANE INSULIN臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SHALLAS ALL'E, DK-4400 KALUNDBORG, DENMARKDENMARK2013-01-17å°ç“¶;;å°ç“¶;;ç›’è£Insulatard
衛署èŒç–«è¼¸å—第000760號2016-02-072003-03-05èŒã€€ç–«DHA01000076006å› é€Ÿä¾†é”èƒ°å³¶ç´ æ³¨å°„æ¶²ç³–å°¿ç—…ã€‚æ³¨å°„åŠ‘å°ç“¶;;å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN MONOCOMPONENT ISOPHANE INSULIN臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SDK 2880 BAGSVAERD, DENMARKDENMARK2013-01-17å°ç“¶;;å°ç“¶;;ç›’è£Insulatard
衛署èŒç–«è¼¸å—第000761號2018-03-242003-03-24èŒã€€ç–«DHA01000076108法舒克注射劑1.5公絲/毫å‡ã€€æ²»ç™‚åŠé é˜²å…·æœ‰è…«ç˜¤è² æ“”å’Œåœ¨é–‹å§‹åŒ–å¸æ²»ç™‚時å¯èƒ½æœƒå¼•ç™¼å¿«é€Ÿè…«ç˜¤æº¶è§£æˆ–èŽç¸®ä¹‹å±éšªçš„血癌患者之急性高尿酸血症。å‡æ™¶æ³¨å°„劑å°ç“¶;;安瓿附溶液;;å°ç“¶;;安瓿附溶液;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨RASBURICASE賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356GRUPPO LEPETIT S.R.L.LOCALITA VALCANELLO 03012 ANAGINI , ITALYITALY2014-11-03å°ç“¶;;安瓿附溶液;;å°ç“¶;;安瓿附溶液;;ç›’è£FASTURTEC POWDER AND SOLVENT FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1.5MG/ML
衛署èŒç–«è¼¸å—第000762號2018-03-252003-03-25èŒã€€ç–«DHA01000076200æ³°ä¼å‚·å¯’ç–«è‹—é 防傷寒。注射劑é 充填型注射器附é‡é é™ç”±é†«å¸«ä½¿ç”¨VI POLYSACCHARIDE OF SALMONELLA TYPHIè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19é 充填型注射器附é‡é TYPHERIX
衛署èŒç–«è¼¸å—第000763號2018-06-032003-04-08èŒã€€ç–«DHA01000076302æžœç´èŠ¬75國際單ä½(5.5微克)(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD)。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT),åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人,å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚(3)Gonal-F®ä½µç”¨äººé¡žçµ¨æ¯›è†œæ€§è…ºåˆºæ¿€ç´ (hCG)ï¼Œç”¨æ–¼æ²»ç™‚æ‚£æœ‰å…ˆå¤©æˆ–å¾Œå¤©æ€§è…ºåˆºæ¿€ç´ ä¸è¶³ä¹‹æ€§è…ºåŠŸèƒ½ä½Žä¸‹ç—‡ä¹‹ç”·æ€§æ‚£è€…,以刺激精å生æˆã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;é‡ç’è£é™„溶劑é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-11-13å°ç“¶;;é‡ç’è£é™„溶劑GONAL-F 75IU(5.5MCG)
衛署èŒç–«è¼¸å—第000763號2018-06-032003-04-08èŒã€€ç–«DHA01000076302æžœç´èŠ¬75國際單ä½(5.5微克)(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD)。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT),åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人,å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚(3)Gonal-F®ä½µç”¨äººé¡žçµ¨æ¯›è†œæ€§è…ºåˆºæ¿€ç´ (hCG)ï¼Œç”¨æ–¼æ²»ç™‚æ‚£æœ‰å…ˆå¤©æˆ–å¾Œå¤©æ€§è…ºåˆºæ¿€ç´ ä¸è¶³ä¹‹æ€§è…ºåŠŸèƒ½ä½Žä¸‹ç—‡ä¹‹ç”·æ€§æ‚£è€…,以刺激精å生æˆã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;é‡ç’è£é™„溶劑é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2014-11-13å°ç“¶;;é‡ç’è£é™„溶劑GONAL-F 75IU(5.5MCG)
衛署èŒç–«è¼¸å—第000763號2018-06-032003-04-08èŒã€€ç–«DHA01000076302æžœç´èŠ¬75國際單ä½(5.5微克)(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD)。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT),åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人,å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚(3)Gonal-F®ä½µç”¨äººé¡žçµ¨æ¯›è†œæ€§è…ºåˆºæ¿€ç´ (hCG)ï¼Œç”¨æ–¼æ²»ç™‚æ‚£æœ‰å…ˆå¤©æˆ–å¾Œå¤©æ€§è…ºåˆºæ¿€ç´ ä¸è¶³ä¹‹æ€§è…ºåŠŸèƒ½ä½Žä¸‹ç—‡ä¹‹ç”·æ€§æ‚£è€…,以刺激精å生æˆã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;é‡ç’è£é™„溶劑é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO SA, AUBONNE BRANCHZONE INDUSTRIELLE DE L'OURIETTAZ, 1170 AUBONNE SWITZERLANDSWITZERLAND2014-11-13å°ç“¶;;é‡ç’è£é™„溶劑GONAL-F 75IU(5.5MCG)
衛署èŒç–«è¼¸å—第000764號2013-06-032003-04-08èŒã€€ç–«DHA01000076401æžœç´èŠ¬ï¼‘5ï¼åœ‹éš›å–®ä½(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD)。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT),åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人,å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;安瓿附溶液é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)臺ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2012-08-29ç›’è£;;安瓿附溶液GONAL-F 150IU
衛署èŒç–«è¼¸å—第000764號2013-06-032003-04-08èŒã€€ç–«DHA01000076401æžœç´èŠ¬ï¼‘5ï¼åœ‹éš›å–®ä½(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD)。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT),åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人,å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;安瓿附溶液é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)臺ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO SA, AUBONNE BRANCHZONE INDUSTRIELLE DE L'OURIETTAZ, 1170 AUBONNE SWITZERLANDSWITZERLAND2012-08-29ç›’è£;;安瓿附溶液GONAL-F 150IU
衛署èŒç–«è¼¸å—第000767號2013-06-262003-06-26èŒã€€ç–«DHA01000076707克痘寧 活性滅毒水痘疫苗é 防水痘。å‡æ™¶æ³¨å°„劑å°ç“¶;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨ATTENUATED LIVE VARICELLA ZOSTER VIRUS OKA STRAIN;;WATER FOR INJECTION賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356THE RESEARCH FOUNDATION FOR MICROBIAL DISEASE OF OSAKA UN9-41 2-CHOME, YAHATA-CHO, KANONJI-CITY KAGAWA, JAPAN3-1 YAMADA-OKA, SUITA, OSAKA, JAPANJAPAN2014-11-03å°ç“¶;;ç›’è£OKAVAX
衛署èŒç–«è¼¸å—第000768號2018-08-042003-08-04èŒã€€ç–«DHA01000076809諾和密斯30諾芯管糖尿病。注射劑支è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN ASPART (INSULIN ASPART: INSULIN ASPART PROTAMINE 30:70)臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693Novo Nordisk Production SAS45, Avenue d’Orleans, F-28002 Chartres, FranceFRANCE2014-04-16支è£NOVOMIX 30 PENFILL 3ML, 100U/ML
衛署èŒç–«è¼¸å—第000769號2013-08-152003-08-15èŒã€€ç–«DHA01000076901"百特" 組織修復å‡åˆåŠ‘標準手術技術ä¸è¶³æ™‚的輔助療法─促進癒åˆçš„密åˆåŠ‘或包括血管ã€è…¸èƒƒå»åˆè¡“ã€ç¥žç¶“外科手術ç‰ç¸«åˆæ”¯æ´ã€‚液劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨APROTININ ( BOVINE);;FACTOR XIII;;HUMAN THROMBIN百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER AGA-1220 VIENNA, INDUSTRIESTRASSES 67, AUSTRIA.AUSTRIA2008-06-25注射é‡ç’TISSUCOL DUO QUICK
衛署èŒç–«è¼¸å—第000773號2018-10-092003-10-09èŒã€€ç–«DHA01000077302æžœç´èŠ¬æ³¨å°„劑 450 國際單ä½/0.75公撮(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD)。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT)ã€åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人ã€å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚(3)Gonal-F®ä½µç”¨äººé¡žçµ¨æ¯›è†œæ€§è…ºåˆºæ¿€ç´ (hCG)ï¼Œç”¨æ–¼æ²»ç™‚æ‚£æœ‰å…ˆå¤©æˆ–å¾Œå¤©æ€§è…ºåˆºæ¿€ç´ ä¸è¶³ä¹‹æ€§è…ºåŠŸèƒ½ä½Žä¸‹ç—‡ä¹‹ç”·æ€§æ‚£è€…,以刺激精å生æˆã€‚å‡æ™¶æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-11-13å°ç“¶GONAL-F 450IU/0.75ML
衛署èŒç–«è¼¸å—第000773號2018-10-092003-10-09èŒã€€ç–«DHA01000077302æžœç´èŠ¬æ³¨å°„劑 450 國際單ä½/0.75公撮(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD)。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT)ã€åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人ã€å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚(3)Gonal-F®ä½µç”¨äººé¡žçµ¨æ¯›è†œæ€§è…ºåˆºæ¿€ç´ (hCG)ï¼Œç”¨æ–¼æ²»ç™‚æ‚£æœ‰å…ˆå¤©æˆ–å¾Œå¤©æ€§è…ºåˆºæ¿€ç´ ä¸è¶³ä¹‹æ€§è…ºåŠŸèƒ½ä½Žä¸‹ç—‡ä¹‹ç”·æ€§æ‚£è€…,以刺激精å生æˆã€‚å‡æ™¶æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2014-11-13å°ç“¶GONAL-F 450IU/0.75ML
衛署èŒç–«è¼¸å—第000774號2018-11-062003-11-06èŒã€€ç–«DHA01000077404"百特" 伊美è€é«˜ç´”度第ä¹å‡è¡€å› å注射劑 600 國際單ä½æ²»ç™‚åŠé é˜²å› å…ˆå¤©æ€§æˆ–å¾Œå¤©æ€§ç¬¬ä¹å‡è¡€å› å缺ä¹æ‰€å¼•èµ·çš„出血。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨HUMAN COAGULATION FACTOR IX百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER AGINDUSTRIESTRASSE 67, A-1221 WIEN, AUSTRIAAUSTRIA2014-07-04å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨IMMUNINE PURIFIED FACTOR IX CONCENTRATE, VIRUS-INACTIVATED 600 IU
衛署èŒç–«è¼¸å—第000774號2018-11-062003-11-06èŒã€€ç–«DHA01000077404"百特" 伊美è€é«˜ç´”度第ä¹å‡è¡€å› å注射劑 600 國際單ä½æ²»ç™‚åŠé é˜²å› å…ˆå¤©æ€§æˆ–å¾Œå¤©æ€§ç¬¬ä¹å‡è¡€å› å缺ä¹æ‰€å¼•èµ·çš„出血。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨HUMAN COAGULATION FACTOR IX百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER AGLange Allee 24, 1221, Wien, AUSTRIAAUSTRIA2014-07-04å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨IMMUNINE PURIFIED FACTOR IX CONCENTRATE, VIRUS-INACTIVATED 600 IU
衛署èŒç–«è¼¸å—第000774號2018-11-062003-11-06èŒã€€ç–«DHA01000077404"百特" 伊美è€é«˜ç´”度第ä¹å‡è¡€å› å注射劑 600 國際單ä½æ²»ç™‚åŠé é˜²å› å…ˆå¤©æ€§æˆ–å¾Œå¤©æ€§ç¬¬ä¹å‡è¡€å› å缺ä¹æ‰€å¼•èµ·çš„出血。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨HUMAN COAGULATION FACTOR IX百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER AGINDUSTRIESTRASSE 72, 1221, WIEN, AUSTRIAAUSTRIA2014-07-04å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨IMMUNINE PURIFIED FACTOR IX CONCENTRATE, VIRUS-INACTIVATED 600 IU
衛署èŒç–«è¼¸å—第000775號2018-11-102003-11-10èŒã€€ç–«DHA01000077506"艾伯ç¶" 復é‚注射劑類風濕性關節炎:HUMIRAé©ç”¨æ–¼æ‚£æœ‰ä¸åº¦è‡³é‡åº¦é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物有ä¸é©ç•¶å應的æˆäººç—…患,å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†(包括主è¦è‡¨åºŠå應和臨床緩解)ã€æŠ‘制çµæ§‹ä¸Šæ害的惡化。HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或其他DMARDs藥物併用。乾癬性關節炎:é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或DMARDs藥物併用。僵直性脊椎炎:é©ç”¨æ–¼æ¸›è¼•æ‚£æœ‰æ´»å‹•æ€§åƒµç›´æ€§è„Šæ¤Žç‚Žçš„病患之症狀與徵兆。克隆æ°ç—‡ï¼šé©ç”¨æ–¼å°å‚³çµ±æ²»ç™‚無效之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡(CD),å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚Humira亦é©ç”¨æ–¼å°infliximab已經失去療效或無è€å—性之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡ï¼Œå¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚乾癬:å°å…¶ä»–全身性治療,包括cyclosporineã€methotrexate或其他光化å¸ç™‚法無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨ADALIMUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958VETTER PHARMA-FERTIGUNG GMBH & CO. KG FOR ABBOTT LABORATORIES.SCHUTZENSTRASSE 87 D-88212 RAVENSBURG, GERMANYGERMANY2014-08-08å°ç“¶HUMIRA 40MG SOLUTION FOR INJECTION, VIAL
衛署èŒç–«è¼¸å—第000775號2018-11-102003-11-10èŒã€€ç–«DHA01000077506"艾伯ç¶" 復é‚注射劑類風濕性關節炎:HUMIRAé©ç”¨æ–¼æ‚£æœ‰ä¸åº¦è‡³é‡åº¦é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物有ä¸é©ç•¶å應的æˆäººç—…患,å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†(包括主è¦è‡¨åºŠå應和臨床緩解)ã€æŠ‘制çµæ§‹ä¸Šæ害的惡化。HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或其他DMARDs藥物併用。乾癬性關節炎:é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或DMARDs藥物併用。僵直性脊椎炎:é©ç”¨æ–¼æ¸›è¼•æ‚£æœ‰æ´»å‹•æ€§åƒµç›´æ€§è„Šæ¤Žç‚Žçš„病患之症狀與徵兆。克隆æ°ç—‡ï¼šé©ç”¨æ–¼å°å‚³çµ±æ²»ç™‚無效之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡(CD),å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚Humira亦é©ç”¨æ–¼å°infliximab已經失去療效或無è€å—性之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡ï¼Œå¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚乾癬:å°å…¶ä»–全身性治療,包括cyclosporineã€methotrexate或其他光化å¸ç™‚法無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨ADALIMUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958VETTER PHARMA-FERTIGUNG GMBH & CO. KGEISENBAHNSTRASSE 2-4, 88085 LANGENARGEN GERMANYGERMANY2014-08-08å°ç“¶HUMIRA 40MG SOLUTION FOR INJECTION, VIAL
衛署èŒç–«è¼¸å—第000775號2018-11-102003-11-10èŒã€€ç–«DHA01000077506"艾伯ç¶" 復é‚注射劑類風濕性關節炎:HUMIRAé©ç”¨æ–¼æ‚£æœ‰ä¸åº¦è‡³é‡åº¦é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物有ä¸é©ç•¶å應的æˆäººç—…患,å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†(包括主è¦è‡¨åºŠå應和臨床緩解)ã€æŠ‘制çµæ§‹ä¸Šæ害的惡化。HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或其他DMARDs藥物併用。乾癬性關節炎:é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或DMARDs藥物併用。僵直性脊椎炎:é©ç”¨æ–¼æ¸›è¼•æ‚£æœ‰æ´»å‹•æ€§åƒµç›´æ€§è„Šæ¤Žç‚Žçš„病患之症狀與徵兆。克隆æ°ç—‡ï¼šé©ç”¨æ–¼å°å‚³çµ±æ²»ç™‚無效之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡(CD),å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚Humira亦é©ç”¨æ–¼å°infliximab已經失去療效或無è€å—性之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡ï¼Œå¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚乾癬:å°å…¶ä»–全身性治療,包括cyclosporineã€methotrexate或其他光化å¸ç™‚法無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨ADALIMUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958ABBVIE BIOTECHNOLOGY GMBHMax-Planck-Ring 2, D-65205 Wiesbaden, GermanyGERMANY2014-08-08å°ç“¶HUMIRA 40MG SOLUTION FOR INJECTION, VIAL
衛署èŒç–«è¼¸å—第000776號2018-11-102003-11-10èŒã€€ç–«DHA01000077608"艾伯ç¶"復é‚é‡ç’è£æ³¨å°„劑類風濕性關節炎:HUMIRAé©ç”¨æ–¼æ‚£æœ‰ä¸åº¦è‡³é‡åº¦é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物有ä¸é©ç•¶å應的æˆäººç—…患,å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†(包括主è¦è‡¨åºŠå應和臨床緩解)ã€æŠ‘制çµæ§‹ä¸Šæ害的惡化。HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或其他DMARDs藥物併用。乾癬性關節炎:é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或DMARDs藥物併用。僵直性脊椎炎:é©ç”¨æ–¼æ¸›è¼•æ‚£æœ‰æ´»å‹•æ€§åƒµç›´æ€§è„Šæ¤Žç‚Žçš„病患之症狀與徵兆。克隆æ°ç—‡ï¼šé©ç”¨æ–¼å°å‚³çµ±æ²»ç™‚無效之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡(CD),å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚Humira亦é©ç”¨æ–¼å°infliximab已經失去療效或無è€å—性之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡ï¼Œå¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚乾癬:å°å…¶ä»–全身性治療,包括cyclosporineã€MTX或其他光化å¸ç™‚法無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。幼年型自發性多關節炎:Humira併用MTXé©ç”¨æ–¼13至17æ²æ‚£æœ‰æ´»å‹•æ€§å¹¼å¹´åž‹è‡ªç™¼æ€§å¤šé—œç¯€ç‚Žï¼Œä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物å應ä¸ä½³çš„é’少年病患。Humiraå¯å–®ç¨ä½¿ç”¨æ–¼å°MTX無法è€å—或ä¸é©åˆæŒçºŒä½¿ç”¨ä¹‹æ‚£è€…。潰ç˜æ€§çµè…¸ç‚Žï¼šé©ç”¨æ–¼å°æ–¼çš®è³ªé¡žå›ºé†‡å’Œ/或6- mercaptopurine (6-MP)或azathioprine (AZA)ç‰å‚³çµ±æ²»ç™‚無效ã€æˆ–å°é€™ç¨®ç™‚法ä¸è€å—或有醫療ç¦å¿Œä¹‹ä¸åº¦è‡³åš´é‡æ´»å‹•æ€§æ½°ç˜æ€§çµè…¸ç‚Žæˆäººç—…患。注射劑注射é‡ç’;;注射ç†è£é™ç”±é†«å¸«ä½¿ç”¨ADALIMUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958AESICA QUEENBOROUGH LIMITEDQUEENBOROUGH KENT, ME11 5EL, ENGLAND UNITED KINGDOM2014-09-11注射é‡ç’;;注射ç†è£HUMIRA 40MG SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
衛署èŒç–«è¼¸å—第000776號2018-11-102003-11-10èŒã€€ç–«DHA01000077608"艾伯ç¶"復é‚é‡ç’è£æ³¨å°„劑類風濕性關節炎:HUMIRAé©ç”¨æ–¼æ‚£æœ‰ä¸åº¦è‡³é‡åº¦é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物有ä¸é©ç•¶å應的æˆäººç—…患,å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†(包括主è¦è‡¨åºŠå應和臨床緩解)ã€æŠ‘制çµæ§‹ä¸Šæ害的惡化。HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或其他DMARDs藥物併用。乾癬性關節炎:é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或DMARDs藥物併用。僵直性脊椎炎:é©ç”¨æ–¼æ¸›è¼•æ‚£æœ‰æ´»å‹•æ€§åƒµç›´æ€§è„Šæ¤Žç‚Žçš„病患之症狀與徵兆。克隆æ°ç—‡ï¼šé©ç”¨æ–¼å°å‚³çµ±æ²»ç™‚無效之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡(CD),å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚Humira亦é©ç”¨æ–¼å°infliximab已經失去療效或無è€å—性之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡ï¼Œå¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚乾癬:å°å…¶ä»–全身性治療,包括cyclosporineã€MTX或其他光化å¸ç™‚法無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。幼年型自發性多關節炎:Humira併用MTXé©ç”¨æ–¼13至17æ²æ‚£æœ‰æ´»å‹•æ€§å¹¼å¹´åž‹è‡ªç™¼æ€§å¤šé—œç¯€ç‚Žï¼Œä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物å應ä¸ä½³çš„é’少年病患。Humiraå¯å–®ç¨ä½¿ç”¨æ–¼å°MTX無法è€å—或ä¸é©åˆæŒçºŒä½¿ç”¨ä¹‹æ‚£è€…。潰ç˜æ€§çµè…¸ç‚Žï¼šé©ç”¨æ–¼å°æ–¼çš®è³ªé¡žå›ºé†‡å’Œ/或6- mercaptopurine (6-MP)或azathioprine (AZA)ç‰å‚³çµ±æ²»ç™‚無效ã€æˆ–å°é€™ç¨®ç™‚法ä¸è€å—或有醫療ç¦å¿Œä¹‹ä¸åº¦è‡³åš´é‡æ´»å‹•æ€§æ½°ç˜æ€§çµè…¸ç‚Žæˆäººç—…患。注射劑注射é‡ç’;;注射ç†è£é™ç”±é†«å¸«ä½¿ç”¨ADALIMUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958AbbVie Biotechnology Ltd.Road No. 2, Km.59.2 Barceloneta Puerto Rico 00617PUERTO RICO2014-09-11注射é‡ç’;;注射ç†è£HUMIRA 40MG SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
衛署èŒç–«è¼¸å—第000776號2018-11-102003-11-10èŒã€€ç–«DHA01000077608"艾伯ç¶"復é‚é‡ç’è£æ³¨å°„劑類風濕性關節炎:HUMIRAé©ç”¨æ–¼æ‚£æœ‰ä¸åº¦è‡³é‡åº¦é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物有ä¸é©ç•¶å應的æˆäººç—…患,å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†(包括主è¦è‡¨åºŠå應和臨床緩解)ã€æŠ‘制çµæ§‹ä¸Šæ害的惡化。HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或其他DMARDs藥物併用。乾癬性關節炎:é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或DMARDs藥物併用。僵直性脊椎炎:é©ç”¨æ–¼æ¸›è¼•æ‚£æœ‰æ´»å‹•æ€§åƒµç›´æ€§è„Šæ¤Žç‚Žçš„病患之症狀與徵兆。克隆æ°ç—‡ï¼šé©ç”¨æ–¼å°å‚³çµ±æ²»ç™‚無效之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡(CD),å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚Humira亦é©ç”¨æ–¼å°infliximab已經失去療效或無è€å—性之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡ï¼Œå¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚乾癬:å°å…¶ä»–全身性治療,包括cyclosporineã€MTX或其他光化å¸ç™‚法無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。幼年型自發性多關節炎:Humira併用MTXé©ç”¨æ–¼13至17æ²æ‚£æœ‰æ´»å‹•æ€§å¹¼å¹´åž‹è‡ªç™¼æ€§å¤šé—œç¯€ç‚Žï¼Œä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物å應ä¸ä½³çš„é’少年病患。Humiraå¯å–®ç¨ä½¿ç”¨æ–¼å°MTX無法è€å—或ä¸é©åˆæŒçºŒä½¿ç”¨ä¹‹æ‚£è€…。潰ç˜æ€§çµè…¸ç‚Žï¼šé©ç”¨æ–¼å°æ–¼çš®è³ªé¡žå›ºé†‡å’Œ/或6- mercaptopurine (6-MP)或azathioprine (AZA)ç‰å‚³çµ±æ²»ç™‚無效ã€æˆ–å°é€™ç¨®ç™‚法ä¸è€å—或有醫療ç¦å¿Œä¹‹ä¸åº¦è‡³åš´é‡æ´»å‹•æ€§æ½°ç˜æ€§çµè…¸ç‚Žæˆäººç—…患。注射劑注射é‡ç’;;注射ç†è£é™ç”±é†«å¸«ä½¿ç”¨ADALIMUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958Lonza Biologics Porrino, S.L.A Relva s/n 36400 O Porrino Pontevedra, SpainSPAIN2014-09-11注射é‡ç’;;注射ç†è£HUMIRA 40MG SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
衛署èŒç–«è¼¸å—第000776號2018-11-102003-11-10èŒã€€ç–«DHA01000077608"艾伯ç¶"復é‚é‡ç’è£æ³¨å°„劑類風濕性關節炎:HUMIRAé©ç”¨æ–¼æ‚£æœ‰ä¸åº¦è‡³é‡åº¦é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物有ä¸é©ç•¶å應的æˆäººç—…患,å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†(包括主è¦è‡¨åºŠå應和臨床緩解)ã€æŠ‘制çµæ§‹ä¸Šæ害的惡化。HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或其他DMARDs藥物併用。乾癬性關節炎:é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或DMARDs藥物併用。僵直性脊椎炎:é©ç”¨æ–¼æ¸›è¼•æ‚£æœ‰æ´»å‹•æ€§åƒµç›´æ€§è„Šæ¤Žç‚Žçš„病患之症狀與徵兆。克隆æ°ç—‡ï¼šé©ç”¨æ–¼å°å‚³çµ±æ²»ç™‚無效之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡(CD),å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚Humira亦é©ç”¨æ–¼å°infliximab已經失去療效或無è€å—性之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡ï¼Œå¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚乾癬:å°å…¶ä»–全身性治療,包括cyclosporineã€MTX或其他光化å¸ç™‚法無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。幼年型自發性多關節炎:Humira併用MTXé©ç”¨æ–¼13至17æ²æ‚£æœ‰æ´»å‹•æ€§å¹¼å¹´åž‹è‡ªç™¼æ€§å¤šé—œç¯€ç‚Žï¼Œä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物å應ä¸ä½³çš„é’少年病患。Humiraå¯å–®ç¨ä½¿ç”¨æ–¼å°MTX無法è€å—或ä¸é©åˆæŒçºŒä½¿ç”¨ä¹‹æ‚£è€…。潰ç˜æ€§çµè…¸ç‚Žï¼šé©ç”¨æ–¼å°æ–¼çš®è³ªé¡žå›ºé†‡å’Œ/或6- mercaptopurine (6-MP)或azathioprine (AZA)ç‰å‚³çµ±æ²»ç™‚無效ã€æˆ–å°é€™ç¨®ç™‚法ä¸è€å—或有醫療ç¦å¿Œä¹‹ä¸åº¦è‡³åš´é‡æ´»å‹•æ€§æ½°ç˜æ€§çµè…¸ç‚Žæˆäººç—…患。注射劑注射é‡ç’;;注射ç†è£é™ç”±é†«å¸«ä½¿ç”¨ADALIMUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958AbbVie Bioresearch Center100 Research Drive, Worcester, MA 01605, USAUNITED STATES2014-09-11注射é‡ç’;;注射ç†è£HUMIRA 40MG SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
衛署èŒç–«è¼¸å—第000776號2018-11-102003-11-10èŒã€€ç–«DHA01000077608"艾伯ç¶"復é‚é‡ç’è£æ³¨å°„劑類風濕性關節炎:HUMIRAé©ç”¨æ–¼æ‚£æœ‰ä¸åº¦è‡³é‡åº¦é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物有ä¸é©ç•¶å應的æˆäººç—…患,å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†(包括主è¦è‡¨åºŠå應和臨床緩解)ã€æŠ‘制çµæ§‹ä¸Šæ害的惡化。HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或其他DMARDs藥物併用。乾癬性關節炎:é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或DMARDs藥物併用。僵直性脊椎炎:é©ç”¨æ–¼æ¸›è¼•æ‚£æœ‰æ´»å‹•æ€§åƒµç›´æ€§è„Šæ¤Žç‚Žçš„病患之症狀與徵兆。克隆æ°ç—‡ï¼šé©ç”¨æ–¼å°å‚³çµ±æ²»ç™‚無效之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡(CD),å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚Humira亦é©ç”¨æ–¼å°infliximab已經失去療效或無è€å—性之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡ï¼Œå¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚乾癬:å°å…¶ä»–全身性治療,包括cyclosporineã€MTX或其他光化å¸ç™‚法無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。幼年型自發性多關節炎:Humira併用MTXé©ç”¨æ–¼13至17æ²æ‚£æœ‰æ´»å‹•æ€§å¹¼å¹´åž‹è‡ªç™¼æ€§å¤šé—œç¯€ç‚Žï¼Œä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物å應ä¸ä½³çš„é’少年病患。Humiraå¯å–®ç¨ä½¿ç”¨æ–¼å°MTX無法è€å—或ä¸é©åˆæŒçºŒä½¿ç”¨ä¹‹æ‚£è€…。潰ç˜æ€§çµè…¸ç‚Žï¼šé©ç”¨æ–¼å°æ–¼çš®è³ªé¡žå›ºé†‡å’Œ/或6- mercaptopurine (6-MP)或azathioprine (AZA)ç‰å‚³çµ±æ²»ç™‚無效ã€æˆ–å°é€™ç¨®ç™‚法ä¸è€å—或有醫療ç¦å¿Œä¹‹ä¸åº¦è‡³åš´é‡æ´»å‹•æ€§æ½°ç˜æ€§çµè…¸ç‚Žæˆäººç—…患。注射劑注射é‡ç’;;注射ç†è£é™ç”±é†«å¸«ä½¿ç”¨ADALIMUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958VETTER PHARMA-FERTIGUNG GMBH & CO. KGSCHUTZENSTRASSE 87 AND 99-101, 88212 RAVENSBURG, GERMANYGERMANY2014-09-11注射é‡ç’;;注射ç†è£HUMIRA 40MG SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
衛署èŒç–«è¼¸å—第000776號2018-11-102003-11-10èŒã€€ç–«DHA01000077608"艾伯ç¶"復é‚é‡ç’è£æ³¨å°„劑類風濕性關節炎:HUMIRAé©ç”¨æ–¼æ‚£æœ‰ä¸åº¦è‡³é‡åº¦é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物有ä¸é©ç•¶å應的æˆäººç—…患,å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†(包括主è¦è‡¨åºŠå應和臨床緩解)ã€æŠ‘制çµæ§‹ä¸Šæ害的惡化。HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或其他DMARDs藥物併用。乾癬性關節炎:é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚HUMIRAå¯å–®ç¨ä½¿ç”¨ä¹Ÿå¯ä»¥å’ŒMTX或DMARDs藥物併用。僵直性脊椎炎:é©ç”¨æ–¼æ¸›è¼•æ‚£æœ‰æ´»å‹•æ€§åƒµç›´æ€§è„Šæ¤Žç‚Žçš„病患之症狀與徵兆。克隆æ°ç—‡ï¼šé©ç”¨æ–¼å°å‚³çµ±æ²»ç™‚無效之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡(CD),å¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚Humira亦é©ç”¨æ–¼å°infliximab已經失去療效或無è€å—性之æˆäººä¸åº¦è‡³é‡åº¦å…‹éš†æ°ç—‡ï¼Œå¯æ¸›è¼•ç—‡ç‹€èˆ‡å¾µå…†åŠèª˜å°Žèˆ‡ç¶æŒè‡¨åºŠç·©è§£ã€‚乾癬:å°å…¶ä»–全身性治療,包括cyclosporineã€MTX或其他光化å¸ç™‚法無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。幼年型自發性多關節炎:Humira併用MTXé©ç”¨æ–¼13至17æ²æ‚£æœ‰æ´»å‹•æ€§å¹¼å¹´åž‹è‡ªç™¼æ€§å¤šé—œç¯€ç‚Žï¼Œä¸¦ä¸”曾經å°ä¸€ç¨®æˆ–超éŽä¸€ç¨®çš„DMARDs藥物å應ä¸ä½³çš„é’少年病患。Humiraå¯å–®ç¨ä½¿ç”¨æ–¼å°MTX無法è€å—或ä¸é©åˆæŒçºŒä½¿ç”¨ä¹‹æ‚£è€…。潰ç˜æ€§çµè…¸ç‚Žï¼šé©ç”¨æ–¼å°æ–¼çš®è³ªé¡žå›ºé†‡å’Œ/或6- mercaptopurine (6-MP)或azathioprine (AZA)ç‰å‚³çµ±æ²»ç™‚無效ã€æˆ–å°é€™ç¨®ç™‚法ä¸è€å—或有醫療ç¦å¿Œä¹‹ä¸åº¦è‡³åš´é‡æ´»å‹•æ€§æ½°ç˜æ€§çµè…¸ç‚Žæˆäººç—…患。注射劑注射é‡ç’;;注射ç†è£é™ç”±é†«å¸«ä½¿ç”¨ADALIMUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958ABBVIE BIOTECHNOLOGY GMBHMax-Planck-Ring 2, D-65205 Wiesbaden, GermanyGERMANY2014-09-11注射é‡ç’;;注射ç†è£HUMIRA 40MG SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
衛署èŒç–«è¼¸å—第000777號2018-11-202003-11-20èŒã€€ç–«DHA01000077700白蛋白注射劑 20%低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN天行貿易股份有é™å…¬å¸å°åŒ—市ä¸å±±å€é•·å®‰æ±è·¯ä¸€æ®µ21號2樓11102308Grifols Therapeutics Inc.8368 US 70 BUS HWY WEST, CLAYTON, NC 27520, U.S.A.UNITED STATES2013-11-08瓶è£PLASBUMIN-20
衛署èŒç–«è¼¸å—第000781號2013-11-252003-11-25èŒã€€ç–«DHA01000078101ä½¿è¡€ç´…æ˜‡æ³¨å°„åŠ‘ï¼’ï¼•æ²»ç™‚èˆ‡æ…¢æ€§è…ŽåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780久裕ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸(委託包è£)桃園市龜山工æ¥å€èˆˆé‚¦è·¯43å··2之1號,C棟4樓TAIWAN2012-05-07å°ç“¶;;ç›’è£ARANESP 25MCG/ML
衛署èŒç–«è¼¸å—第000781號2013-11-252003-11-25èŒã€€ç–«DHA01000078101ä½¿è¡€ç´…æ˜‡æ³¨å°„åŠ‘ï¼’ï¼•æ²»ç™‚èˆ‡æ…¢æ€§è…ŽåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780AMGEN MANUFACTURING,LIMITEDSTATE ROAD 31,KM 24.6 JUNCOS,PUERTO RICO 00777-4060PUERTO RICO2012-05-07å°ç“¶;;ç›’è£ARANESP 25MCG/ML
衛署èŒç–«è¼¸å—第000782號2013-11-252003-11-25èŒã€€ç–«DHA01000078203使血紅昇注射劑4ï¼æ²»ç™‚èˆ‡æ…¢æ€§è…ŽåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780久裕ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸(委託包è£)桃園市龜山工æ¥å€èˆˆé‚¦è·¯43å··2之1號,C棟4樓TAIWAN2012-05-07å°ç“¶;;ç›’è£ARANESP 40MCG/ML
衛署èŒç–«è¼¸å—第000782號2013-11-252003-11-25èŒã€€ç–«DHA01000078203使血紅昇注射劑4ï¼æ²»ç™‚èˆ‡æ…¢æ€§è…ŽåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780AMGEN MANUFACTURING,LIMITEDSTATE ROAD 31,KM 24.6 JUNCOS,PUERTO RICO 00777-4060PUERTO RICO2012-05-07å°ç“¶;;ç›’è£ARANESP 40MCG/ML
衛署èŒç–«è¼¸å—第000782號2013-11-252003-11-25èŒã€€ç–«DHA01000078203使血紅昇注射劑4ï¼æ²»ç™‚èˆ‡æ…¢æ€§è…ŽåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780AMGEN INC.ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 U.S.A.UNITED STATES2012-05-07å°ç“¶;;ç›’è£ARANESP 40MCG/ML
衛署èŒç–«è¼¸å—第000783號2013-11-252003-11-25èŒã€€ç–«DHA01000078305使血紅昇注射劑6ï¼æ²»ç™‚èˆ‡æ…¢æ€§è…ŽåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780久裕ä¼æ¥è‚¡ä»½æœ‰é™å…¬å¸(委託包è£)桃園市龜山工æ¥å€èˆˆé‚¦è·¯43å··2之1號,C棟4樓TAIWAN2012-05-07å°ç“¶;;ç›’è£ARANESP 60MCG/ML
衛署èŒç–«è¼¸å—第000783號2013-11-252003-11-25èŒã€€ç–«DHA01000078305使血紅昇注射劑6ï¼æ²»ç™‚èˆ‡æ…¢æ€§è…ŽåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780AMGEN MANUFACTURING,LIMITEDSTATE ROAD 31,KM 24.6 JUNCOS,PUERTO RICO 00777-4060PUERTO RICO2012-05-07å°ç“¶;;ç›’è£ARANESP 60MCG/ML
衛署èŒç–«è¼¸å—第000783號2013-11-252003-11-25èŒã€€ç–«DHA01000078305使血紅昇注射劑6ï¼æ²»ç™‚èˆ‡æ…¢æ€§è…ŽåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780AMGEN INC.ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 U.S.A.UNITED STATES2012-05-07å°ç“¶;;ç›’è£ARANESP 60MCG/ML
衛署èŒç–«è¼¸å—第000787號2018-12-162003-12-16èŒã€€ç–«DHA01000078700骨穩 注射液åœç¶“後婦女骨質ç–鬆症具高度骨折風險者。男性原發性或次發於性腺功能低下症之骨質ç–鬆且具有高度骨折風險者。女性åŠç”·æ€§å› 糖化皮質類固醇治療引起之骨質ç–鬆症且具高度骨折風險者。注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨TERIPARATIDE臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY FRANCE2 RUE DU COLONEL LILLY 67640 FEGERSHEIM, FRANCEFRANCE2014-05-29注射ç†;;ç›’è£FORTEO FOR INJECTION
衛署èŒç–«è¼¸å—第000815號2015-10-072005-10-07èŒã€€ç–«DHA01000081505æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 50μg/Pen用於治療慢性Cåž‹è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MSD International GmbH (Singapore Branch)60, TUAS WEST DRIVE, SINGAPORE, 638413SINGAPORE2014-03-25注射ç†;;ç›’è£Peg-Intron Redipen 50μg/Penè«‹åƒç…§ä»¿å–®å…§å®¹
衛署èŒç–«è¼¸å—第000788號2019-01-062004-01-06èŒã€€ç–«DHA01000078802ç®æ ¼è¥¿æ–½ 注射劑135微公克/0.5毫å‡æ²»ç™‚慢性Båž‹è‚炎:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人,ç®æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性,有病毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚炎。治療慢性Cåž‹è‚炎:單ç¨æˆ–åˆä½µRIBAVIRIN使用的ç®æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.GRENZACHERSTRASSE 124 CH-4070 BASEL,SWITZERLANDSWITZERLAND2014-06-27注射é‡ç’;;ç›’è£PEGASYS PREFILLED SYRINGES 135MCG/0.5ML詳如ä¸æ–‡ä»¿å–®æ ¸å®šæœ¬ã€‚
衛署èŒç–«è¼¸å—第000788號2019-01-062004-01-06èŒã€€ç–«DHA01000078802ç®æ ¼è¥¿æ–½ 注射劑135微公克/0.5毫å‡æ²»ç™‚慢性Båž‹è‚炎:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人,ç®æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性,有病毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚炎。治療慢性Cåž‹è‚炎:單ç¨æˆ–åˆä½µRIBAVIRIN使用的ç®æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303 KAISERAUGST, SWITZERLANDSWITZERLAND2014-06-27注射é‡ç’;;ç›’è£PEGASYS PREFILLED SYRINGES 135MCG/0.5ML詳如ä¸æ–‡ä»¿å–®æ ¸å®šæœ¬ã€‚
衛署èŒç–«è¼¸å—第000788號2019-01-062004-01-06èŒã€€ç–«DHA01000078802ç®æ ¼è¥¿æ–½ 注射劑135微公克/0.5毫å‡æ²»ç™‚慢性Båž‹è‚炎:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人,ç®æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性,有病毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚炎。治療慢性Cåž‹è‚炎:單ç¨æˆ–åˆä½µRIBAVIRIN使用的ç®æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-06-27注射é‡ç’;;ç›’è£PEGASYS PREFILLED SYRINGES 135MCG/0.5ML詳如ä¸æ–‡ä»¿å–®æ ¸å®šæœ¬ã€‚
衛署èŒç–«è¼¸å—第000789號2019-01-062004-01-06èŒã€€ç–«DHA01000078904ç®æ ¼è¥¿æ–½ 注射劑180微公克/0.5毫å‡æ²»ç™‚慢性Båž‹è‚炎:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人,ç®æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性,有病毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚炎。治療慢性Cåž‹è‚炎:單ç¨æˆ–åˆä½µRIBAVIRIN使用的ç®æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.GRENZACHERSTRASSE 124 CH-4070 BASEL,SWITZERLANDSWITZERLAND2014-07-17注射é‡ç’;;ç›’è£PEGASYS PREFILLED SYRINGES 180MCG/0.5ML詳如ä¸æ–‡ä»¿å–®æ ¸å®šæœ¬ã€‚
衛署èŒç–«è¼¸å—第000789號2019-01-062004-01-06èŒã€€ç–«DHA01000078904ç®æ ¼è¥¿æ–½ 注射劑180微公克/0.5毫å‡æ²»ç™‚慢性Båž‹è‚炎:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人,ç®æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性,有病毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚炎。治療慢性Cåž‹è‚炎:單ç¨æˆ–åˆä½µRIBAVIRIN使用的ç®æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303 KAISERAUGST, SWITZERLANDSWITZERLAND2014-07-17注射é‡ç’;;ç›’è£PEGASYS PREFILLED SYRINGES 180MCG/0.5ML詳如ä¸æ–‡ä»¿å–®æ ¸å®šæœ¬ã€‚
衛署èŒç–«è¼¸å—第000789號2019-01-062004-01-06èŒã€€ç–«DHA01000078904ç®æ ¼è¥¿æ–½ 注射劑180微公克/0.5毫å‡æ²»ç™‚慢性Båž‹è‚炎:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人,ç®æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性,有病毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚炎。治療慢性Cåž‹è‚炎:單ç¨æˆ–åˆä½µRIBAVIRIN使用的ç®æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-07-17注射é‡ç’;;ç›’è£PEGASYS PREFILLED SYRINGES 180MCG/0.5ML詳如ä¸æ–‡ä»¿å–®æ ¸å®šæœ¬ã€‚
衛署èŒç–«è¼¸å—第000790號2019-02-042004-02-04èŒã€€ç–«DHA01000079002賀癌平å‡æ™¶æ³¨å°„劑15ï¼å…¬çµ²Herceptin應使用於下列HER2éŽåº¦è¡¨ç¾æˆ–HER2åŸºå› amplification之早期乳癌ã€è½‰ç§»æ€§ä¹³ç™Œæ‚£è€…:1.早期乳癌(EBC):(1)經外科手術ã€åŒ–å¸ç™‚法(è¡“å‰æˆ–術後)之輔助療法。(2)以doxorubicin與cyclophosphamide治療,å†åˆä½µpactlitaxel或docetaxel之輔助療法。(3)與docetaxelåŠcarboplatin併用之輔助療法。(4)è¡“å‰èˆ‡åŒ–å¸ç™‚法併用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2厘米)。2.轉移性乳癌(MBC):(1)å–®ç¨ä½¿ç”¨æ–¼æ›¾æŽ¥å—éŽä¸€æ¬¡(å«)以上化å¸ç™‚法之轉移性乳癌;除éžæ‚£è€…ä¸é©åˆä½¿ç”¨anthracyclin或taxane,å¦å‰‡å…ˆå‰ä¹‹åŒ–å¸æ²»ç™‚應至少包括anthracyclin或taxane。使用於è·çˆ¾è’™ç™‚法失敗之è·çˆ¾è’™å—體陽性之患者,除éžæ‚£è€…ä¸é©ç”¨è·çˆ¾è’™ç™‚法。(2)與pactlitaxel或docetaxel併用於未曾接å—éŽåŒ–å¸ç™‚法之轉移性乳癌。(3)與芳香環?抑制劑併用於è·çˆ¾è’™å—體陽性之轉移性乳癌。3.轉移性胃癌(MGC):Herceptinåˆä½µcapecitabine(或5-fluorouracil)åŠcisplatiné©ç”¨æ–¼æœªæ›¾æŽ¥å—éŽåŒ–å¸æ²»ç™‚之HER2éŽåº¦è¡¨ç¾è½‰ç§»æ€§èƒƒè…ºç™Œ(或胃食é“接åˆè™•è…ºç™Œ)的治療。說明:(1)HER2éŽåº¦è¡¨ç¾ä¹‹æª¢æ¸¬æ–¹æ³•é ˆç¶“è¡›ç”Ÿä¸»ç®¡æ©Ÿé—œæ ¸å‡†(用於胃癌之檢驗),請åƒç…§ç›¸é—œæª¢æ¸¬å¥—組仿單ä¸é©æ‡‰ç—‡ï¼Œç¢ºæ•ˆ(validation)åŠæ•ˆèƒ½(performance)之敘述,å¦è«‹åƒç…§æœ¬ä»¿å–®ã€Œ12.3轉移性胃癌ã€ä¹‹æ•˜è¿°ã€‚(2)樞ç´è©¦é©—確èªç™‚效僅顯ç¾æ–¼æœ‰è¼ƒé«˜HER2蛋白表ç¾(IHC2+/FISH+或IHC3+)之æ—群。å‡æ™¶æ³¨å°„劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨TRASTUZUMABç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F. HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303 KAISERAUGST, SWITZERLANDSWITZERLAND2014-05-06å°ç“¶;;ç›’è£HERCEPTIN VIAL 150MG
衛署èŒç–«è¼¸å—第000790號2019-02-042004-02-04èŒã€€ç–«DHA01000079002賀癌平å‡æ™¶æ³¨å°„劑15ï¼å…¬çµ²Herceptin應使用於下列HER2éŽåº¦è¡¨ç¾æˆ–HER2åŸºå› amplification之早期乳癌ã€è½‰ç§»æ€§ä¹³ç™Œæ‚£è€…:1.早期乳癌(EBC):(1)經外科手術ã€åŒ–å¸ç™‚法(è¡“å‰æˆ–術後)之輔助療法。(2)以doxorubicin與cyclophosphamide治療,å†åˆä½µpactlitaxel或docetaxel之輔助療法。(3)與docetaxelåŠcarboplatin併用之輔助療法。(4)è¡“å‰èˆ‡åŒ–å¸ç™‚法併用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2厘米)。2.轉移性乳癌(MBC):(1)å–®ç¨ä½¿ç”¨æ–¼æ›¾æŽ¥å—éŽä¸€æ¬¡(å«)以上化å¸ç™‚法之轉移性乳癌;除éžæ‚£è€…ä¸é©åˆä½¿ç”¨anthracyclin或taxane,å¦å‰‡å…ˆå‰ä¹‹åŒ–å¸æ²»ç™‚應至少包括anthracyclin或taxane。使用於è·çˆ¾è’™ç™‚法失敗之è·çˆ¾è’™å—體陽性之患者,除éžæ‚£è€…ä¸é©ç”¨è·çˆ¾è’™ç™‚法。(2)與pactlitaxel或docetaxel併用於未曾接å—éŽåŒ–å¸ç™‚法之轉移性乳癌。(3)與芳香環?抑制劑併用於è·çˆ¾è’™å—體陽性之轉移性乳癌。3.轉移性胃癌(MGC):Herceptinåˆä½µcapecitabine(或5-fluorouracil)åŠcisplatiné©ç”¨æ–¼æœªæ›¾æŽ¥å—éŽåŒ–å¸æ²»ç™‚之HER2éŽåº¦è¡¨ç¾è½‰ç§»æ€§èƒƒè…ºç™Œ(或胃食é“接åˆè™•è…ºç™Œ)的治療。說明:(1)HER2éŽåº¦è¡¨ç¾ä¹‹æª¢æ¸¬æ–¹æ³•é ˆç¶“è¡›ç”Ÿä¸»ç®¡æ©Ÿé—œæ ¸å‡†(用於胃癌之檢驗),請åƒç…§ç›¸é—œæª¢æ¸¬å¥—組仿單ä¸é©æ‡‰ç—‡ï¼Œç¢ºæ•ˆ(validation)åŠæ•ˆèƒ½(performance)之敘述,å¦è«‹åƒç…§æœ¬ä»¿å–®ã€Œ12.3轉移性胃癌ã€ä¹‹æ•˜è¿°ã€‚(2)樞ç´è©¦é©—確èªç™‚效僅顯ç¾æ–¼æœ‰è¼ƒé«˜HER2蛋白表ç¾(IHC2+/FISH+或IHC3+)之æ—群。å‡æ™¶æ³¨å°„劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨TRASTUZUMABç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06å°ç“¶;;ç›’è£HERCEPTIN VIAL 150MG
衛署èŒç–«è¼¸å—第000790號2019-02-042004-02-04èŒã€€ç–«DHA01000079002賀癌平å‡æ™¶æ³¨å°„劑15ï¼å…¬çµ²Herceptin應使用於下列HER2éŽåº¦è¡¨ç¾æˆ–HER2åŸºå› amplification之早期乳癌ã€è½‰ç§»æ€§ä¹³ç™Œæ‚£è€…:1.早期乳癌(EBC):(1)經外科手術ã€åŒ–å¸ç™‚法(è¡“å‰æˆ–術後)之輔助療法。(2)以doxorubicin與cyclophosphamide治療,å†åˆä½µpactlitaxel或docetaxel之輔助療法。(3)與docetaxelåŠcarboplatin併用之輔助療法。(4)è¡“å‰èˆ‡åŒ–å¸ç™‚法併用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2厘米)。2.轉移性乳癌(MBC):(1)å–®ç¨ä½¿ç”¨æ–¼æ›¾æŽ¥å—éŽä¸€æ¬¡(å«)以上化å¸ç™‚法之轉移性乳癌;除éžæ‚£è€…ä¸é©åˆä½¿ç”¨anthracyclin或taxane,å¦å‰‡å…ˆå‰ä¹‹åŒ–å¸æ²»ç™‚應至少包括anthracyclin或taxane。使用於è·çˆ¾è’™ç™‚法失敗之è·çˆ¾è’™å—體陽性之患者,除éžæ‚£è€…ä¸é©ç”¨è·çˆ¾è’™ç™‚法。(2)與pactlitaxel或docetaxel併用於未曾接å—éŽåŒ–å¸ç™‚法之轉移性乳癌。(3)與芳香環?抑制劑併用於è·çˆ¾è’™å—體陽性之轉移性乳癌。3.轉移性胃癌(MGC):Herceptinåˆä½µcapecitabine(或5-fluorouracil)åŠcisplatiné©ç”¨æ–¼æœªæ›¾æŽ¥å—éŽåŒ–å¸æ²»ç™‚之HER2éŽåº¦è¡¨ç¾è½‰ç§»æ€§èƒƒè…ºç™Œ(或胃食é“接åˆè™•è…ºç™Œ)的治療。說明:(1)HER2éŽåº¦è¡¨ç¾ä¹‹æª¢æ¸¬æ–¹æ³•é ˆç¶“è¡›ç”Ÿä¸»ç®¡æ©Ÿé—œæ ¸å‡†(用於胃癌之檢驗),請åƒç…§ç›¸é—œæª¢æ¸¬å¥—組仿單ä¸é©æ‡‰ç—‡ï¼Œç¢ºæ•ˆ(validation)åŠæ•ˆèƒ½(performance)之敘述,å¦è«‹åƒç…§æœ¬ä»¿å–®ã€Œ12.3轉移性胃癌ã€ä¹‹æ•˜è¿°ã€‚(2)樞ç´è©¦é©—確èªç™‚效僅顯ç¾æ–¼æœ‰è¼ƒé«˜HER2蛋白表ç¾(IHC2+/FISH+或IHC3+)之æ—群。å‡æ™¶æ³¨å°„劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨TRASTUZUMABç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06å°ç“¶;;ç›’è£HERCEPTIN VIAL 150MG
衛署èŒç–«è¼¸å—第000792號2019-01-082004-04-05èŒã€€ç–«DHA01000079206å¸¥å¥ 1.33å…¬çµ²è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€å…¶ä»–GONADOL DYSGENESIS (TURNER'S SYNDROME)所導致之生長é²æ»¯ã€é’春期å‰å› 慢性腎臟衰ç«å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯åŠæˆäººç”Ÿé•·æ¿€ç´ åš´é‡åˆ†æ³Œä¸è¶³ä¹‹è£œå……療法。低出生體é‡å…’(Small for Gestational Ageï¼›SGA)逾四æ²è€…之生長障礙。å‡æ™¶æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨SOMATOTROPIN HUMANå°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2014-11-13å°ç“¶SAIZEN 1.33MG
衛署èŒç–«è¼¸å—第000797號2019-10-142004-10-14èŒã€€ç–«DHA01000079703嬰è·å¯§å…åˆä¸€ç–«è‹—INFANRIX HEXA é©ç”¨æ–¼6週大以上之嬰兒的基礎å…疫接種åŠè¿½åŠ å…疫接種,以å°æŠ—白喉ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³ã€Båž‹è‚ç‚Žã€å°å…’麻痺åŠB型嗜血桿èŒã€‚æ»…èŒä¹¾ç²‰æ‡¸æ¶²æ³¨å°„劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PERTUSSIS TOXOID;;DIPHTHERIA TOXOID;;TETANUS TOXOID;;PERTACTIN;;FILAMENTOUS HAEMAGGLUTININ;;r-DNA HEPATITIS B SURFACE ANTIGEN ADSORBED (HbsAg);;INACTIVATED POLIO VIRUS -TYPE 1;;INACTIVATED POLIO VIRUS - TYPE 2;;INACTIVATED POLIO VIRUS -TYPE 3;;CONJUGATED OF HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (PRP) AND TETANUS TOXOID (T), ADSORBEDè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-12-05å°ç“¶INFANRIX HEXA
衛署èŒç–«è¼¸å—第000797號2019-10-142004-10-14èŒã€€ç–«DHA01000079703嬰è·å¯§å…åˆä¸€ç–«è‹—INFANRIX HEXA é©ç”¨æ–¼6週大以上之嬰兒的基礎å…疫接種åŠè¿½åŠ å…疫接種,以å°æŠ—白喉ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³ã€Båž‹è‚ç‚Žã€å°å…’麻痺åŠB型嗜血桿èŒã€‚æ»…èŒä¹¾ç²‰æ‡¸æ¶²æ³¨å°„劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PERTUSSIS TOXOID;;DIPHTHERIA TOXOID;;TETANUS TOXOID;;PERTACTIN;;FILAMENTOUS HAEMAGGLUTININ;;r-DNA HEPATITIS B SURFACE ANTIGEN ADSORBED (HbsAg);;INACTIVATED POLIO VIRUS -TYPE 1;;INACTIVATED POLIO VIRUS - TYPE 2;;INACTIVATED POLIO VIRUS -TYPE 3;;CONJUGATED OF HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (PRP) AND TETANUS TOXOID (T), ADSORBEDè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.PARC DE LA NOIRE EPINE, RUE FLEMING 20, B-1300 WAVRE, BELGIUMBELGIUM2014-12-05å°ç“¶INFANRIX HEXA
衛署èŒç–«è¼¸å—第000797號2019-10-142004-10-14èŒã€€ç–«DHA01000079703嬰è·å¯§å…åˆä¸€ç–«è‹—INFANRIX HEXA é©ç”¨æ–¼6週大以上之嬰兒的基礎å…疫接種åŠè¿½åŠ å…疫接種,以å°æŠ—白喉ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³ã€Båž‹è‚ç‚Žã€å°å…’麻痺åŠB型嗜血桿èŒã€‚æ»…èŒä¹¾ç²‰æ‡¸æ¶²æ³¨å°„劑å°ç“¶é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PERTUSSIS TOXOID;;DIPHTHERIA TOXOID;;TETANUS TOXOID;;PERTACTIN;;FILAMENTOUS HAEMAGGLUTININ;;r-DNA HEPATITIS B SURFACE ANTIGEN ADSORBED (HbsAg);;INACTIVATED POLIO VIRUS -TYPE 1;;INACTIVATED POLIO VIRUS - TYPE 2;;INACTIVATED POLIO VIRUS -TYPE 3;;CONJUGATED OF HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (PRP) AND TETANUS TOXOID (T), ADSORBEDè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438NOVARTIS VACCINES AND DIAGNOSTICS GMBH & CO. KGEMIL-VON-BEHRING-STR. 76 35041 MARBURG GERMANYGERMANY2014-12-05å°ç“¶INFANRIX HEXA
衛署èŒç–«è¼¸å—第000799號2019-12-142004-12-14èŒã€€ç–«DHA01000079907克得諾注射液250微克1.實施人工生殖å”助技術(ART),如體外授精(IVF)的超誘導排åµï¼šæŠ•èˆ‡OVIDRELå¯å¼•èµ·æœ€çµ‚濾泡æˆç†Ÿèˆ‡ç¶“刺激æˆé•·çš„濾泡黃體化。2.無排åµæˆ–排åµéŽå°‘婦女的誘導排åµï¼šæŠ•èˆ‡OVIDRELå¯å¼•èµ·ç¶“刺激æˆé•·çš„無排åµæˆ–排åµéŽå°‘婦女的排åµåŠé»ƒé«”化。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨CHORIOGONADOTROPIN ALFAå°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-12-02注射é‡ç’;;ç›’è£OVIDREL 250 MICROGRAMS SOLUTION FOR INJECTION
衛署èŒç–«è¼¸å—第000800號2020-02-052005-02-05èŒã€€ç–«DHA01000080005容å¯æ›¼é‡ç’è£æ³¨å°„劑 30000 國際單ä½æ²»ç™‚慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467MADE FOR F. HOFFMANN-LA ROCHE LTD, BASEL, SWITZERLAND BY ROCHE DIAGNOSTICS GMBH, MANNHEIM, GERMANYROCHE DIAGNOSTICS GMBH, SANDHOFER STRASSE 116, D-68305 MANNHEIM, GERMANYGERMANY2014-09-16注射é‡ç’;;ç›’è£RECORMON SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30000IU
衛署èŒç–«è¼¸å—第000800號2020-02-052005-02-05èŒã€€ç–«DHA01000080005容å¯æ›¼é‡ç’è£æ³¨å°„劑 30000 國際單ä½æ²»ç™‚慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-09-16注射é‡ç’;;ç›’è£RECORMON SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30000IU
衛署èŒç–«è¼¸å—第000801號2015-05-042005-05-04èŒã€€ç–«DHA01000080107æžœç´èŠ¬æ³¨å°„ç†300國際單ä½/0.5公撮(22微克/0.5公撮)女性患者(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD) 。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT),åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人,å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚(3)èˆ‡é»ƒé«”åˆºæ¿€ç´ (LH)併用,使用於嚴é‡ç¼ºä¹é»ƒé«”åˆºæ¿€æ¿€ç´ èˆ‡æ¿¾æ³¡åˆºæ¿€æ¿€ç´ æ‚£è€…çš„æ¿¾æ³¡åˆºæ¿€æˆé•·ã€‚男性患者治療男性å°æ–¼æ‚£æœ‰å…ˆå¤©æˆ–å¾Œå¤©æ€§è…ºåˆºæ¿€ç´ ä¸è¶³ä¹‹æ€§è…ºåŠŸèƒ½ä½Žä¸‹ç—‡ï¼Œä½µç”¨äººé¡žçµ¨æ¯›è†œæ€§è…ºåˆºæ¿€ç´ (hCG),刺激精å生æˆã€‚注射劑注射匣;;注射器;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-11-13注射匣;;注射器;;ç›’è£GONAL-F 300IU/0.5ML (22MICROGRAMS/0.5ML)
衛署èŒç–«è¼¸å—第000801號2015-05-042005-05-04èŒã€€ç–«DHA01000080107æžœç´èŠ¬æ³¨å°„ç†300國際單ä½/0.5公撮(22微克/0.5公撮)女性患者(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD) 。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT),åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人,å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚(3)èˆ‡é»ƒé«”åˆºæ¿€ç´ (LH)併用,使用於嚴é‡ç¼ºä¹é»ƒé«”åˆºæ¿€æ¿€ç´ èˆ‡æ¿¾æ³¡åˆºæ¿€æ¿€ç´ æ‚£è€…çš„æ¿¾æ³¡åˆºæ¿€æˆé•·ã€‚男性患者治療男性å°æ–¼æ‚£æœ‰å…ˆå¤©æˆ–å¾Œå¤©æ€§è…ºåˆºæ¿€ç´ ä¸è¶³ä¹‹æ€§è…ºåŠŸèƒ½ä½Žä¸‹ç—‡ï¼Œä½µç”¨äººé¡žçµ¨æ¯›è†œæ€§è…ºåˆºæ¿€ç´ (hCG),刺激精å生æˆã€‚注射劑注射匣;;注射器;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2014-11-13注射匣;;注射器;;ç›’è£GONAL-F 300IU/0.5ML (22MICROGRAMS/0.5ML)
衛署èŒç–«è¼¸å—第000802號2015-05-042005-05-04èŒã€€ç–«DHA01000080209æžœç´èŠ¬æ³¨å°„ç†450國際單ä½/0.75公撮(33微克/0.75公撮)女性患者(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD) 。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT),åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人,å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚(3)èˆ‡é»ƒé«”åˆºæ¿€ç´ (LH)併用,使用於嚴é‡ç¼ºä¹é»ƒé«”åˆºæ¿€æ¿€ç´ èˆ‡æ¿¾æ³¡åˆºæ¿€æ¿€ç´ æ‚£è€…çš„æ¿¾æ³¡åˆºæ¿€æˆé•·ã€‚男性患者治療男性å°æ–¼æ‚£æœ‰å…ˆå¤©æˆ–å¾Œå¤©æ€§è…ºåˆºæ¿€ç´ ä¸è¶³ä¹‹æ€§è…ºåŠŸèƒ½ä½Žä¸‹ç—‡ï¼Œä½µç”¨äººé¡žçµ¨æ¯›è†œæ€§è…ºåˆºæ¿€ç´ (hCG),刺激精å生æˆã€‚注射劑注射匣;;注射器;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-11-13注射匣;;注射器;;ç›’è£GONAL-F 450IU/0.75ML (33MICROGRAMS/0.75ML)
衛署èŒç–«è¼¸å—第000816號2015-10-072005-10-07èŒã€€ç–«DHA01000081607æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 100μg/Pen用於治療慢性Cåž‹è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH LABO N.V.INDUSTRIEPARK 30,B-2220 HEIST-OP-DEN-BERG BELGIUMBELGIUM2014-03-25ç›’è£;;ç›’è£Peg-Intron Redipen 100μg/Penè«‹åƒç…§ä»¿å–®å…§å®¹
衛署èŒç–«è¼¸å—第000802號2015-05-042005-05-04èŒã€€ç–«DHA01000080209æžœç´èŠ¬æ³¨å°„ç†450國際單ä½/0.75公撮(33微克/0.75公撮)女性患者(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD) 。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT),åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人,å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚(3)èˆ‡é»ƒé«”åˆºæ¿€ç´ (LH)併用,使用於嚴é‡ç¼ºä¹é»ƒé«”åˆºæ¿€æ¿€ç´ èˆ‡æ¿¾æ³¡åˆºæ¿€æ¿€ç´ æ‚£è€…çš„æ¿¾æ³¡åˆºæ¿€æˆé•·ã€‚男性患者治療男性å°æ–¼æ‚£æœ‰å…ˆå¤©æˆ–å¾Œå¤©æ€§è…ºåˆºæ¿€ç´ ä¸è¶³ä¹‹æ€§è…ºåŠŸèƒ½ä½Žä¸‹ç—‡ï¼Œä½µç”¨äººé¡žçµ¨æ¯›è†œæ€§è…ºåˆºæ¿€ç´ (hCG),刺激精å生æˆã€‚注射劑注射匣;;注射器;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2014-11-13注射匣;;注射器;;ç›’è£GONAL-F 450IU/0.75ML (33MICROGRAMS/0.75ML)
衛署èŒç–«è¼¸å—第000803號2015-05-062005-05-06èŒã€€ç–«DHA01000080301愛胰é”注射劑糖尿病。注射劑注射匣;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨INSULIN GLULISINE (HOE 901)賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI-AVENTIS DEUTSCHLAND GMBH,INDUSTRIEPARK HOECHSTD-65926 FRANKFURT AM MAIN,GERMANYGERMANY2014-11-03注射匣;;注射ç†Apidra 100 U/ml solution for Injection
衛署èŒç–«è¼¸å—第000804號2015-05-062005-05-06èŒã€€ç–«DHA01000080400愛胰é”10公撮å°ç“¶æ³¨å°„劑糖尿病。注射劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨INSULIN GLULISINE (HOE 901)賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI-AVENTIS DEUTSCHLAND GMBH, INDUSTRIEPARK HOECHSTBRUNINGSTRASSE 50, D-65926 FRANKFURT (MAIN), GERMANYGERMANY2014-11-03å°ç“¶Apidra 100U/ml Solution for Injection, 10ml Vial
衛署èŒç–«è¼¸å—第000805號2015-05-092005-05-09èŒã€€ç–«DHA01000080502æžœ?芬注射ç†900國際單ä½/1.5公撮(66微克/1.5公撮)女性患者(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD) 。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT),åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人,å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚(3)èˆ‡é»ƒé«”åˆºæ¿€ç´ (LH)併用,使用於嚴é‡ç¼ºä¹é»ƒé«”åˆºæ¿€æ¿€ç´ èˆ‡æ¿¾æ³¡åˆºæ¿€æ¿€ç´ æ‚£è€…çš„æ¿¾æ³¡åˆºæ¿€æˆé•·ã€‚男性患者治療男性å°æ–¼æ‚£æœ‰å…ˆå¤©æˆ–å¾Œå¤©æ€§è…ºåˆºæ¿€ç´ ä¸è¶³ä¹‹æ€§è…ºåŠŸèƒ½ä½Žä¸‹ç—‡ï¼Œä½µç”¨äººé¡žçµ¨æ¯›è†œæ€§è…ºåˆºæ¿€ç´ (hCG),刺激精å生æˆã€‚注射劑注射匣;;注射器;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-11-13注射匣;;注射器;;ç›’è£GONAL-F 900IU/1.5ML (66 MICROGRAMS/1.5ML)
衛署èŒç–«è¼¸å—第000805號2015-05-092005-05-09èŒã€€ç–«DHA01000080502æžœ?芬注射ç†900國際單ä½/1.5公撮(66微克/1.5公撮)女性患者(1)婦女經CLOMIPHENE CITRATE治療,ä»ç„¡æ³•æŽ’åµè€…(å«å¤šå›Šæ€§åµå·¢ç—‡ï¼ŒPCOD) 。(2)å°æ–¼å¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF),é…å輸åµç®¡æ¤å…¥(GIFT),åˆå輸åµç®¡æ¤å…¥(ZIFT)的病人,å¯åˆºæ¿€å…¶å¤šæ¿¾æ³¡ç™¼è‚²ã€‚(3)èˆ‡é»ƒé«”åˆºæ¿€ç´ (LH)併用,使用於嚴é‡ç¼ºä¹é»ƒé«”åˆºæ¿€æ¿€ç´ èˆ‡æ¿¾æ³¡åˆºæ¿€æ¿€ç´ æ‚£è€…çš„æ¿¾æ³¡åˆºæ¿€æˆé•·ã€‚男性患者治療男性å°æ–¼æ‚£æœ‰å…ˆå¤©æˆ–å¾Œå¤©æ€§è…ºåˆºæ¿€ç´ ä¸è¶³ä¹‹æ€§è…ºåŠŸèƒ½ä½Žä¸‹ç—‡ï¼Œä½µç”¨äººé¡žçµ¨æ¯›è†œæ€§è…ºåˆºæ¿€ç´ (hCG),刺激精å生æˆã€‚注射劑注射匣;;注射器;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2014-11-13注射匣;;注射器;;ç›’è£GONAL-F 900IU/1.5ML (66 MICROGRAMS/1.5ML)
衛署èŒç–«è¼¸å—第000816號2015-10-072005-10-07èŒã€€ç–«DHA01000081607æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 100μg/Pen用於治療慢性Cåž‹è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH (BRINNY) COMPANYINNISHANNON, COUNTY CORK, IRELANDIRELAND2014-03-25ç›’è£;;ç›’è£Peg-Intron Redipen 100μg/Penè«‹åƒç…§ä»¿å–®å…§å®¹
衛署èŒç–«è¼¸å—第000807號2015-05-242005-05-24èŒã€€ç–«DHA01000080706癌æ€åœ 注射劑1.轉移性大腸直腸癌(mCRC):(1)Avastin(Bevacizumab)與å«æœ‰irinotecan/5-fluorouracil/Leucovorin或 5-fluorouracil/Leucovorin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºè½‰ç§»æ€§å¤§è…¸æˆ–直腸癌患者之第一線治療。(2)Avastin與å«æœ‰5-fluorouracil/Leucovorin/Oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºå…ˆå‰æŽ¥å—éŽä»¥Fluoropyrimidine為基礎之化å¸ç™‚法無效且未曾接å—éŽAvastin治療之轉移性大腸或直腸癌患者之治療。(3)Avastin與å«æœ‰Fluoropyrimidine-oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç¬¬ä¸€ç·šå·²æŽ¥å—éŽAvastin併用Fluoropyrimidine-irinotecan為基礎之化療後惡化之轉移性大腸或直腸癌患者之第二線治療。2.轉移性乳癌(mBC):Avastin與Paclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºHER2 (-)轉移性乳癌患者之第一線治療。3.æƒ¡æ€§ç¥žç¶“è† è³ªç˜¤(WHO第4ç´š) - ç¥žç¶“è† æ¯ç´°èƒžç˜¤ï¼šAvastin å–®ç¨ä½¿ç”¨å¯ç”¨æ–¼æ²»ç™‚曾接å—標準放射線治療且å«Temozolomide在內之化å¸è—¥ç‰©æ²»ç™‚å¤±æ•—ä¹‹å¤šåž‹æ€§ç¥žç¶“è† æ¯ç´°èƒžç˜¤(Glioblastoma Multiforme)復發之æˆäººæ‚£è€…。4.晚期ã€è½‰ç§»æ€§æˆ–復發性éžé±—ç‹€éžå°ç´°èƒžè‚ºç™Œ(NSCLC):Avastin與CarboplatinåŠPaclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç„¡æ³•åˆ‡é™¤ä¹‹æ™šæœŸã€è½‰ç§»æ€§æˆ–復發性éžå°ç´°èƒžè‚ºç™Œæ‚£è€…之第一線治療。5.復發性åµå·¢ä¸Šçš®ç´°èƒžã€è¼¸åµç®¡æˆ–原發性腹膜癌:Avastin與CarboplatinåŠGemcitabineåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºæ›¾æŽ¥å—éŽç¬¬ä¸€ç·šå«é‰‘類藥物(Platinum-based)化å¸æ²»ç™‚後間隔至少6個月å†å¾©ç™¼(å³å°å«é‰‘藥物具感å—性)且未曾接å—éŽBevacizumabæˆ–å…¶ä»–è¡€ç®¡å…§çš®ç´°èƒžç”Ÿé•·å› å(VEGF)æŠ‘åˆ¶åŠ‘æˆ–è¡€ç®¡å…§çš®ç´°èƒžç”Ÿé•·å› å接å—器之標é¶è—¥ç‰©(VEGF Receptor-targeted Agents)治療之復發性åµå·¢ä¸Šçš®ç´°èƒžã€è¼¸åµç®¡æˆ–原發性腹膜癌患者之治療。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨BEVACIZUMABç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F. HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303 KAISERAUGST, SWITZERLANDSWITZERLAND2014-08-22å°ç“¶;;ç›’è£AVASTIN INJECTION詳見仿單
衛署èŒç–«è¼¸å—第000807號2015-05-242005-05-24èŒã€€ç–«DHA01000080706癌æ€åœ 注射劑1.轉移性大腸直腸癌(mCRC):(1)Avastin(Bevacizumab)與å«æœ‰irinotecan/5-fluorouracil/Leucovorin或 5-fluorouracil/Leucovorin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºè½‰ç§»æ€§å¤§è…¸æˆ–直腸癌患者之第一線治療。(2)Avastin與å«æœ‰5-fluorouracil/Leucovorin/Oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºå…ˆå‰æŽ¥å—éŽä»¥Fluoropyrimidine為基礎之化å¸ç™‚法無效且未曾接å—éŽAvastin治療之轉移性大腸或直腸癌患者之治療。(3)Avastin與å«æœ‰Fluoropyrimidine-oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç¬¬ä¸€ç·šå·²æŽ¥å—éŽAvastin併用Fluoropyrimidine-irinotecan為基礎之化療後惡化之轉移性大腸或直腸癌患者之第二線治療。2.轉移性乳癌(mBC):Avastin與Paclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºHER2 (-)轉移性乳癌患者之第一線治療。3.æƒ¡æ€§ç¥žç¶“è† è³ªç˜¤(WHO第4ç´š) - ç¥žç¶“è† æ¯ç´°èƒžç˜¤ï¼šAvastin å–®ç¨ä½¿ç”¨å¯ç”¨æ–¼æ²»ç™‚曾接å—標準放射線治療且å«Temozolomide在內之化å¸è—¥ç‰©æ²»ç™‚å¤±æ•—ä¹‹å¤šåž‹æ€§ç¥žç¶“è† æ¯ç´°èƒžç˜¤(Glioblastoma Multiforme)復發之æˆäººæ‚£è€…。4.晚期ã€è½‰ç§»æ€§æˆ–復發性éžé±—ç‹€éžå°ç´°èƒžè‚ºç™Œ(NSCLC):Avastin與CarboplatinåŠPaclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç„¡æ³•åˆ‡é™¤ä¹‹æ™šæœŸã€è½‰ç§»æ€§æˆ–復發性éžå°ç´°èƒžè‚ºç™Œæ‚£è€…之第一線治療。5.復發性åµå·¢ä¸Šçš®ç´°èƒžã€è¼¸åµç®¡æˆ–原發性腹膜癌:Avastin與CarboplatinåŠGemcitabineåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºæ›¾æŽ¥å—éŽç¬¬ä¸€ç·šå«é‰‘類藥物(Platinum-based)化å¸æ²»ç™‚後間隔至少6個月å†å¾©ç™¼(å³å°å«é‰‘藥物具感å—性)且未曾接å—éŽBevacizumabæˆ–å…¶ä»–è¡€ç®¡å…§çš®ç´°èƒžç”Ÿé•·å› å(VEGF)æŠ‘åˆ¶åŠ‘æˆ–è¡€ç®¡å…§çš®ç´°èƒžç”Ÿé•·å› å接å—器之標é¶è—¥ç‰©(VEGF Receptor-targeted Agents)治療之復發性åµå·¢ä¸Šçš®ç´°èƒžã€è¼¸åµç®¡æˆ–原發性腹膜癌患者之治療。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨BEVACIZUMABç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F. HOFFMANN-LA ROCHE LTD.GRENZACHERSTRASSE 124, CH-4070 BASEL, SWITZERLANDSWITZERLAND2014-08-22å°ç“¶;;ç›’è£AVASTIN INJECTION詳見仿單
衛署èŒç–«è¼¸å—第000807號2015-05-242005-05-24èŒã€€ç–«DHA01000080706癌æ€åœ 注射劑1.轉移性大腸直腸癌(mCRC):(1)Avastin(Bevacizumab)與å«æœ‰irinotecan/5-fluorouracil/Leucovorin或 5-fluorouracil/Leucovorin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºè½‰ç§»æ€§å¤§è…¸æˆ–直腸癌患者之第一線治療。(2)Avastin與å«æœ‰5-fluorouracil/Leucovorin/Oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºå…ˆå‰æŽ¥å—éŽä»¥Fluoropyrimidine為基礎之化å¸ç™‚法無效且未曾接å—éŽAvastin治療之轉移性大腸或直腸癌患者之治療。(3)Avastin與å«æœ‰Fluoropyrimidine-oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç¬¬ä¸€ç·šå·²æŽ¥å—éŽAvastin併用Fluoropyrimidine-irinotecan為基礎之化療後惡化之轉移性大腸或直腸癌患者之第二線治療。2.轉移性乳癌(mBC):Avastin與Paclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºHER2 (-)轉移性乳癌患者之第一線治療。3.æƒ¡æ€§ç¥žç¶“è† è³ªç˜¤(WHO第4ç´š) - ç¥žç¶“è† æ¯ç´°èƒžç˜¤ï¼šAvastin å–®ç¨ä½¿ç”¨å¯ç”¨æ–¼æ²»ç™‚曾接å—標準放射線治療且å«Temozolomide在內之化å¸è—¥ç‰©æ²»ç™‚å¤±æ•—ä¹‹å¤šåž‹æ€§ç¥žç¶“è† æ¯ç´°èƒžç˜¤(Glioblastoma Multiforme)復發之æˆäººæ‚£è€…。4.晚期ã€è½‰ç§»æ€§æˆ–復發性éžé±—ç‹€éžå°ç´°èƒžè‚ºç™Œ(NSCLC):Avastin與CarboplatinåŠPaclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç„¡æ³•åˆ‡é™¤ä¹‹æ™šæœŸã€è½‰ç§»æ€§æˆ–復發性éžå°ç´°èƒžè‚ºç™Œæ‚£è€…之第一線治療。5.復發性åµå·¢ä¸Šçš®ç´°èƒžã€è¼¸åµç®¡æˆ–原發性腹膜癌:Avastin與CarboplatinåŠGemcitabineåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºæ›¾æŽ¥å—éŽç¬¬ä¸€ç·šå«é‰‘類藥物(Platinum-based)化å¸æ²»ç™‚後間隔至少6個月å†å¾©ç™¼(å³å°å«é‰‘藥物具感å—性)且未曾接å—éŽBevacizumabæˆ–å…¶ä»–è¡€ç®¡å…§çš®ç´°èƒžç”Ÿé•·å› å(VEGF)æŠ‘åˆ¶åŠ‘æˆ–è¡€ç®¡å…§çš®ç´°èƒžç”Ÿé•·å› å接å—器之標é¶è—¥ç‰©(VEGF Receptor-targeted Agents)治療之復發性åµå·¢ä¸Šçš®ç´°èƒžã€è¼¸åµç®¡æˆ–原發性腹膜癌患者之治療。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨BEVACIZUMABç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467GENENTECH, INC.1000 NEW HORIZONS WAY, VACAVILLE, CA 95688, USAUNITED STATES2014-08-22å°ç“¶;;ç›’è£AVASTIN INJECTION詳見仿單
衛署èŒç–«è¼¸å—第000807號2015-05-242005-05-24èŒã€€ç–«DHA01000080706癌æ€åœ 注射劑1.轉移性大腸直腸癌(mCRC):(1)Avastin(Bevacizumab)與å«æœ‰irinotecan/5-fluorouracil/Leucovorin或 5-fluorouracil/Leucovorin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºè½‰ç§»æ€§å¤§è…¸æˆ–直腸癌患者之第一線治療。(2)Avastin與å«æœ‰5-fluorouracil/Leucovorin/Oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºå…ˆå‰æŽ¥å—éŽä»¥Fluoropyrimidine為基礎之化å¸ç™‚法無效且未曾接å—éŽAvastin治療之轉移性大腸或直腸癌患者之治療。(3)Avastin與å«æœ‰Fluoropyrimidine-oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç¬¬ä¸€ç·šå·²æŽ¥å—éŽAvastin併用Fluoropyrimidine-irinotecan為基礎之化療後惡化之轉移性大腸或直腸癌患者之第二線治療。2.轉移性乳癌(mBC):Avastin與Paclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºHER2 (-)轉移性乳癌患者之第一線治療。3.æƒ¡æ€§ç¥žç¶“è† è³ªç˜¤(WHO第4ç´š) - ç¥žç¶“è† æ¯ç´°èƒžç˜¤ï¼šAvastin å–®ç¨ä½¿ç”¨å¯ç”¨æ–¼æ²»ç™‚曾接å—標準放射線治療且å«Temozolomide在內之化å¸è—¥ç‰©æ²»ç™‚å¤±æ•—ä¹‹å¤šåž‹æ€§ç¥žç¶“è† æ¯ç´°èƒžç˜¤(Glioblastoma Multiforme)復發之æˆäººæ‚£è€…。4.晚期ã€è½‰ç§»æ€§æˆ–復發性éžé±—ç‹€éžå°ç´°èƒžè‚ºç™Œ(NSCLC):Avastin與CarboplatinåŠPaclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç„¡æ³•åˆ‡é™¤ä¹‹æ™šæœŸã€è½‰ç§»æ€§æˆ–復發性éžå°ç´°èƒžè‚ºç™Œæ‚£è€…之第一線治療。5.復發性åµå·¢ä¸Šçš®ç´°èƒžã€è¼¸åµç®¡æˆ–原發性腹膜癌:Avastin與CarboplatinåŠGemcitabineåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºæ›¾æŽ¥å—éŽç¬¬ä¸€ç·šå«é‰‘類藥物(Platinum-based)化å¸æ²»ç™‚後間隔至少6個月å†å¾©ç™¼(å³å°å«é‰‘藥物具感å—性)且未曾接å—éŽBevacizumabæˆ–å…¶ä»–è¡€ç®¡å…§çš®ç´°èƒžç”Ÿé•·å› å(VEGF)æŠ‘åˆ¶åŠ‘æˆ–è¡€ç®¡å…§çš®ç´°èƒžç”Ÿé•·å› å接å—器之標é¶è—¥ç‰©(VEGF Receptor-targeted Agents)治療之復發性åµå·¢ä¸Šçš®ç´°èƒžã€è¼¸åµç®¡æˆ–原發性腹膜癌患者之治療。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨BEVACIZUMABç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-08-22å°ç“¶;;ç›’è£AVASTIN INJECTION詳見仿單
衛署èŒç–«è¼¸å—第000812號2015-09-072005-09-07èŒã€€ç–«DHA01000081202西那å‰æ–¯å‡æ™¶æ³¨å°„劑 50 毫克Palivizumab å¯ä½œç”¨æ–¼RSV 疾病高å±éšªç¾¤ä¹‹å¹¼å…’病患,包括支氣管肺發育ä¸å…¨(BPD)嬰兒ã€æ—©ç”¢å…’(å°æ–¼æˆ–ç‰æ–¼35å¦Šå¨ é€±),åŠæ‚£æœ‰è¡€æ¶²å‹•åŠ›å¸ä¸Šé¡¯è‘—之先天性心臟病(CHD)幼兒æ—群,é é˜²å› RSV感染所引起之嚴é‡ä¸‹å‘¼å¸é“疾病。å‡æ™¶æ³¨å°„劑å°ç“¶;;安瓿é™ç”±é†«å¸«ä½¿ç”¨PALIVIZUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958BOEHRINGER INGELHEIM PHARMA GMBH &CO. KG.BIRKENDORFER STRASSE 65 D88397 BIBERACH AN DER RISS,GERMANYGERMANY2014-08-08å°ç“¶;;安瓿SYNAGIS INJECTION 50MG
衛署èŒç–«è¼¸å—第000808號2015-06-292005-06-29èŒã€€ç–«DHA01000080808"喜斯悅" 人體å…ç–«çƒè›‹ç™½éœè„ˆæ³¨å°„劑Intragam P 是 IgG 的替代治療用藥,é©æ‡‰ç—‡åŒ…括:?原發性å…ç–«ä¸å…¨ç—‡(primary immune deficiency)。?骨髓瘤(myeloma)與慢性淋巴癌(chronic lymphatic leukaemia)引致嚴é‡æ¬¡ç™¼æ€§å…ç–«çƒè›‹ç™½ç¼ºä¹(severe secondary hypogammaglobulinaemia)與復發性感染(recurrent infections)。?伴隨復發性感染之先天性å…ç–«ä¸å…¨ç—‡(AIDS with recurrent infections)。Intragam P 也å¯ç”¨æ–¼æ”¹å–„å…疫機能的治療,é©æ‡‰ç—‡åŒ…括:? 原發性血å°æ¿ç¼ºä¹ç´«æ–‘ç—‡ [idiopathic thrombocytopenic purpura (ITP)], 有出血å±éšªçš„æˆäººæˆ–å°å©ITP患者;或者,手術å‰ç”¨ä»¥ä¿®æ£è¡€å°æ¿æ•¸ç›®ã€‚?異體骨髓移æ¤(allogeneic bone marrow transplantation)。?å·å´Žæ°ç—‡(Kawasaki Disease)。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨IMMUNOGLOBULIN HUMAN世信生物科技股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路201之36號5樓16447082CSL LTD.189-209 CAMP ROAD BROADMEADOWS VICTORIA 3047 AUSTRALIA45 POPLAR ROAD PARKVILLE VICTORIA 3052,AUSTRALIAAUSTRALIA2010-07-02瓶è£"CSL" INTRAGAM P (HUMAN NORMAL IMMUNOGLOBULIN SOLUTION FOR INTRAVENOUS INJECTION)詳見說明書
衛署èŒç–«è¼¸å—第000809號2015-07-052005-07-05èŒã€€ç–«DHA01000080900瑞和密爾諾芯管糖尿病。注射劑注射ç†é™ç”±é†«å¸«ä½¿ç”¨INSULIN DETEMIR臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693Novo Nordisk Production SAS45, Avenue d’Orleans, F-28002 Chartres, FranceFRANCE2014-04-16注射ç†LEVEMIR PENFILLLEVEMIR的劑é‡æ‡‰ä¾å€‹äººæƒ…æ³èª¿æ•´ã€‚æ ¹æ“šç—…äººçš„éœ€æ±‚ï¼ŒLEVEMIR應一天投予一到二次。LEVEMIR採皮下注射。
衛署èŒç–«è¼¸å—第000810號2015-07-052005-07-05èŒã€€ç–«DHA01000081008瑞和密爾諾易ç†ç³–尿病注射劑注射ç†è£½åŠ‘原料INSULIN DETEMIR臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693Novo Nordisk Production SAS45, Avenue d’Orleans, F-28002 Chartres, FranceFRANCE2014-04-16注射ç†LEVEMIR FLEX PENLEVEMIR的劑é‡æ‡‰ä¾å€‹äººæƒ…æ³èª¿æ•´ã€‚æ ¹æ“šç—…äººçš„éœ€æ±‚ï¼ŒLEVEMIR應一天投予一到二次。LEVEMIR採皮下注射。
衛署èŒç–«è¼¸å—第000812號2015-09-072005-09-07èŒã€€ç–«DHA01000081202西那å‰æ–¯å‡æ™¶æ³¨å°„劑 50 毫克Palivizumab å¯ä½œç”¨æ–¼RSV 疾病高å±éšªç¾¤ä¹‹å¹¼å…’病患,包括支氣管肺發育ä¸å…¨(BPD)嬰兒ã€æ—©ç”¢å…’(å°æ–¼æˆ–ç‰æ–¼35å¦Šå¨ é€±),åŠæ‚£æœ‰è¡€æ¶²å‹•åŠ›å¸ä¸Šé¡¯è‘—之先天性心臟病(CHD)幼兒æ—群,é é˜²å› RSV感染所引起之嚴é‡ä¸‹å‘¼å¸é“疾病。å‡æ™¶æ³¨å°„劑å°ç“¶;;安瓿é™ç”±é†«å¸«ä½¿ç”¨PALIVIZUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958ABBVIE S.R.L.S.R. 148 Pontina Km 52, SNC-Campoverde di Aprilia (LT) 04011 ItalyITALY2014-08-08å°ç“¶;;安瓿SYNAGIS INJECTION 50MG
衛署èŒç–«è¼¸å—第000812號2015-09-072005-09-07èŒã€€ç–«DHA01000081202西那å‰æ–¯å‡æ™¶æ³¨å°„劑 50 毫克Palivizumab å¯ä½œç”¨æ–¼RSV 疾病高å±éšªç¾¤ä¹‹å¹¼å…’病患,包括支氣管肺發育ä¸å…¨(BPD)嬰兒ã€æ—©ç”¢å…’(å°æ–¼æˆ–ç‰æ–¼35å¦Šå¨ é€±),åŠæ‚£æœ‰è¡€æ¶²å‹•åŠ›å¸ä¸Šé¡¯è‘—之先天性心臟病(CHD)幼兒æ—群,é é˜²å› RSV感染所引起之嚴é‡ä¸‹å‘¼å¸é“疾病。å‡æ™¶æ³¨å°„劑å°ç“¶;;安瓿é™ç”±é†«å¸«ä½¿ç”¨PALIVIZUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958HOSPIRA S.P.A.VIA FOSSE ARDEATINE, 2 20060 LISCATE (MILAN), ITALTITALY2014-08-08å°ç“¶;;安瓿SYNAGIS INJECTION 50MG
衛署èŒç–«è¼¸å—第000813號2015-09-072005-09-07èŒã€€ç–«DHA01000081301西那å‰æ–¯å‡æ™¶æ³¨å°„劑 100 毫克Palivizumab å¯ä½œç”¨æ–¼RSV 疾病高å±éšªç¾¤ä¹‹å¹¼å…’病患,包括支氣管肺發育ä¸å…¨(BPD)嬰兒ã€æ—©ç”¢å…’(å°æ–¼æˆ–ç‰æ–¼35å¦Šå¨ é€±),åŠæ‚£æœ‰è¡€æ¶²å‹•åŠ›å¸ä¸Šé¡¯è‘—之先天性心臟病(CHD)幼兒æ—群,é é˜²å› RSV感染所引起之嚴é‡ä¸‹å‘¼å¸é“疾病。å‡æ™¶æ³¨å°„劑å°ç“¶;;安瓿é™ç”±é†«å¸«ä½¿ç”¨PALIVIZUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958HOSPIRA S.P.A.VIA FOSSE ARDEATINE, 2 20060 LISCATE (MILAN), ITALTITALY2014-08-08å°ç“¶;;安瓿SYNAGIS INJECTION 100MG
衛署èŒç–«è¼¸å—第000813號2015-09-072005-09-07èŒã€€ç–«DHA01000081301西那å‰æ–¯å‡æ™¶æ³¨å°„劑 100 毫克Palivizumab å¯ä½œç”¨æ–¼RSV 疾病高å±éšªç¾¤ä¹‹å¹¼å…’病患,包括支氣管肺發育ä¸å…¨(BPD)嬰兒ã€æ—©ç”¢å…’(å°æ–¼æˆ–ç‰æ–¼35å¦Šå¨ é€±),åŠæ‚£æœ‰è¡€æ¶²å‹•åŠ›å¸ä¸Šé¡¯è‘—之先天性心臟病(CHD)幼兒æ—群,é é˜²å› RSV感染所引起之嚴é‡ä¸‹å‘¼å¸é“疾病。å‡æ™¶æ³¨å°„劑å°ç“¶;;安瓿é™ç”±é†«å¸«ä½¿ç”¨PALIVIZUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958AbbVie S.r.l.S.R. 148 PONTINA KM 52 SNC 04011 CAMPOVERDE DI APRILIA, LATINA, ITALYITALY2014-08-08å°ç“¶;;安瓿SYNAGIS INJECTION 100MG
衛署èŒç–«è¼¸å—第000813號2015-09-072005-09-07èŒã€€ç–«DHA01000081301西那å‰æ–¯å‡æ™¶æ³¨å°„劑 100 毫克Palivizumab å¯ä½œç”¨æ–¼RSV 疾病高å±éšªç¾¤ä¹‹å¹¼å…’病患,包括支氣管肺發育ä¸å…¨(BPD)嬰兒ã€æ—©ç”¢å…’(å°æ–¼æˆ–ç‰æ–¼35å¦Šå¨ é€±),åŠæ‚£æœ‰è¡€æ¶²å‹•åŠ›å¸ä¸Šé¡¯è‘—之先天性心臟病(CHD)幼兒æ—群,é é˜²å› RSV感染所引起之嚴é‡ä¸‹å‘¼å¸é“疾病。å‡æ™¶æ³¨å°„劑å°ç“¶;;安瓿é™ç”±é†«å¸«ä½¿ç”¨PALIVIZUMAB瑞士商艾伯ç¶è—¥å“有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸å±±å€æ°‘生æ±è·¯ä¸‰æ®µ49號åŠ51號15樓53653958BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGBIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS, GERMANYGERMANY2014-08-08å°ç“¶;;安瓿SYNAGIS INJECTION 100MG
衛署èŒç–«è¼¸å—第000814號2015-10-072005-10-07èŒã€€ç–«DHA01000081403æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 150μg/Pen用於治療慢性Cåž‹è‚炎。盒è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH LABO N.V.INDUSTRIEPARK 30,B-2220 HEIST-OP-DEN-BERG BELGIUMBELGIUM2014-03-25ç›’è£;;ç›’è£Peg-Intron Redipen 150μg/Pen
衛署èŒç–«è¼¸å—第000814號2015-10-072005-10-07èŒã€€ç–«DHA01000081403æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 150μg/Pen用於治療慢性Cåž‹è‚炎。盒è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH (BRINNY) COMPANYINNISHANNON, COUNTY CORK, IRELANDIRELAND2014-03-25ç›’è£;;ç›’è£Peg-Intron Redipen 150μg/Pen
衛署èŒç–«è¼¸å—第000815號2015-10-072005-10-07èŒã€€ç–«DHA01000081505æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 50μg/Pen用於治療慢性Cåž‹è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH LABO N.V.INDUSTRIEPARK 30,B-2220 HEIST-OP-DEN-BERG BELGIUMBELGIUM2014-03-25注射ç†;;ç›’è£Peg-Intron Redipen 50μg/Penè«‹åƒç…§ä»¿å–®å…§å®¹
衛署èŒç–«è¼¸å—第000815號2015-10-072005-10-07èŒã€€ç–«DHA01000081505æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 50μg/Pen用於治療慢性Cåž‹è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH (BRINNY) COMPANYINNISHANNON, COUNTY CORK, IRELANDIRELAND2014-03-25注射ç†;;ç›’è£Peg-Intron Redipen 50μg/Penè«‹åƒç…§ä»¿å–®å…§å®¹
衛署èŒç–«è¼¸å—第000816號2015-10-072005-10-07èŒã€€ç–«DHA01000081607æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 100μg/Pen用於治療慢性Cåž‹è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MSD International GmbH (Singapore Branch)60, TUAS WEST DRIVE, SINGAPORE, 638413SINGAPORE2014-03-25ç›’è£;;ç›’è£Peg-Intron Redipen 100μg/Penè«‹åƒç…§ä»¿å–®å…§å®¹
衛署èŒç–«è¼¸å—第000817號2015-10-072005-10-07èŒã€€ç–«DHA01000081709æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 120μg/Pen用於治療慢性Cåž‹è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH LABO N.V.INDUSTRIEPARK 30,B-2220 HEIST-OP-DEN-BERG BELGIUMBELGIUM2012-08-27ç›’è£;;ç›’è£Peg-Intron Redipen 120μg/Penè«‹åƒç…§ä»¿å–®å…§å®¹
衛署èŒç–«è¼¸å—第000817號2015-10-072005-10-07èŒã€€ç–«DHA01000081709æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 120μg/Pen用於治療慢性Cåž‹è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH (BRINNY) COMPANYINNISHANNON, COUNTY CORK, IRELANDIRELAND2012-08-27ç›’è£;;ç›’è£Peg-Intron Redipen 120μg/Penè«‹åƒç…§ä»¿å–®å…§å®¹
衛署èŒç–«è¼¸å—第000817號2015-10-072005-10-07èŒã€€ç–«DHA01000081709æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 120μg/Pen用於治療慢性Cåž‹è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MSD International GmbH (Singapore Branch)60, TUAS WEST DRIVE, SINGAPORE, 638413SINGAPORE2012-08-27ç›’è£;;ç›’è£Peg-Intron Redipen 120μg/Penè«‹åƒç…§ä»¿å–®å…§å®¹
衛署èŒç–«è¼¸å—第000818號2015-10-072005-10-07èŒã€€ç–«DHA01000081801æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 80μg/Pen用於治療慢性Cåž‹è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH LABO N.V.INDUSTRIEPARK 30,B-2220 HEIST-OP-DEN-BERG BELGIUMBELGIUM2012-08-27ç›’è£;;ç›’è£Peg-Intron Redipen 80μg/Pen
衛署èŒç–«è¼¸å—第000818號2015-10-072005-10-07èŒã€€ç–«DHA01000081801æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 80μg/Pen用於治療慢性Cåž‹è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH (BRINNY) COMPANYINNISHANNON, COUNTY CORK, IRELANDIRELAND2012-08-27ç›’è£;;ç›’è£Peg-Intron Redipen 80μg/Pen
衛署èŒç–«è¼¸å—第000818號2015-10-072005-10-07èŒã€€ç–«DHA01000081801æ´¾æ¨‚èƒ½ç°¡ä¾¿æ³¨å°„ç† 80μg/Pen用於治療慢性Cåž‹è‚炎。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑盒è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2b美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MSD International GmbH (Singapore Branch)60, TUAS WEST DRIVE, SINGAPORE, 638413SINGAPORE2012-08-27ç›’è£;;ç›’è£Peg-Intron Redipen 80μg/Pen
衛署èŒç–«è¼¸å—第000820號2015-12-142005-12-14èŒã€€ç–«DHA01000082001諾和密斯 30è«¾æ˜“ç† æ³¨å°„åŠ‘ç³–å°¿ç—…ã€‚æ³¨å°„åŠ‘æ”¯è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN ASPART (INSULIN ASPART: INSULIN ASPART PROTAMINE 30:70)臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693Novo Nordisk Production SAS45, Avenue d’Orleans, F-28002 Chartres, FranceFRANCE2014-04-16支è£NovoMix 30 FlexPenNovoMix 30的劑é‡æ˜¯æŒ‰ç…§å€‹åˆ¥æƒ…æ³èˆ‡ç—…人的需è¦è€Œæ±ºå®šã€‚NovoMix 30以皮下注射方å¼æ³¨å°„在大腿或腹å£ï¼Œå¦‚果方便,也å¯æ³¨å°„在臀部和三角肌。
衛署èŒç–«è¼¸å—第000821號2016-01-192006-01-19èŒã€€ç–«DHA01000082100"巴斯德" 五åˆä¸€ç–«è‹—(白喉ã€ç™¾æ—¥å’³ã€ç ´å‚·é¢¨ã€å°å…’麻痺åŠbåž‹æµè¡Œæ€§æ„Ÿå†’嗜血桿èŒç–«è‹—)å¯ä½¿å‡ºç”Ÿå¾ŒäºŒå€‹æœˆè‡³ä¸ƒæ²çš„å©ç«¥å°ç™½å–‰ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³ã€å°å…’麻痺症åŠä¾µè¥²æ€§båž‹æµè¡Œæ€§æ„Ÿå†’嗜血桿èŒæ„ŸæŸ“症產生å…疫力。注射劑盒è£;;注射é‡ç’;;瓶è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨è³½è«¾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR LIMITED1755 STEELES AVENUE TORONTO ONTARIO CANADA M2R 3T4CANADA2014-11-03ç›’è£;;注射é‡ç’;;瓶è£;;ç›’è£PediacelTM一劑為0.5mlå°æ–¼åˆæ¬¡æŽ¥ç¨®è€…,建è°ä½¿ç”¨ä¸‹åˆ—的時間:於出生後二個月ã€å››å€‹æœˆã€å…個月åŠå八個月å„施打一劑,æ¯æ¬¡è‚Œè‚‰æ³¨å°„0.5ml。本疫苗應以肌肉注射方å¼æŠ•äºˆã€‚
衛署èŒç–«è¼¸å—第000821號2016-01-192006-01-19èŒã€€ç–«DHA01000082100"巴斯德" 五åˆä¸€ç–«è‹—(白喉ã€ç™¾æ—¥å’³ã€ç ´å‚·é¢¨ã€å°å…’麻痺åŠbåž‹æµè¡Œæ€§æ„Ÿå†’嗜血桿èŒç–«è‹—)å¯ä½¿å‡ºç”Ÿå¾ŒäºŒå€‹æœˆè‡³ä¸ƒæ²çš„å©ç«¥å°ç™½å–‰ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³ã€å°å…’麻痺症åŠä¾µè¥²æ€§båž‹æµè¡Œæ€§æ„Ÿå†’嗜血桿èŒæ„ŸæŸ“症產生å…疫力。注射劑盒è£;;注射é‡ç’;;瓶è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨è³½è«¾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356AVENTIS PASTEUR S.A.1541, AV. MARCEL-MERIEUX, 69280 MARCY L'ETOILE FRANCEFRANCE2014-11-03ç›’è£;;注射é‡ç’;;瓶è£;;ç›’è£PediacelTM一劑為0.5mlå°æ–¼åˆæ¬¡æŽ¥ç¨®è€…,建è°ä½¿ç”¨ä¸‹åˆ—的時間:於出生後二個月ã€å››å€‹æœˆã€å…個月åŠå八個月å„施打一劑,æ¯æ¬¡è‚Œè‚‰æ³¨å°„0.5ml。本疫苗應以肌肉注射方å¼æŠ•äºˆã€‚
衛署èŒç–«è¼¸å—第000822號2016-03-102006-03-10èŒã€€ç–«DHA01000082202"喜斯悅" 第八å‡è¡€å› åå‡æ™¶æ³¨å°„劑Biostate 是用以治療和é é˜²ï¼Œå› Aåž‹è¡€å‹ç—…引起之第八å‡è¡€å› å缺ä¹ç›¸é—œçš„出血病症。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑瓶è£;;瓶è£é™ç”±é†«å¸«ä½¿ç”¨FACTOR VIII;;VWF: Rco世信生物科技股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路201之36號5樓16447082CSL LTD.189-209 CAMP ROAD BROADMEADOWS VICTORIA 3047 AUSTRALIA45 POPLAR ROAD PARKVILLE VICTORIA 3052,AUSTRALIAAUSTRALIA2011-07-05瓶è£;;瓶è£"CSL" Biostate (Human Coagulation Factor VIII, Freeze-dried)詳見說明書
衛署èŒç–«è¼¸å—第000822號2016-03-102006-03-10èŒã€€ç–«DHA01000082202"喜斯悅" 第八å‡è¡€å› åå‡æ™¶æ³¨å°„劑Biostate 是用以治療和é é˜²ï¼Œå› Aåž‹è¡€å‹ç—…引起之第八å‡è¡€å› å缺ä¹ç›¸é—œçš„出血病症。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑瓶è£;;瓶è£é™ç”±é†«å¸«ä½¿ç”¨FACTOR VIII;;VWF: Rco世信生物科技股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ•¦åŒ–北路201之36號5樓16447082ZLB BEHRING GMBHEMIL-VON-BEHRING, STRASSE 76, 35041 MARBURG, GERMANYGERMANY2011-07-05瓶è£;;瓶è£"CSL" Biostate (Human Coagulation Factor VIII, Freeze-dried)詳見說明書
衛署èŒç–«è¼¸å—第000823號2016-06-092006-06-09èŒã€€ç–«DHA01000082304諾和瑞 諾易ç†ç³–尿病。注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693Novo Nordisk Production SAS45, Avenue d’Orleans, F-28002 Chartres, FranceFRANCE2014-04-16ç›’è£NovoRapid FlexPené†«ç”Ÿæœƒæ ¹æ“šç—…æ‚£å€‹åˆ¥éœ€è¦çµ¦é©ç•¶ä¹‹NovoRapid劑é‡ã€‚NovoRapid常與ä¸æ•ˆåž‹æˆ–é•·æ•ˆåž‹èƒ°å³¶ç´ ä½µç”¨æ²»ç™‚ï¼Œè‡³å°‘ä¸€å¤©ä¸€æ¬¡ã€‚NovoRapid採腹部ã€å¤§è…¿ã€ä¸‰è§’肌或臀部皮下部ä½æ³¨å°„,在åŒä¸€éƒ¨ä½æ³¨å°„é»žå¿…é ˆè¼ªæ›¿ã€‚
衛署èŒç–«è¼¸å—第000824號2016-07-182006-07-18èŒã€€ç–«DHA01000082406æ©åšå‡æ™¶æ³¨å°„劑50公絲é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,例如methotrexate) ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。亦é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate 或光化療法(PUVA) )無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之8æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPT;;WATER FOR INJECTIONç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH PHARMACEUTICALSNEW LANE, HAVANT HAMPSHIREUNITED KINGDOM2012-06-18å°ç“¶;;注射é‡ç’Enbrel 50mg powder and solvent for solution for injection詳如仿單
衛署èŒç–«è¼¸å—第000824號2016-07-182006-07-18èŒã€€ç–«DHA01000082406æ©åšå‡æ™¶æ³¨å°„劑50公絲é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,例如methotrexate) ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。亦é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate 或光化療法(PUVA) )無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之8æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPT;;WATER FOR INJECTIONç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGBIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS, GERMANYGERMANY2012-06-18å°ç“¶;;注射é‡ç’Enbrel 50mg powder and solvent for solution for injection詳如仿單
衛署èŒç–«è¼¸å—第000824號2016-07-182006-07-18èŒã€€ç–«DHA01000082406æ©åšå‡æ™¶æ³¨å°„劑50公絲é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,例如methotrexate) ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。亦é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate 或光化療法(PUVA) )無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之8æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPT;;WATER FOR INJECTIONç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410VETTER PHARMA-FERTIGUNG GMBH & CO. KG FOR ABBOTT GMBH CO. KGSCHUTZENSTRASSE 87 D-88212 RAVENSBURG, GERMANYGERMANY2012-06-18å°ç“¶;;注射é‡ç’Enbrel 50mg powder and solvent for solution for injection詳如仿單
衛署èŒç–«è¼¸å—第000849號2012-10-112007-10-11èŒã€€ç–«DHA01000084909“百特â€è‰¾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 250 åœ‹éš›å–®ä½ (ç‘žå£«å» )控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)之出血事件。å‡æ™¶æ³¨å°„劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER S.A.BD. R. BRANQUART 80, 7860 LESSINES, BELGIUMBELGIUM2007-11-06瓶è£â€œBaxter†Advate 250 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000825號2016-08-312006-08-31èŒã€€ç–«DHA01000082508輪é”åœå£æœæ´»æ€§äº”價輪狀病毒疫苗é 防輪狀病毒所引起的腸胃炎(G1ã€G2ã€G3ã€G4,以åŠå«æœ‰P1A〔8〕之G血清型如G9)。內æœæ¶²åŠ‘å¡‘è† è»Ÿç®¡è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨G1 REASSORTANT;;G2 REASSORTANT;;G3 REASSORTANT;;G4 REASSORTANT;;P1 REASSORTANT美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME CORP.770 SUMNEYTOWN PIKE, WEST POINT, PA 19486 U.S.A.UNITED STATES2012-07-19å¡‘è† è»Ÿç®¡è£;;ç›’è£RotaTeq (Rotavirus vaccine, live, oral, pentavalent)詳見仿單。
衛署èŒç–«è¼¸å—第000826號2016-08-312006-08-31èŒã€€ç–«DHA01000082600羅特律輪狀病毒疫苗é 防輪狀病毒所引起的腸胃炎(G1與éžG1血清型如G2ã€G3ã€G4å’ŒG9)。å‡æ™¶å£æœæ‡¸æ¶²åŠ‘å°ç“¶è£é™„ç‰åŠ‘é‡ç¨€é‡‹æ¶²é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨HUMAN ROTAVIRUS LIVE ATTENUATED RIX4414 STRAINè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE I'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19å°ç“¶è£é™„ç‰åŠ‘é‡ç¨€é‡‹æ¶²ROTARIX劑é‡:完整疫苗接種程åºå…±é ˆæŽ¥ç¨®å…©åŠ‘。第一劑應於出生滿å…週後投予,最é²å¿…é ˆåœ¨å‡ºç”Ÿå¾ŒäºŒå四週內完æˆã€‚兩劑間隔ä¸å¾—少於四週。建è°æœ€å¥½åœ¨å‡ºç”Ÿå¾Œåå…週內完æˆæŽ¥ç¨®ã€‚用法:Rotarix僅供å£æœä½¿ç”¨ã€‚在任何情æ³ä¸‹å‡ä¸å¯ä»¥æ³¨å°„æ–¹å¼æŠ•äºˆROTARIX。在接種疫苗之å‰æˆ–之後,嬰兒的飲食(包括æ¯ä¹³)å‡ç„¡ä»»ä½•é™åˆ¶ã€‚
衛署èŒç–«è¼¸å—第000827號2016-09-262006-09-26èŒã€€ç–«DHA01000082702嘉喜[四價人類乳çªç—…毒(第6,11,16,18åž‹)åŸºå› é‡çµ„ç–«è‹—]9â€26 æ²å¥³æ€§ä¹‹é 防接種;é 防發生疫苗所å«çš„人類乳çªç—…毒第6ã€11ã€16 åŠ18 型所引起的åå®®é ¸ç™Œå‰æœŸæˆ–分化ä¸è‰¯çš„病變和癌症ã€é™°é“åŠå¤–陰部癌å‰æœŸæˆ–分化ä¸è‰¯çš„病變ã€ç”Ÿæ®–器疣(俗稱èœèŠ±)。9â€26 æ²ç”·æ€§ä¹‹é 防接種;é 防發生人類乳çªç—…毒第6 與11 型所引起的生殖器疣。16â€26 æ²ç”·æ€§é«˜å±éšªæ—群之é 防接種,以é 防第6ã€11ã€16 åŠ18 åž‹HPV 所引起的第2 級與第3 級肛門上皮內贅瘤(AIN)以åŠç¬¬16 åŠ18 åž‹HPV 所引起的肛門癌。說明:男性高å±éšªæ—群指曾有åŒæ€§æ€§è¡Œç‚ºä¹‹ç”·æ€§ã€‚注射劑注射é‡ç’;;å°ç“¶;;ç›’è£;;注射é‡ç’ ( 附或ä¸é™„é‡é )é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨TYPE 6 L1 PROTEIN;;TYPE 11 L1 PROTEIN;;TYPE 16 L1 PROTEIN;;TYPE 18 L1 PROTEIN美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME (AUSTRALIA) PTY LTD.54-68 FERNDELL STREET,SOUTH GRANVILLE N.S.W. 2142 AUSTRALIA.AUSTRALIA2014-03-18注射é‡ç’;;å°ç“¶;;ç›’è£;;注射é‡ç’ ( 附或ä¸é™„é‡é )GARDASIL [Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine]åƒè€ƒä»¿å–®èªªæ˜Ž
衛署èŒç–«è¼¸å—第000827號2016-09-262006-09-26èŒã€€ç–«DHA01000082702嘉喜[四價人類乳çªç—…毒(第6,11,16,18åž‹)åŸºå› é‡çµ„ç–«è‹—]9â€26 æ²å¥³æ€§ä¹‹é 防接種;é 防發生疫苗所å«çš„人類乳çªç—…毒第6ã€11ã€16 åŠ18 型所引起的åå®®é ¸ç™Œå‰æœŸæˆ–分化ä¸è‰¯çš„病變和癌症ã€é™°é“åŠå¤–陰部癌å‰æœŸæˆ–分化ä¸è‰¯çš„病變ã€ç”Ÿæ®–器疣(俗稱èœèŠ±)。9â€26 æ²ç”·æ€§ä¹‹é 防接種;é 防發生人類乳çªç—…毒第6 與11 型所引起的生殖器疣。16â€26 æ²ç”·æ€§é«˜å±éšªæ—群之é 防接種,以é 防第6ã€11ã€16 åŠ18 åž‹HPV 所引起的第2 級與第3 級肛門上皮內贅瘤(AIN)以åŠç¬¬16 åŠ18 åž‹HPV 所引起的肛門癌。說明:男性高å±éšªæ—群指曾有åŒæ€§æ€§è¡Œç‚ºä¹‹ç”·æ€§ã€‚注射劑注射é‡ç’;;å°ç“¶;;ç›’è£;;注射é‡ç’ ( 附或ä¸é™„é‡é )é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨TYPE 6 L1 PROTEIN;;TYPE 11 L1 PROTEIN;;TYPE 16 L1 PROTEIN;;TYPE 18 L1 PROTEIN美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME B.V.WAARDERWEG 39,2031 BN,HAARLEM,THE NETHERLANDNETHERLANDS2014-03-18注射é‡ç’;;å°ç“¶;;ç›’è£;;注射é‡ç’ ( 附或ä¸é™„é‡é )GARDASIL [Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine]åƒè€ƒä»¿å–®èªªæ˜Ž
衛署èŒç–«è¼¸å—第000827號2016-09-262006-09-26èŒã€€ç–«DHA01000082702嘉喜[四價人類乳çªç—…毒(第6,11,16,18åž‹)åŸºå› é‡çµ„ç–«è‹—]9â€26 æ²å¥³æ€§ä¹‹é 防接種;é 防發生疫苗所å«çš„人類乳çªç—…毒第6ã€11ã€16 åŠ18 型所引起的åå®®é ¸ç™Œå‰æœŸæˆ–分化ä¸è‰¯çš„病變和癌症ã€é™°é“åŠå¤–陰部癌å‰æœŸæˆ–分化ä¸è‰¯çš„病變ã€ç”Ÿæ®–器疣(俗稱èœèŠ±)。9â€26 æ²ç”·æ€§ä¹‹é 防接種;é 防發生人類乳çªç—…毒第6 與11 型所引起的生殖器疣。16â€26 æ²ç”·æ€§é«˜å±éšªæ—群之é 防接種,以é 防第6ã€11ã€16 åŠ18 åž‹HPV 所引起的第2 級與第3 級肛門上皮內贅瘤(AIN)以åŠç¬¬16 åŠ18 åž‹HPV 所引起的肛門癌。說明:男性高å±éšªæ—群指曾有åŒæ€§æ€§è¡Œç‚ºä¹‹ç”·æ€§ã€‚注射劑注射é‡ç’;;å°ç“¶;;ç›’è£;;注射é‡ç’ ( 附或ä¸é™„é‡é )é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨TYPE 6 L1 PROTEIN;;TYPE 11 L1 PROTEIN;;TYPE 16 L1 PROTEIN;;TYPE 18 L1 PROTEIN美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME CORP.770 SUMNEYTOWN PIKE, WEST POINT, PA 19486 U.S.A.UNITED STATES2014-03-18注射é‡ç’;;å°ç“¶;;ç›’è£;;注射é‡ç’ ( 附或ä¸é™„é‡é )GARDASIL [Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine]åƒè€ƒä»¿å–®èªªæ˜Ž
衛署èŒç–«è¼¸å—第000828號2016-10-022006-10-02èŒã€€ç–«DHA01000082801"瑞士" 宜ä¿åˆ©è¡€æ³¨å°„液40000å–®ä½/å…¬æ’®æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者ã€æ²»ç™‚與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN ALFA嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854CILAG AGHOCHSTRASSE 201, CH-8200 SCHAFFHAUSEN, SWITZERLANDSWITZERLAND2014-12-11注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;ç›’è£Eprex Injection 40000 IU/ml本è¦é™ç”±é†«å¸«ä½¿ç”¨ã€‚詳細用法用é‡è«‹åƒè¦‹ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000829號2016-10-272006-10-27èŒã€€ç–«DHA01000082903補施追安痺å¨ç–«è‹—boostrixTM polio é©ç”¨æ–¼å››æ²ä»¥ä¸Šè€…çš„è¿½åŠ ç–«è‹—æŽ¥ç¨®ï¼Œç”¨ä»¥é 防白喉ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³åŠå°å…’麻痺。boostrixTM polio並éžä¾›åŸºç¤Žå…疫接種之用。懸浮注射劑é 充填型注射器附é‡é ;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨PERTUSSIS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;PERTACTINE (OUTER MEMBRANE PROTEIN 69K);;DIPHTHERIA TOXOID;;TETANUS TOXOID;;INACTIVATED POLIO VIRUS -TYPE 1;;INACTIVATED POLIO VIRUS - TYPE 2;;INACTIVATED POLIO VIRUS -TYPE 3è·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE L'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19é 充填型注射器附é‡é ;;å°ç“¶boostrixTM polio劑é‡æœ¬ç–«è‹—的建è°æ–½æ‰“劑é‡ç‚ºå–®åŠ‘0.5毫å‡ã€‚å››æ²ä»¥ä¸Šå³å¯æŽ¥ç¨®boostrixTM polio。BoostrixTM polio的施打應éµå¾ªä½¿ç”¨ä½ŽåŠ‘é‡ï¼ˆæˆäººç”¨åŠ‘é‡ï¼‰ç™½å–‰é¡žæ¯’ç´ ã€ç ´å‚·é¢¨é¡žæ¯’ç´ ã€ç™¾æ—¥å’³æŠ—原ã€å°å…’麻痺抗原混åˆç–«è‹—的法定建è°åŠï¼ˆæˆ–)當地常è¦ã€‚ç›®å‰ç„¡è¶³å¤ 臨床試驗å¯æ”¯æŒBoostrixTM (dTpa) Polio用於基礎接種系列。å°å…ˆå‰æ›¾æŽ¥ç¨®éŽç ´å‚·é¢¨é¡žæ¯’ç´ ç–«è‹—ä¹‹åŸºç¤ŽæŽ¥ç¨®ç³»åˆ—çš„äººï¼Œç•¶å› å—å‚·è€Œæœ‰æ„ŸæŸ“ç ´å‚·é¢¨ä¹‹å¯èƒ½æ™‚,亦å¯æŽ¥ç¨®æ‡‰æŽ¥ç¨®boostrixTM polio。æ¤å¤–並應ä¾ç…§æ³•å®šå»ºè°åŒæ™‚æ–½æ‰“ç ´å‚·é¢¨å…ç–«çƒè›‹ç™½ã€‚é‡æ–°æŽ¥ç¨®é 防白喉ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³åŠå°å…’麻痺症的疫苗時,應採å–符åˆæ³•å®šå»ºè°çš„間隔時間(通常為10å¹´)。用法boostrixTM polio 的投予方å¼ç‚ºæ·±éƒ¨è‚Œè‚‰æ³¨å°„,最好注射在上臂三角肌å€åŸŸã€‚本藥é™ç”±é†«å¸«è™•æ–¹ä½¿ç”¨ã€‚
衛署èŒç–«è¼¸å—第000829號2016-10-272006-10-27èŒã€€ç–«DHA01000082903補施追安痺å¨ç–«è‹—boostrixTM polio é©ç”¨æ–¼å››æ²ä»¥ä¸Šè€…çš„è¿½åŠ ç–«è‹—æŽ¥ç¨®ï¼Œç”¨ä»¥é 防白喉ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³åŠå°å…’麻痺。boostrixTM polio並éžä¾›åŸºç¤Žå…疫接種之用。懸浮注射劑é 充填型注射器附é‡é ;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨PERTUSSIS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;PERTACTINE (OUTER MEMBRANE PROTEIN 69K);;DIPHTHERIA TOXOID;;TETANUS TOXOID;;INACTIVATED POLIO VIRUS -TYPE 1;;INACTIVATED POLIO VIRUS - TYPE 2;;INACTIVATED POLIO VIRUS -TYPE 3è·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.PARC DE LA NOIRE EPINE, RUE FLEMING 20, B-1300 WAVRE, BELGIUMBELGIUM2014-08-19é 充填型注射器附é‡é ;;å°ç“¶boostrixTM polio劑é‡æœ¬ç–«è‹—的建è°æ–½æ‰“劑é‡ç‚ºå–®åŠ‘0.5毫å‡ã€‚å››æ²ä»¥ä¸Šå³å¯æŽ¥ç¨®boostrixTM polio。BoostrixTM polio的施打應éµå¾ªä½¿ç”¨ä½ŽåŠ‘é‡ï¼ˆæˆäººç”¨åŠ‘é‡ï¼‰ç™½å–‰é¡žæ¯’ç´ ã€ç ´å‚·é¢¨é¡žæ¯’ç´ ã€ç™¾æ—¥å’³æŠ—原ã€å°å…’麻痺抗原混åˆç–«è‹—的法定建è°åŠï¼ˆæˆ–)當地常è¦ã€‚ç›®å‰ç„¡è¶³å¤ 臨床試驗å¯æ”¯æŒBoostrixTM (dTpa) Polio用於基礎接種系列。å°å…ˆå‰æ›¾æŽ¥ç¨®éŽç ´å‚·é¢¨é¡žæ¯’ç´ ç–«è‹—ä¹‹åŸºç¤ŽæŽ¥ç¨®ç³»åˆ—çš„äººï¼Œç•¶å› å—å‚·è€Œæœ‰æ„ŸæŸ“ç ´å‚·é¢¨ä¹‹å¯èƒ½æ™‚,亦å¯æŽ¥ç¨®æ‡‰æŽ¥ç¨®boostrixTM polio。æ¤å¤–並應ä¾ç…§æ³•å®šå»ºè°åŒæ™‚æ–½æ‰“ç ´å‚·é¢¨å…ç–«çƒè›‹ç™½ã€‚é‡æ–°æŽ¥ç¨®é 防白喉ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³åŠå°å…’麻痺症的疫苗時,應採å–符åˆæ³•å®šå»ºè°çš„間隔時間(通常為10å¹´)。用法boostrixTM polio 的投予方å¼ç‚ºæ·±éƒ¨è‚Œè‚‰æ³¨å°„,最好注射在上臂三角肌å€åŸŸã€‚本藥é™ç”±é†«å¸«è™•æ–¹ä½¿ç”¨ã€‚
衛署èŒç–«è¼¸å—第000830號2011-12-042006-12-04èŒã€€ç–«DHA01000083001宜爾å‡ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑250IU控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH PHARMACEUTICALSNEW LANE, HAVANT, HAMPSHIRE PO9 2NG, UNITED KINGDOMUNITED KINGDOM2014-03-10å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨ReFacto 250IU詳如仿單
衛署èŒç–«è¼¸å—第000830號2011-12-042006-12-04èŒã€€ç–«DHA01000083001宜爾å‡ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑250IU控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH FARMA, S.A.CARRETERA DE BURGOS KM 23, DESVIO ALGETE, KM1, 28700 SAN SEBASTIAN DE LOS REYES, MADRID, SPAINSPAIN2014-03-10å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨ReFacto 250IU詳如仿單
衛署èŒç–«è¼¸å—第000830號2011-12-042006-12-04èŒã€€ç–«DHA01000083001宜爾å‡ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑250IU控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410VETTER PHARMA - FERTIGUNG GMBH & CO. KGSCHUTZENSTRABE 87, 88212 RAVENSBURG, FEDERAL REPUBLIC OF GERMANYGERMANY2014-03-10å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨ReFacto 250IU詳如仿單
衛署èŒç–«è¼¸å—第000831號2011-12-042006-12-04èŒã€€ç–«DHA01000083103宜爾å‡ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑500IU控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH PHARMACEUTICALSNEW LANE, HAVANT, HAMPSHIRE PO9 2NG, UNITED KINGDOMUNITED KINGDOM2014-03-10å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨ReFacto 500IU詳如仿單
衛署èŒç–«è¼¸å—第000831號2011-12-042006-12-04èŒã€€ç–«DHA01000083103宜爾å‡ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑500IU控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH FARMA, S.A.CARRETERA DE BURGOS KM 23, DESVIO ALGETE, KM1, 28700 SAN SEBASTIAN DE LOS REYES, MADRID, SPAINSPAIN2014-03-10å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨ReFacto 500IU詳如仿單
衛署èŒç–«è¼¸å—第000831號2011-12-042006-12-04èŒã€€ç–«DHA01000083103宜爾å‡ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑500IU控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410VETTER PHARMA - FERTIGUNG GMBH & CO. KGSCHUTZENSTRABE 87, 88212 RAVENSBURG, FEDERAL REPUBLIC OF GERMANYGERMANY2014-03-10å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨ReFacto 500IU詳如仿單
衛署èŒç–«è¼¸å—第000832號2011-12-042006-12-04èŒã€€ç–«DHA01000083205宜爾å‡ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑1000IU控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH PHARMACEUTICALSNEW LANE, HAVANT, HAMPSHIRE PO9 2NG, UNITED KINGDOMUNITED KINGDOM2014-03-10å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨ReFacto 1000IU詳如仿單
衛署èŒç–«è¼¸å—第000832號2011-12-042006-12-04èŒã€€ç–«DHA01000083205宜爾å‡ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑1000IU控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH FARMA, S.A.CARRETERA DE BURGOS KM 23, DESVIO ALGETE, KM1, 28700 SAN SEBASTIAN DE LOS REYES, MADRID, SPAINSPAIN2014-03-10å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨ReFacto 1000IU詳如仿單
衛署èŒç–«è¼¸å—第000832號2011-12-042006-12-04èŒã€€ç–«DHA01000083205宜爾å‡ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑1000IU控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸è‡ºç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410VETTER PHARMA - FERTIGUNG GMBH & CO. KGSCHUTZENSTRABE 87, 88212 RAVENSBURG, FEDERAL REPUBLIC OF GERMANYGERMANY2014-03-10å°ç“¶é™„溶液åŠæ³¨å°„é‡ç’;;å°ç“¶é™„溶液åŠè¼¸æ³¨å™¨ReFacto 1000IU詳如仿單
衛署èŒç–«è¼¸å—第000833號2016-12-132006-12-13èŒã€€ç–«DHA01000083307ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液150國際單ä½/0.18毫å‡1. 無排åµç—‡(包括多囊性åµå·¢ç—‡å€™ç¾¤ï¼ŒPCOS),且å°Climphene citrate之治療無å應之婦女。2.å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。3.ç”·æ€§æ–¹æ€§ï¼šå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ã€‚注射劑注射匣 æ¯æ³¨å°„匣附3支é‡é ;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANONKLOOSTERSTRAAT 6 5349 AB OSS,THE NETHERLANDSNETHERLANDS2014-11-11注射匣 æ¯æ³¨å°„匣附3支é‡é ::,,;;ç›’è£::,,Puregon 150I.U./0.18ml solution for injection皮下注射,ä¾æ‚£è€…åµå·¢çš„個別å應,在超音波åŠè¡€æ¸…é›Œæ¿€ç´ æ¿ƒåº¦æŒ‡å¼•ä¸‹ï¼Œèª¿æ•´çµ¦äºˆçš„é©ç•¶åŠ‘é‡(詳如仿單所述)。
衛署èŒç–«è¼¸å—第000833號2016-12-132006-12-13èŒã€€ç–«DHA01000083307ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液150國際單ä½/0.18毫å‡1. 無排åµç—‡(包括多囊性åµå·¢ç—‡å€™ç¾¤ï¼ŒPCOS),且å°Climphene citrate之治療無å應之婦女。2.å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。3.ç”·æ€§æ–¹æ€§ï¼šå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ã€‚注射劑注射匣 æ¯æ³¨å°„匣附3支é‡é ;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANON-SITE DIOSITEVEERSEMEER 4, 5347 JN OSS, THE NETHERLANDSNETHERLANDS2014-11-11注射匣 æ¯æ³¨å°„匣附3支é‡é ::,,;;ç›’è£::,,Puregon 150I.U./0.18ml solution for injection皮下注射,ä¾æ‚£è€…åµå·¢çš„個別å應,在超音波åŠè¡€æ¸…é›Œæ¿€ç´ æ¿ƒåº¦æŒ‡å¼•ä¸‹ï¼Œèª¿æ•´çµ¦äºˆçš„é©ç•¶åŠ‘é‡(詳如仿單所述)。
衛署èŒç–«è¼¸å—第000844號2017-10-112007-10-11èŒã€€ç–«DHA01000084402“國血製劑益康â€é«˜ç´”度第八å‡è¡€å› å注射劑治療和é é˜²å› ç¼ºä¹ç¬¬å…«å‡è¡€å› å而引起之Aåž‹è¡€å‹ç—…相關的出血病症。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑瓶è£;;瓶è£é™ç”±é†«å¸«ä½¿ç”¨FACTOR VIII;;VWF: Rco醫療財團法人å°ç£è¡€æ¶²åŸºé‡‘會å°åŒ—市ä¸æ£å€å—海路3號3樓01010553CSL LIMITED.189-209 CAMP ROAD BROADMEADOWS VICTORIA 3047 AUSTRALIAAUSTRALIA2014-03-03瓶è£;;瓶è£"TBSF" High Purity Factor VIII Concentrate詳見仿單。
衛署èŒç–«è¼¸å—第000849號2012-10-112007-10-11èŒã€€ç–«DHA01000084909“百特â€è‰¾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 250 åœ‹éš›å–®ä½ (ç‘žå£«å» )控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)之出血事件。å‡æ™¶æ³¨å°„劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER BIOSCIENCE MANUFACTURING S.A.R.L.ROUTE DE PIERRE-A-BOT 111, CH-2000 NEUCHATEL, SWITZERLAND.SWITZERLAND2007-11-06瓶è£â€œBaxter†Advate 250 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000833號2016-12-132006-12-13èŒã€€ç–«DHA01000083307ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液150國際單ä½/0.18毫å‡1. 無排åµç—‡(包括多囊性åµå·¢ç—‡å€™ç¾¤ï¼ŒPCOS),且å°Climphene citrate之治療無å應之婦女。2.å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。3.ç”·æ€§æ–¹æ€§ï¼šå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ã€‚注射劑注射匣 æ¯æ³¨å°„匣附3支é‡é ;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720ORGANON IRELAND LIMITEDDRYNAM ROAD, SWORDS, CO. DUBLIN, IRELANDIRELAND2014-11-11注射匣 æ¯æ³¨å°„匣附3支é‡é ::,,;;ç›’è£::,,Puregon 150I.U./0.18ml solution for injection皮下注射,ä¾æ‚£è€…åµå·¢çš„個別å應,在超音波åŠè¡€æ¸…é›Œæ¿€ç´ æ¿ƒåº¦æŒ‡å¼•ä¸‹ï¼Œèª¿æ•´çµ¦äºˆçš„é©ç•¶åŠ‘é‡(詳如仿單所述)。
衛署èŒç–«è¼¸å—第000833號2016-12-132006-12-13èŒã€€ç–«DHA01000083307ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液150國際單ä½/0.18毫å‡1. 無排åµç—‡(包括多囊性åµå·¢ç—‡å€™ç¾¤ï¼ŒPCOS),且å°Climphene citrate之治療無å應之婦女。2.å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。3.ç”·æ€§æ–¹æ€§ï¼šå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ã€‚注射劑注射匣 æ¯æ³¨å°„匣附3支é‡é ;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720VETTER PHARMA-FERTIGUNG GMBH & CO. KG FOR N.V. ORGANONSCHUTZENSTRASSE 87 AND 99/101, D-88212 RAVENSBURG, GERMANYGERMANY2014-11-11注射匣 æ¯æ³¨å°„匣附3支é‡é ::,,;;ç›’è£::,,Puregon 150I.U./0.18ml solution for injection皮下注射,ä¾æ‚£è€…åµå·¢çš„個別å應,在超音波åŠè¡€æ¸…é›Œæ¿€ç´ æ¿ƒåº¦æŒ‡å¼•ä¸‹ï¼Œèª¿æ•´çµ¦äºˆçš„é©ç•¶åŠ‘é‡(詳如仿單所述)。
衛署èŒç–«è¼¸å—第000834號2016-12-142006-12-14èŒã€€ç–«DHA01000083409ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液900國際單ä½/1.08毫å‡1. 無排åµç—‡(包括多囊性åµå·¢ç—‡å€™ç¾¤ï¼ŒPCOS),且å°Climphene citrate之治療無å應之婦女。2.å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。3.ç”·æ€§æ–¹æ€§ï¼šå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ã€‚注射劑注射匣;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANONKLOOSTERSTRAAT 6 5349 AB OSS,THE NETHERLANDSNETHERLANDS2014-11-07注射匣;;ç›’è£Puregon 900I.U./1.08ml solution for injection皮下注射,ä¾æ‚£è€…åµå·¢çš„個別å應,在超音波åŠè¡€æ¸…é›Œæ¿€ç´ æ¿ƒåº¦æŒ‡å¼•ä¸‹ï¼Œèª¿æ•´çµ¦äºˆçš„é©ç•¶åŠ‘é‡(詳如仿單所述)。
衛署èŒç–«è¼¸å—第000834號2016-12-142006-12-14èŒã€€ç–«DHA01000083409ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液900國際單ä½/1.08毫å‡1. 無排åµç—‡(包括多囊性åµå·¢ç—‡å€™ç¾¤ï¼ŒPCOS),且å°Climphene citrate之治療無å應之婦女。2.å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。3.ç”·æ€§æ–¹æ€§ï¼šå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ã€‚注射劑注射匣;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANON-SITE DIOSITEVEERSEMEER 4, 5347 JN OSS, THE NETHERLANDSNETHERLANDS2014-11-07注射匣;;ç›’è£Puregon 900I.U./1.08ml solution for injection皮下注射,ä¾æ‚£è€…åµå·¢çš„個別å應,在超音波åŠè¡€æ¸…é›Œæ¿€ç´ æ¿ƒåº¦æŒ‡å¼•ä¸‹ï¼Œèª¿æ•´çµ¦äºˆçš„é©ç•¶åŠ‘é‡(詳如仿單所述)。
衛署èŒç–«è¼¸å—第000844號2017-10-112007-10-11èŒã€€ç–«DHA01000084402“國血製劑益康â€é«˜ç´”度第八å‡è¡€å› å注射劑治療和é é˜²å› ç¼ºä¹ç¬¬å…«å‡è¡€å› å而引起之Aåž‹è¡€å‹ç—…相關的出血病症。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑瓶è£;;瓶è£é™ç”±é†«å¸«ä½¿ç”¨FACTOR VIII;;VWF: Rco醫療財團法人å°ç£è¡€æ¶²åŸºé‡‘會å°åŒ—市ä¸æ£å€å—海路3號3樓01010553CSL BEHRING GMBHEMIL-VON-BEHRING-STRABE 76,35041 MARBURG, GERMANYGERMANY2014-03-03瓶è£;;瓶è£"TBSF" High Purity Factor VIII Concentrate詳見仿單。
衛署èŒç–«è¼¸å—第000834號2016-12-142006-12-14èŒã€€ç–«DHA01000083409ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液900國際單ä½/1.08毫å‡1. 無排åµç—‡(包括多囊性åµå·¢ç—‡å€™ç¾¤ï¼ŒPCOS),且å°Climphene citrate之治療無å應之婦女。2.å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。3.ç”·æ€§æ–¹æ€§ï¼šå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ã€‚注射劑注射匣;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720ORGANON IRELAND LIMITEDDRYNAM ROAD, SWORDS, CO. DUBLIN, IRELANDIRELAND2014-11-07注射匣;;ç›’è£Puregon 900I.U./1.08ml solution for injection皮下注射,ä¾æ‚£è€…åµå·¢çš„個別å應,在超音波åŠè¡€æ¸…é›Œæ¿€ç´ æ¿ƒåº¦æŒ‡å¼•ä¸‹ï¼Œèª¿æ•´çµ¦äºˆçš„é©ç•¶åŠ‘é‡(詳如仿單所述)。
衛署èŒç–«è¼¸å—第000834號2016-12-142006-12-14èŒã€€ç–«DHA01000083409ä¿å¦Šåº·åŒ£å¼æ³¨å°„溶液900國際單ä½/1.08毫å‡1. 無排åµç—‡(包括多囊性åµå·¢ç—‡å€™ç¾¤ï¼ŒPCOS),且å°Climphene citrate之治療無å應之婦女。2.å—控制下之åµå·¢éŽåº¦åˆºæ¿€ï¼Œèª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ï¼Œæ‡‰ç”¨åœ¨å„種人工å”助生殖計劃。3.ç”·æ€§æ–¹æ€§ï¼šå› ä¿ƒæ€§è…ºæ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å¼•èµ·çš„ç²¾å生æˆä¸è¶³ã€‚注射劑注射匣;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN BETA美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720VETTER PHARMA-FERTIGUNG GMBH & CO. KGMOOSWIESEN 2, 88214 RAVENSBURG, GERMANYGERMANY2014-11-07注射匣;;ç›’è£Puregon 900I.U./1.08ml solution for injection皮下注射,ä¾æ‚£è€…åµå·¢çš„個別å應,在超音波åŠè¡€æ¸…é›Œæ¿€ç´ æ¿ƒåº¦æŒ‡å¼•ä¸‹ï¼Œèª¿æ•´çµ¦äºˆçš„é©ç•¶åŠ‘é‡(詳如仿單所述)。
衛署èŒç–«è¼¸å—第000835號2017-04-092007-04-09èŒã€€ç–«DHA01000083501喜瑞樂å‡æ™¶æ³¨å°„劑150æ¯«å…‹æ¨‚ç„¡å–˜ç‚ºé™„åŠ ç™‚æ³•ç”¨æ–¼æ”¹å–„å·²æŽ¥å—高劑é‡å¸å…¥æ€§é¡žå›ºé†‡è£½åŠ‘åŠé•·æ•ˆä¹™äºŒåž‹ä½œç”¨åŠ‘(B2-agonist)治療下ä»æœ‰é »ç¹çš„日間症狀或夜間覺醒且具有多次é‡åº¦æ°£å–˜æƒ¡åŒ–紀錄的é‡åº¦æŒçºŒéŽæ•æ€§æ°£å–˜æˆäººã€é’å°‘å¹´åŠå…’ç«¥(6æ²åŠä»¥ä¸Š)çš„æ°£å–˜æŽ§åˆ¶ã€‚é€™äº›æ°£å–˜æ‚£è€…å¿…é ˆæœ‰ç¶“ç”±çš®è†šæ¸¬è©¦æˆ–é«”å¤–è©¦é©—é¡¯ç¤ºå°é•·æœŸç©ºæ°£ä¸éŽæ•åŽŸå‘ˆé™½æ€§ä¸”肺功能é™ä½Ž(FEV1<80%)。樂無喘僅é©ç”¨æ–¼è‰å¯¦ç‚ºIgE媒介型的氣喘病人。å‡æ™¶æ³¨å°„劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨OMALIZUMABå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589TAKEDA AUSTRIA GMBHST. PETER-STRASSE 25 A-4020 LINZ, AUSTRIAAUSTRIA2014-10-27å°ç“¶;;ç›’è£Xolair 150 mg powder and solvent for solution for injection詳見仿單。
衛署èŒç–«è¼¸å—第000835號2017-04-092007-04-09èŒã€€ç–«DHA01000083501喜瑞樂å‡æ™¶æ³¨å°„劑150æ¯«å…‹æ¨‚ç„¡å–˜ç‚ºé™„åŠ ç™‚æ³•ç”¨æ–¼æ”¹å–„å·²æŽ¥å—高劑é‡å¸å…¥æ€§é¡žå›ºé†‡è£½åŠ‘åŠé•·æ•ˆä¹™äºŒåž‹ä½œç”¨åŠ‘(B2-agonist)治療下ä»æœ‰é »ç¹çš„日間症狀或夜間覺醒且具有多次é‡åº¦æ°£å–˜æƒ¡åŒ–紀錄的é‡åº¦æŒçºŒéŽæ•æ€§æ°£å–˜æˆäººã€é’å°‘å¹´åŠå…’ç«¥(6æ²åŠä»¥ä¸Š)çš„æ°£å–˜æŽ§åˆ¶ã€‚é€™äº›æ°£å–˜æ‚£è€…å¿…é ˆæœ‰ç¶“ç”±çš®è†šæ¸¬è©¦æˆ–é«”å¤–è©¦é©—é¡¯ç¤ºå°é•·æœŸç©ºæ°£ä¸éŽæ•åŽŸå‘ˆé™½æ€§ä¸”肺功能é™ä½Ž(FEV1<80%)。樂無喘僅é©ç”¨æ–¼è‰å¯¦ç‚ºIgE媒介型的氣喘病人。å‡æ™¶æ³¨å°„劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨OMALIZUMABå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS PHARMA S.A.S.8, RUE DE L'INDUSTRIE, F-68330 HUNINGUE, FRANCEFRANCE2014-10-27å°ç“¶;;ç›’è£Xolair 150 mg powder and solvent for solution for injection詳見仿單。
衛署èŒç–«è¼¸å—第000846號2017-08-012007-08-01èŒã€€ç–«DHA01000084603æ©åšé‡ç’è£æ³¨å°„劑 50 毫克é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,包括methotrexate)ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。亦é©ç”¨æ–¼methotrexate治療無效或無法è€å—çš„2æ²ä»¥ä¸Šå…’ç«¥åŠé’少年的活動性多關節幼年型慢性關節炎。尚未å°ä¸è¶³2æ²çš„兒童進行試驗。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate或光化療法(PUVA))無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之6æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚注射劑é å……å¼æ³¨å°„é‡ç’;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPTç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410VETTER PHARMA - FERTIGUNG GMBH & CO. KGEisenbahnstrasse 2-4, 88085 Langenargen, GermanyGERMANY2014-10-24é å……å¼æ³¨å°„é‡ç’;;注射ç†Enbrel 50mg solution for injection in pre-filled syringe詳如仿單。
衛署èŒç–«è¼¸å—第000835號2017-04-092007-04-09èŒã€€ç–«DHA01000083501喜瑞樂å‡æ™¶æ³¨å°„劑150æ¯«å…‹æ¨‚ç„¡å–˜ç‚ºé™„åŠ ç™‚æ³•ç”¨æ–¼æ”¹å–„å·²æŽ¥å—高劑é‡å¸å…¥æ€§é¡žå›ºé†‡è£½åŠ‘åŠé•·æ•ˆä¹™äºŒåž‹ä½œç”¨åŠ‘(B2-agonist)治療下ä»æœ‰é »ç¹çš„日間症狀或夜間覺醒且具有多次é‡åº¦æ°£å–˜æƒ¡åŒ–紀錄的é‡åº¦æŒçºŒéŽæ•æ€§æ°£å–˜æˆäººã€é’å°‘å¹´åŠå…’ç«¥(6æ²åŠä»¥ä¸Š)çš„æ°£å–˜æŽ§åˆ¶ã€‚é€™äº›æ°£å–˜æ‚£è€…å¿…é ˆæœ‰ç¶“ç”±çš®è†šæ¸¬è©¦æˆ–é«”å¤–è©¦é©—é¡¯ç¤ºå°é•·æœŸç©ºæ°£ä¸éŽæ•åŽŸå‘ˆé™½æ€§ä¸”肺功能é™ä½Ž(FEV1<80%)。樂無喘僅é©ç”¨æ–¼è‰å¯¦ç‚ºIgE媒介型的氣喘病人。å‡æ™¶æ³¨å°„劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨OMALIZUMABå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS PHARMA STEIN AGSCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLANDSWITZERLAND2014-10-27å°ç“¶;;ç›’è£Xolair 150 mg powder and solvent for solution for injection詳見仿單。
衛署èŒç–«è¼¸å—第000836號2017-05-092007-05-09èŒã€€ç–«DHA01000083600"百特"艾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 500國際單ä½æŽ§åˆ¶åŠé 防æˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者之出血事件。æˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者手術å‰ä¸å¾Œä¹‹è™•ç½®ã€‚åšç‚ºä¾‹è¡Œé 防,é 防或é™ä½ŽæˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者之出血事件發生率。說明:本å“ä¸èƒ½åšç‚ºvon willebrandæ°ç–¾ç—…之治療。å‡æ™¶æ³¨å°„劑瓶è£;;é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA;;WATER FOR INJECTION百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER BIOSCIENCE MANUFACTURING S.A.R.L.ROUTE DE PIERRE-A-BOT 111, CH-2000 NEUCHATEL, SWITZERLAND.SWITZERLAND2014-06-11瓶è£;;é‡ç’è£"Baxter" Advate 500 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000836號2017-05-092007-05-09èŒã€€ç–«DHA01000083600"百特"艾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 500國際單ä½æŽ§åˆ¶åŠé 防æˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者之出血事件。æˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者手術å‰ä¸å¾Œä¹‹è™•ç½®ã€‚åšç‚ºä¾‹è¡Œé 防,é 防或é™ä½ŽæˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者之出血事件發生率。說明:本å“ä¸èƒ½åšç‚ºvon willebrandæ°ç–¾ç—…之治療。å‡æ™¶æ³¨å°„劑瓶è£;;é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA;;WATER FOR INJECTION百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION911 NORTH DAVIS,CLEVELAND,MISSISSIPPI,38732,USAUNITED STATES2014-06-11瓶è£;;é‡ç’è£"Baxter" Advate 500 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000837號2017-05-092007-05-09èŒã€€ç–«DHA01000083702“百特â€è‰¾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 250國際單ä½æŽ§åˆ¶åŠé 防æˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者之出血事件。æˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者手術å‰ä¸å¾Œä¹‹è™•ç½®ã€‚åšç‚ºä¾‹è¡Œé 防,é 防或é™ä½ŽæˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者之出血事件發生率。說明:本å“ä¸èƒ½åšç‚ºvon willebrandæ°ç–¾ç—…之治療。å‡æ™¶æ³¨å°„劑瓶è£;;é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA;;WATER FOR INJECTION百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER BIOSCIENCE MANUFACTURING S.A.R.L.ROUTE DE PIERRE-A-BOT 111, CH-2000 NEUCHATEL, SWITZERLAND.SWITZERLAND2014-06-11瓶è£;;é‡ç’è£â€œBaxterâ€Advate 250 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000837號2017-05-092007-05-09èŒã€€ç–«DHA01000083702“百特â€è‰¾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 250國際單ä½æŽ§åˆ¶åŠé 防æˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者之出血事件。æˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者手術å‰ä¸å¾Œä¹‹è™•ç½®ã€‚åšç‚ºä¾‹è¡Œé 防,é 防或é™ä½ŽæˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者之出血事件發生率。說明:本å“ä¸èƒ½åšç‚ºvon willebrandæ°ç–¾ç—…之治療。å‡æ™¶æ³¨å°„劑瓶è£;;é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA;;WATER FOR INJECTION百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION911 NORTH DAVIS,CLEVELAND,MISSISSIPPI,38732,USAUNITED STATES2014-06-11瓶è£;;é‡ç’è£â€œBaxterâ€Advate 250 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000898號2015-09-162010-09-16èŒã€€ç–«DHA01000089809優泌樂ç†-æ··åˆåž‹ 25 100 å–®ä½/毫å‡ç³–尿病注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN LISPRO;;INSULIN LISPRO臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY DEL CARIBE INC.12.3 KM, 65TH INFANTRY ROAD, CAROLINA 00985, PUERTO RICOPUERTO RICO2014-09-29注射ç†;;ç›’è£Humalog Mix 25 100U/ml KwikPen醫師é‡å°æ‚£è€…的需求決定劑é‡
衛署èŒç–«è¼¸å—第000838號2017-05-092007-05-09èŒã€€ç–«DHA01000083804“百特â€è‰¾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 1000國際單ä½æŽ§åˆ¶åŠé 防æˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者之出血事件。æˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者手術å‰ä¸å¾Œä¹‹è™•ç½®ã€‚åšç‚ºä¾‹è¡Œé 防,é 防或é™ä½ŽæˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者之出血事件發生率。說明:本å“ä¸èƒ½åšç‚ºvon willebrandæ°ç–¾ç—…之治療。å‡æ™¶æ³¨å°„劑瓶è£;;é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA;;WATER FOR INJECTION百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER BIOSCIENCE MANUFACTURING S.A.R.L.ROUTE DE PIERRE-A-BOT 111, CH-2000 NEUCHATEL, SWITZERLAND.SWITZERLAND2014-06-11瓶è£;;é‡ç’è£â€œBaxterâ€Advate 1000 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000838號2017-05-092007-05-09èŒã€€ç–«DHA01000083804“百特â€è‰¾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 1000國際單ä½æŽ§åˆ¶åŠé 防æˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者之出血事件。æˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者手術å‰ä¸å¾Œä¹‹è™•ç½®ã€‚åšç‚ºä¾‹è¡Œé 防,é 防或é™ä½ŽæˆäººåŠå…’ç«¥Aåž‹è¡€å‹ç—…患者之出血事件發生率。說明:本å“ä¸èƒ½åšç‚ºvon willebrandæ°ç–¾ç—…之治療。å‡æ™¶æ³¨å°„劑瓶è£;;é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA;;WATER FOR INJECTION百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION911 NORTH DAVIS,CLEVELAND,MISSISSIPPI,38732,USAUNITED STATES2014-06-11瓶è£;;é‡ç’è£â€œBaxterâ€Advate 1000 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000840號2017-06-232007-06-23èŒã€€ç–«DHA01000084004“巴斯德â€ä¸‰åˆä¸€è£œè¿½ç–«è‹—é©ç”¨æ–¼4-64æ²é–“ä¹‹è¿½åŠ ç–«è‹—æŽ¥ç¨®ï¼Œä»¥é 防白喉ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³ã€‚懸浮注射劑瓶è£;;ç›’è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PERTUSSIS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;AGGLUTINOGENS FIMBRIAE 2+3;;PERTACTIN;;DIPHTHERIA TOXOID;;TETANUS TOXOID賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR LIMITED1755 STEELES AVENUE WEST, TORONTO, ONTARIO, CANADA, M2R 3T4CANADA2014-11-03瓶è£;;ç›’è£;;ç›’è£Adacel TM一劑為0.5ml,本疫苗應以肌肉注射方å¼æŠ•äºˆã€‚
衛署èŒç–«è¼¸å—第000841號2017-07-122007-07-12èŒã€€ç–«DHA01000084106“國血製劑益康â€äººé¡žå…ç–«çƒè›‹ç™½éœè„ˆæ³¨å°„劑IgG的替代治療用藥,é©æ‡‰ç—‡åŒ…括:1原發性å…ç–«ä¸å…¨ç—‡ï¼ˆprimary immune deficiency)。2骨髓瘤(myeloma)與慢性淋巴癌(chronic lymphatic leukamia)引致嚴é‡æ¬¡ç™¼æ€§å…ç–«çƒè›‹ç™½ç¼ºä¹ï¼ˆsevere secondary hypogammaglobulinaemia)與復發性感染(recurrent infections)。3伴隨復發性感染之先天性å…ç–«ä¸å…¨ç—‡ï¼ˆAIDS with recurrent infections)。用於改善å…疫機能的治療,é©æ‡‰ç—‡åŒ…括:4原發性血å°æ¿ç¼ºä¹æ€§ç´«æ–‘ç—‡ã€idiopathic thrombocytopenic purpura(ITP)】,有出血å±éšªçš„æˆäººæˆ–å°å©ITP患者;或者,手術å‰ç”¨ä»¥ä¿®æ£è¡€å°æ¿æ•¸ç›®ã€‚5異體骨髓移æ¤ï¼ˆallogeneic bone marrow transplantation)。6å·å´Žæ°ç—‡ï¼ˆKawasaki Disease)。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨MALTOSE;;Human Immunoglobulin G醫療財團法人å°ç£è¡€æ¶²åŸºé‡‘會å°åŒ—市ä¸æ£å€å—海路3號3樓01010553CSL LIMITED189-209 CAMP ROAD BROADMEADOWS VICTORIA 3047 AUSTRALIA AUSTRALIA2014-03-03瓶è£"TBSF" Human Immunoglobulin for Intravenous Use詳見仿單。
衛署èŒç–«è¼¸å—第000842號2017-07-162007-07-16èŒã€€ç–«DHA01000084208“國血製劑益康â€(20%)人血清白蛋白注射劑低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。éœè„ˆé»žæ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨HUMAN ALBUMIN醫療財團法人å°ç£è¡€æ¶²åŸºé‡‘會å°åŒ—市ä¸æ£å€å—海路3號3樓01010553CSL Limited189-209 CAMP ROAD BROADMEADOWS VICTORIA 3047 AUSTRALIA AUSTRALIA2014-03-03å°ç“¶"TBSF" (20%) Human Albumin Solution詳見仿單。
衛署èŒç–«è¼¸å—第000843號2017-07-162007-07-16èŒã€€ç–«DHA01000084300“國血製劑益康â€é«˜ç´”度第ä¹å‡è¡€å› å注射劑用以治療和é é˜²ï¼Œå› ç¼ºä¹ç¬¬ä¹å‡è¡€å› å而引起之Båž‹è¡€å‹ç—…相關的出血病症。å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑å°ç“¶;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨FACTOR IX;;HEPARIN;;ANTITHROMBIN III;;PLASMA PROTEIN;;SODIUM (ACETATE);;PHOSPHATE;;CITRATE;;CHLORIDE醫療財團法人å°ç£è¡€æ¶²åŸºé‡‘會å°åŒ—市ä¸æ£å€å—海路3號3樓01010553CSL Limited189-209 CAMP ROAD BROADMEADOWS VICTORIA 3047 AUSTRALIA AUSTRALIA2014-03-03å°ç“¶;;å°ç“¶"TBSF" High Purity Factor IX Concentrate詳見仿單。
衛署èŒç–«è¼¸å—第000845號2017-07-302007-07-30èŒã€€ç–«DHA01000084501增若托平注射劑 12 æ¯«å…‹è…¦ä¸‹åž‚é«”ä¹‹ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾ï¼›TURNER'S sydrome 所導致之生長干擾;Prader-Willi syndrome 所導致之生長干擾;慢性腎臟功能ä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾ï¼›æˆäººç”Ÿé•·æ¿€ç´ åš´é‡ç¼ºä¹ä¹‹è£œå……療法;低出生體é‡å…’Small for Gestational Age(SGA) 逾四æ²è€…之生長障礙。å‡æ™¶æ³¨å°„劑雙內腔å¡åŒ£è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨SOMATROPIN (BIOSYNTHETIC HUMAN GROWTH HORMONE);;M-CRESOL ;;MANNITOL;;WATER FOR INJECTIONè¼ç‘žå¤§è—¥å» 股份有é™å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µï¼‘77號37199708PFIZER MANUFACTURING BELGIUM NVRIJKSWEG 12, 2870, PUURS, BELGIUMBELGIUM2013-02-20雙內腔å¡åŒ£è£;;注射ç†Genotropin 12 mg詳如仿單。
衛署èŒç–«è¼¸å—第000845號2017-07-302007-07-30èŒã€€ç–«DHA01000084501增若托平注射劑 12 æ¯«å…‹è…¦ä¸‹åž‚é«”ä¹‹ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾ï¼›TURNER'S sydrome 所導致之生長干擾;Prader-Willi syndrome 所導致之生長干擾;慢性腎臟功能ä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾ï¼›æˆäººç”Ÿé•·æ¿€ç´ åš´é‡ç¼ºä¹ä¹‹è£œå……療法;低出生體é‡å…’Small for Gestational Age(SGA) 逾四æ²è€…之生長障礙。å‡æ™¶æ³¨å°„劑雙內腔å¡åŒ£è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨SOMATROPIN (BIOSYNTHETIC HUMAN GROWTH HORMONE);;M-CRESOL ;;MANNITOL;;WATER FOR INJECTIONè¼ç‘žå¤§è—¥å» 股份有é™å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µï¼‘77號37199708PFIZER HEALTH ABMARIEFREDSVAGEN 37, SE-645 41 STRANGNAS, SWEDENSWEDEN2013-02-20雙內腔å¡åŒ£è£;;注射ç†Genotropin 12 mg詳如仿單。
衛署èŒç–«è¼¸å—第000849號2012-10-112007-10-11èŒã€€ç–«DHA01000084909“百特â€è‰¾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 250 åœ‹éš›å–®ä½ (ç‘žå£«å» )控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)之出血事件。å‡æ™¶æ³¨å°„劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION911 NORTH DAVIS, CLEVELAND, MISSISSIPPI, 38732 USA UNITED STATES2007-11-06瓶è£â€œBaxter†Advate 250 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000845號2017-07-302007-07-30èŒã€€ç–«DHA01000084501增若托平注射劑 12 æ¯«å…‹è…¦ä¸‹åž‚é«”ä¹‹ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾ï¼›TURNER'S sydrome 所導致之生長干擾;Prader-Willi syndrome 所導致之生長干擾;慢性腎臟功能ä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾ï¼›æˆäººç”Ÿé•·æ¿€ç´ åš´é‡ç¼ºä¹ä¹‹è£œå……療法;低出生體é‡å…’Small for Gestational Age(SGA) 逾四æ²è€…之生長障礙。å‡æ™¶æ³¨å°„劑雙內腔å¡åŒ£è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨SOMATROPIN (BIOSYNTHETIC HUMAN GROWTH HORMONE);;M-CRESOL ;;MANNITOL;;WATER FOR INJECTIONè¼ç‘žå¤§è—¥å» 股份有é™å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µï¼‘77號37199708VETTER PHARMA-FERTIGUNG GMBH & CO. KGEISENBAHNSTRASSE 2-4, 88085 LANGENARGEN GERMANYGERMANY2013-02-20雙內腔å¡åŒ£è£;;注射ç†Genotropin 12 mg詳如仿單。
衛署èŒç–«è¼¸å—第000846號2017-08-012007-08-01èŒã€€ç–«DHA01000084603æ©åšé‡ç’è£æ³¨å°„劑 50 毫克é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,包括methotrexate)ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。亦é©ç”¨æ–¼methotrexate治療無效或無法è€å—çš„2æ²ä»¥ä¸Šå…’ç«¥åŠé’少年的活動性多關節幼年型慢性關節炎。尚未å°ä¸è¶³2æ²çš„兒童進行試驗。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate或光化療法(PUVA))無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之6æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚注射劑é å……å¼æ³¨å°„é‡ç’;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPTç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH PHARMACEUTICALSNEW LANE, HAVANT, HAMPSHIRE PO9 2NG, UNITED KINGDOMUNITED KINGDOM2014-10-24é å……å¼æ³¨å°„é‡ç’;;注射ç†Enbrel 50mg solution for injection in pre-filled syringe詳如仿單。
衛署èŒç–«è¼¸å—第000846號2017-08-012007-08-01èŒã€€ç–«DHA01000084603æ©åšé‡ç’è£æ³¨å°„劑 50 毫克é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,包括methotrexate)ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。亦é©ç”¨æ–¼methotrexate治療無效或無法è€å—çš„2æ²ä»¥ä¸Šå…’ç«¥åŠé’少年的活動性多關節幼年型慢性關節炎。尚未å°ä¸è¶³2æ²çš„兒童進行試驗。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate或光化療法(PUVA))無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之6æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚注射劑é å……å¼æ³¨å°„é‡ç’;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPTç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410Pfizer Ireland PharmaceuticalsGrange Castle Business Park, Clondalkin, Dublin 22, IrelandIRELAND2014-10-24é å……å¼æ³¨å°„é‡ç’;;注射ç†Enbrel 50mg solution for injection in pre-filled syringe詳如仿單。
衛署èŒç–«è¼¸å—第000847號2012-08-082007-08-08èŒã€€ç–«DHA01000084705“百特â€è‰¾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 500åœ‹éš›å–®ä½ (ç‘žå£«å» )控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)之出血事件。å‡æ™¶æ³¨å°„劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA;;WATER FOR INJECTION百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER AGINDUSTRIESSTRASSE 67, A-1220 VIENNA, AUSTRIA.AUSTRIA2007-11-05瓶è£â€œBaxterâ€Advate 500 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000847號2012-08-082007-08-08èŒã€€ç–«DHA01000084705“百特â€è‰¾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 500åœ‹éš›å–®ä½ (ç‘žå£«å» )控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)之出血事件。å‡æ™¶æ³¨å°„劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA;;WATER FOR INJECTION百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER S.A.BOULEVARD RENE BRANQUART, 80, B-7860 LESSINES, BELGIUMBELGIUM2007-11-05瓶è£â€œBaxterâ€Advate 500 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000847號2012-08-082007-08-08èŒã€€ç–«DHA01000084705“百特â€è‰¾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 500åœ‹éš›å–®ä½ (ç‘žå£«å» )控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)之出血事件。å‡æ™¶æ³¨å°„劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA;;WATER FOR INJECTION百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER BIOSCIENCE MANUFACTURING S.A.R.L.ROUTE DE PIERRE-A-BOT 111, CH-2000 NEUCHATEL, SWITZERLAND.SWITZERLAND2007-11-05瓶è£â€œBaxterâ€Advate 500 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000847號2012-08-082007-08-08èŒã€€ç–«DHA01000084705“百特â€è‰¾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 500åœ‹éš›å–®ä½ (ç‘žå£«å» )控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)之出血事件。å‡æ™¶æ³¨å°„劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA;;WATER FOR INJECTION百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION911 NORTH DAVIS, CLEVELAND, MISSISSIPPI, 38732 USAUNITED STATES2007-11-05瓶è£â€œBaxterâ€Advate 500 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000849號2012-10-112007-10-11èŒã€€ç–«DHA01000084909“百特â€è‰¾éžç‰¹åŸºå› 工程第八å‡è¡€å› å製劑 250 åœ‹éš›å–®ä½ (ç‘žå£«å» )控制和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)之出血事件。å‡æ™¶æ³¨å°„劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨OCTOCOG ALFA百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER AGINDUSTRIESSTRASSE 67, A-1220 VIENNA, AUSTRIAAUSTRIA2007-11-06瓶è£â€œBaxter†Advate 250 IU Powder and solvent for injection詳如仿單。
衛署èŒç–«è¼¸å—第000850號2012-10-242007-10-24èŒã€€ç–«DHA01000085007æ©åšå‡æ™¶æ³¨å°„劑 25 毫克é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,例如methotrexate) ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。亦é©ç”¨æ–¼methotrexate治療無效或無法è€å—çš„4æ²ä»¥ä¸Šå…’ç«¥åŠé’少年的活動性多關節幼年型慢性關節炎。尚未å°4æ²ä»¥ä¸‹çš„兒童進行試驗。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate 或光化療法(PUVA) )無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之8æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶è£;;é‡ç’è£é™„溶劑é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPTç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH PHARMACEUTICALSNEW LANE, HAVANT, HAMPSHIRE PO9 2NG, UNITED KINGDOMUNITED KINGDOM2012-06-18å°ç“¶è£;;é‡ç’è£é™„溶劑Enbrel 25mg powder and solvent for solution for injection詳見仿單。
衛署èŒç–«è¼¸å—第000850號2012-10-242007-10-24èŒã€€ç–«DHA01000085007æ©åšå‡æ™¶æ³¨å°„劑 25 毫克é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,例如methotrexate) ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。亦é©ç”¨æ–¼methotrexate治療無效或無法è€å—çš„4æ²ä»¥ä¸Šå…’ç«¥åŠé’少年的活動性多關節幼年型慢性關節炎。尚未å°4æ²ä»¥ä¸‹çš„兒童進行試驗。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate 或光化療法(PUVA) )無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之8æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶è£;;é‡ç’è£é™„溶劑é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPTç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410DSM PHARMACEUTICALS, INC.5900 MARTIN LUTHER KING JR HIGHWAY, GREENVILLE, NORTH CAROLINA 27834, USAUNITED STATES2012-06-18å°ç“¶è£;;é‡ç’è£é™„溶劑Enbrel 25mg powder and solvent for solution for injection詳見仿單。
衛署èŒç–«è¼¸å—第000850號2012-10-242007-10-24èŒã€€ç–«DHA01000085007æ©åšå‡æ™¶æ³¨å°„劑 25 毫克é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,例如methotrexate) ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。亦é©ç”¨æ–¼methotrexate治療無效或無法è€å—çš„4æ²ä»¥ä¸Šå…’ç«¥åŠé’少年的活動性多關節幼年型慢性關節炎。尚未å°4æ²ä»¥ä¸‹çš„兒童進行試驗。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate 或光化療法(PUVA) )無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之8æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚å‡æ™¶æ³¨å°„劑å°ç“¶è£;;é‡ç’è£é™„溶劑é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPTç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410VETTER PHARMA-FERTIGUNG GMBH & CO. KG (DILUENT)SCHUTZENSTRASSE 87 88212 RAVENSBURG, GERMANYGERMANY2012-06-18å°ç“¶è£;;é‡ç’è£é™„溶劑Enbrel 25mg powder and solvent for solution for injection詳見仿單。
衛署èŒç–«è¼¸å—第000851號2017-12-202007-12-20èŒã€€ç–«DHA01000085109æ©åšé‡ç’è£æ³¨å°„劑 25毫克é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,例如methotrexate) ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。亦é©ç”¨æ–¼methotrexate治療無效或無法è€å—çš„2æ²ä»¥ä¸Šå…’ç«¥åŠé’少年的活動性多關節幼年型慢性關節炎。尚未å°ä¸è¶³2æ²çš„兒童進行試驗。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate 或光化療法(PUVA) )無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之6æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚注射劑é å……å¼æ³¨å°„é‡ç’é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPTç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH PHARMACEUTICALSNEW LANE, HAVANT, HAMPSHIRE, PO9 2NG, UNITED KINGDOMUNITED KINGDOM2014-10-24é å……å¼æ³¨å°„é‡ç’Enbrel 25mg solution for injection in pre-filled syringe詳如仿單。
衛署èŒç–«è¼¸å—第000851號2017-12-202007-12-20èŒã€€ç–«DHA01000085109æ©åšé‡ç’è£æ³¨å°„劑 25毫克é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,例如methotrexate) ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。亦é©ç”¨æ–¼methotrexate治療無效或無法è€å—çš„2æ²ä»¥ä¸Šå…’ç«¥åŠé’少年的活動性多關節幼年型慢性關節炎。尚未å°ä¸è¶³2æ²çš„兒童進行試驗。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate 或光化療法(PUVA) )無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之6æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚注射劑é å……å¼æ³¨å°„é‡ç’é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPTç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410Pfizer Ireland PharmaceuticalsGrange Castle Business Park, Clondalkin, Dublin 22, IrelandIRELAND2014-10-24é å……å¼æ³¨å°„é‡ç’Enbrel 25mg solution for injection in pre-filled syringe詳如仿單。
衛署èŒç–«è¼¸å—第000855號2013-02-182008-02-18èŒã€€ç–«DHA01000085504宜ä¿åˆ©è¡€æ³¨å°„液 40000 å–®ä½/毫å‡æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者ã€æ²»ç™‚與癌症化å¸æ²»ç™‚有關的貧血。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN ALFA嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854CILAG AG.HOCHSTRASSE 201, CH-8205 SCHAFFHAUSEN SWITZERLANDSWITZERLAND2014-12-11å°ç“¶;;ç›’è£Eprex Injection 40000 IU/ml詳細用法用é‡è«‹åƒè¦‹ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000851號2017-12-202007-12-20èŒã€€ç–«DHA01000085109æ©åšé‡ç’è£æ³¨å°„劑 25毫克é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物(å³DMARDs,例如methotrexate) ç„¡é©ç•¶ç™‚效之æˆäººæ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚也é©ç”¨æ–¼å…ˆå‰æœªä½¿ç”¨methotrexate治療之æˆäººä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žã€‚這些病人的X光檢查顯示,本å“å¯ä»¥æ¸›ç·©ç–¾ç—…é€ æˆçš„關節çµæ§‹æ€§å—æ。亦é©ç”¨æ–¼methotrexate治療無效或無法è€å—çš„2æ²ä»¥ä¸Šå…’ç«¥åŠé’少年的活動性多關節幼年型慢性關節炎。尚未å°ä¸è¶³2æ²çš„兒童進行試驗。é©ç”¨æ–¼å°ç–¾ç—…緩解型抗風濕性藥物無療效之æˆäººæ´»å‹•æ€§èˆ‡é€²è¡Œæ€§ä¹¾ç™¬æ€§é—œç¯€ç‚Žã€‚治療活動性僵直性脊椎炎。é©ç”¨æ–¼å°å…¶ä»–全身性治療(包括cyclosporineã€methotrexate 或光化療法(PUVA) )無效ã€æœ‰ç¦å¿Œæˆ–無法è€å—之ä¸åº¦è‡³é‡åº¦ä¹¾ç™¬æˆäººæ‚£è€…。é©ç”¨æ–¼å°å…¶ä»–全身性治療或光化療法無法有效控制或無法è€å—之6æ²ä»¥ä¸Šå…’ç«¥åŠé’å°‘å¹´çš„é‡åº¦ä¹¾ç™¬ã€‚注射劑é å……å¼æ³¨å°„é‡ç’é™ç”±é†«å¸«ä½¿ç”¨ETANERCEPTç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410VETTER PHARMA - FERTIGUNG GMBH & CO. KGEisenbahnstrasse 2-4, 88085 Langenargen, GermanyGERMANY2014-10-24é å……å¼æ³¨å°„é‡ç’Enbrel 25mg solution for injection in pre-filled syringe詳如仿單。
衛署èŒç–«è¼¸å—第000852號2018-01-242008-01-24èŒã€€ç–«DHA01000085201ä»»æ·ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑 500 IU治療和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„注射é‡ç’è£æº¶æ¶²åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH FARMA, S.A.AUTOVIA DEL NORTE A1 KM 23 DESVIO ALGETE KM1 SAN SEBASTIAN DE LOS REYES 28700 MADRID, SPAINSPAIN2013-06-24å°ç“¶é™„注射é‡ç’è£æº¶æ¶²åŠè¼¸æ³¨å™¨Xyntha 500 IU詳如仿單。
衛署èŒç–«è¼¸å—第000852號2018-01-242008-01-24èŒã€€ç–«DHA01000085201ä»»æ·ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑 500 IU治療和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„注射é‡ç’è£æº¶æ¶²åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410VETTER PHARMA - FERTIGUNG GMBH & CO. KGSCHUTZENSTRAβE 87, 88212 RAVENSBURG, FEDERAL REPUBLIC OF GERMANYGERMANY2013-06-24å°ç“¶é™„注射é‡ç’è£æº¶æ¶²åŠè¼¸æ³¨å™¨Xyntha 500 IU詳如仿單。
衛署èŒç–«è¼¸å—第000853號2018-01-242008-01-24èŒã€€ç–«DHA01000085300ä»»æ·ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑 250 IU治療和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„注射é‡ç’è£æº¶æ¶²åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH FARMA, S.A.AUTOVIA DEL NORTE A1 KM 23 DESVIO ALGETE KM1 SAN SEBASTIAN DE LOS REYES 28700 MADRID, SPAINSPAIN2013-06-24å°ç“¶é™„注射é‡ç’è£æº¶æ¶²åŠè¼¸æ³¨å™¨Xyntha 250 IU詳如仿單。
衛署èŒç–«è¼¸å—第000853號2018-01-242008-01-24èŒã€€ç–«DHA01000085300ä»»æ·ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑 250 IU治療和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„注射é‡ç’è£æº¶æ¶²åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410VETTER PHARMA - FERTIGUNG GMBH & CO. KGSCHUTZENSTRAβE 87, 88212 RAVENSBURG, FEDERAL REPUBLIC OF GERMANYGERMANY2013-06-24å°ç“¶é™„注射é‡ç’è£æº¶æ¶²åŠè¼¸æ³¨å™¨Xyntha 250 IU詳如仿單。
衛署èŒç–«è¼¸å—第000854號2018-01-242008-01-24èŒã€€ç–«DHA01000085402ä»»æ·ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑 1000 IU治療和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„注射é‡ç’è£æº¶æ¶²åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH FARMA, S.A.AUTOVIA DEL NORTE A1 KM 23 DESVIO ALGETE KM1 SAN SEBASTIAN DE LOS REYES 28700 MADRID, SPAINSPAIN2013-05-07å°ç“¶é™„注射é‡ç’è£æº¶æ¶²åŠè¼¸æ³¨å™¨Xyntha 1000 IU詳如仿單。
衛署èŒç–«è¼¸å—第000854號2018-01-242008-01-24èŒã€€ç–«DHA01000085402ä»»æ·ç¬¬å…«å‡è¡€å› åå‡æ™¶æ³¨å°„劑 1000 IU治療和é 防Aåž‹è¡€å‹ç—…患者(先天性第八å‡è¡€å› å缺ä¹)的出血。å‡æ™¶æ³¨å°„劑å°ç“¶é™„注射é‡ç’è£æº¶æ¶²åŠè¼¸æ³¨å™¨é™ç”±é†«å¸«ä½¿ç”¨MOROCTOCOG Alfa;;0.9% SODIUM CHLORIDEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410VETTER PHARMA - FERTIGUNG GMBH & CO. KGSCHUTZENSTRAβE 87, 88212 RAVENSBURG, FEDERAL REPUBLIC OF GERMANYGERMANY2013-05-07å°ç“¶é™„注射é‡ç’è£æº¶æ¶²åŠè¼¸æ³¨å™¨Xyntha 1000 IU詳如仿單。
衛署èŒç–«è¼¸å—第000860號2013-08-192008-08-19èŒã€€ç–«DHA01000086000美血樂注射劑 50 微公克/毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH,GENMANY (PENZBERG SITE)NONNENWALD 2, D-82372 PENZBERG, GERMANYGERMANY2008-09-25å°ç“¶è£Mircera Solution for injection in Vial 50 mcg/ml詳見仿單。
衛署èŒç–«è¼¸å—第000899號2015-09-162010-09-16èŒã€€ç–«DHA01000089901優泌樂ç†-æ··åˆåž‹ 50 100å–®ä½/毫å‡ç³–尿病注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN LISPRO;;INSULIN LISPRO臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY FRANCE S.A.S.ZONE INDUSTRIELLE 2 RUE DU COLONEL LILLY 67640 FEGERSHEIM, FRANCEFRANCE2014-09-29注射ç†;;ç›’è£Humalog Mix 50 100U/ml KwikPen醫師é‡å°æ‚£è€…的需求決定劑é‡
衛署èŒç–«è¼¸å—第000856號2018-03-272008-03-27èŒã€€ç–«DHA01000085606ä¿è““TM人類乳çªç—…毒第16/18åž‹ç–«è‹—é©ç”¨æ–¼ç‚º10æ²è‡³25æ²çš„女性接種,藉以é 防致癌性人類乳çªç—…毒(HPV)第16型與第18型所引起的å¶ç™¼æ€§åŠæŒçºŒæ€§æ„ŸæŸ“ã€èˆ‡åå®®é ¸ä¸Šçš®å…§è´…ç˜¤ã€åŠç™Œå‰ç—…變,從而é 防åå®®é ¸ç™Œã€‚æ¤é …é©æ‡‰ç—‡çš„ä¾æ“šç‚º15-25æ²ä¹‹å¥³æ€§åœ¨æŽ¥ç¨®Cervarix後所呈ç¾ä¹‹é 防功效,以åŠæœ¬ç–«è‹—用於10-25æ²ä¹‹å¥³ç«¥åŠå©¦å¥³æ‰€ç”¢ç”Ÿä¹‹å…疫生æˆæ€§ã€‚懸浮注射劑é 充填型注射器附é‡é ;;å°ç“¶è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN;;HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEINè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸è‡ºåŒ—市æ¾å±±å€æ°‘生æ±è·¯ï¼“段156號8樓之1之2之3之5åŠä¹‹ï¼–86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE L'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19é 充填型注射器附é‡é ;;å°ç“¶è£;;ç›’è£Cervarix TM Human Papillomavirus vaccine Type 16 and 18 (Recombinant, AS04 adjuvanted)æœ¬è—¥é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨ã€‚æœ¬ç–«è‹—ä¹‹å»ºè°æŽ¥ç¨®æ™‚程為第0ã€1ã€6å€‹æœˆã€‚é›–ç„¶æŽ¥ç¨®è¿½åŠ åŠ‘é‡çš„å¿…è¦æ€§å°šæœªç¢ºç«‹ã€‚但曾在施打一劑刺激劑é‡(challenge dose)之後觀察到出ç¾å…疫記憶å應(anamnestic response)çš„ç¾è±¡(åƒè¦‹è—¥æ•ˆå¸)。建è°ç¬¬ä¸€åŠ‘接種Cervarix的人應以Cervarix完æˆ3劑的接種程åº(åƒè¦‹è¦èªž)。Cervarix應以肌肉注射的方å¼æ–½æ‰“於上臂三角肌部ä½ã€‚
衛署èŒç–«è¼¸å—第000857號2018-04-292008-04-29èŒã€€ç–«DHA01000085708å„ªçŒ›èŒ æ³¨å°„åŠ‘ 12 毫克å°è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æˆ–功能ä¸å…¨é€ æˆçš„生長åœé “ã€Turner症候群和æˆäººåž‹ç”Ÿé•·æ¿€ç´ 缺ä¹ç—‡ã€ä½Žå‡ºç”Ÿé«”é‡å…’(Small for Gestational Age, SGA)逾四æ²è€…之生長障礙ã€SHOX缺ä¹ç—‡ã€‚注射劑å°ç“¶è£;;支è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨SOMATROPIN (BIOSYNTHETIC HUMAN GROWTH HORMONE)å°ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803CATALENT BELGIUM S.A.FONT SAINT LANDRY, 10 1120 BRUSSELS, BELGIUMBELGIUM2014-06-20å°ç“¶è£;;支è£;;ç›’è£Humatrope for injection 12 mgHumatrope用法用é‡é‡å°ä¸åŒç—…人而有差異。請åƒé–±èªªæ˜Žæ›¸ã€‚
衛署èŒç–«è¼¸å—第000857號2018-04-292008-04-29èŒã€€ç–«DHA01000085708å„ªçŒ›èŒ æ³¨å°„åŠ‘ 12 毫克å°è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æˆ–功能ä¸å…¨é€ æˆçš„生長åœé “ã€Turner症候群和æˆäººåž‹ç”Ÿé•·æ¿€ç´ 缺ä¹ç—‡ã€ä½Žå‡ºç”Ÿé«”é‡å…’(Small for Gestational Age, SGA)逾四æ²è€…之生長障礙ã€SHOX缺ä¹ç—‡ã€‚注射劑å°ç“¶è£;;支è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨SOMATROPIN (BIOSYNTHETIC HUMAN GROWTH HORMONE)å°ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY FRANCE2 RUE DU COLONEL LILLY 67640 FEGERSHEIM, FRANCEFRANCE2014-06-20å°ç“¶è£;;支è£;;ç›’è£Humatrope for injection 12 mgHumatrope用法用é‡é‡å°ä¸åŒç—…人而有差異。請åƒé–±èªªæ˜Žæ›¸ã€‚
衛署èŒç–«è¼¸å—第000858號2013-08-192008-08-19èŒã€€ç–«DHA01000085800美血樂注射劑 1000 微公克/毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.GRENZACHERSTRASSE 124 CH-4070 BASLE,SWITZERLANDSWITZERLAND2008-09-25å°ç“¶è£Mircera Solution for injection in Vial 1000 mcg/ml詳見仿單。
衛署èŒç–«è¼¸å—第000858號2013-08-192008-08-19èŒã€€ç–«DHA01000085800美血樂注射劑 1000 微公克/毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH,GENMANY (PENZBERG SITE)NONNENWALD 2, D-82372 PENZBERG, GERMANYGERMANY2008-09-25å°ç“¶è£Mircera Solution for injection in Vial 1000 mcg/ml詳見仿單。
衛署èŒç–«è¼¸å—第000859號2013-08-192008-08-19èŒã€€ç–«DHA01000085902美血樂注射劑 200 微公克/毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.GRENZACHERSTRASSE 124 CH-4070 BASLE,SWITZERLANDSWITZERLAND2008-09-25å°ç“¶è£Mircera Solution for injection in Vial 200 mcg/ml詳見仿單。
衛署èŒç–«è¼¸å—第000859號2013-08-192008-08-19èŒã€€ç–«DHA01000085902美血樂注射劑 200 微公克/毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH,GENMANY (PENZBERG SITE)NONNENWALD 2, D-82372 PENZBERG, GERMANYGERMANY2008-09-25å°ç“¶è£Mircera Solution for injection in Vial 200 mcg/ml詳見仿單。
衛署èŒç–«è¼¸å—第000860號2013-08-192008-08-19èŒã€€ç–«DHA01000086000美血樂注射劑 50 微公克/毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.GRENZACHERSTRASSE 124 CH-4070 BASLE,SWITZERLANDSWITZERLAND2008-09-25å°ç“¶è£Mircera Solution for injection in Vial 50 mcg/ml詳見仿單。
衛署èŒç–«è¼¸å—第000880號2014-06-022009-06-02èŒã€€ç–«DHA01000088003è€è¡€æ¯”注射劑 10æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD.1-6-1 OHTEMACHI, CHIYODA-KU, TOKYO, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 10 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000861號2013-08-192008-08-19èŒã€€ç–«DHA01000086102美血樂注射劑 300 微公克/毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.GRENZACHERSTRASSE 124 CH-4070 BASLE,SWITZERLANDSWITZERLAND2008-09-25å°ç“¶è£Mircera Solution for injection in Vial 300 mcg/ml詳見仿單。
衛署èŒç–«è¼¸å—第000861號2013-08-192008-08-19èŒã€€ç–«DHA01000086102美血樂注射劑 300 微公克/毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH,GENMANY (PENZBERG SITE)NONNENWALD 2, D-82372 PENZBERG, GERMANYGERMANY2008-09-25å°ç“¶è£Mircera Solution for injection in Vial 300 mcg/ml詳見仿單。
衛署èŒç–«è¼¸å—第000862號2013-08-192008-08-19èŒã€€ç–«DHA01000086201美血樂注射劑 100 微公克/毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.GRENZACHERSTRASSE 124 CH-4070 BASLE,SWITZERLANDSWITZERLAND2008-09-25å°ç“¶è£Mircera Solution for injection in Vial 100 mcg/ml詳見仿單。
衛署èŒç–«è¼¸å—第000862號2013-08-192008-08-19èŒã€€ç–«DHA01000086201美血樂注射劑 100 微公克/毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH,GENMANY (PENZBERG SITE)NONNENWALD 2, D-82372 PENZBERG, GERMANYGERMANY2008-09-25å°ç“¶è£Mircera Solution for injection in Vial 100 mcg/ml詳見仿單。
衛署èŒç–«è¼¸å—第000863號2018-08-192008-08-19èŒã€€ç–«DHA01000086303美血樂é‡ç’è£æ³¨å°„劑 200 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 200 mcg/0.3ml詳見仿單。
衛署èŒç–«è¼¸å—第000863號2018-08-192008-08-19èŒã€€ç–«DHA01000086303美血樂é‡ç’è£æ³¨å°„劑 200 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH,GENMANY (PENZBERG SITE)NONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 200 mcg/0.3ml詳見仿單。
衛署èŒç–«è¼¸å—第000864號2018-08-192008-08-19èŒã€€ç–«DHA01000086405美血樂é‡ç’è£æ³¨å°„劑 250 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 250 mcg/0.3ml詳見仿單。
衛署èŒç–«è¼¸å—第000864號2018-08-192008-08-19èŒã€€ç–«DHA01000086405美血樂é‡ç’è£æ³¨å°„劑 250 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH,GENMANY (PENZBERG SITE)NONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 250 mcg/0.3ml詳見仿單。
衛署èŒç–«è¼¸å—第000865號2018-08-192008-08-19èŒã€€ç–«DHA01000086507美血樂é‡ç’è£æ³¨å°„劑 150 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 150 mcg/0.3ml詳見仿單。
衛署èŒç–«è¼¸å—第000865號2018-08-192008-08-19èŒã€€ç–«DHA01000086507美血樂é‡ç’è£æ³¨å°„劑 150 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH,GENMANY (PENZBERG SITE)NONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 150 mcg/0.3ml詳見仿單。
衛署èŒç–«è¼¸å—第000866號2013-08-192008-08-19èŒã€€ç–«DHA01000086609美血樂é‡ç’è£æ³¨å°„劑 800 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 800 mcg/0.6ml詳見仿單。
衛署èŒç–«è¼¸å—第000866號2013-08-192008-08-19èŒã€€ç–«DHA01000086609美血樂é‡ç’è£æ³¨å°„劑 800 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH,GENMANY (PENZBERG SITE)NONNENWALD 2, D-82372 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 800 mcg/0.6ml詳見仿單。
衛署èŒç–«è¼¸å—第000867號2018-08-192008-08-19èŒã€€ç–«DHA01000086701美血樂é‡ç’è£æ³¨å°„劑 75 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 75 mcg/0.3ml詳見仿單。
衛署èŒç–«è¼¸å—第000867號2018-08-192008-08-19èŒã€€ç–«DHA01000086701美血樂é‡ç’è£æ³¨å°„劑 75 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH,GENMANY (PENZBERG SITE)NONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 75 mcg/0.3ml詳見仿單。
衛署èŒç–«è¼¸å—第000868號2018-08-192008-08-19èŒã€€ç–«DHA01000086800美血樂é‡ç’è£æ³¨å°„劑 50 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116, D-68305 MANNHEIM, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 50 mcg/0.3ml詳見仿單。
衛署èŒç–«è¼¸å—第000868號2018-08-192008-08-19èŒã€€ç–«DHA01000086800美血樂é‡ç’è£æ³¨å°„劑 50 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH,GENMANY (PENZBERG SITE)NONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 50 mcg/0.3ml詳見仿單。
衛署èŒç–«è¼¸å—第000869號2018-08-192008-08-19èŒã€€ç–«DHA01000086902美血樂é‡ç’è£æ³¨å°„劑 100 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 100 mcg/0.3ml詳見仿單。
衛署èŒç–«è¼¸å—第000869號2018-08-192008-08-19èŒã€€ç–«DHA01000086902美血樂é‡ç’è£æ³¨å°„劑 100 微公克/0.3毫å‡æ²»ç™‚慢性腎病所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸ç™‚法引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH,GENMANY (PENZBERG SITE)NONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 100 mcg/0.3ml詳見仿單。
衛署èŒç–«è¼¸å—第000870號2018-09-102008-09-10èŒã€€ç–«DHA01000087000儷緻注射劑眼瞼痙攣ã€åŠé‚Šé¡é¢ç—™æ”£ã€ç—™æ”£æ€§æ–œé ¸ã€å°å…’腦性麻痺引起之肌肉痙攣ã€æˆäººä¸é¢¨å¾Œä¹‹æ‰‹è‡‚痙攣ã€çšºçœ‰ç´‹åŠè…‹çª©å¤šæ±—症。å‡æ™¶æ³¨å°„劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨CLOSTRIDIUM BOTULINUM TYPE A TOXIN-HAEMAGGLUTININ COMPLEX法商益普生股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯äºŒæ®µ81號4樓之427230363IPSEN BIOPHARM LIMITEDASH ROAD, WREXHAM INDUSTRIAL ESTATE, WREXHAM, CLWYD,LL 13 9UF, UKUNITED KINGDOM2014-11-07å°ç“¶è£Dysport, Powder for Injection用法用é‡ä¾æ³¨å°„部ä½ã€è‡¨åºŠå€‹é«”å應åŠé©æ‡‰ç—‡è€Œç•°ã€‚詳細請åƒè¦‹ä»¿å–®ã€‚æˆäººä¸é¢¨å¾Œä¹‹æ‰‹è‡‚痙攣:建è°åŠ‘é‡ç‚º1000å–®ä½ï¼Œè‚Œè‚‰æ³¨å°„於:屈指深肌(FDP), 屈指淺肌(FDS), å°ºå´å±ˆè…•è‚Œ(FCU), 橈å´å±ˆè…•è‚Œ(FCR)åŠè‚±äºŒé è‚Œ(BB)。å°å…’腦性麻痺引起之肌肉痙攣:肌肉注射,æ¯å…¬æ–¤é«”é‡10å–®ä½å’Œ30å–®ä½ç‰åˆ†ç‚ºå…©å´å°è…¿åŸºä¹‹é–“。最大å£é‡ä¸å¾—超éŽæ¯ä½ç—…æ‚£1000å–®ä½ã€‚ç—™æ”£æ€§æ–œé ¸ï¼šè‚Œè‚‰æ³¨å°„ï¼Œå»ºè°åŠ‘é‡ç‚º250~1000å–®ä½ã€‚眼瞼痙攣åŠåŠé‚Šé¡é¢ç—™æ”£ï¼šåˆå§‹åŠ‘é‡ç‚ºæ¯çœ¼å„120å–®ä½ã€‚之後,å¯é€æ¥æ¸›è‡³60å–®ä½ã€‚
衛署èŒç–«è¼¸å—第000871號2018-10-212008-10-21èŒã€€ç–«DHA01000087102ç®æ ¼è¥¿æ–½é‡ç’è£æ³¨å°„劑 135 微公克/0.5 毫å‡æ²»ç™‚慢性Båž‹è‚炎:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚ç¡¬åŒ–ç—…äººï¼Œä½©æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性ã€æœ‰ç—…毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚炎;治療慢性Cåž‹è‚炎:單ç¨æˆ–åˆä½µribavirinä½¿ç”¨çš„ä½©æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303 KAISERAUGST, SWITZERLANDSWITZERLAND2014-05-06注射é‡ç’;;ç›’è£Pegasys pre-filled syringes 135 mcg/0.5 ml詳見仿單。
衛署èŒç–«è¼¸å—第000871號2018-10-212008-10-21èŒã€€ç–«DHA01000087102ç®æ ¼è¥¿æ–½é‡ç’è£æ³¨å°„劑 135 微公克/0.5 毫å‡æ²»ç™‚慢性Båž‹è‚炎:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚ç¡¬åŒ–ç—…äººï¼Œä½©æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性ã€æœ‰ç—…毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚炎;治療慢性Cåž‹è‚炎:單ç¨æˆ–åˆä½µribavirinä½¿ç”¨çš„ä½©æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116, D-68305 MANNHEIM GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Pegasys pre-filled syringes 135 mcg/0.5 ml詳見仿單。
衛署èŒç–«è¼¸å—第000871號2018-10-212008-10-21èŒã€€ç–«DHA01000087102ç®æ ¼è¥¿æ–½é‡ç’è£æ³¨å°„劑 135 微公克/0.5 毫å‡æ²»ç™‚慢性Båž‹è‚炎:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚ç¡¬åŒ–ç—…äººï¼Œä½©æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性ã€æœ‰ç—…毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚炎;治療慢性Cåž‹è‚炎:單ç¨æˆ–åˆä½µribavirinä½¿ç”¨çš„ä½©æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Pegasys pre-filled syringes 135 mcg/0.5 ml詳見仿單。
衛署èŒç–«è¼¸å—第000872號2018-10-212008-10-21èŒã€€ç–«DHA01000087204ç®æ ¼è¥¿æ–½é‡ç’è£æ³¨å°„劑 180 微公克/0.5 毫å‡æ²»ç™‚慢性Båž‹è‚炎:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚ç¡¬åŒ–ç—…äººï¼Œä½©æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性ã€æœ‰ç—…毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚炎;治療慢性Cåž‹è‚炎:單ç¨æˆ–åˆä½µribavirinä½¿ç”¨çš„ä½©æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303 KAISERAUGST, SWITZERLANDSWITZERLAND2014-05-06注射é‡ç’;;ç›’è£Pegasys pre-filled syringes 180 mcg/0.5 ml詳見仿單。
衛署èŒç–«è¼¸å—第000872號2018-10-212008-10-21èŒã€€ç–«DHA01000087204ç®æ ¼è¥¿æ–½é‡ç’è£æ³¨å°„劑 180 微公克/0.5 毫å‡æ²»ç™‚慢性Båž‹è‚炎:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚ç¡¬åŒ–ç—…äººï¼Œä½©æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性ã€æœ‰ç—…毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚炎;治療慢性Cåž‹è‚炎:單ç¨æˆ–åˆä½µribavirinä½¿ç”¨çš„ä½©æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116, D-68305 MANNHEIM GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Pegasys pre-filled syringes 180 mcg/0.5 ml詳見仿單。
衛署èŒç–«è¼¸å—第000872號2018-10-212008-10-21èŒã€€ç–«DHA01000087204ç®æ ¼è¥¿æ–½é‡ç’è£æ³¨å°„劑 180 微公克/0.5 毫å‡æ²»ç™‚慢性Båž‹è‚炎:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚ç¡¬åŒ–ç—…äººï¼Œä½©æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性ã€æœ‰ç—…毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚炎;治療慢性Cåž‹è‚炎:單ç¨æˆ–åˆä½µribavirinä½¿ç”¨çš„ä½©æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Pegasys pre-filled syringes 180 mcg/0.5 ml詳見仿單。
衛署èŒç–«è¼¸å—第000873號2018-12-152008-12-15èŒã€€ç–«DHA01000087306ä¼å¸¶ç–¹ 活性帶狀疱疹疫苗é 防50~79æ²ä¹‹æˆäººå¸¶ç‹€ç–±ç–¹ã€‚å‡æ™¶ä¹¾ç²‰æ³¨å°„劑å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨(PLAQUE-FORMING UNITS) OF OKA/MERCK STRAIN OF VZV美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME B.V.WAARDERWEG 39,2031 BN HAARLEM,THE NETHERLANDSNETHERLANDS2013-12-17å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£ZOSTAVAX [zoster virus vaccine live (Oka/Merck), MSD]åƒè€ƒä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000873號2018-12-152008-12-15èŒã€€ç–«DHA01000087306ä¼å¸¶ç–¹ 活性帶狀疱疹疫苗é 防50~79æ²ä¹‹æˆäººå¸¶ç‹€ç–±ç–¹ã€‚å‡æ™¶ä¹¾ç²‰æ³¨å°„劑å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨(PLAQUE-FORMING UNITS) OF OKA/MERCK STRAIN OF VZV美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME CORP.770 SUMNEYTOWN PIKE, WEST POINT, PA 19486, U.S.A.UNITED STATES2013-12-17å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£ZOSTAVAX [zoster virus vaccine live (Oka/Merck), MSD]åƒè€ƒä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000873號2018-12-152008-12-15èŒã€€ç–«DHA01000087306ä¼å¸¶ç–¹ 活性帶狀疱疹疫苗é 防50~79æ²ä¹‹æˆäººå¸¶ç‹€ç–±ç–¹ã€‚å‡æ™¶ä¹¾ç²‰æ³¨å°„劑å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨(PLAQUE-FORMING UNITS) OF OKA/MERCK STRAIN OF VZV美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720Jubilant HollisterStier LLC (Small Volume Parenteral Facilities)3525 NORTH REGAL STREET SPOKANE, WA 99207, USAUNITED STATES2013-12-17å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£ZOSTAVAX [zoster virus vaccine live (Oka/Merck), MSD]åƒè€ƒä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000881號2014-06-022009-06-02èŒã€€ç–«DHA01000088105è€è¡€æ¯”注射劑 15æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780Teva Pharma Japan Inc. Takayama Plant1040-22 MATSUNOKI-CHO, TAKAYAMA-SHI, GIFU, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 15 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000873號2018-12-152008-12-15èŒã€€ç–«DHA01000087306ä¼å¸¶ç–¹ 活性帶狀疱疹疫苗é 防50~79æ²ä¹‹æˆäººå¸¶ç‹€ç–±ç–¹ã€‚å‡æ™¶ä¹¾ç²‰æ³¨å°„劑å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨(PLAQUE-FORMING UNITS) OF OKA/MERCK STRAIN OF VZV美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720VETTER PHARMA-FERTIGUNG GMBH & CO. KGSCHUTZENSTRASSE 87, D-88212 RAVENSBURG, GERMANYGERMANY2013-12-17å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£ZOSTAVAX [zoster virus vaccine live (Oka/Merck), MSD]åƒè€ƒä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000874號2019-01-192009-01-19èŒã€€ç–«DHA01000087408癌æ€åœ 注射劑 (ç‘žå£«å» )é©æ‡‰ç—‡è®Šæ›´1. 轉移性大腸直腸癌(mCRC)Avastin(Bevacizumab)與å«æœ‰irinotecan/5-fluorouracil/Leucovorin或5-fluorouracil/Leucovorin 之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºè½‰ç§»æ€§å¤§è…¸æˆ–直腸癌患者之第一線治療。Avastin與å«æœ‰5-fluorouracil/Leucovorin/Oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºå…ˆå‰æŽ¥å—éŽä»¥Fluoropyrimidine為基礎之化å¸ç™‚法無效且未曾接å—éŽAvastin治療之轉移性大腸或直腸癌患者之治療。Avastin與å«æœ‰Fluoropyrimidine-oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç¬¬ä¸€ç·šå·²æŽ¥å—éŽAvastin併用Fluoropyrimidine-irinotecan為基礎之化療後惡化之轉移性大腸或直腸癌患者之第二線治療。2. 轉移性乳癌(mBC)Avastin與Paclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºHER2 (-)轉移性乳癌患者之第一線治療。3. æƒ¡æ€§ç¥žç¶“è† è³ªç˜¤(WHO第4ç´š) - ç¥žç¶“è† æ¯ç´°èƒžç˜¤Avastin å–®ç¨ä½¿ç”¨å¯ç”¨æ–¼æ²»ç™‚曾接å—標準放射線治療且å«Temozolomide 在內之化å¸è—¥ç‰©æ²»ç™‚å¤±æ•—ä¹‹å¤šåž‹æ€§ç¥žç¶“è† æ¯ç´°èƒžç˜¤(Glioblastoma Multiforme)復發之æˆäººæ‚£è€…。4. 晚期ã€è½‰ç§»æ€§æˆ–復發性éžé±—ç‹€éžå°ç´°èƒžè‚ºç™Œ(NSCLC)Avastin與CarbolatinåŠPaclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç„¡æ³•åˆ‡é™¤ä¹‹æ™šæœŸã€è½‰ç§»æ€§æˆ–復發性éžå°ç´°èƒžè‚ºç™Œæ‚£è€…之第一線治療。注射劑å°ç“¶è£;;å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨BEVACIZUMABç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F. HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303 KAISERAUGST, SWITZERLANDSWITZERLAND2014-05-06å°ç“¶è£;;å°ç“¶è£;;ç›’è£Avastin Injection詳見仿單內文
衛署èŒç–«è¼¸å—第000874號2019-01-192009-01-19èŒã€€ç–«DHA01000087408癌æ€åœ 注射劑 (ç‘žå£«å» )é©æ‡‰ç—‡è®Šæ›´1. 轉移性大腸直腸癌(mCRC)Avastin(Bevacizumab)與å«æœ‰irinotecan/5-fluorouracil/Leucovorin或5-fluorouracil/Leucovorin 之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºè½‰ç§»æ€§å¤§è…¸æˆ–直腸癌患者之第一線治療。Avastin與å«æœ‰5-fluorouracil/Leucovorin/Oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºå…ˆå‰æŽ¥å—éŽä»¥Fluoropyrimidine為基礎之化å¸ç™‚法無效且未曾接å—éŽAvastin治療之轉移性大腸或直腸癌患者之治療。Avastin與å«æœ‰Fluoropyrimidine-oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç¬¬ä¸€ç·šå·²æŽ¥å—éŽAvastin併用Fluoropyrimidine-irinotecan為基礎之化療後惡化之轉移性大腸或直腸癌患者之第二線治療。2. 轉移性乳癌(mBC)Avastin與Paclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºHER2 (-)轉移性乳癌患者之第一線治療。3. æƒ¡æ€§ç¥žç¶“è† è³ªç˜¤(WHO第4ç´š) - ç¥žç¶“è† æ¯ç´°èƒžç˜¤Avastin å–®ç¨ä½¿ç”¨å¯ç”¨æ–¼æ²»ç™‚曾接å—標準放射線治療且å«Temozolomide 在內之化å¸è—¥ç‰©æ²»ç™‚å¤±æ•—ä¹‹å¤šåž‹æ€§ç¥žç¶“è† æ¯ç´°èƒžç˜¤(Glioblastoma Multiforme)復發之æˆäººæ‚£è€…。4. 晚期ã€è½‰ç§»æ€§æˆ–復發性éžé±—ç‹€éžå°ç´°èƒžè‚ºç™Œ(NSCLC)Avastin與CarbolatinåŠPaclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç„¡æ³•åˆ‡é™¤ä¹‹æ™šæœŸã€è½‰ç§»æ€§æˆ–復發性éžå°ç´°èƒžè‚ºç™Œæ‚£è€…之第一線治療。注射劑å°ç“¶è£;;å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨BEVACIZUMABç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F. HOFFMANN-LA ROCHE LTD.GRENZACHERSTRASSE 124, CH-4070 BASEL, SWITZERLANDSWITZERLAND2014-05-06å°ç“¶è£;;å°ç“¶è£;;ç›’è£Avastin Injection詳見仿單內文
衛署èŒç–«è¼¸å—第000874號2019-01-192009-01-19èŒã€€ç–«DHA01000087408癌æ€åœ 注射劑 (ç‘žå£«å» )é©æ‡‰ç—‡è®Šæ›´1. 轉移性大腸直腸癌(mCRC)Avastin(Bevacizumab)與å«æœ‰irinotecan/5-fluorouracil/Leucovorin或5-fluorouracil/Leucovorin 之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºè½‰ç§»æ€§å¤§è…¸æˆ–直腸癌患者之第一線治療。Avastin與å«æœ‰5-fluorouracil/Leucovorin/Oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºå…ˆå‰æŽ¥å—éŽä»¥Fluoropyrimidine為基礎之化å¸ç™‚法無效且未曾接å—éŽAvastin治療之轉移性大腸或直腸癌患者之治療。Avastin與å«æœ‰Fluoropyrimidine-oxaliplatin之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç¬¬ä¸€ç·šå·²æŽ¥å—éŽAvastin併用Fluoropyrimidine-irinotecan為基礎之化療後惡化之轉移性大腸或直腸癌患者之第二線治療。2. 轉移性乳癌(mBC)Avastin與Paclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºHER2 (-)轉移性乳癌患者之第一線治療。3. æƒ¡æ€§ç¥žç¶“è† è³ªç˜¤(WHO第4ç´š) - ç¥žç¶“è† æ¯ç´°èƒžç˜¤Avastin å–®ç¨ä½¿ç”¨å¯ç”¨æ–¼æ²»ç™‚曾接å—標準放射線治療且å«Temozolomide 在內之化å¸è—¥ç‰©æ²»ç™‚å¤±æ•—ä¹‹å¤šåž‹æ€§ç¥žç¶“è† æ¯ç´°èƒžç˜¤(Glioblastoma Multiforme)復發之æˆäººæ‚£è€…。4. 晚期ã€è½‰ç§»æ€§æˆ–復發性éžé±—ç‹€éžå°ç´°èƒžè‚ºç™Œ(NSCLC)Avastin與CarbolatinåŠPaclitaxelåˆä½µä½¿ç”¨ï¼Œå¯ä½œç‚ºç„¡æ³•åˆ‡é™¤ä¹‹æ™šæœŸã€è½‰ç§»æ€§æˆ–復發性éžå°ç´°èƒžè‚ºç™Œæ‚£è€…之第一線治療。注射劑å°ç“¶è£;;å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨BEVACIZUMABç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467GENENTECH, INC.1 ANTIBODY WAY, OCEANSIDE, CA 92056, USAUNITED STATES2014-05-06å°ç“¶è£;;å°ç“¶è£;;ç›’è£Avastin Injection詳見仿單內文
衛署èŒç–«è¼¸å—第000875號2019-02-262009-02-26èŒã€€ç–«DHA01000087500容å¯æ›¼é‡ç’è£æ³¨å°„劑 5000 åœ‹éš›å–®ä½ (德國ç¶ç‰¹å» )治療慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ (low grade non-Hodgkin's lymphoma) 或慢性淋巴性白血病 (chronic lymphocytic leukemia) æˆäººæ‚£è€…的症狀性貧血。注射劑é‡ç’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F. HOFFMANN-LA ROCHE LTD.GRENZACHERSTRASSE 124, CH-4070 BASEL, SWITZERLANDSWITZERLAND2014-05-06é‡ç’è£;;ç›’è£Recormon solution for injection in pre-filled syringe 5000IU詳見仿單。
衛署èŒç–«è¼¸å—第000875號2019-02-262009-02-26èŒã€€ç–«DHA01000087500容å¯æ›¼é‡ç’è£æ³¨å°„劑 5000 åœ‹éš›å–®ä½ (德國ç¶ç‰¹å» )治療慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ (low grade non-Hodgkin's lymphoma) 或慢性淋巴性白血病 (chronic lymphocytic leukemia) æˆäººæ‚£è€…的症狀性貧血。注射劑é‡ç’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06é‡ç’è£;;ç›’è£Recormon solution for injection in pre-filled syringe 5000IU詳見仿單。
衛署èŒç–«è¼¸å—第000875號2019-02-262009-02-26èŒã€€ç–«DHA01000087500容å¯æ›¼é‡ç’è£æ³¨å°„劑 5000 åœ‹éš›å–®ä½ (德國ç¶ç‰¹å» )治療慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ (low grade non-Hodgkin's lymphoma) 或慢性淋巴性白血病 (chronic lymphocytic leukemia) æˆäººæ‚£è€…的症狀性貧血。注射劑é‡ç’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467VETTER PHARMA-FERTIGUNG GMBH & CO. KGSCHUTZENSTRASSE 87 AND 99/101, D-88212 RAVENSBURG, GERMANYGERMANY2014-05-06é‡ç’è£;;ç›’è£Recormon solution for injection in pre-filled syringe 5000IU詳見仿單。
衛署èŒç–«è¼¸å—第000875號2019-02-262009-02-26èŒã€€ç–«DHA01000087500容å¯æ›¼é‡ç’è£æ³¨å°„劑 5000 åœ‹éš›å–®ä½ (德國ç¶ç‰¹å» )治療慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ (low grade non-Hodgkin's lymphoma) 或慢性淋巴性白血病 (chronic lymphocytic leukemia) æˆäººæ‚£è€…的症狀性貧血。注射劑é‡ç’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH, GERMANY (PENZBERG SITE)NONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06é‡ç’è£;;ç›’è£Recormon solution for injection in pre-filled syringe 5000IU詳見仿單。
衛署èŒç–«è¼¸å—第000876號2019-02-262009-02-26èŒã€€ç–«DHA01000087602容å¯æ›¼é‡ç’è£æ³¨å°„劑 2000 國際單ä½"德國ç¶ç‰¹å» "治療慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—腫瘤治療之多發性骨髓瘤 (multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ (low grade non-Hodgkin's lymphoma) 或慢性淋巴性白血病 (chronic lymphocytic leukemia) æˆäººæ‚£è€…的症狀性貧血。注射劑é‡ç’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.GRENZACHERSTRASSE 124 CH-4070 BASEL,SWITZERLANDSWITZERLAND2014-05-06é‡ç’è£;;ç›’è£Recormon solution for injection in pre-filled syringe 2000IU詳見仿單。
衛署èŒç–«è¼¸å—第000876號2019-02-262009-02-26èŒã€€ç–«DHA01000087602容å¯æ›¼é‡ç’è£æ³¨å°„劑 2000 國際單ä½"德國ç¶ç‰¹å» "治療慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—腫瘤治療之多發性骨髓瘤 (multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ (low grade non-Hodgkin's lymphoma) 或慢性淋巴性白血病 (chronic lymphocytic leukemia) æˆäººæ‚£è€…的症狀性貧血。注射劑é‡ç’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06é‡ç’è£;;ç›’è£Recormon solution for injection in pre-filled syringe 2000IU詳見仿單。
衛署èŒç–«è¼¸å—第000876號2019-02-262009-02-26èŒã€€ç–«DHA01000087602容å¯æ›¼é‡ç’è£æ³¨å°„劑 2000 國際單ä½"德國ç¶ç‰¹å» "治療慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—腫瘤治療之多發性骨髓瘤 (multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ (low grade non-Hodgkin's lymphoma) 或慢性淋巴性白血病 (chronic lymphocytic leukemia) æˆäººæ‚£è€…的症狀性貧血。注射劑é‡ç’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467VETTER PHARMA-FERTIGUNG GMBH & CO. KGSCHUTZENSTRASSE 87 AND 99/101, D-88212 RAVENSBURG, GERMANYGERMANY2014-05-06é‡ç’è£;;ç›’è£Recormon solution for injection in pre-filled syringe 2000IU詳見仿單。
衛署èŒç–«è¼¸å—第000876號2019-02-262009-02-26èŒã€€ç–«DHA01000087602容å¯æ›¼é‡ç’è£æ³¨å°„劑 2000 國際單ä½"德國ç¶ç‰¹å» "治療慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—腫瘤治療之多發性骨髓瘤 (multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ (low grade non-Hodgkin's lymphoma) 或慢性淋巴性白血病 (chronic lymphocytic leukemia) æˆäººæ‚£è€…的症狀性貧血。注射劑é‡ç’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH, GERMANY (PENZBERG SITE)NONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06é‡ç’è£;;ç›’è£Recormon solution for injection in pre-filled syringe 2000IU詳見仿單。
衛署èŒç–«è¼¸å—第000908號2016-01-122011-01-12èŒã€€ç–«DHA01000090802諾和密斯50諾易ç†ç³–尿病注射劑支è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN ASPART臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SHALLAS ALLE, DK-4400 KALUNDBORG, DENMARKDENMARK2014-05-16支è£NovoMix 50 FlexPenè©³è¦‹ç¶“è¡›ç”Ÿç½²æ ¸å‡†ä¹‹ä»¿å–®
衛署èŒç–«è¼¸å—第000877號2019-03-112009-03-11èŒã€€ç–«DHA01000087701爾必得舒 注射液 5 毫克/毫å‡Erbitux與FOLFIRI(Folinic acid/5-FU/Irinotecan)åˆä½µä½¿ç”¨æ–¼æ²»ç™‚å…·è¡¨çš®ç”Ÿé•·å› åå—體表ç¾åž‹(EGFR expressing),KRAS原生型(wild-type)之轉移性直腸çµè…¸ç™Œç—…患之第一線治療。Erbitux與放射線療法åˆä½µä½¿ç”¨ï¼Œæ²»ç™‚局部晚期之å£å’½ç™Œã€ä¸‹å’½ç™ŒåŠå–‰ç™Œæ‚£è€…。Erbitux與內å«platinum類之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œæ²»ç™‚復發åŠ/或轉移性é é ¸éƒ¨é±—ç‹€ç´°èƒžç™Œæ‚£è€…ã€‚æ³¨å°„åŠ‘å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨CETUXIMAB, CHIMERIC ANTIBODYå°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610BOEHRINGER INGELHEIM Pharma GmbH & Co.KGBIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS. GERMANYGERMANY2014-11-13å°ç“¶è£;;ç›’è£Erbitux 5mg/ml Solution for infusion病患第一次輸注å‰ï¼Œä¸€å®šè¦å…ˆçµ¦äºˆæŠ—組織胺藥劑。並建è°ä¹‹å¾Œçš„æ¯ä¸€æ¬¡æ³¨å°„都è¦å…ˆçµ¦äºˆæŠ—組織胺藥劑。在治療, Erbitux為一星期輸注一次, 起始劑é‡æ˜¯æ¯å¹³æ–¹å…¬å°ºèº«é«”表é¢ç© 400 毫克(400mg/m2)建è°çš„輸注時間是120分é˜ã€‚之後æ¯ä¸€æ˜ŸæœŸçš„劑é‡æ˜¯æ¯å¹³æ–¹å…¬å°ºèº«é«”é¢ç© 250 毫克(250mg/m2) 建è°çš„輸注時間是60分é˜ã€‚Erbitux最快的輸注速率ä¸èƒ½è¶…éŽ 10 毫克/分。直腸çµè…¸ç™Œï¼šErbitux與irinotecanåˆä½µä½¿ç”¨, 治療轉移直腸çµè…¸ç™Œæ‚£è€…。åˆç”¨irinotecan的劑é‡ï¼Œè«‹åƒé–±irinotecan的產å“資料。一般狀æ³ä¸‹, 併用irinotecan的治療劑é‡, å¯æŠ•äºˆèˆ‡æœ€è¿‘治療療程相åŒåŠ‘é‡çš„irinotecanã€‚å¿…é ˆåœ¨è¼¸æ³¨Erbitux一å°æ™‚之後,æ‰èƒ½çµ¦äºˆã€‚建è°æŒçºŒErbitux治療直到病情惡化。å£å’½ç™Œã€ä¸‹å’½ç™ŒåŠå–‰ç™Œï¼šErbitux與放射腺療法åˆä½µä½¿ç”¨, 治療局部晚期之å£å’½ç™Œã€ä¸‹å’½ç™ŒåŠå–‰ç™Œæ‚£è€…。建è°åœ¨æŽ¥å—放射線療法的å‰ä¸€é€±é–‹å§‹Erbitux的治療且æŒçºŒä½¿ç”¨Erbitux治療至放射線治療期çµæŸã€‚
衛署èŒç–«è¼¸å—第000877號2019-03-112009-03-11èŒã€€ç–«DHA01000087701爾必得舒 注射液 5 毫克/毫å‡Erbitux與FOLFIRI(Folinic acid/5-FU/Irinotecan)åˆä½µä½¿ç”¨æ–¼æ²»ç™‚å…·è¡¨çš®ç”Ÿé•·å› åå—體表ç¾åž‹(EGFR expressing),KRAS原生型(wild-type)之轉移性直腸çµè…¸ç™Œç—…患之第一線治療。Erbitux與放射線療法åˆä½µä½¿ç”¨ï¼Œæ²»ç™‚局部晚期之å£å’½ç™Œã€ä¸‹å’½ç™ŒåŠå–‰ç™Œæ‚£è€…。Erbitux與內å«platinum類之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œæ²»ç™‚復發åŠ/或轉移性é é ¸éƒ¨é±—ç‹€ç´°èƒžç™Œæ‚£è€…ã€‚æ³¨å°„åŠ‘å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨CETUXIMAB, CHIMERIC ANTIBODYå°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK KGaAFRANKFURTER STRASSE 250, D-64293 DARMSTADT, GERMANYGERMANY2014-11-13å°ç“¶è£;;ç›’è£Erbitux 5mg/ml Solution for infusion病患第一次輸注å‰ï¼Œä¸€å®šè¦å…ˆçµ¦äºˆæŠ—組織胺藥劑。並建è°ä¹‹å¾Œçš„æ¯ä¸€æ¬¡æ³¨å°„都è¦å…ˆçµ¦äºˆæŠ—組織胺藥劑。在治療, Erbitux為一星期輸注一次, 起始劑é‡æ˜¯æ¯å¹³æ–¹å…¬å°ºèº«é«”表é¢ç© 400 毫克(400mg/m2)建è°çš„輸注時間是120分é˜ã€‚之後æ¯ä¸€æ˜ŸæœŸçš„劑é‡æ˜¯æ¯å¹³æ–¹å…¬å°ºèº«é«”é¢ç© 250 毫克(250mg/m2) 建è°çš„輸注時間是60分é˜ã€‚Erbitux最快的輸注速率ä¸èƒ½è¶…éŽ 10 毫克/分。直腸çµè…¸ç™Œï¼šErbitux與irinotecanåˆä½µä½¿ç”¨, 治療轉移直腸çµè…¸ç™Œæ‚£è€…。åˆç”¨irinotecan的劑é‡ï¼Œè«‹åƒé–±irinotecan的產å“資料。一般狀æ³ä¸‹, 併用irinotecan的治療劑é‡, å¯æŠ•äºˆèˆ‡æœ€è¿‘治療療程相åŒåŠ‘é‡çš„irinotecanã€‚å¿…é ˆåœ¨è¼¸æ³¨Erbitux一å°æ™‚之後,æ‰èƒ½çµ¦äºˆã€‚建è°æŒçºŒErbitux治療直到病情惡化。å£å’½ç™Œã€ä¸‹å’½ç™ŒåŠå–‰ç™Œï¼šErbitux與放射腺療法åˆä½µä½¿ç”¨, 治療局部晚期之å£å’½ç™Œã€ä¸‹å’½ç™ŒåŠå–‰ç™Œæ‚£è€…。建è°åœ¨æŽ¥å—放射線療法的å‰ä¸€é€±é–‹å§‹Erbitux的治療且æŒçºŒä½¿ç”¨Erbitux治療至放射線治療期çµæŸã€‚
衛署èŒç–«è¼¸å—第000877號2019-03-112009-03-11èŒã€€ç–«DHA01000087701爾必得舒 注射液 5 毫克/毫å‡Erbitux與FOLFIRI(Folinic acid/5-FU/Irinotecan)åˆä½µä½¿ç”¨æ–¼æ²»ç™‚å…·è¡¨çš®ç”Ÿé•·å› åå—體表ç¾åž‹(EGFR expressing),KRAS原生型(wild-type)之轉移性直腸çµè…¸ç™Œç—…患之第一線治療。Erbitux與放射線療法åˆä½µä½¿ç”¨ï¼Œæ²»ç™‚局部晚期之å£å’½ç™Œã€ä¸‹å’½ç™ŒåŠå–‰ç™Œæ‚£è€…。Erbitux與內å«platinum類之化å¸ç™‚法åˆä½µä½¿ç”¨ï¼Œæ²»ç™‚復發åŠ/或轉移性é é ¸éƒ¨é±—ç‹€ç´°èƒžç™Œæ‚£è€…ã€‚æ³¨å°„åŠ‘å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨CETUXIMAB, CHIMERIC ANTIBODYå°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGBIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS, GERMANY GERMANY2014-11-13å°ç“¶è£;;ç›’è£Erbitux 5mg/ml Solution for infusion病患第一次輸注å‰ï¼Œä¸€å®šè¦å…ˆçµ¦äºˆæŠ—組織胺藥劑。並建è°ä¹‹å¾Œçš„æ¯ä¸€æ¬¡æ³¨å°„都è¦å…ˆçµ¦äºˆæŠ—組織胺藥劑。在治療, Erbitux為一星期輸注一次, 起始劑é‡æ˜¯æ¯å¹³æ–¹å…¬å°ºèº«é«”表é¢ç© 400 毫克(400mg/m2)建è°çš„輸注時間是120分é˜ã€‚之後æ¯ä¸€æ˜ŸæœŸçš„劑é‡æ˜¯æ¯å¹³æ–¹å…¬å°ºèº«é«”é¢ç© 250 毫克(250mg/m2) 建è°çš„輸注時間是60分é˜ã€‚Erbitux最快的輸注速率ä¸èƒ½è¶…éŽ 10 毫克/分。直腸çµè…¸ç™Œï¼šErbitux與irinotecanåˆä½µä½¿ç”¨, 治療轉移直腸çµè…¸ç™Œæ‚£è€…。åˆç”¨irinotecan的劑é‡ï¼Œè«‹åƒé–±irinotecan的產å“資料。一般狀æ³ä¸‹, 併用irinotecan的治療劑é‡, å¯æŠ•äºˆèˆ‡æœ€è¿‘治療療程相åŒåŠ‘é‡çš„irinotecanã€‚å¿…é ˆåœ¨è¼¸æ³¨Erbitux一å°æ™‚之後,æ‰èƒ½çµ¦äºˆã€‚建è°æŒçºŒErbitux治療直到病情惡化。å£å’½ç™Œã€ä¸‹å’½ç™ŒåŠå–‰ç™Œï¼šErbitux與放射腺療法åˆä½µä½¿ç”¨, 治療局部晚期之å£å’½ç™Œã€ä¸‹å’½ç™ŒåŠå–‰ç™Œæ‚£è€…。建è°åœ¨æŽ¥å—放射線療法的å‰ä¸€é€±é–‹å§‹Erbitux的治療且æŒçºŒä½¿ç”¨Erbitux治療至放射線治療期çµæŸã€‚
衛署èŒç–«è¼¸å—第000879號2019-03-302009-03-30èŒã€€ç–«DHA01000087905樂舒晴注射劑 10 公絲/毫å‡Lucentisé©ç”¨æ–¼ï¼š(1)治療血管新生型(濕性)年齡相關性黃斑部退化病變 (age-related macular degeneration, AMD)。(2)治療糖尿病引起黃斑部水腫 (diabetic macular edema, DME)所導致的視力æ害。(3)治療視網膜éœè„ˆé˜»å¡ž(分支或ä¸å¤®è¦–網膜éœè„ˆ; branch or central retinal vein occlusion; BRVO或CRVO)續發黃斑部水腫所導致的視力æ害。(4)治療病ç†æ€§è¿‘視(PM)續發的脈絡膜血管新生(CNV)所導致的視力æ害注射劑瓶è£é™„注射é‡ç’ã€é‡é ã€éŽæ¿¾é‡é é™ç”±é†«å¸«ä½¿ç”¨RANIBIZUMABå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589Roche Singapore Technical Operations Pte.Ltd.10 Tuas Bay Link, 637394 SingaporeSINGAPORE2014-09-05瓶è£é™„注射é‡ç’ã€é‡é ã€éŽæ¿¾é‡é Lucentis 10mg/ml solution for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000879號2019-03-302009-03-30èŒã€€ç–«DHA01000087905樂舒晴注射劑 10 公絲/毫å‡Lucentisé©ç”¨æ–¼ï¼š(1)治療血管新生型(濕性)年齡相關性黃斑部退化病變 (age-related macular degeneration, AMD)。(2)治療糖尿病引起黃斑部水腫 (diabetic macular edema, DME)所導致的視力æ害。(3)治療視網膜éœè„ˆé˜»å¡ž(分支或ä¸å¤®è¦–網膜éœè„ˆ; branch or central retinal vein occlusion; BRVO或CRVO)續發黃斑部水腫所導致的視力æ害。(4)治療病ç†æ€§è¿‘視(PM)續發的脈絡膜血管新生(CNV)所導致的視力æ害注射劑瓶è£é™„注射é‡ç’ã€é‡é ã€éŽæ¿¾é‡é é™ç”±é†«å¸«ä½¿ç”¨RANIBIZUMABå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS PHARMA STEIN AGSCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLANDSWITZERLAND2014-09-05瓶è£é™„注射é‡ç’ã€é‡é ã€éŽæ¿¾é‡é Lucentis 10mg/ml solution for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000898號2015-09-162010-09-16èŒã€€ç–«DHA01000089809優泌樂ç†-æ··åˆåž‹ 25 100 å–®ä½/毫å‡ç³–尿病注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN LISPRO;;INSULIN LISPRO臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803ELI LILLY AND COMPANYINDIANAPOLIS, INDIANA 46285, U.S.A.UNITED STATES2014-09-29注射ç†;;ç›’è£Humalog Mix 25 100U/ml KwikPen醫師é‡å°æ‚£è€…的需求決定劑é‡
衛署èŒç–«è¼¸å—第000879號2019-03-302009-03-30èŒã€€ç–«DHA01000087905樂舒晴注射劑 10 公絲/毫å‡Lucentisé©ç”¨æ–¼ï¼š(1)治療血管新生型(濕性)年齡相關性黃斑部退化病變 (age-related macular degeneration, AMD)。(2)治療糖尿病引起黃斑部水腫 (diabetic macular edema, DME)所導致的視力æ害。(3)治療視網膜éœè„ˆé˜»å¡ž(分支或ä¸å¤®è¦–網膜éœè„ˆ; branch or central retinal vein occlusion; BRVO或CRVO)續發黃斑部水腫所導致的視力æ害。(4)治療病ç†æ€§è¿‘視(PM)續發的脈絡膜血管新生(CNV)所導致的視力æ害注射劑瓶è£é™„注射é‡ç’ã€é‡é ã€éŽæ¿¾é‡é é™ç”±é†«å¸«ä½¿ç”¨RANIBIZUMABå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS PHARMA. AGLICHTSTRASSE 35 CH-4056 BASLE, SWITZERLANDSWITZERLAND2014-09-05瓶è£é™„注射é‡ç’ã€é‡é ã€éŽæ¿¾é‡é Lucentis 10mg/ml solution for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000879號2019-03-302009-03-30èŒã€€ç–«DHA01000087905樂舒晴注射劑 10 公絲/毫å‡Lucentisé©ç”¨æ–¼ï¼š(1)治療血管新生型(濕性)年齡相關性黃斑部退化病變 (age-related macular degeneration, AMD)。(2)治療糖尿病引起黃斑部水腫 (diabetic macular edema, DME)所導致的視力æ害。(3)治療視網膜éœè„ˆé˜»å¡ž(分支或ä¸å¤®è¦–網膜éœè„ˆ; branch or central retinal vein occlusion; BRVO或CRVO)續發黃斑部水腫所導致的視力æ害。(4)治療病ç†æ€§è¿‘視(PM)續發的脈絡膜血管新生(CNV)所導致的視力æ害注射劑瓶è£é™„注射é‡ç’ã€é‡é ã€éŽæ¿¾é‡é é™ç”±é†«å¸«ä½¿ç”¨RANIBIZUMABå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589GENETECH, INC.1 DNA WAY SOUTH SAN FRANCISCO CA 94080-4990, U.S.A.UNITED STATES2014-09-05瓶è£é™„注射é‡ç’ã€é‡é ã€éŽæ¿¾é‡é Lucentis 10mg/ml solution for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000880號2014-06-022009-06-02èŒã€€ç–«DHA01000088003è€è¡€æ¯”注射劑 10æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780Teva Pharma Japan Inc. Takayama Plant1040-22 MATSUNOKI-CHO, TAKAYAMA-SHI, GIFU, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 10 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000880號2014-06-022009-06-02èŒã€€ç–«DHA01000088003è€è¡€æ¯”注射劑 10æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD. TAKASAKI PLANT100-1 HAGIWARA-MACHI, TAKASAKI-SHI, GUNMA, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 10 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000881號2014-06-022009-06-02èŒã€€ç–«DHA01000088105è€è¡€æ¯”注射劑 15æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD. TAKASAKI PLANT100-1 HAGIWARA-MACHI, TAKASAKI-SHI, GUNMA, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 15 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000881號2014-06-022009-06-02èŒã€€ç–«DHA01000088105è€è¡€æ¯”注射劑 15æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD.1-6-1 OHTEMACHI, CHIYODA-KU, TOKYO, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 15 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000882號2014-06-022009-06-02èŒã€€ç–«DHA01000088207è€è¡€æ¯”注射劑 20æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780Teva Pharma Japan Inc. Takayama Plant1040-22 MATSUNOKI-CHO, TAKAYAMA-SHI, GIFU, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 20 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000882號2014-06-022009-06-02èŒã€€ç–«DHA01000088207è€è¡€æ¯”注射劑 20æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD. TAKASAKI PLANT100-1 HAGIWARA-MACHI, TAKASAKI-SHI, GUNMA, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 20 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000882號2014-06-022009-06-02èŒã€€ç–«DHA01000088207è€è¡€æ¯”注射劑 20æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD.1-6-1 OHTEMACHI, CHIYODA-KU, TOKYO, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 20 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000883號2014-06-022009-06-02èŒã€€ç–«DHA01000088309è€è¡€æ¯”注射劑 30æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780Teva Pharma Japan Inc. Takayama Plant1040-22 MATSUNOKI-CHO, TAKAYAMA-SHI, GIFU, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 30 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000883號2014-06-022009-06-02èŒã€€ç–«DHA01000088309è€è¡€æ¯”注射劑 30æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD. TAKASAKI PLANT100-1 HAGIWARA-MACHI, TAKASAKI-SHI, GUNMA, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 30 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000883號2014-06-022009-06-02èŒã€€ç–«DHA01000088309è€è¡€æ¯”注射劑 30æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD.1-6-1 OHTEMACHI, CHIYODA-KU, TOKYO, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 30 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000884號2014-06-022009-06-02èŒã€€ç–«DHA01000088401è€è¡€æ¯”注射劑 40æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780Teva Pharma Japan Inc. Takayama Plant1040-22 MATSUNOKI-CHO, TAKAYAMA-SHI, GIFU, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 40 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000884號2014-06-022009-06-02èŒã€€ç–«DHA01000088401è€è¡€æ¯”注射劑 40æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD. TAKASAKI PLANT100-1 HAGIWARA-MACHI, TAKASAKI-SHI, GUNMA, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 40 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000884號2014-06-022009-06-02èŒã€€ç–«DHA01000088401è€è¡€æ¯”注射劑 40æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD.1-6-1 OHTEMACHI, CHIYODA-KU, TOKYO, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 40 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000898號2015-09-162010-09-16èŒã€€ç–«DHA01000089809優泌樂ç†-æ··åˆåž‹ 25 100 å–®ä½/毫å‡ç³–尿病注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN LISPRO;;INSULIN LISPRO臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY FRANCE S.A.S.ZONE INDUSTRIELLE 2 RUE DU COLONEL LILLY 67640 FEGERSHEIM, FRANCEFRANCE2014-09-29注射ç†;;ç›’è£Humalog Mix 25 100U/ml KwikPen醫師é‡å°æ‚£è€…的需求決定劑é‡
衛署èŒç–«è¼¸å—第000885號2014-06-022009-06-02èŒã€€ç–«DHA01000088500è€è¡€æ¯”注射劑 60æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780Teva Pharma Japan Inc. Takayama Plant1040-22 MATSUNOKI-CHO, TAKAYAMA-SHI, GIFU, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 60 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000885號2014-06-022009-06-02èŒã€€ç–«DHA01000088500è€è¡€æ¯”注射劑 60æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD. TAKASAKI PLANT100-1 HAGIWARA-MACHI, TAKASAKI-SHI, GUNMA, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 60 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000885號2014-06-022009-06-02èŒã€€ç–«DHA01000088500è€è¡€æ¯”注射劑 60æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD.1-6-1 OHTEMACHI, CHIYODA-KU, TOKYO, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 60 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000886號2014-06-022009-06-02èŒã€€ç–«DHA01000088602è€è¡€æ¯”注射劑 120æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780Teva Pharma Japan Inc. Takayama Plant1040-22 MATSUNOKI-CHO, TAKAYAMA-SHI, GIFU, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 120 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000886號2014-06-022009-06-02èŒã€€ç–«DHA01000088602è€è¡€æ¯”注射劑 120æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD. TAKASAKI PLANT100-1 HAGIWARA-MACHI, TAKASAKI-SHI, GUNMA, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 120 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000886號2014-06-022009-06-02èŒã€€ç–«DHA01000088602è€è¡€æ¯”注射劑 120æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€çš„患者,治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨DARBEPOETIN ALFAå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780KYOWA HAKKO KIRIN CO., LTD.1-6-1 OHTEMACHI, CHIYODA-KU, TOKYO, JAPANJAPAN2013-04-01注射é‡ç’NESP Injection Syringe 120 mcgè«‹åƒç…§ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000887號2019-07-072009-07-07èŒã€€ç–«DHA01000088704美血樂é‡ç’è£æ³¨å°„劑 30 微公克/0.3毫å‡æ²»ç™‚慢性腎病(CKD, chronic kidney disease)所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸æ²»ç™‚引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 30 mcg/0.3 ml詳見仿單。
衛署èŒç–«è¼¸å—第000887號2019-07-072009-07-07èŒã€€ç–«DHA01000088704美血樂é‡ç’è£æ³¨å°„劑 30 微公克/0.3毫å‡æ²»ç™‚慢性腎病(CKD, chronic kidney disease)所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸æ²»ç™‚引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 30 mcg/0.3 ml詳見仿單。
衛署èŒç–«è¼¸å—第000888號2019-07-072009-07-07èŒã€€ç–«DHA01000088806美血樂é‡ç’è£æ³¨å°„劑 120 微公克/0.3毫å‡æ²»ç™‚慢性腎病(CKD, chronic kidney disease)所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸æ²»ç™‚引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116, D-68305 MANNHEIM, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 120 mcg/0.3 ml詳見仿單。
衛署èŒç–«è¼¸å—第000888號2019-07-072009-07-07èŒã€€ç–«DHA01000088806美血樂é‡ç’è£æ³¨å°„劑 120 微公克/0.3毫å‡æ²»ç™‚慢性腎病(CKD, chronic kidney disease)所引起的症狀性貧血。Mirceraå°šæœªæ ¸å‡†æ–¼æ²»ç™‚å› ç™Œç—‡åŒ–å¸æ²»ç™‚引起的貧血。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射é‡ç’;;ç›’è£Mircera solution for injection in pre-filled syringe 120 mcg/0.3 ml詳見仿單。
衛署èŒç–«è¼¸å—第000889號2019-08-122009-08-12èŒã€€ç–«DHA01000088908æœæ¨‚ç¶éˆæµæ„Ÿç–«è‹—é 防æµæ„Ÿã€‚懸浮注射劑é‡ç’è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/California/7/2009(H1N1);;A/Victoria/361/2011(H3N2);;B/Massachusetts/02/2012å°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589裕利大園物æµä¸å¿ƒæ¡ƒåœ’縣大園鄉和平æ‘舊åŽå1é„°1-2號TAIWAN2014-06-03é‡ç’è£;;ç›’è£Fluvirin Suspension for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000889號2019-08-122009-08-12èŒã€€ç–«DHA01000088908æœæ¨‚ç¶éˆæµæ„Ÿç–«è‹—é 防æµæ„Ÿã€‚懸浮注射劑é‡ç’è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/California/7/2009(H1N1);;A/Victoria/361/2011(H3N2);;B/Massachusetts/02/2012å°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS VACCINES AND DIAGNOSTICS LIMITEDGASKILL ROAD, SPEKE, LIVERPOOL, L24 9GR, UNITED KINGDOMUNITED KINGDOM2014-06-03é‡ç’è£;;ç›’è£Fluvirin Suspension for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000889號2019-08-122009-08-12èŒã€€ç–«DHA01000088908æœæ¨‚ç¶éˆæµæ„Ÿç–«è‹—é 防æµæ„Ÿã€‚懸浮注射劑é‡ç’è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/California/7/2009(H1N1);;A/Victoria/361/2011(H3N2);;B/Massachusetts/02/2012å°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS VACCINES AND DIAGNOSTICS S.R.L.BELLARIA ROSIA 53018 SOVICILLE (SIENA), ITLAYITALY2014-06-03é‡ç’è£;;ç›’è£Fluvirin Suspension for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000890號2014-11-092009-11-09èŒã€€ç–«DHA01000089006普康 麻疹ã€è…®è…ºç‚Žã€å¾·åœ‹éº»ç–¹åŠæ°´ç—˜ç—…毒活毒疫苗(冷è—安定é…æ–¹)é 防麻疹ã€è…®è…ºç‚Žã€å¾·åœ‹éº»ç–¹åŠæ°´ç—˜ï¼Œé©ç”¨æ–¼12個月至6æ²çš„å©ç«¥ã€‚å‡æ™¶ä¹¾ç²‰æ³¨å°„劑å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–注射é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨MEASLES VIRUS;;MUMPS VIRUS;;RUBELLA VIRUS;;VARICELLA VIRUS美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME (AUSTRALIA) PTY LTD.54-68 FERNDELL STREET,SOUTH GRANVILLE, N.S.W. 2142 AUSTRALIA.AUSTRALIA2014-03-10å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–注射é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£ProQuad [Measles, Mumps, Rubella and Varicella (Oka/Merck) Virus Vaccine Live, MSD](Refrigerator Stable formulation)詳見仿單。
衛署èŒç–«è¼¸å—第000890號2014-11-092009-11-09èŒã€€ç–«DHA01000089006普康 麻疹ã€è…®è…ºç‚Žã€å¾·åœ‹éº»ç–¹åŠæ°´ç—˜ç—…毒活毒疫苗(冷è—安定é…æ–¹)é 防麻疹ã€è…®è…ºç‚Žã€å¾·åœ‹éº»ç–¹åŠæ°´ç—˜ï¼Œé©ç”¨æ–¼12個月至6æ²çš„å©ç«¥ã€‚å‡æ™¶ä¹¾ç²‰æ³¨å°„劑å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–注射é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨MEASLES VIRUS;;MUMPS VIRUS;;RUBELLA VIRUS;;VARICELLA VIRUS美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME B.V.WAARDERWEG 39,2031 BN HAARLEM,THE NETHERLANDSNETHERLANDS2014-03-10å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–注射é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£ProQuad [Measles, Mumps, Rubella and Varicella (Oka/Merck) Virus Vaccine Live, MSD](Refrigerator Stable formulation)詳見仿單。
衛署èŒç–«è¼¸å—第000890號2014-11-092009-11-09èŒã€€ç–«DHA01000089006普康 麻疹ã€è…®è…ºç‚Žã€å¾·åœ‹éº»ç–¹åŠæ°´ç—˜ç—…毒活毒疫苗(冷è—安定é…æ–¹)é 防麻疹ã€è…®è…ºç‚Žã€å¾·åœ‹éº»ç–¹åŠæ°´ç—˜ï¼Œé©ç”¨æ–¼12個月至6æ²çš„å©ç«¥ã€‚å‡æ™¶ä¹¾ç²‰æ³¨å°„劑å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–注射é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨MEASLES VIRUS;;MUMPS VIRUS;;RUBELLA VIRUS;;VARICELLA VIRUS美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720MERCK SHARP & DOHME CORP.770 SUMNEYTOWN PIKE, WEST POINT, PA 19486, U.S.A.UNITED STATES2014-03-10å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–注射é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£ProQuad [Measles, Mumps, Rubella and Varicella (Oka/Merck) Virus Vaccine Live, MSD](Refrigerator Stable formulation)詳見仿單。
衛署èŒç–«è¼¸å—第000890號2014-11-092009-11-09èŒã€€ç–«DHA01000089006普康 麻疹ã€è…®è…ºç‚Žã€å¾·åœ‹éº»ç–¹åŠæ°´ç—˜ç—…毒活毒疫苗(冷è—安定é…æ–¹)é 防麻疹ã€è…®è…ºç‚Žã€å¾·åœ‹éº»ç–¹åŠæ°´ç—˜ï¼Œé©ç”¨æ–¼12個月至6æ²çš„å©ç«¥ã€‚å‡æ™¶ä¹¾ç²‰æ³¨å°„劑å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–注射é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨MEASLES VIRUS;;MUMPS VIRUS;;RUBELLA VIRUS;;VARICELLA VIRUS美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720Jubilant HollisterStier LLC3525 NORTH REGAL STREET SPOKANE, WA 99207, USAUNITED STATES2014-03-10å°ç“¶è£é™„ç‰æ”¯æ•¸å°ç“¶è£æˆ–注射é‡ç’è£(附或ä¸é™„é‡é )稀釋液;;ç›’è£ProQuad [Measles, Mumps, Rubella and Varicella (Oka/Merck) Virus Vaccine Live, MSD](Refrigerator Stable formulation)詳見仿單。
衛署èŒç–«è¼¸å—第000891號2019-11-252009-11-25èŒã€€ç–«DHA01000089108é›™ä¼å¨è‚ºç‚ŽéˆçƒèŒå價接åˆåž‹ç–«è‹—6週至5æ²å¤§å¬°å…’與幼兒之主動å…疫接種,é 防由肺炎éˆçƒèŒè¡€æ¸…åž‹1ã€4ã€5ã€6Bã€7Fã€9Vã€14ã€18Cã€19Få’Œ23F引起的侵襲性肺炎éˆçƒèŒæ„ŸæŸ“åŠæ€¥æ€§ä¸è€³ç‚Žã€‚é 充填型注射é‡å™¨é™„é‡é ;;å°ç“¶è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F;;CARRIER PROTEIN (PROTEIN D (PD));;CARRIER PROTEIN (TETANUS TOXOID (TT));;CARRIER PROTEIN (DIPHTHERIA TOXOID (DT))è·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE 1'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-11-26é 充填型注射é‡å™¨é™„é‡é ;;å°ç“¶è£;;ç›’è£SynflorixTM請祥åƒä»¿å–®å…§å®¹ã€‚
衛署èŒç–«è¼¸å—第000891號2019-11-252009-11-25èŒã€€ç–«DHA01000089108é›™ä¼å¨è‚ºç‚ŽéˆçƒèŒå價接åˆåž‹ç–«è‹—6週至5æ²å¤§å¬°å…’與幼兒之主動å…疫接種,é 防由肺炎éˆçƒèŒè¡€æ¸…åž‹1ã€4ã€5ã€6Bã€7Fã€9Vã€14ã€18Cã€19Få’Œ23F引起的侵襲性肺炎éˆçƒèŒæ„ŸæŸ“åŠæ€¥æ€§ä¸è€³ç‚Žã€‚é 充填型注射é‡å™¨é™„é‡é ;;å°ç“¶è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F;;CARRIER PROTEIN (PROTEIN D (PD));;CARRIER PROTEIN (TETANUS TOXOID (TT));;CARRIER PROTEIN (DIPHTHERIA TOXOID (DT))è·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.PARC DE LA NOIRE EPINE, RUE FLEMING 20, B-1300 WAVRE, BELGIUMBELGIUM2014-11-26é 充填型注射é‡å™¨é™„é‡é ;;å°ç“¶è£;;ç›’è£SynflorixTM請祥åƒä»¿å–®å…§å®¹ã€‚
衛署èŒç–«è¼¸å—第000891號2019-11-252009-11-25èŒã€€ç–«DHA01000089108é›™ä¼å¨è‚ºç‚ŽéˆçƒèŒå價接åˆåž‹ç–«è‹—6週至5æ²å¤§å¬°å…’與幼兒之主動å…疫接種,é 防由肺炎éˆçƒèŒè¡€æ¸…åž‹1ã€4ã€5ã€6Bã€7Fã€9Vã€14ã€18Cã€19Få’Œ23F引起的侵襲性肺炎éˆçƒèŒæ„ŸæŸ“åŠæ€¥æ€§ä¸è€³ç‚Žã€‚é 充填型注射é‡å™¨é™„é‡é ;;å°ç“¶è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F;;CARRIER PROTEIN (PROTEIN D (PD));;CARRIER PROTEIN (TETANUS TOXOID (TT));;CARRIER PROTEIN (DIPHTHERIA TOXOID (DT))è·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GlaxoSmithKline Biologicals KftHomoki Nagy Istvan ucta 1, 2100 Godollo, HungaryHUNGARY2014-11-26é 充填型注射é‡å™¨é™„é‡é ;;å°ç“¶è£;;ç›’è£SynflorixTM請祥åƒä»¿å–®å…§å®¹ã€‚
衛署èŒç–«è¼¸å—第000892號2014-12-172009-12-17èŒã€€ç–«DHA01000089200羅特律輪狀病毒疫苗å£æœæ‡¸æ¶²åŠ‘é 防輪狀病毒所引起的腸胃炎(G1與éžG1血清型如G2ã€G3ã€G4å’ŒG9)。å‡æ™¶å£æœæ‡¸æ¶²åŠ‘å¡‘è† ç®¡è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨HUMAN ROTAVIRUS LIVE ATTENUATED RIX4414 STRAINè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE 1'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19å¡‘è† ç®¡è£Rotarix Oral Suspension
衛署èŒç–«è¼¸å—第000893號2015-03-182010-03-18èŒã€€ç–«DHA01000089302æ密拓“山德士â€æ³¨å°„液5毫克/1.5毫å‡è…¦ä¸‹åž‚é«”ä¹‹ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾;TURNER'S SYNDROME所導致之生長干擾;PRADER-WILLI SYNDROME所導致之生長干擾;慢性腎臟功能ä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾;低出生體é‡å…’Small for Gestational Age(SGA)逾四æ²è€…之生長障礙;æˆäººç”Ÿé•·æ¿€ç´ åš´é‡ç¼ºä¹ä¹‹è£œå……療法。注射劑雙內腔å¡åŒ£è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨RECOMBINANT SOMATROPINå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589SANDOZ GMBHBIOCHEMIESTRASSE 10, A-6250 KUNDL, AUSTRIAAUSTRIA2013-10-07雙內腔å¡åŒ£è£;;注射ç†Omnitrope 3.3mg/ml Solution for Injection您的醫生將會告訴您關於個人的Omnitrope劑é‡èˆ‡æ²»ç™‚計畫。通常Omnitrope在æ¯å¤©æ™šä¸Šæ³¨å°„一次。請ä¸è¦åœ¨æ²’有請教醫生的情形下變更劑é‡èˆ‡æ²»ç™‚計畫。藥物的劑é‡å¯èƒ½éœ€è¦éš¨è‘—æ™‚é–“è€Œèª¿æ•´ï¼Œæ ¹æ“šæ‚¨çš„é«”é‡çš„å¢žåŠ èˆ‡å應。(詳細請åƒé–±ä»¿å–®)
衛署èŒç–«è¼¸å—第000897號2015-05-272010-05-27èŒã€€ç–«DHA01000089707æ©ç‘žèˆ’å‡æ™¶æ³¨å°„劑250毫克1.類風濕性關節炎:Orencia與methotrexate併用,用於治療罹患有ä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žä¸”å°å…¶ä»–疾病修飾抗風濕病藥物[包括methotrexate (MTX)或一種腫瘤壞æ»å› å(TNF)抑制劑]å應ä¸è‰¯æˆ–è€å—性ä¸ä½³çš„æˆäººæ‚£è€…。2.幼年型慢性關節炎:Orencia與methotrexate併用,用於治療罹患有ä¸åº¦è‡³é‡åº¦å¹¼å¹´åž‹æ…¢æ€§é—œç¯€ç‚Žä¸”å°å…¶ä»–疾病修飾抗風濕病藥物[包括一種腫瘤壞æ»å› å(TNF)抑制劑]å應ä¸è‰¯æˆ–è€å—性ä¸ä½³çš„6æ²æˆ–6æ²ä»¥ä¸Šå…’童患者。**Orencia未於6æ²ä»¥ä¸‹çš„å…’ç«¥é€²è¡Œä»»ä½•ç ”ç©¶ã€‚3.é‡è¦ç”¨è—¥é™åˆ¶ï¼šOrenciaä¸å¯èˆ‡å…¶ä»–治療類風濕性關節炎(RA)的生物製劑åŒæ™‚使用。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;ç›’è£;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨ABATACEPT臺ç£å¿…治妥施貴寶股份有é™å…¬å¸å°åŒ—市æ¾å±±å€å¥åº·è·¯156號4樓ã€5樓ã€6樓11922609LONZA BIOLOGICAL INC.101 INTERNATIONAL DRIVE, PEASE INTERNATIONAL TRADEPORT, PORTSMOUTH, NEW HAMPSHIRE 03801, U.S.A.UNITED STATES2014-12-09å°ç“¶è£;;ç›’è£;;注射é‡ç’Orencia Lyophilized Powder for IV Infusion 250mg請詳åƒä»¿å–®å…§å®¹ã€‚
衛署èŒç–«è¼¸å—第000893號2015-03-182010-03-18èŒã€€ç–«DHA01000089302æ密拓“山德士â€æ³¨å°„液5毫克/1.5毫å‡è…¦ä¸‹åž‚é«”ä¹‹ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾;TURNER'S SYNDROME所導致之生長干擾;PRADER-WILLI SYNDROME所導致之生長干擾;慢性腎臟功能ä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾;低出生體é‡å…’Small for Gestational Age(SGA)逾四æ²è€…之生長障礙;æˆäººç”Ÿé•·æ¿€ç´ åš´é‡ç¼ºä¹ä¹‹è£œå……療法。注射劑雙內腔å¡åŒ£è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨RECOMBINANT SOMATROPINå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589SANDOZ GMBH SCHAFTENAU PLANTBIOCHEMIESTRASSE 10, A-6336 LANGKAMPFEN, AUSTRIAAUSTRIA2013-10-07雙內腔å¡åŒ£è£;;注射ç†Omnitrope 3.3mg/ml Solution for Injection您的醫生將會告訴您關於個人的Omnitrope劑é‡èˆ‡æ²»ç™‚計畫。通常Omnitrope在æ¯å¤©æ™šä¸Šæ³¨å°„一次。請ä¸è¦åœ¨æ²’有請教醫生的情形下變更劑é‡èˆ‡æ²»ç™‚計畫。藥物的劑é‡å¯èƒ½éœ€è¦éš¨è‘—æ™‚é–“è€Œèª¿æ•´ï¼Œæ ¹æ“šæ‚¨çš„é«”é‡çš„å¢žåŠ èˆ‡å應。(詳細請åƒé–±ä»¿å–®)
衛署èŒç–«è¼¸å—第000894號2015-02-112010-02-11èŒã€€ç–«DHA01000089401瑞犬ä¼ç‹‚犬病疫苗 注射用å‡æ™¶ç²‰æœ«é 防狂犬病。注射用å‡æ™¶ç²‰æœ«å°ç“¶è£;;安瓿;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨INACTIVATED RABIES VIRUS;;WATER FOR INJECTIONå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS VACCINES AND DIAGNOSTICS S.R.L.BELLARIA ROSIA 53018 SOVICILLE (SIENA), ITLAYITALY2013-10-07å°ç“¶è£;;安瓿;;ç›’è£Rabipur PCEC Rabies Vaccines Behring Powder and solvent for solution for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000894號2015-02-112010-02-11èŒã€€ç–«DHA01000089401瑞犬ä¼ç‹‚犬病疫苗 注射用å‡æ™¶ç²‰æœ«é 防狂犬病。注射用å‡æ™¶ç²‰æœ«å°ç“¶è£;;安瓿;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨INACTIVATED RABIES VIRUS;;WATER FOR INJECTIONå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS VACCINES AND DIAGNOSTICS GMBH & CO. KGEMIL-VON BEHRING-STR. 76, 35041 MARBURG, GERMANYGERMANY2013-10-07å°ç“¶è£;;安瓿;;ç›’è£Rabipur PCEC Rabies Vaccines Behring Powder and solvent for solution for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000895號2015-02-242010-02-24èŒã€€ç–«DHA01000089503“百特â€å…‹æç¶äººé¡žå…ç–«çƒè›‹ç™½éœè„ˆè¼¸æ³¨æ¶² 100 毫克/ 毫å‡åŽŸç™¼æ€§å…ç–«ä¸å…¨ç—‡ã€åŽŸç™¼æ€§è¡€å°æ¿ç¼ºä¹ç´«æ–‘症。注射液瓶è£;;瓶è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN NORMAL IMMUNOGLOBULIN (IVIG)百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER AGINDUSTRIESTRASSES 67, A-1220 VIENNA, AUSTRIAAUSTRIA2010-05-18瓶è£;;瓶è£â€œBaxterâ€KIOVIG 100 mg/ml Solution for Infusion詳如仿單。
衛署èŒç–«è¼¸å—第000895號2015-02-242010-02-24èŒã€€ç–«DHA01000089503“百特â€å…‹æç¶äººé¡žå…ç–«çƒè›‹ç™½éœè„ˆè¼¸æ³¨æ¶² 100 毫克/ 毫å‡åŽŸç™¼æ€§å…ç–«ä¸å…¨ç—‡ã€åŽŸç™¼æ€§è¡€å°æ¿ç¼ºä¹ç´«æ–‘症。注射液瓶è£;;瓶è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN NORMAL IMMUNOGLOBULIN (IVIG)百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER AGINDUSTRIESSTRASSE 131, A-1220 VIENNA, AUSTRIAAUSTRIA2010-05-18瓶è£;;瓶è£â€œBaxterâ€KIOVIG 100 mg/ml Solution for Infusion詳如仿單。
衛署èŒç–«è¼¸å—第000895號2015-02-242010-02-24èŒã€€ç–«DHA01000089503“百特â€å…‹æç¶äººé¡žå…ç–«çƒè›‹ç™½éœè„ˆè¼¸æ³¨æ¶² 100 毫克/ 毫å‡åŽŸç™¼æ€§å…ç–«ä¸å…¨ç—‡ã€åŽŸç™¼æ€§è¡€å°æ¿ç¼ºä¹ç´«æ–‘症。注射液瓶è£;;瓶è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN NORMAL IMMUNOGLOBULIN (IVIG)百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER S.A.BOULEVARD RENE BRANQUART, 80, B-7860, LESSINES, BELGIUMBELGIUM2010-05-18瓶è£;;瓶è£â€œBaxterâ€KIOVIG 100 mg/ml Solution for Infusion詳如仿單。
衛署èŒç–«è¼¸å—第000895號2015-02-242010-02-24èŒã€€ç–«DHA01000089503“百特â€å…‹æç¶äººé¡žå…ç–«çƒè›‹ç™½éœè„ˆè¼¸æ³¨æ¶² 100 毫克/ 毫å‡åŽŸç™¼æ€§å…ç–«ä¸å…¨ç—‡ã€åŽŸç™¼æ€§è¡€å°æ¿ç¼ºä¹ç´«æ–‘症。注射液瓶è£;;瓶è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN NORMAL IMMUNOGLOBULIN (IVIG)百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER HEALTHCARE CORPORATION4501 COLORADO BOULEVARD, LOS ANGELES, CALIFORNIA 90039, USAUNITED STATES2010-05-18瓶è£;;瓶è£â€œBaxterâ€KIOVIG 100 mg/ml Solution for Infusion詳如仿單。
衛署èŒç–«è¼¸å—第000896號2015-03-182010-03-18èŒã€€ç–«DHA01000089605æ密拓“山德士â€æ³¨å°„液10毫克/1.5毫å‡è…¦ä¸‹åž‚é«”ä¹‹ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾;TURNER'S SYNDROME所導致之生長干擾;PRADER-WILLI SYNDROME所導致之生長干擾;慢性腎臟功能ä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾;低出生體é‡å…’Small for Gestational Age(SGA)逾四æ²è€…之生長障礙;æˆäººç”Ÿé•·æ¿€ç´ åš´é‡ç¼ºä¹ä¹‹è£œå……療法。注射劑雙內腔å¡åŒ£è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨RECOMBINANT SOMATROPINå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589SANDOZ GMBHBIOCHEMIESTRASSE 10, A-6250 KUNDL, AUSTRIAAUSTRIA2013-10-07雙內腔å¡åŒ£è£;;注射ç†Omnitrope 6.7mg/ml Solution for Injection您的醫生將會告訴您關於個人的Omnitrope劑é‡èˆ‡æ²»ç™‚計畫。通常Omnitrope在æ¯å¤©æ™šä¸Šæ³¨å°„一次。請ä¸è¦åœ¨æ²’有請教醫生的情形下變更劑é‡èˆ‡æ²»ç™‚計畫。藥物的劑é‡å¯èƒ½éœ€è¦éš¨è‘—æ™‚é–“è€Œèª¿æ•´ï¼Œæ ¹æ“šæ‚¨çš„é«”é‡çš„å¢žåŠ èˆ‡å應。(詳細請åƒé–±ä»¿å–®)
衛署èŒç–«è¼¸å—第000896號2015-03-182010-03-18èŒã€€ç–«DHA01000089605æ密拓“山德士â€æ³¨å°„液10毫克/1.5毫å‡è…¦ä¸‹åž‚é«”ä¹‹ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾;TURNER'S SYNDROME所導致之生長干擾;PRADER-WILLI SYNDROME所導致之生長干擾;慢性腎臟功能ä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·å¹²æ“¾;低出生體é‡å…’Small for Gestational Age(SGA)逾四æ²è€…之生長障礙;æˆäººç”Ÿé•·æ¿€ç´ åš´é‡ç¼ºä¹ä¹‹è£œå……療法。注射劑雙內腔å¡åŒ£è£;;注射ç†é™ç”±é†«å¸«ä½¿ç”¨RECOMBINANT SOMATROPINå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589SANDOZ GMBH SCHAFTENAU PLANTBIOCHEMIESTRASSE 10, A-6336 LANGKAMPFEN, AUSTRIAAUSTRIA2013-10-07雙內腔å¡åŒ£è£;;注射ç†Omnitrope 6.7mg/ml Solution for Injection您的醫生將會告訴您關於個人的Omnitrope劑é‡èˆ‡æ²»ç™‚計畫。通常Omnitrope在æ¯å¤©æ™šä¸Šæ³¨å°„一次。請ä¸è¦åœ¨æ²’有請教醫生的情形下變更劑é‡èˆ‡æ²»ç™‚計畫。藥物的劑é‡å¯èƒ½éœ€è¦éš¨è‘—æ™‚é–“è€Œèª¿æ•´ï¼Œæ ¹æ“šæ‚¨çš„é«”é‡çš„å¢žåŠ èˆ‡å應。(詳細請åƒé–±ä»¿å–®)
衛署èŒç–«è¼¸å—第000897號2015-05-272010-05-27èŒã€€ç–«DHA01000089707æ©ç‘žèˆ’å‡æ™¶æ³¨å°„劑250毫克1.類風濕性關節炎:Orencia與methotrexate併用,用於治療罹患有ä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žä¸”å°å…¶ä»–疾病修飾抗風濕病藥物[包括methotrexate (MTX)或一種腫瘤壞æ»å› å(TNF)抑制劑]å應ä¸è‰¯æˆ–è€å—性ä¸ä½³çš„æˆäººæ‚£è€…。2.幼年型慢性關節炎:Orencia與methotrexate併用,用於治療罹患有ä¸åº¦è‡³é‡åº¦å¹¼å¹´åž‹æ…¢æ€§é—œç¯€ç‚Žä¸”å°å…¶ä»–疾病修飾抗風濕病藥物[包括一種腫瘤壞æ»å› å(TNF)抑制劑]å應ä¸è‰¯æˆ–è€å—性ä¸ä½³çš„6æ²æˆ–6æ²ä»¥ä¸Šå…’童患者。**Orencia未於6æ²ä»¥ä¸‹çš„å…’ç«¥é€²è¡Œä»»ä½•ç ”ç©¶ã€‚3.é‡è¦ç”¨è—¥é™åˆ¶ï¼šOrenciaä¸å¯èˆ‡å…¶ä»–治療類風濕性關節炎(RA)的生物製劑åŒæ™‚使用。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;ç›’è£;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨ABATACEPT臺ç£å¿…治妥施貴寶股份有é™å…¬å¸å°åŒ—市æ¾å±±å€å¥åº·è·¯156號4樓ã€5樓ã€6樓11922609BRISTOL-MYERS SQUIBB S.R.L.LOCALITA FONTANA DEL CERASO, 03012 ANAGNI, ITALYITALY2014-12-09å°ç“¶è£;;ç›’è£;;注射é‡ç’Orencia Lyophilized Powder for IV Infusion 250mg請詳åƒä»¿å–®å…§å®¹ã€‚
衛署èŒç–«è¼¸å—第000897號2015-05-272010-05-27èŒã€€ç–«DHA01000089707æ©ç‘žèˆ’å‡æ™¶æ³¨å°„劑250毫克1.類風濕性關節炎:Orencia與methotrexate併用,用於治療罹患有ä¸åº¦è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žä¸”å°å…¶ä»–疾病修飾抗風濕病藥物[包括methotrexate (MTX)或一種腫瘤壞æ»å› å(TNF)抑制劑]å應ä¸è‰¯æˆ–è€å—性ä¸ä½³çš„æˆäººæ‚£è€…。2.幼年型慢性關節炎:Orencia與methotrexate併用,用於治療罹患有ä¸åº¦è‡³é‡åº¦å¹¼å¹´åž‹æ…¢æ€§é—œç¯€ç‚Žä¸”å°å…¶ä»–疾病修飾抗風濕病藥物[包括一種腫瘤壞æ»å› å(TNF)抑制劑]å應ä¸è‰¯æˆ–è€å—性ä¸ä½³çš„6æ²æˆ–6æ²ä»¥ä¸Šå…’童患者。**Orencia未於6æ²ä»¥ä¸‹çš„å…’ç«¥é€²è¡Œä»»ä½•ç ”ç©¶ã€‚3.é‡è¦ç”¨è—¥é™åˆ¶ï¼šOrenciaä¸å¯èˆ‡å…¶ä»–治療類風濕性關節炎(RA)的生物製劑åŒæ™‚使用。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;ç›’è£;;注射é‡ç’é™ç”±é†«å¸«ä½¿ç”¨ABATACEPT臺ç£å¿…治妥施貴寶股份有é™å…¬å¸å°åŒ—市æ¾å±±å€å¥åº·è·¯156號4樓ã€5樓ã€6樓11922609BRISTOL-MYERS SQUIBB HOLDINGS PHARMA, LTD.BO. TIERRAS NUEVAS, ROUTE 686, KM 2.3, MANATI, PUERTO RICO 00674, U.S.A.UNITED STATES2014-12-09å°ç“¶è£;;ç›’è£;;注射é‡ç’Orencia Lyophilized Powder for IV Infusion 250mg請詳åƒä»¿å–®å…§å®¹ã€‚
衛署èŒç–«è¼¸å—第000899號2015-09-162010-09-16èŒã€€ç–«DHA01000089901優泌樂ç†-æ··åˆåž‹ 50 100å–®ä½/毫å‡ç³–尿病注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN LISPRO;;INSULIN LISPRO臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY DEL CARIBE INC.12.3 KM, 65TH INFANTRY ROAD, CAROLINA 00985, PUERTO RICOPUERTO RICO2014-09-29注射ç†;;ç›’è£Humalog Mix 50 100U/ml KwikPen醫師é‡å°æ‚£è€…的需求決定劑é‡
衛署èŒç–«è¼¸å—第000899號2015-09-162010-09-16èŒã€€ç–«DHA01000089901優泌樂ç†-æ··åˆåž‹ 50 100å–®ä½/毫å‡ç³–尿病注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN LISPRO;;INSULIN LISPRO臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803ELI LILLY AND COMPANYINDIANAPOLIS, INDIANA 46285, U.S.A.UNITED STATES2014-09-29注射ç†;;ç›’è£Humalog Mix 50 100U/ml KwikPen醫師é‡å°æ‚£è€…的需求決定劑é‡
衛署èŒç–«è¼¸å—第000900號2015-09-162010-09-16èŒã€€ç–«DHA01000090009優泌樂ç†æ³¨å°„劑 100å–®ä½/毫å‡ç³–尿病注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN LISPRO;;INSULIN LISPRO臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY FRANCE S.A.S.ZONE INDUSTRIELLE 2 RUE DU COLONEL LILLY 67640 FEGERSHEIM, FRANCEFRANCE2014-09-29注射ç†;;ç›’è£Humalog 100U/ml KwikPen醫師é‡å°æ‚£è€…的需求決定劑é‡
衛署èŒç–«è¼¸å—第000900號2015-09-162010-09-16èŒã€€ç–«DHA01000090009優泌樂ç†æ³¨å°„劑 100å–®ä½/毫å‡ç³–尿病注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN LISPRO;;INSULIN LISPRO臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY DEL CARIBE INC.12.3 KM, 65TH INFANTRY ROAD, CAROLINA 00985, PUERTO RICOPUERTO RICO2014-09-29注射ç†;;ç›’è£Humalog 100U/ml KwikPen醫師é‡å°æ‚£è€…的需求決定劑é‡
衛署èŒç–«è¼¸å—第000900號2015-09-162010-09-16èŒã€€ç–«DHA01000090009優泌樂ç†æ³¨å°„劑 100å–®ä½/毫å‡ç³–尿病注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN LISPRO;;INSULIN LISPRO臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803ELI LILLY AND COMPANYINDIANAPOLIS, INDIANA 46285, U.S.A.UNITED STATES2014-09-29注射ç†;;ç›’è£Humalog 100U/ml KwikPen醫師é‡å°æ‚£è€…的需求決定劑é‡
衛署èŒç–«è¼¸å—第000901號2015-10-172010-10-17èŒã€€ç–«DHA01000090101安爾ä¿æµæ„Ÿç–«è‹—é 防æµæ„Ÿã€‚懸浮注射劑é‡ç’è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/California/7/2009(H1N1)-pdm09 like strain(A/California/7/2009, NYMC X-181 );;A/Texas/50/2012 (H3/N2)-like strain (A/Texas/50/2012, NYMC X-223);;B/Massachusetts/02/2012-like strain (B/Massachusetts/02/2012 wild type )å°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS VACCINES AND DIAGNOSTICS LIMITEDGASKILL ROAD, SPEKE, LIVERPOOL, MERSEYSIDE, L24 9GR, UNITED KINGDOMUNITED KINGDOM2014-09-15é‡ç’è£;;ç›’è£AGRIPPAL S1 Suspension for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000901號2015-10-172010-10-17èŒã€€ç–«DHA01000090101安爾ä¿æµæ„Ÿç–«è‹—é 防æµæ„Ÿã€‚懸浮注射劑é‡ç’è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/California/7/2009(H1N1)-pdm09 like strain(A/California/7/2009, NYMC X-181 );;A/Texas/50/2012 (H3/N2)-like strain (A/Texas/50/2012, NYMC X-223);;B/Massachusetts/02/2012-like strain (B/Massachusetts/02/2012 wild type )å°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS VACCINES AND DIAGNOSTICS S.R.L.VIA FIORENTINA, 1 53100 SIENA, ITALYITALY2014-09-15é‡ç’è£;;ç›’è£AGRIPPAL S1 Suspension for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000901號2015-10-172010-10-17èŒã€€ç–«DHA01000090101安爾ä¿æµæ„Ÿç–«è‹—é 防æµæ„Ÿã€‚懸浮注射劑é‡ç’è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/California/7/2009(H1N1)-pdm09 like strain(A/California/7/2009, NYMC X-181 );;A/Texas/50/2012 (H3/N2)-like strain (A/Texas/50/2012, NYMC X-223);;B/Massachusetts/02/2012-like strain (B/Massachusetts/02/2012 wild type )å°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS VACCINES AND DIAGNOSTICS S.R.L.BELLARIA ROSIA 53018 SOVICILLE (SIENA), ITLAYITALY2014-09-15é‡ç’è£;;ç›’è£AGRIPPAL S1 Suspension for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000902號2015-10-192010-10-19èŒã€€ç–«DHA01000090200“百特â€æ„›ç· 絲低溫冷å‡å¯†åˆåŠ‘溶液Artiss用於將自體移æ¤çš®è†šç²˜åˆåœ¨ç¶“外科處ç†éŽçš„燒燙傷創é¢ï¼Œå¯é©ç”¨æ–¼æˆäººå’Œå…’童患者。Artiss之用途為臉部整形之除皺(facial rhytidectomyåˆç¨±face-lift)手術éŽç¨‹ä¸çš„組織皮瓣粘åˆã€‚Artissä¸å¯ä½œæ¢è¡€ç”¨é€”。液劑é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨FIBRINOGEN HUMAN;;APROTININ;;HUMAN THROMBIN;;CALCIUM CHLORIDE百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER AGINDUSTRIESSTRASSE 67, A-1220 VIENNA, AUSTRIA.AUSTRIA2014-02-10é‡ç’è£â€œBaxterâ€Artiss solution for Sealant詳如仿單。
衛署èŒç–«è¼¸å—第000903號2015-11-122010-11-12èŒã€€ç–«DHA01000090302伊諾娃注射液 150 微克/0.5 毫å‡åœ¨å©¦å¥³æŽ¥å—人工å”助生殖技術計劃時,本å“èˆ‡æ€§è…ºåˆºæ¿€ç´ é‡‹æ”¾æ¿€ç´ æ‹®æŠ—åŠ‘ï¼ˆGnRH antagonist)併用,使用於控制下刺激åµå·¢ï¼Œä»¥èª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ã€‚注射液注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Corifollitropin alfa美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANONKLOOSTERSTRAATE 6, 5349 AB OSS,THE NETHERLANDSNETHERLANDS2014-08-19注射é‡ç’;;ç›’è£Elonva Solution for Injection 150ug/0.5ml皮下注射。詳如仿單所述。
衛署èŒç–«è¼¸å—第000903號2015-11-122010-11-12èŒã€€ç–«DHA01000090302伊諾娃注射液 150 微克/0.5 毫å‡åœ¨å©¦å¥³æŽ¥å—人工å”助生殖技術計劃時,本å“èˆ‡æ€§è…ºåˆºæ¿€ç´ é‡‹æ”¾æ¿€ç´ æ‹®æŠ—åŠ‘ï¼ˆGnRH antagonist)併用,使用於控制下刺激åµå·¢ï¼Œä»¥èª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ã€‚注射液注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Corifollitropin alfa美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720ORGANON (IRELAND) LTD.P.O. BOX 2857, DRYNAM ROAD, SWORDS, CO., DUBLIN, IRELANDIRELAND2014-08-19注射é‡ç’;;ç›’è£Elonva Solution for Injection 150ug/0.5ml皮下注射。詳如仿單所述。
衛署èŒç–«è¼¸å—第000903號2015-11-122010-11-12èŒã€€ç–«DHA01000090302伊諾娃注射液 150 微克/0.5 毫å‡åœ¨å©¦å¥³æŽ¥å—人工å”助生殖技術計劃時,本å“èˆ‡æ€§è…ºåˆºæ¿€ç´ é‡‹æ”¾æ¿€ç´ æ‹®æŠ—åŠ‘ï¼ˆGnRH antagonist)併用,使用於控制下刺激åµå·¢ï¼Œä»¥èª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ã€‚注射液注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Corifollitropin alfa美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720VETTER PHARMA-FERTIGUNG GMBH & CO. KG FOR N.V. ORGANONSCHUTZENSTRASSE 87 AND 99/101, D-88212 RAVENSBURG, GERMANYGERMANY2014-08-19注射é‡ç’;;ç›’è£Elonva Solution for Injection 150ug/0.5ml皮下注射。詳如仿單所述。
衛署èŒç–«è¼¸å—第000904號2015-11-122010-11-12èŒã€€ç–«DHA01000090404伊諾娃注射液 100 微克/0.5 毫å‡åœ¨å©¦å¥³æŽ¥å—人工å”助生殖技術計劃時,本å“èˆ‡æ€§è…ºåˆºæ¿€ç´ é‡‹æ”¾æ¿€ç´ æ‹®æŠ—åŠ‘ï¼ˆGnRH antagonist)併用,使用於控制下刺激åµå·¢ï¼Œä»¥èª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ã€‚注射液注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Corifollitropin alfa美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720N.V. ORGANONKLOOSTERSTRAATE 6, 5349 AB OSS,THE NETHERLANDSNETHERLANDS2014-08-19注射é‡ç’;;ç›’è£Elonva Solution for Injection 100ug/0.5ml皮下注射。詳如仿單所述。
衛署èŒç–«è¼¸å—第000908號2016-01-122011-01-12èŒã€€ç–«DHA01000090802諾和密斯50諾易ç†ç³–尿病注射劑支è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN ASPART臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SBRENNUM PARK DK-3400 HILLEROED DENMARKDENMARK2014-05-16支è£NovoMix 50 FlexPenè©³è¦‹ç¶“è¡›ç”Ÿç½²æ ¸å‡†ä¹‹ä»¿å–®
衛署èŒç–«è¼¸å—第000904號2015-11-122010-11-12èŒã€€ç–«DHA01000090404伊諾娃注射液 100 微克/0.5 毫å‡åœ¨å©¦å¥³æŽ¥å—人工å”助生殖技術計劃時,本å“èˆ‡æ€§è…ºåˆºæ¿€ç´ é‡‹æ”¾æ¿€ç´ æ‹®æŠ—åŠ‘ï¼ˆGnRH antagonist)併用,使用於控制下刺激åµå·¢ï¼Œä»¥èª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ã€‚注射液注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Corifollitropin alfa美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720ORGANON (IRELAND) LTD.P.O. BOX 2857, DRYNAM ROAD, SWORDS, CO., DUBLIN, IRELANDIRELAND2014-08-19注射é‡ç’;;ç›’è£Elonva Solution for Injection 100ug/0.5ml皮下注射。詳如仿單所述。
衛署èŒç–«è¼¸å—第000904號2015-11-122010-11-12èŒã€€ç–«DHA01000090404伊諾娃注射液 100 微克/0.5 毫å‡åœ¨å©¦å¥³æŽ¥å—人工å”助生殖技術計劃時,本å“èˆ‡æ€§è…ºåˆºæ¿€ç´ é‡‹æ”¾æ¿€ç´ æ‹®æŠ—åŠ‘ï¼ˆGnRH antagonist)併用,使用於控制下刺激åµå·¢ï¼Œä»¥èª˜å°Žå¤šå€‹æ¿¾æ³¡ç™¼è‚²ã€‚注射液注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Corifollitropin alfa美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720VETTER PHARMA-FERTIGUNG GMBH & CO. KG FOR N.V. ORGANONSCHUTZENSTRASSE 87 AND 99/101, D-88212 RAVENSBURG, GERMANYGERMANY2014-08-19注射é‡ç’;;ç›’è£Elonva Solution for Injection 100ug/0.5ml皮下注射。詳如仿單所述。
衛署èŒç–«è¼¸å—第000905號2015-11-152010-11-15èŒã€€ç–«DHA01000090506易來力å‡æ™¶æ³¨å°„劑150毫克Ilarisé©ç”¨æ–¼æ²»ç™‚æˆäººã€é’å°‘å¹´åŠ4æ²ä»¥ä¸Šå…’ç«¥(é«”é‡è¶…éŽ15kg)之Cryopyrin相關週期性症候群(CAPS),包括:嚴é‡åž‹çš„家æ—æ€§å†·å› æ€§è‡ªé«”ç™¼ç‚Žç—‡å€™ç¾¤(FCAS)/家æ—性寒冷è•éº»ç–¹(FCU)ã€Muckle-Wells症候群(MWS)ã€æ–°ç”Ÿå…’多é‡ç³»çµ±ç™¼ç‚Žç–¾ç—…(NOMID)/慢性嬰兒神經å¸ã€çš®è†šã€é—œç¯€ç—‡å€™ç¾¤(CINCA)。å‡æ™¶æ³¨å°„劑瓶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Canakinumabå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS PHARMA S.A.S.8, RUE DE L'INDUSTRIE, 68330 HUNINGUE, FRANCEFRANCE2013-10-07瓶è£;;ç›’è£Ilaris 150 mg powder for solution for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000905號2015-11-152010-11-15èŒã€€ç–«DHA01000090506易來力å‡æ™¶æ³¨å°„劑150毫克Ilarisé©ç”¨æ–¼æ²»ç™‚æˆäººã€é’å°‘å¹´åŠ4æ²ä»¥ä¸Šå…’ç«¥(é«”é‡è¶…éŽ15kg)之Cryopyrin相關週期性症候群(CAPS),包括:嚴é‡åž‹çš„家æ—æ€§å†·å› æ€§è‡ªé«”ç™¼ç‚Žç—‡å€™ç¾¤(FCAS)/家æ—性寒冷è•éº»ç–¹(FCU)ã€Muckle-Wells症候群(MWS)ã€æ–°ç”Ÿå…’多é‡ç³»çµ±ç™¼ç‚Žç–¾ç—…(NOMID)/慢性嬰兒神經å¸ã€çš®è†šã€é—œç¯€ç—‡å€™ç¾¤(CINCA)。å‡æ™¶æ³¨å°„劑瓶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Canakinumabå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS PHARMA STEIN AGSCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLANDSWITZERLAND2013-10-07瓶è£;;ç›’è£Ilaris 150 mg powder for solution for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000905號2015-11-152010-11-15èŒã€€ç–«DHA01000090506易來力å‡æ™¶æ³¨å°„劑150毫克Ilarisé©ç”¨æ–¼æ²»ç™‚æˆäººã€é’å°‘å¹´åŠ4æ²ä»¥ä¸Šå…’ç«¥(é«”é‡è¶…éŽ15kg)之Cryopyrin相關週期性症候群(CAPS),包括:嚴é‡åž‹çš„家æ—æ€§å†·å› æ€§è‡ªé«”ç™¼ç‚Žç—‡å€™ç¾¤(FCAS)/家æ—性寒冷è•éº»ç–¹(FCU)ã€Muckle-Wells症候群(MWS)ã€æ–°ç”Ÿå…’多é‡ç³»çµ±ç™¼ç‚Žç–¾ç—…(NOMID)/慢性嬰兒神經å¸ã€çš®è†šã€é—œç¯€ç—‡å€™ç¾¤(CINCA)。å‡æ™¶æ³¨å°„劑瓶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Canakinumabå°ç£è«¾è¯è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市ä¸æ£å€ä»æ„›è·¯äºŒæ®µ99號11ã€12ã€13樓01516589NOVARTIS PHARMA AGLICHTSTRASSE 35, 4056 BASEL, SWITZERLANDSWITZERLAND2013-10-07瓶è£;;ç›’è£Ilaris 150 mg powder for solution for injectionè«‹åƒç…§ä»¿å–®èªªæ˜Žã€‚
衛署èŒç–«è¼¸å—第000924號2017-06-142012-06-14èŒã€€ç–«DHA01000092400癌骨瓦 注射液XGEVAé©ç”¨æ–¼é 防後期惡性腫瘤已擴散至骨骼的患者發生骨骼相關事件。注射液å°ç“¶è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨Denosumabè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438AMGEN MANUFACTURING,LIMITEDSTATE ROAD 31, KILOMETER 24.6, JUNCOS, PUERTO RICO 00777PUERTO RICO2014-08-19å°ç“¶è£;;ç›’è£XGEVAXGEVA的建è°åŠ‘é‡ç‚ºæ¯4週一次於大腿ã€è…¹éƒ¨æˆ–上臂皮下注射120毫克。
衛署èŒç–«è¼¸å—第000906號2015-11-182010-11-18èŒã€€ç–«DHA01000090608沛兒肺炎éˆçƒèŒå三價çµåˆåž‹ç–«è‹—å¯ç”¨æ–¼å‡ºç”Ÿ2個月至17æ²å¬°å…’åŠå…’童與é’少年的主動å…疫接種,以é 防血清型1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19FåŠ23Fç‰è‚ºç‚ŽçƒèŒ(Streptococcus pneumoniae)所引起的侵入性疾病。沛兒肺炎éˆçƒèŒå三價çµåˆåž‹ç–«è‹—也å¯ç”¨æ–¼é 防2æ²ä»¥ä¸‹å¬°å¹¼å…’血清型4, 6B, 9V, 14, 18C, 19FåŠ23F肺炎éˆçƒèŒå¼•èµ·çš„ä¸è€³ç‚Žã€‚本疫苗å¯ç”¨æ–¼18æ²(å«)以上之æˆäººèˆ‡è€å¹´äººçš„主動å…疫接種,以é 防血清型1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A,19FåŠ23Fç‰è‚ºç‚ŽéˆçƒèŒ(Streptococcus pneumoniae)所引起的侵入性疾病。注射劑é 充填注射é‡ç’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14;;OLIGOSACCHARIDE SEROTYPE 18C;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F;;CRM197 CARRIER PROTEIN;;ALUMINUM PHOSPHATEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH PHARMACEUTICALSNEW LANE, HAVANT, HAMPSHIRE, PO9 2NG, UNITED KINGDOMUNITED KINGDOM2014-12-11é 充填注射é‡ç’è£Prevenar 13, Pneumococcal 13-Valent Conjugate Vaccineè«‹åƒè¦‹ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000906號2015-11-182010-11-18èŒã€€ç–«DHA01000090608沛兒肺炎éˆçƒèŒå三價çµåˆåž‹ç–«è‹—å¯ç”¨æ–¼å‡ºç”Ÿ2個月至17æ²å¬°å…’åŠå…’童與é’少年的主動å…疫接種,以é 防血清型1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19FåŠ23Fç‰è‚ºç‚ŽçƒèŒ(Streptococcus pneumoniae)所引起的侵入性疾病。沛兒肺炎éˆçƒèŒå三價çµåˆåž‹ç–«è‹—也å¯ç”¨æ–¼é 防2æ²ä»¥ä¸‹å¬°å¹¼å…’血清型4, 6B, 9V, 14, 18C, 19FåŠ23F肺炎éˆçƒèŒå¼•èµ·çš„ä¸è€³ç‚Žã€‚本疫苗å¯ç”¨æ–¼18æ²(å«)以上之æˆäººèˆ‡è€å¹´äººçš„主動å…疫接種,以é 防血清型1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A,19FåŠ23Fç‰è‚ºç‚ŽéˆçƒèŒ(Streptococcus pneumoniae)所引起的侵入性疾病。注射劑é 充填注射é‡ç’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14;;OLIGOSACCHARIDE SEROTYPE 18C;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F;;CRM197 CARRIER PROTEIN;;ALUMINUM PHOSPHATEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410Pfizer Ireland PharmaceuticalsGrange Castle Business Park, Clondalkin, Dublin 22, IrelandIRELAND2014-12-11é 充填注射é‡ç’è£Prevenar 13, Pneumococcal 13-Valent Conjugate Vaccineè«‹åƒè¦‹ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000906號2015-11-182010-11-18èŒã€€ç–«DHA01000090608沛兒肺炎éˆçƒèŒå三價çµåˆåž‹ç–«è‹—å¯ç”¨æ–¼å‡ºç”Ÿ2個月至17æ²å¬°å…’åŠå…’童與é’少年的主動å…疫接種,以é 防血清型1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19FåŠ23Fç‰è‚ºç‚ŽçƒèŒ(Streptococcus pneumoniae)所引起的侵入性疾病。沛兒肺炎éˆçƒèŒå三價çµåˆåž‹ç–«è‹—也å¯ç”¨æ–¼é 防2æ²ä»¥ä¸‹å¬°å¹¼å…’血清型4, 6B, 9V, 14, 18C, 19FåŠ23F肺炎éˆçƒèŒå¼•èµ·çš„ä¸è€³ç‚Žã€‚本疫苗å¯ç”¨æ–¼18æ²(å«)以上之æˆäººèˆ‡è€å¹´äººçš„主動å…疫接種,以é 防血清型1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A,19FåŠ23Fç‰è‚ºç‚ŽéˆçƒèŒ(Streptococcus pneumoniae)所引起的侵入性疾病。注射劑é 充填注射é‡ç’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14;;OLIGOSACCHARIDE SEROTYPE 18C;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F;;CRM197 CARRIER PROTEIN;;ALUMINUM PHOSPHATEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH PHARMACEUTICAL DIVISION OF WYETH HOLDINGS CORPORATION,A SUBSIDIARY OF PFIZER INC.4300 OAK PARK, SANFORD, NORTH CAROLINA 27330, U.S.A.UNITED STATES2014-12-11é 充填注射é‡ç’è£Prevenar 13, Pneumococcal 13-Valent Conjugate Vaccineè«‹åƒè¦‹ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000906號2015-11-182010-11-18èŒã€€ç–«DHA01000090608沛兒肺炎éˆçƒèŒå三價çµåˆåž‹ç–«è‹—å¯ç”¨æ–¼å‡ºç”Ÿ2個月至17æ²å¬°å…’åŠå…’童與é’少年的主動å…疫接種,以é 防血清型1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19FåŠ23Fç‰è‚ºç‚ŽçƒèŒ(Streptococcus pneumoniae)所引起的侵入性疾病。沛兒肺炎éˆçƒèŒå三價çµåˆåž‹ç–«è‹—也å¯ç”¨æ–¼é 防2æ²ä»¥ä¸‹å¬°å¹¼å…’血清型4, 6B, 9V, 14, 18C, 19FåŠ23F肺炎éˆçƒèŒå¼•èµ·çš„ä¸è€³ç‚Žã€‚本疫苗å¯ç”¨æ–¼18æ²(å«)以上之æˆäººèˆ‡è€å¹´äººçš„主動å…疫接種,以é 防血清型1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A,19FåŠ23Fç‰è‚ºç‚ŽéˆçƒèŒ(Streptococcus pneumoniae)所引起的侵入性疾病。注射劑é 充填注射é‡ç’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14;;OLIGOSACCHARIDE SEROTYPE 18C;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F;;CRM197 CARRIER PROTEIN;;ALUMINUM PHOSPHATEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH PHARMACEUTICAL DIVISION OF WYETH HOLDINGS CORPORATION401 NORTH MIDDLETOWN ROAD., PEARL RIVER, NY 10965-1299, U.S.A.UNITED STATES2014-12-11é 充填注射é‡ç’è£Prevenar 13, Pneumococcal 13-Valent Conjugate Vaccineè«‹åƒè¦‹ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000914號2016-03-032011-03-03èŒã€€ç–«DHA01000091407胰妥善注射液第2型糖尿病。當患者已接å—metformin或sulphonylurea單一治療至最大å¯å¿å—劑é‡ä»æœªé”ç†æƒ³è¡€ç³–控制時,與metformin或sulphonylurea併用;或當患者已接å—metforminåŠ ä¸Šsulphonylurea或metforminåŠ ä¸Šthiazolidinedione兩種藥物治療ä»æœªé”ç†æƒ³è¡€ç³–控制時,與metforminåŠ ä¸Šsulphonylurea或metforminåŠ ä¸Šthiazolidinedione併用。注射劑注射ç†è£;;支è£é™ç”±é†«å¸«ä½¿ç”¨LIRAGLUTIDE臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SBRENNUM PARK DK-3400 HILLEROD DENMARKDENMARK2013-05-27注射ç†è£;;支è£Victozaè©³è¦‹ç¶“è¡›ç”Ÿç½²æ ¸å‡†ä¹‹ä»¿å–®
衛署èŒç–«è¼¸å—第000906號2015-11-182010-11-18èŒã€€ç–«DHA01000090608沛兒肺炎éˆçƒèŒå三價çµåˆåž‹ç–«è‹—å¯ç”¨æ–¼å‡ºç”Ÿ2個月至17æ²å¬°å…’åŠå…’童與é’少年的主動å…疫接種,以é 防血清型1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19FåŠ23Fç‰è‚ºç‚ŽçƒèŒ(Streptococcus pneumoniae)所引起的侵入性疾病。沛兒肺炎éˆçƒèŒå三價çµåˆåž‹ç–«è‹—也å¯ç”¨æ–¼é 防2æ²ä»¥ä¸‹å¬°å¹¼å…’血清型4, 6B, 9V, 14, 18C, 19FåŠ23F肺炎éˆçƒèŒå¼•èµ·çš„ä¸è€³ç‚Žã€‚本疫苗å¯ç”¨æ–¼18æ²(å«)以上之æˆäººèˆ‡è€å¹´äººçš„主動å…疫接種,以é 防血清型1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A,19FåŠ23Fç‰è‚ºç‚ŽéˆçƒèŒ(Streptococcus pneumoniae)所引起的侵入性疾病。注射劑é 充填注射é‡ç’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14;;OLIGOSACCHARIDE SEROTYPE 18C;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F;;PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F;;CRM197 CARRIER PROTEIN;;ALUMINUM PHOSPHATEç¾Žå•†æƒ æ°è—¥å» (亞洲)股份有é™å…¬å¸å°ç£åˆ†å…¬å¸æ–°åŒ—市淡水å€ä¸æ£æ±è·¯äºŒæ®µ177號23984410WYETH BIOPHARMA DIVISION OF WYETH PHARMACEUTICALS INC, A SUBSIDIARY OF PFIZER INC.ONE BURTT ROAD, ANDOVER, MA 01810, USAUNITED STATES2014-12-11é 充填注射é‡ç’è£Prevenar 13, Pneumococcal 13-Valent Conjugate Vaccineè«‹åƒè¦‹ä»¿å–®ã€‚
衛署èŒç–«è¼¸å—第000907號2016-07-012011-07-01èŒã€€ç–«DHA01000090700安挺樂 éœè„ˆé»žæ»´æ³¨å°„劑類風濕性關節炎(RA)-Actemra åˆä½µMethotrexate(MTX)å¯ç”¨æ–¼æ²»ç™‚æˆå¹´äººä¸åº¦è‡³é‡åº¦é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žï¼Œæ›¾ä½¿ç”¨ä¸€ç¨®æˆ–一種以上之DMARD藥物治療或腫瘤壞æ»å› å拮抗劑(TNF antagonist)治療而å應ä¸ä½³æˆ–無法è€å—的患者。在這些患者ä¸ï¼Œè‹¥ç—…æ‚£å°MTX無法è€å—或ä¸é©åˆç¹¼çºŒæŠ•èˆ‡MTX,å¯çµ¦äºˆActemraå–®ç¨æ²»ç™‚。全身性幼年型原發性關節炎(SJIA)-Actemraé©ç”¨æ–¼æ²»ç™‚2æ²(å«)以上的活動性全身性幼年型原發性關節炎患者,且å°NSAIDåŠé¡žå›ºé†‡æ²»ç™‚å應ä¸ä½³æˆ–無法è€å—者。注射劑å°ç“¶;;å°ç“¶;;å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Tocilizumab臺ç£ä¸å¤–製藥股份有é™å…¬å¸å°åŒ—市內湖å€æ´²åè¡—73號3樓23060795UTSUNOMIYA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD.16-3 KIYOHARA KOGYODANCHI, UTSUNOMIYA-CITY, TOCHIGI, JAPANJAPAN2012-11-22å°ç“¶;;å°ç“¶;;å°ç“¶;;ç›’è£Actemra Solution for Infusion建è°èµ·å§‹åŠ‘é‡ç‚ºæ¯4週4mg/Kgï¼Œæ ¹æ“šè‡¨åºŠå應å¯å¢žåŠ 至æ¯4週8mg/Kg。
衛署èŒç–«è¼¸å—第000908號2016-01-122011-01-12èŒã€€ç–«DHA01000090802諾和密斯50諾易ç†ç³–尿病注射劑支è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN ASPART臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SNOVO ALLE DK-2880 BAGSVAERD DENMARKDENMARK2014-05-16支è£NovoMix 50 FlexPenè©³è¦‹ç¶“è¡›ç”Ÿç½²æ ¸å‡†ä¹‹ä»¿å–®
衛署èŒç–«è¼¸å—第000909號2016-01-122011-01-12èŒã€€ç–«DHA01000090901諾和密斯50諾芯管糖尿病注射劑支è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN ASPART臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SHALLAS ALLE, DK-4400 KALUNDBORG, DENMARKDENMARK2014-04-25支è£NovoMix 50 Penfillè©³è¦‹ç¶“è¡›ç”Ÿç½²æ ¸å‡†ä¹‹ä»¿å–®
衛署èŒç–«è¼¸å—第000910號2016-01-122011-01-12èŒã€€ç–«DHA01000091002愛微æ¢çº–ç¶è›‹ç™½å‡åˆåŠ‘組愛微æ¢é©ç”¨æ–¼æ‰‹è¡“ä¸ä½¿ç”¨æ¨™æº–外科æ¢è¡€æŠ€è¡“ä»ç„¡æ³•æœ‰æ•ˆæŽ§åˆ¶å‡ºè¡€æ™‚之輔助性治療,å”助æ¢è¡€.液劑盒è£;;玻璃å°ç“¶è£;;玻璃å°ç“¶è£;;玻璃å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨FIBRINOGEN HUMAN;;HUMAN THROMBIN壯生醫療器æ股份有é™å…¬å¸è‡ºåŒ—市大安å€æ•¦åŒ–å—路二段319號6樓16439055OMRIX BIOPHARMACEUTICALS LTD.MDA BLOOD BANK, SHEBA HOSPITAL, RAMAT GAN, POB 888, KIRYAT ONO 55000, ISRAELISRAEL2014-11-18ç›’è£;;玻璃å°ç“¶è£;;玻璃å°ç“¶è£;;玻璃å°ç“¶è£EVICEL Fibrin Sealant使用é™åˆ¶ï¼šé™æœ‰å—éŽè¨“練並有使用愛微æ¢ç¶“驗之外科醫師æ‰å¯ä½¿ç”¨æœ¬ç”¢å“。用é‡ï¼šå‹™å¿…按照患者之基本臨床需求,調整愛微æ¢ä¹‹ç”¨é‡èˆ‡æ–½ç”¨æ¬¡æ•¸ã€‚本產å“之用é‡å–æ±ºæ–¼å¤šé …è®Šæ•¸ï¼ŒåŒ…æ‹¬ä½†ä¸é™æ–¼ï¼šæ‰‹è¡“治療類型ã€é¢ç©å¤§å°ã€é 期施用方å¼èˆ‡æ–½ç”¨æ¬¡æ•¸ã€‚本產å“é ˆç”±æ²»ç™‚é†«å¸«è¦–ç‹€æ³æ–½ç”¨ï¼›åœ¨è‡¨åºŠè©¦é©—ä¸ï¼Œè¡€ç®¡æ‰‹è¡“之æ¯æ¬¡ç”¨é‡æœ€é«˜ç‚º4mL,腹膜腔後或腹腔內手術之æ¯æ¬¡ç”¨é‡æœ€é«˜ç‚º10mLï¼›ä¸éŽæœ‰äº›æ‰‹è¡“å¯èƒ½éœ€è¦æ›´é«˜ç”¨é‡ã€‚產å“æ–¼é¸å®šçµ„織部ä½æˆ–目標表é¢å€åŸŸä¹‹æœ€åˆç”¨é‡ï¼Œæ‡‰è¶³ä»¥å®Œå…¨è¦†è“‹é 期施用範園;必è¦æ™‚å¯é‡è¤‡æ–½ç”¨ã€‚給藥方å¼èˆ‡è·¯å¾‘:é©ç”¨æ–¼å‚·å£è¡¨é¢ã€‚為é¿å…å¯èƒ½è‡´å‘½ä¹‹æ°£é«”æ “å¡žï¼Œæ„›å¾®æ¢åƒ…é™ä»¥äºŒæ°§åŒ–ç¢³åŠ å£“ä¹‹çµ¦è—¥è£ç½®å™´ç‘使用。施用愛微æ¢ä¹‹å‰ï¼Œæ‡‰ä»¥æ¨™æº–技術(例如間æ‡åŠ 壓ã€æ£‰èŠ±ã€æŠ½å¸è£ç½®)確ä¿å‚·å£è¡¨é¢ä¹¾ç‡¥ã€‚本產å“僅é™æŒ‰ç…§æŒ‡ç¤ºé…製,並æé…本產å“建è°ä¹‹è£ç½®çµ¦è—¥ã€‚æ ¹æ“šä¸åŒå¤–科手術類型與所用噴嘴長度,噴ç‘時所需壓力以åŠèˆ‡çµ„織之間è·é›¢å»ºè°å€¼ï¼Œè«‹åƒè€ƒç« 節「è¦èªžåŠä½¿ç”¨æ³¨æ„äº‹é …ã€èˆ‡ã€Œä½¿ç”¨ã€è™•ç†èˆ‡å»¢æ£„物處置說明ã€ä¹‹å£“力與è·é›¢è¡¨ã€‚
衛署èŒç–«è¼¸å—第000911號2016-06-112011-06-11èŒã€€ç–«DHA01000091101欣普尼 注射液類風濕性關節炎:欣普尼SIMPONI與methotrexate併用é©ç”¨æ–¼æ²»ç™‚ä¸è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žæˆäººæ‚£è€…。僵直性脊椎炎:欣普尼SIMPONIé©ç”¨æ–¼æ²»ç™‚活動性僵直性脊椎炎æˆäººæ‚£è€…。乾癬性關節炎:欣普尼SIMPONIå–®ç¨ä½¿ç”¨æˆ–與methotrexate併用é©ç”¨æ–¼æ²»ç™‚å°ç–¾ç—…修飾性抗風濕藥物(DMARDs)無效之活動性乾癬性關節炎æˆäººæ‚£è€…。注射劑注射é‡ç’;;自動注射器(SmartJect autoinjector)é™ç”±é†«å¸«ä½¿ç”¨Golimumab嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854JANSSEN BIOLOGICS B.V.EINSTEINWEG 101, 2333 CB LEIDEN, THE NETHERLANDSNETHERLANDS2014-12-11注射é‡ç’;;自動注射器(SmartJect autoinjector)Simponi TM (golimumab),Solution for Injection詳見仿單
衛署èŒç–«è¼¸å—第000915號2016-03-102011-03-10èŒã€€ç–«DHA01000091509å€å•åŠ›å‡æ™¶æ³¨å°„åŠ‘ä½¿ç”¨æ–¼é»ƒé«”åˆºæ¿€æ¿€ç´ (LH)èˆ‡æ¿¾æ³¡åˆºæ¿€æ¿€ç´ (FSH)åš´é‡ç¼ºä¹çš„婦女,以刺激濾泡發育。æ¤é¡žæ‚£è€…臨床試驗ä¸å®šç¾©ç‚ºå…§ç”Ÿæ€§é»ƒé«”åˆºæ¿€æ¿€ç´ è¡€ä¸æ¿ƒåº¦å°‘æ–¼1.2 IU/Lå‡æ™¶ä¹¾ç‡¥æ³¨å°„劑瓶è£é™„ç‰æ”¯æ•¸1mL溶劑;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH);;RECOMBINANT HUMAN LUTENISING HORMONEå°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2014-11-13瓶è£é™„ç‰æ”¯æ•¸1mL溶劑;;ç›’è£Pergoverisä¾ä»¿å–®æ‰€ç¤ºã€‚
衛署èŒç–«è¼¸å—第000911號2016-06-112011-06-11èŒã€€ç–«DHA01000091101欣普尼 注射液類風濕性關節炎:欣普尼SIMPONI與methotrexate併用é©ç”¨æ–¼æ²»ç™‚ä¸è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žæˆäººæ‚£è€…。僵直性脊椎炎:欣普尼SIMPONIé©ç”¨æ–¼æ²»ç™‚活動性僵直性脊椎炎æˆäººæ‚£è€…。乾癬性關節炎:欣普尼SIMPONIå–®ç¨ä½¿ç”¨æˆ–與methotrexate併用é©ç”¨æ–¼æ²»ç™‚å°ç–¾ç—…修飾性抗風濕藥物(DMARDs)無效之活動性乾癬性關節炎æˆäººæ‚£è€…。注射劑注射é‡ç’;;自動注射器(SmartJect autoinjector)é™ç”±é†«å¸«ä½¿ç”¨Golimumab嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854CILAG AG,SWITZERLANDHOCHSTRASSE 201,8205 SCHAFFHAUSEN , SWITZERLANDSWITZERLAND2014-12-11注射é‡ç’;;自動注射器(SmartJect autoinjector)Simponi TM (golimumab),Solution for Injection詳見仿單
衛署èŒç–«è¼¸å—第000911號2016-06-112011-06-11èŒã€€ç–«DHA01000091101欣普尼 注射液類風濕性關節炎:欣普尼SIMPONI與methotrexate併用é©ç”¨æ–¼æ²»ç™‚ä¸è‡³é‡åº¦æ´»å‹•æ€§é¡žé¢¨æ¿•æ€§é—œç¯€ç‚Žæˆäººæ‚£è€…。僵直性脊椎炎:欣普尼SIMPONIé©ç”¨æ–¼æ²»ç™‚活動性僵直性脊椎炎æˆäººæ‚£è€…。乾癬性關節炎:欣普尼SIMPONIå–®ç¨ä½¿ç”¨æˆ–與methotrexate併用é©ç”¨æ–¼æ²»ç™‚å°ç–¾ç—…修飾性抗風濕藥物(DMARDs)無效之活動性乾癬性關節炎æˆäººæ‚£è€…。注射劑注射é‡ç’;;自動注射器(SmartJect autoinjector)é™ç”±é†«å¸«ä½¿ç”¨Golimumab嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854BAXTER PHARMACEUTICAL SOLUTIONS LLC927 SOUTH CURRY PIKE, BLOOMINGTON, IN 47403 USAUNITED STATES2014-12-11注射é‡ç’;;自動注射器(SmartJect autoinjector)Simponi TM (golimumab),Solution for Injection詳見仿單
衛署èŒç–«è¼¸å—第000912號2016-01-132011-01-13èŒã€€ç–«DHA01000091203â€å·´æ–¯å¾·â€å››åˆä¸€è£œè¿½ç–«è‹—本疫苗é©ç”¨æ–¼4-64æ²é–“ä¹‹è¿½åŠ ç–«è‹—æŽ¥ç¨®ï¼Œä»¥é 防白喉ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³åŠå°å…’麻痺。懸浮注射液é 充填型注射器附é‡é é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PERTUSSIS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;AGGLUTINOGENS FIMBRIAE 2+3;;PERTACTIN;;DIPHTHERIA TOXOID;;TETANUS TOXOID;;INACTIVATED POLIOVIRUS VACCINE TYPE I;;INACTIVATED POLIOVIRUS VACCINE TYPE II;;INACTIVATED POLIOVIRUS VACCINE TYPE III賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR LIMITED1755 STEELES AVENUE WEST, TORONTO, ONTARIO, CANADA, M2R 3T4CANADA2014-11-03é 充填型注射器附é‡é Adacel Polio一劑為0.5mL。本疫苗應以肌肉注射方å¼æŠ•äºˆã€‚
衛署èŒç–«è¼¸å—第000912號2016-01-132011-01-13èŒã€€ç–«DHA01000091203â€å·´æ–¯å¾·â€å››åˆä¸€è£œè¿½ç–«è‹—本疫苗é©ç”¨æ–¼4-64æ²é–“ä¹‹è¿½åŠ ç–«è‹—æŽ¥ç¨®ï¼Œä»¥é 防白喉ã€ç ´å‚·é¢¨ã€ç™¾æ—¥å’³åŠå°å…’麻痺。懸浮注射液é 充填型注射器附é‡é é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PERTUSSIS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;AGGLUTINOGENS FIMBRIAE 2+3;;PERTACTIN;;DIPHTHERIA TOXOID;;TETANUS TOXOID;;INACTIVATED POLIOVIRUS VACCINE TYPE I;;INACTIVATED POLIOVIRUS VACCINE TYPE II;;INACTIVATED POLIOVIRUS VACCINE TYPE III賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI PASTEUR S.A.1541, AV. MARCEL MERIEUX, 69280 MARCY L'ETOILE, FRANCEFRANCE2014-11-03é 充填型注射器附é‡é Adacel Polio一劑為0.5mL。本疫苗應以肌肉注射方å¼æŠ•äºˆã€‚
衛署èŒç–«è¼¸å—第000913號2016-01-312011-01-31èŒã€€ç–«DHA01000091305"國血製劑益康"人冷å‡ä¹¾ç‡¥è¤‡åˆå‡è¡€æ¯åŽŸé 防或治療一種或多種先天性或後天性第ä¹ã€ç¬¬äºŒæˆ–第åå‡è¡€å› å缺ä¹ç—‡ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑瓶è£;;瓶è£æ³¨å°„用水é™ç”±é†«å¸«ä½¿ç”¨FACTOR IX;;FACTOR II;;FACTOR X醫療財團法人å°ç£è¡€æ¶²åŸºé‡‘會å°åŒ—市ä¸æ£å€å—海路3號3樓01010553CSL LIMITED189-209 CAMP ROAD BROADMEADOWS VICTORIA 3047 AUSTRALIAAUSTRALIA2014-03-03瓶è£;;瓶è£æ³¨å°„用水"TBSF" Prothrombin Complex Concentrate詳見仿單。
衛署èŒç–«è¼¸å—第000913號2016-01-312011-01-31èŒã€€ç–«DHA01000091305"國血製劑益康"人冷å‡ä¹¾ç‡¥è¤‡åˆå‡è¡€æ¯åŽŸé 防或治療一種或多種先天性或後天性第ä¹ã€ç¬¬äºŒæˆ–第åå‡è¡€å› å缺ä¹ç—‡ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑瓶è£;;瓶è£æ³¨å°„用水é™ç”±é†«å¸«ä½¿ç”¨FACTOR IX;;FACTOR II;;FACTOR X醫療財團法人å°ç£è¡€æ¶²åŸºé‡‘會å°åŒ—市ä¸æ£å€å—海路3號3樓01010553CSL BEHRING GMBHEMIL-VON-BEHRING-STRASSE 76, 35041 MARBURG GERMANYGERMANY2014-03-03瓶è£;;瓶è£æ³¨å°„用水"TBSF" Prothrombin Complex Concentrate詳見仿單。
衛署èŒç–«è¼¸å—第000914號2016-03-032011-03-03èŒã€€ç–«DHA01000091407胰妥善注射液第2型糖尿病。當患者已接å—metformin或sulphonylurea單一治療至最大å¯å¿å—劑é‡ä»æœªé”ç†æƒ³è¡€ç³–控制時,與metformin或sulphonylurea併用;或當患者已接å—metforminåŠ ä¸Šsulphonylurea或metforminåŠ ä¸Šthiazolidinedione兩種藥物治療ä»æœªé”ç†æƒ³è¡€ç³–控制時,與metforminåŠ ä¸Šsulphonylurea或metforminåŠ ä¸Šthiazolidinedione併用。注射劑注射ç†è£;;支è£é™ç”±é†«å¸«ä½¿ç”¨LIRAGLUTIDE臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SNOVO ALLE, DK-2880 BAGSVAERD, DENMARKDENMARK2013-05-27注射ç†è£;;支è£Victozaè©³è¦‹ç¶“è¡›ç”Ÿç½²æ ¸å‡†ä¹‹ä»¿å–®
衛署èŒç–«è¼¸å—第000914號2016-03-032011-03-03èŒã€€ç–«DHA01000091407胰妥善注射液第2型糖尿病。當患者已接å—metformin或sulphonylurea單一治療至最大å¯å¿å—劑é‡ä»æœªé”ç†æƒ³è¡€ç³–控制時,與metformin或sulphonylurea併用;或當患者已接å—metforminåŠ ä¸Šsulphonylurea或metforminåŠ ä¸Šthiazolidinedione兩種藥物治療ä»æœªé”ç†æƒ³è¡€ç³–控制時,與metforminåŠ ä¸Šsulphonylurea或metforminåŠ ä¸Šthiazolidinedione併用。注射劑注射ç†è£;;支è£é™ç”±é†«å¸«ä½¿ç”¨LIRAGLUTIDE臺ç£è«¾å’Œè«¾å¾·è—¥å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號7樓ï¼ï¼‘23528693NOVO NORDISK A/SHALLAS ALLE, DK-4400 KALUNDBORG, DENMARKDENMARK2013-05-27注射ç†è£;;支è£Victozaè©³è¦‹ç¶“è¡›ç”Ÿç½²æ ¸å‡†ä¹‹ä»¿å–®
衛署èŒç–«è¼¸å—第000915號2016-03-102011-03-10èŒã€€ç–«DHA01000091509å€å•åŠ›å‡æ™¶æ³¨å°„åŠ‘ä½¿ç”¨æ–¼é»ƒé«”åˆºæ¿€æ¿€ç´ (LH)èˆ‡æ¿¾æ³¡åˆºæ¿€æ¿€ç´ (FSH)åš´é‡ç¼ºä¹çš„婦女,以刺激濾泡發育。æ¤é¡žæ‚£è€…臨床試驗ä¸å®šç¾©ç‚ºå…§ç”Ÿæ€§é»ƒé«”åˆºæ¿€æ¿€ç´ è¡€ä¸æ¿ƒåº¦å°‘æ–¼1.2 IU/Lå‡æ™¶ä¹¾ç‡¥æ³¨å°„劑瓶è£é™„ç‰æ”¯æ•¸1mL溶劑;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨FOLLITROPIN ALFA(r-hFSH);;RECOMBINANT HUMAN LUTENISING HORMONEå°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO SA. AUBONNE BRANCHZONE INDUSTRIELLE DE L'OURIETTAZ 1170 AUBONNE, SWITZERLANDSWITZERLAND2014-11-13瓶è£é™„ç‰æ”¯æ•¸1mL溶劑;;ç›’è£Pergoverisä¾ä»¿å–®æ‰€ç¤ºã€‚
衛署èŒç–«è¼¸å—第000916號2016-03-082011-03-08èŒã€€ç–«DHA01000091601平禽律疫苗用於18æ²è‡³60æ²çš„æˆäººä¸»å‹•å…疫接種,以é 防H5N1ç—…æ¯’æ ªæ‰€å¼•èµ·çš„æµæ„Ÿã€‚懸浮注射劑å°ç“¶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨Purified antigen fractions of inactivated split virions A/Indonesia/05/2005 (H5N1) PR8-IBCDC-RG2;;SQUALENE;;TOCOPHEROL ALPHA DL- (EQ TO DL-ALPHA TOCOPHEROL);;TWEEN 80 (EQ TO POLYSORBATE 80)è·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89, RUE DE 1'INSTITUT B-1330 RIXENSART, BELGIUMBELGIUM2014-08-19å°ç“¶è£Prepandrix TM如仿單。
衛署èŒç–«è¼¸å—第000916號2016-03-082011-03-08èŒã€€ç–«DHA01000091601平禽律疫苗用於18æ²è‡³60æ²çš„æˆäººä¸»å‹•å…疫接種,以é 防H5N1ç—…æ¯’æ ªæ‰€å¼•èµ·çš„æµæ„Ÿã€‚懸浮注射劑å°ç“¶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨Purified antigen fractions of inactivated split virions A/Indonesia/05/2005 (H5N1) PR8-IBCDC-RG2;;SQUALENE;;TOCOPHEROL ALPHA DL- (EQ TO DL-ALPHA TOCOPHEROL);;TWEEN 80 (EQ TO POLYSORBATE 80)è·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS, BRANCH OF SMITHKLINE BEECHAM PHARMA GMBH & CO. KGZIRKUSSTR 40, 01069 DRESDEN, GERMANYGERMANY2014-08-19å°ç“¶è£Prepandrix TM如仿單。
衛署èŒç–«è¼¸å—第000917號2016-03-222011-03-22èŒã€€ç–«DHA01000091700å¹³æµæ„Ÿç–«è‹—é 防æµæ„Ÿæ‡¸æµ®æ³¨å°„劑å°ç“¶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/California/7/2009(H1N1)-like virus;;A/Perth/16/2009 (H3N2)-like virus;;B/Brisbane/60/2008-like virusè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438ID BIOMEDICAL CORPORATION2323 PARC TECHNOLOGIQUE BLVD. SAINTE-FOY, QUEBEC, CANADA, G1P 4R8CANADA2014-08-19å°ç“¶è£FluLaval詳見仿單
衛署èŒç–«è¼¸å—第000925號2017-01-302012-01-30èŒã€€ç–«DHA01000092502"百特"組織修復å‡åˆåŠ‘(第二代)標準手術技術ä¸è¶³æ™‚的輔助療法,å”助æ¢è¡€ã€‚說明: (1) è«‹åƒè€ƒ5.1 藥物藥效å¸ç‰¹æ€§ã€‚ (2) 在æŸäº›è‡¨åºŠè©¦é©—,充份給予è‚ç´ çš„ç—…äººèº«ä¸Šå·²è‰å¯¦ç”¢å“的療效。注射劑毫å‡è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨PROTEIN CLOTTABLE ( HUMAN ) ( FIBRINOGEN 70-110mg, PLASMAFIBRONECTIN 2-9mg, PLASMINOGEN 0.04-0.12mg);;APROTININ ( BOVINE);;THROMBIN;;CALCIUM CHLORIDE百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER AGA-1220 VIENNA, INDUSTRIESTRASSES 67, AUSTRIA.AUSTRIA2014-11-18毫å‡è£Tisseel Solution for sealant請詳見產å“仿單
衛署èŒç–«è¼¸å—第000918號2016-08-182011-08-18èŒã€€ç–«DHA01000091802ä¿éª¼éº—注射液治療有骨折高風險性之åœç¶“後婦女骨質ç–鬆症。說明:有骨折高風險性之åœç¶“後婦女骨質ç–鬆症,包å«ä¸‹åˆ—任一狀æ³ï¼šæœ‰éª¨è³ªç–鬆症骨折病å²ã€å…·æœ‰å¤šé …骨折å±éšªå› åã€å…ˆå‰æŽ¥å—其他骨質ç–鬆症療法失敗或無法è€å—其他骨質ç–鬆症療法之病患。å°æ‚£æœ‰éª¨è³ªç–鬆症之åœç¶“後婦女,Proliaå¯é™ä½Žè„Šæ¤Žã€éžè„Šæ¤Žå’Œé«–骨骨折的發生率。治療有高度骨折風險之骨質ç–é¬†ç—‡ç”·æ€§æ‚£è€…ï¼Œä»¥å¢žåŠ éª¨é‡(bone mass)。說明:Prolia é©ç”¨æ–¼æ²»ç™‚有高度骨折風險(定義為有骨質ç–鬆症骨折病å²ï¼Œæˆ–å…·æœ‰å¤šé …éª¨æŠ˜å±éšªå› å)之骨質ç–鬆症男性患者,或先å‰æ›¾æŽ¥å—其他骨質ç–鬆症療法失敗或無法è€å—其他骨質ç–é¬†ç—‡ç™‚æ³•çš„æ‚£è€…ï¼Œä»¥å¢žåŠ éª¨é‡(bone mass)ã€‚æ²»ç™‚å› ç‚ºéžè½‰ç§»æ€§æ”è·è…ºç™Œè€Œé€²è¡Œé›„性è·çˆ¾è’™æŠ‘制治療且具高度骨折風險之男性患者的骨質æµå¤±ç¾è±¡ã€‚注射劑é 充填型注射é‡å™¨é™„é‡é 或ä¸é™„é‡é ;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Denosumabè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438AMGEN MANUFACTURING, LIMITEDSTATE ROAD 31, KILOMETER 24.6, JUNCOS, PUERTO RICO 00777PUERTO RICO2014-08-19é 充填型注射é‡å™¨é™„é‡é 或ä¸é™„é‡é ;;ç›’è£Prolia用法:施打本å“應由å—éŽé©ç•¶æ³¨å°„技巧訓練的人來進行。劑é‡:PROLIA 的建è°åŠ‘é‡ç‚ºæ¯6個月一次皮下注射單劑60毫克。患者在治療期間應使用鈣補充劑與ç¶ç”Ÿç´ D補充劑。
衛署èŒç–«è¼¸å—第000918號2016-08-182011-08-18èŒã€€ç–«DHA01000091802ä¿éª¼éº—注射液治療有骨折高風險性之åœç¶“後婦女骨質ç–鬆症。說明:有骨折高風險性之åœç¶“後婦女骨質ç–鬆症,包å«ä¸‹åˆ—任一狀æ³ï¼šæœ‰éª¨è³ªç–鬆症骨折病å²ã€å…·æœ‰å¤šé …骨折å±éšªå› åã€å…ˆå‰æŽ¥å—其他骨質ç–鬆症療法失敗或無法è€å—其他骨質ç–鬆症療法之病患。å°æ‚£æœ‰éª¨è³ªç–鬆症之åœç¶“後婦女,Proliaå¯é™ä½Žè„Šæ¤Žã€éžè„Šæ¤Žå’Œé«–骨骨折的發生率。治療有高度骨折風險之骨質ç–é¬†ç—‡ç”·æ€§æ‚£è€…ï¼Œä»¥å¢žåŠ éª¨é‡(bone mass)。說明:Prolia é©ç”¨æ–¼æ²»ç™‚有高度骨折風險(定義為有骨質ç–鬆症骨折病å²ï¼Œæˆ–å…·æœ‰å¤šé …éª¨æŠ˜å±éšªå› å)之骨質ç–鬆症男性患者,或先å‰æ›¾æŽ¥å—其他骨質ç–鬆症療法失敗或無法è€å—其他骨質ç–é¬†ç—‡ç™‚æ³•çš„æ‚£è€…ï¼Œä»¥å¢žåŠ éª¨é‡(bone mass)ã€‚æ²»ç™‚å› ç‚ºéžè½‰ç§»æ€§æ”è·è…ºç™Œè€Œé€²è¡Œé›„性è·çˆ¾è’™æŠ‘制治療且具高度骨折風險之男性患者的骨質æµå¤±ç¾è±¡ã€‚注射劑é 充填型注射é‡å™¨é™„é‡é 或ä¸é™„é‡é ;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Denosumabè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438BOEHRINGER INGELHEIM Pharma GmbH & Co. KGBIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS, GERMANYGERMANY2014-08-19é 充填型注射é‡å™¨é™„é‡é 或ä¸é™„é‡é ;;ç›’è£Prolia用法:施打本å“應由å—éŽé©ç•¶æ³¨å°„技巧訓練的人來進行。劑é‡:PROLIA 的建è°åŠ‘é‡ç‚ºæ¯6個月一次皮下注射單劑60毫克。患者在治療期間應使用鈣補充劑與ç¶ç”Ÿç´ D補充劑。
衛署èŒç–«è¼¸å—第000919號2016-09-082011-09-08èŒã€€ç–«DHA01000091904å€è¡€æ·»æ³¨å°„劑é©ç”¨æ–¼éžéª¨é«“性癌症患者在接å—易引起臨床上有顯著發生率的嗜ä¸æ€§ç™½è¡€çƒæ¸›å°‘ç—‡åˆä½µç™¼ç‡’之骨髓抑制性抗癌藥物治療時,以é™ä½Žå—œä¸æ€§ç™½è¡€çƒæ¸›å°‘ç—‡åˆä½µç™¼ç‡’為表ç¾ä¹‹æ„ŸæŸ“發生率。注射劑注射é‡ç’;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Pegfilgrastimå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780AMGEN MANUFACTURING, LIMITEDSTATE ROAD 31, KILOMETER 24.6, JUNCOS, PUERTO RICO 00777-4060PUERTO RICO2012-05-07注射é‡ç’;;ç›’è£Neulasta請詳åƒä»¿å–®å…§å®¹
衛署èŒç–«è¼¸å—第000920號2016-12-052011-12-05èŒã€€ç–«DHA01000092002å–œé”諾 TM 注射液1.乾癬(Ps)Stelaraé©ç”¨æ–¼æ²»ç™‚é©åˆæŽ¥å—光療法或全身性治療的ä¸è‡³é‡åº¦æ–‘塊性乾癬æˆäººæ‚£è€…(18æ²(å«)以上)。2.乾癬性關節炎(PsA)Stelaraé©ç”¨æ–¼æ²»ç™‚å°ç–¾ç—…緩解型抗風濕性藥物(DMARDs)療效ä¸ä½³ä¹‹æˆäºº(18æ²åŠä»¥ä¸Š)活動性乾癬性關節炎。Stelaraå¯å–®ç¨ä½¿ç”¨ï¼Œäº¦å¯èˆ‡methotrexat(MTX併用é å……å¡«å¼æ³¨å°„劑é 充填注射é‡ç’è£;;é 充填注射é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨Ustekinumab嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854CILAG AGHOCHSTRASSE 201, 8205 SCHAFFHAUSEN, SWITZERLANDSWITZERLAND2014-12-11é 充填注射é‡ç’è£;;é 充填注射é‡ç’è£Stelara TM Solution for Injection詳見仿單。
衛署èŒç–«è¼¸å—第000920號2016-12-052011-12-05èŒã€€ç–«DHA01000092002å–œé”諾 TM 注射液1.乾癬(Ps)Stelaraé©ç”¨æ–¼æ²»ç™‚é©åˆæŽ¥å—光療法或全身性治療的ä¸è‡³é‡åº¦æ–‘塊性乾癬æˆäººæ‚£è€…(18æ²(å«)以上)。2.乾癬性關節炎(PsA)Stelaraé©ç”¨æ–¼æ²»ç™‚å°ç–¾ç—…緩解型抗風濕性藥物(DMARDs)療效ä¸ä½³ä¹‹æˆäºº(18æ²åŠä»¥ä¸Š)活動性乾癬性關節炎。Stelaraå¯å–®ç¨ä½¿ç”¨ï¼Œäº¦å¯èˆ‡methotrexat(MTX併用é å……å¡«å¼æ³¨å°„劑é 充填注射é‡ç’è£;;é 充填注射é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨Ustekinumab嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854GALLUS BIOPHARMACEUTICALS, LLC4766 LAGUARDIA DRIVE SAINT LOUIS, MISSOURI 63134, USAUNITED STATES2014-12-11é 充填注射é‡ç’è£;;é 充填注射é‡ç’è£Stelara TM Solution for Injection詳見仿單。
衛署èŒç–«è¼¸å—第000920號2016-12-052011-12-05èŒã€€ç–«DHA01000092002å–œé”諾 TM 注射液1.乾癬(Ps)Stelaraé©ç”¨æ–¼æ²»ç™‚é©åˆæŽ¥å—光療法或全身性治療的ä¸è‡³é‡åº¦æ–‘塊性乾癬æˆäººæ‚£è€…(18æ²(å«)以上)。2.乾癬性關節炎(PsA)Stelaraé©ç”¨æ–¼æ²»ç™‚å°ç–¾ç—…緩解型抗風濕性藥物(DMARDs)療效ä¸ä½³ä¹‹æˆäºº(18æ²åŠä»¥ä¸Š)活動性乾癬性關節炎。Stelaraå¯å–®ç¨ä½¿ç”¨ï¼Œäº¦å¯èˆ‡methotrexat(MTX併用é å……å¡«å¼æ³¨å°„劑é 充填注射é‡ç’è£;;é 充填注射é‡ç’è£é™ç”±é†«å¸«ä½¿ç”¨Ustekinumab嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854BAXTER PHARMACEUTICAL SOLUTIONS LLC927 SOUTH CURRY PIKE, BLOOMINGTON, INDIANA 47403, USAUNITED STATES2014-12-11é 充填注射é‡ç’è£;;é 充填注射é‡ç’è£Stelara TM Solution for Injection詳見仿單。
衛署èŒç–«è¼¸å—第000921號2017-02-172012-02-17èŒã€€ç–«DHA01000092104安律平新型æµæ„Ÿç–«è‹—é 防新型æµæ„Ÿã€‚懸浮注射劑å°ç“¶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/California/7/2009(H1N1)v-like virus;;SQUALENE;;TOCOPHEROL ALPHA DL- (EQ TO DL-ALPHA TOCOPHEROL);;TWEEN 80 (EQ TO POLYSORBATE 80)è·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438ID BIOMEDICAL CORPORATION2323 PARC TECHNOLOGIQUE BLVD. SAINTE-FOY, QUEBEC, CANADA, G1P 4R8CANADA2014-08-19å°ç“¶è£Arepanrix TM H1N1如仿單
衛署èŒç–«è¼¸å—第000921號2017-02-172012-02-17èŒã€€ç–«DHA01000092104安律平新型æµæ„Ÿç–«è‹—é 防新型æµæ„Ÿã€‚懸浮注射劑å°ç“¶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/California/7/2009(H1N1)v-like virus;;SQUALENE;;TOCOPHEROL ALPHA DL- (EQ TO DL-ALPHA TOCOPHEROL);;TWEEN 80 (EQ TO POLYSORBATE 80)è·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438BAXTER PHARMACEUTICAL SOLUTIONS LLC927 SOUTH CURRY PIKE, BLOOMINGTON, IN 47403 USAUNITED STATES2014-08-19å°ç“¶è£Arepanrix TM H1N1如仿單
衛署èŒç–«è¼¸å—第000922號2016-07-292011-07-29èŒã€€ç–«DHA01000092206“百特â€æ–°ä¸€ä»£äººé¡žè¡€æ¸…白蛋白低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。注射劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨ALBUMIN HUMAN百特醫療產å“股份有é™å…¬å¸å°åŒ—市敦化å—路二段216號15樓12350071BAXTER AGA-1220 VIENNA, INDUSTRIESTRASSES 67, AUSTRIA.AUSTRIA2014-02-11瓶è£Human Albumin 200g/l Baxter"百特"新一帶人類血清白蛋白注射劑是於醫院ä¸ä½¿ç”¨çš„藥物,它將由專æ¥é†«è·äººå“¡æ–¼é†«é™¢ä¸è™•ç†æ‡‰ç”¨ï¼Œé†«å¸«ä¹Ÿå°‡ä¾å€‹äººç‹€æ³ä¾†æ±ºå®šè—¥å“用é‡ã€çµ¦è—¥é »çŽ‡ä»¥åŠç™‚期。"百特"新一帶人類血清白蛋白注射劑應由éœè„ˆè¼¸æ³¨ã€‚å¯å°‡å…§å®¹æ¶²ç›´æŽ¥è¼¸æ³¨æˆ–以ç‰å¼µæº¶æ¶²(例如5%è‘¡è„糖液(5%glucose)或0.9%氯化鈉(0.9% sodium chloride)稀釋後使用。
衛署èŒç–«è¼¸å—第000926號2017-05-222012-05-22èŒã€€ç–«DHA01000092601優曼人體血清白蛋白 20%輸注液低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。輸注液玻璃瓶è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN ALBUMIN輔凱生物科技股份有é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯5段5號(6樓F02)22368493å‰åœ°å–œè‚¡ä»½æœ‰é™å…¬å¸æ–°ç«¹ç¸£æ–°è±é„‰æ–°è±æ‘紅毛23之5號TAIWAN2014-03-10玻璃瓶è£Uman Albumin solution for infusion 20%使用劑é‡å–決於病人體型ã€å‰µå‚·æˆ–疾病嚴é‡åº¦ä»¥åŠé«”液和蛋白質的æŒçºŒæ€§æµå¤±ï¼Œæ‰€éœ€åŠ‘é‡å–決於循環血é‡è¶³å¤ 與å¦ï¼Œè€Œéžè¡€æ¼¿ç™½è›‹ç™½æ¿ƒåº¦ã€‚
衛署èŒç–«è¼¸å—第000926號2017-05-222012-05-22èŒã€€ç–«DHA01000092601優曼人體血清白蛋白 20%輸注液低蛋白血症ã€ä¼‘å…‹ã€ç‡’傷。輸注液玻璃瓶è£é™ç”±é†«å¸«ä½¿ç”¨HUMAN ALBUMIN輔凱生物科技股份有é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯5段5號(6樓F02)22368493KEDRION S.P.A.BOLOGNANA GALLICANO 55027 LUCCA ITALYITALY2014-03-10玻璃瓶è£Uman Albumin solution for infusion 20%使用劑é‡å–決於病人體型ã€å‰µå‚·æˆ–疾病嚴é‡åº¦ä»¥åŠé«”液和蛋白質的æŒçºŒæ€§æµå¤±ï¼Œæ‰€éœ€åŠ‘é‡å–決於循環血é‡è¶³å¤ 與å¦ï¼Œè€Œéžè¡€æ¼¿ç™½è›‹ç™½æ¿ƒåº¦ã€‚
衛署èŒç–«è¼¸å—第000927號2017-05-242012-05-24èŒã€€ç–«DHA01000092703æ©æ²›æ¿ 注射用å‡æ™¶ç²‰æœ«ç”¨æ–¼æ²»ç™‚在脾臟切除後且å°æ–¼å…¶ä»–治療(例如:類固醇ã€å…ç–«çƒè›‹ç™½ç‰)失敗之æˆå¹´æ…¢æ€§è‡ªç™¼æ€§(å…疫性)è¡€å°æ¿ç¼ºä¹ç´«æ–‘ç—‡(ITP)患者,或å°æ–¼ä¸é©åˆé€²è¡Œè„¾è‡Ÿåˆ‡é™¤ä¹‹æˆå¹´æ…¢æ€§è‡ªç™¼æ€§(å…疫性)è¡€å°æ¿ç¼ºä¹ç´«æ–‘ç—‡(ITP)患者之第二線治療。注射用å‡æ™¶ç²‰æœ«æ³¨å°„瓶é™ç”±é†«å¸«ä½¿ç”¨ROMIPLOSTIMå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780AMGEN EUROPE B.V.MINERVUM 7061, NL-4817 ZK, BREDA, THE NETHERLANDSNETHERLANDS2014-03-10注射瓶Nplate injection請詳見仿單
衛署èŒç–«è¼¸å—第000927號2017-05-242012-05-24èŒã€€ç–«DHA01000092703æ©æ²›æ¿ 注射用å‡æ™¶ç²‰æœ«ç”¨æ–¼æ²»ç™‚在脾臟切除後且å°æ–¼å…¶ä»–治療(例如:類固醇ã€å…ç–«çƒè›‹ç™½ç‰)失敗之æˆå¹´æ…¢æ€§è‡ªç™¼æ€§(å…疫性)è¡€å°æ¿ç¼ºä¹ç´«æ–‘ç—‡(ITP)患者,或å°æ–¼ä¸é©åˆé€²è¡Œè„¾è‡Ÿåˆ‡é™¤ä¹‹æˆå¹´æ…¢æ€§è‡ªç™¼æ€§(å…疫性)è¡€å°æ¿ç¼ºä¹ç´«æ–‘ç—‡(ITP)患者之第二線治療。注射用å‡æ™¶ç²‰æœ«æ³¨å°„瓶é™ç”±é†«å¸«ä½¿ç”¨ROMIPLOSTIMå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780PATHEON ITALIA S.P.A.VIALE G.B. STUCCHI, 110, MONZA, ITALYITALY2014-03-10注射瓶Nplate injection請詳見仿單
衛署èŒç–«è¼¸å—第000927號2017-05-242012-05-24èŒã€€ç–«DHA01000092703æ©æ²›æ¿ 注射用å‡æ™¶ç²‰æœ«ç”¨æ–¼æ²»ç™‚在脾臟切除後且å°æ–¼å…¶ä»–治療(例如:類固醇ã€å…ç–«çƒè›‹ç™½ç‰)失敗之æˆå¹´æ…¢æ€§è‡ªç™¼æ€§(å…疫性)è¡€å°æ¿ç¼ºä¹ç´«æ–‘ç—‡(ITP)患者,或å°æ–¼ä¸é©åˆé€²è¡Œè„¾è‡Ÿåˆ‡é™¤ä¹‹æˆå¹´æ…¢æ€§è‡ªç™¼æ€§(å…疫性)è¡€å°æ¿ç¼ºä¹ç´«æ–‘ç—‡(ITP)患者之第二線治療。注射用å‡æ™¶ç²‰æœ«æ³¨å°„瓶é™ç”±é†«å¸«ä½¿ç”¨ROMIPLOSTIMå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780AMGEN INC.ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA 91320-1799UNITED STATES2014-03-10注射瓶Nplate injection請詳見仿單
衛署èŒç–«è¼¸å—第000927號2017-05-242012-05-24èŒã€€ç–«DHA01000092703æ©æ²›æ¿ 注射用å‡æ™¶ç²‰æœ«ç”¨æ–¼æ²»ç™‚在脾臟切除後且å°æ–¼å…¶ä»–治療(例如:類固醇ã€å…ç–«çƒè›‹ç™½ç‰)失敗之æˆå¹´æ…¢æ€§è‡ªç™¼æ€§(å…疫性)è¡€å°æ¿ç¼ºä¹ç´«æ–‘ç—‡(ITP)患者,或å°æ–¼ä¸é©åˆé€²è¡Œè„¾è‡Ÿåˆ‡é™¤ä¹‹æˆå¹´æ…¢æ€§è‡ªç™¼æ€§(å…疫性)è¡€å°æ¿ç¼ºä¹ç´«æ–‘ç—‡(ITP)患者之第二線治療。注射用å‡æ™¶ç²‰æœ«æ³¨å°„瓶é™ç”±é†«å¸«ä½¿ç”¨ROMIPLOSTIMå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780AMGEN INC. (ACO)5550 AIRPORT ROAD BOULDER, CO 80301, U.S.AUNITED STATES2014-03-10注射瓶Nplate injection請詳見仿單
衛署èŒç–«è¼¸å—第000927號2017-05-242012-05-24èŒã€€ç–«DHA01000092703æ©æ²›æ¿ 注射用å‡æ™¶ç²‰æœ«ç”¨æ–¼æ²»ç™‚在脾臟切除後且å°æ–¼å…¶ä»–治療(例如:類固醇ã€å…ç–«çƒè›‹ç™½ç‰)失敗之æˆå¹´æ…¢æ€§è‡ªç™¼æ€§(å…疫性)è¡€å°æ¿ç¼ºä¹ç´«æ–‘ç—‡(ITP)患者,或å°æ–¼ä¸é©åˆé€²è¡Œè„¾è‡Ÿåˆ‡é™¤ä¹‹æˆå¹´æ…¢æ€§è‡ªç™¼æ€§(å…疫性)è¡€å°æ¿ç¼ºä¹ç´«æ–‘ç—‡(ITP)患者之第二線治療。注射用å‡æ™¶ç²‰æœ«æ³¨å°„瓶é™ç”±é†«å¸«ä½¿ç”¨ROMIPLOSTIMå°ç£å”和醱酵麒麟股份有é™å…¬å¸å°åŒ—市ä¸å±±å€ä¸å±±åŒ—路二段44號9樓23929780AMGEN INC. (ACO)4000 NELSON ROAD, LONGMONT CO 80503, U.S.A.UNITED STATES2014-03-10注射瓶Nplate injection請詳見仿單
衛署èŒç–«è¼¸å—第000928號2017-06-192012-06-19èŒã€€ç–«DHA01000092805èŽ«é ˆç˜¤æ³¨å°„åŠ‘(å¾·åœ‹å» )éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ï¼šç”¨æ–¼å¾©ç™¼æˆ–å°åŒ–å¸ç™‚法有抗性之低惡度B-細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚併用CVP化å¸ç™‚法用於未經治療之和緩性(組織型態為濾泡型)B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤çš„病人。併用CHOP或其他化å¸ç™‚法用於CD20抗原陽性之瀰漫性大型B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚用於åšç‚ºæ¿¾æ³¡æ€§æ·‹å·´ç˜¤æ‚£è€…å°èª˜å°Žç™‚法產生å應之後的ç¶æŒæ²»ç™‚用藥。類風濕性關節炎:與methotrexate併用,é©ç”¨æ–¼æ²»ç™‚曾接å—一種(å«)以上之腫瘤壞æ»å› å(TNF)抑制療法治療但效果ä¸å½°ï¼Œæˆ–無法è€å—的活動性類風濕性關節炎æˆäººæ‚£è€…ã€‚èŽ«é ˆç˜¤(MabThera)與methotrexate併用,經X光檢查已è‰å¯¦å¯æ¸›ç·©é—œç¯€çµæ§‹å—æ的進展。慢性淋巴çƒæ€§ç™½è¡€ç—…ï¼šèŽ«é ˆç˜¤(MabThera)é©ç”¨æ–¼èˆ‡fludarabineåŠcyclophosphamide併用,åšç‚ºCD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…(CLL)æ‚£è€…çš„ç¬¬ä¸€ç·šç”¨è—¥ã€‚èŽ«é ˆç˜¤(MabThera)é©ç”¨æ–¼èˆ‡åŒ–å¸ç™‚法併用,åšç‚ºå¾©ç™¼/é ‘å›ºæ€§çš„CD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…病患的治療用藥。「肉芽腫性血管炎(Granulomatosis with Polyangiitis,GPA)(Wegener’s 肉芽腫症)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(Microscopic Polyangiitis ,MPA)ï¼šèŽ«é ˆç˜¤(MabThera)與葡è„ç³–çš®è³ªç´ (glucocorticoids)併用,é©ç”¨æ–¼æ²»ç™‚æˆäººä¹‹è‚‰èŠ½è…«æ€§è¡€ç®¡ç‚Ž(GPAï¼Œäº¦ç¨±ç‚ºéŸ‹æ ¼ç´è‚‰èŠ½è…«ç—‡)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(MPA)。注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨Rituximabç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F.HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303, KAISERAUGST, SWITZERLANDSWITZERLAND2014-05-06ç›’è£Mabthera solution for Infusion詳如仿單內容
衛署èŒç–«è¼¸å—第000928號2017-06-192012-06-19èŒã€€ç–«DHA01000092805èŽ«é ˆç˜¤æ³¨å°„åŠ‘(å¾·åœ‹å» )éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ï¼šç”¨æ–¼å¾©ç™¼æˆ–å°åŒ–å¸ç™‚法有抗性之低惡度B-細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚併用CVP化å¸ç™‚法用於未經治療之和緩性(組織型態為濾泡型)B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤çš„病人。併用CHOP或其他化å¸ç™‚法用於CD20抗原陽性之瀰漫性大型B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚用於åšç‚ºæ¿¾æ³¡æ€§æ·‹å·´ç˜¤æ‚£è€…å°èª˜å°Žç™‚法產生å應之後的ç¶æŒæ²»ç™‚用藥。類風濕性關節炎:與methotrexate併用,é©ç”¨æ–¼æ²»ç™‚曾接å—一種(å«)以上之腫瘤壞æ»å› å(TNF)抑制療法治療但效果ä¸å½°ï¼Œæˆ–無法è€å—的活動性類風濕性關節炎æˆäººæ‚£è€…ã€‚èŽ«é ˆç˜¤(MabThera)與methotrexate併用,經X光檢查已è‰å¯¦å¯æ¸›ç·©é—œç¯€çµæ§‹å—æ的進展。慢性淋巴çƒæ€§ç™½è¡€ç—…ï¼šèŽ«é ˆç˜¤(MabThera)é©ç”¨æ–¼èˆ‡fludarabineåŠcyclophosphamide併用,åšç‚ºCD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…(CLL)æ‚£è€…çš„ç¬¬ä¸€ç·šç”¨è—¥ã€‚èŽ«é ˆç˜¤(MabThera)é©ç”¨æ–¼èˆ‡åŒ–å¸ç™‚法併用,åšç‚ºå¾©ç™¼/é ‘å›ºæ€§çš„CD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…病患的治療用藥。「肉芽腫性血管炎(Granulomatosis with Polyangiitis,GPA)(Wegener’s 肉芽腫症)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(Microscopic Polyangiitis ,MPA)ï¼šèŽ«é ˆç˜¤(MabThera)與葡è„ç³–çš®è³ªç´ (glucocorticoids)併用,é©ç”¨æ–¼æ²»ç™‚æˆäººä¹‹è‚‰èŠ½è…«æ€§è¡€ç®¡ç‚Ž(GPAï¼Œäº¦ç¨±ç‚ºéŸ‹æ ¼ç´è‚‰èŠ½è…«ç—‡)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(MPA)。注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨Rituximabç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467GENENTECH, INC.1000 NEW HORIZONS WAY, VACAVILLE, CA 95688, USAUNITED STATES2014-05-06ç›’è£Mabthera solution for Infusion詳如仿單內容
衛署èŒç–«è¼¸å—第000928號2017-06-192012-06-19èŒã€€ç–«DHA01000092805èŽ«é ˆç˜¤æ³¨å°„åŠ‘(å¾·åœ‹å» )éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ï¼šç”¨æ–¼å¾©ç™¼æˆ–å°åŒ–å¸ç™‚法有抗性之低惡度B-細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚併用CVP化å¸ç™‚法用於未經治療之和緩性(組織型態為濾泡型)B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤çš„病人。併用CHOP或其他化å¸ç™‚法用於CD20抗原陽性之瀰漫性大型B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚用於åšç‚ºæ¿¾æ³¡æ€§æ·‹å·´ç˜¤æ‚£è€…å°èª˜å°Žç™‚法產生å應之後的ç¶æŒæ²»ç™‚用藥。類風濕性關節炎:與methotrexate併用,é©ç”¨æ–¼æ²»ç™‚曾接å—一種(å«)以上之腫瘤壞æ»å› å(TNF)抑制療法治療但效果ä¸å½°ï¼Œæˆ–無法è€å—的活動性類風濕性關節炎æˆäººæ‚£è€…ã€‚èŽ«é ˆç˜¤(MabThera)與methotrexate併用,經X光檢查已è‰å¯¦å¯æ¸›ç·©é—œç¯€çµæ§‹å—æ的進展。慢性淋巴çƒæ€§ç™½è¡€ç—…ï¼šèŽ«é ˆç˜¤(MabThera)é©ç”¨æ–¼èˆ‡fludarabineåŠcyclophosphamide併用,åšç‚ºCD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…(CLL)æ‚£è€…çš„ç¬¬ä¸€ç·šç”¨è—¥ã€‚èŽ«é ˆç˜¤(MabThera)é©ç”¨æ–¼èˆ‡åŒ–å¸ç™‚法併用,åšç‚ºå¾©ç™¼/é ‘å›ºæ€§çš„CD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…病患的治療用藥。「肉芽腫性血管炎(Granulomatosis with Polyangiitis,GPA)(Wegener’s 肉芽腫症)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(Microscopic Polyangiitis ,MPA)ï¼šèŽ«é ˆç˜¤(MabThera)與葡è„ç³–çš®è³ªç´ (glucocorticoids)併用,é©ç”¨æ–¼æ²»ç™‚æˆäººä¹‹è‚‰èŠ½è…«æ€§è¡€ç®¡ç‚Ž(GPAï¼Œäº¦ç¨±ç‚ºéŸ‹æ ¼ç´è‚‰èŠ½è…«ç—‡)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(MPA)。注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨Rituximabç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467GENENTECH, INC.1 ANTIBODY WAY, OCEANSIDE, CA 92056, USAUNITED STATES2014-05-06ç›’è£Mabthera solution for Infusion詳如仿單內容
衛署èŒç–«è¼¸å—第000942號2018-06-142013-06-14èŒã€€ç–«DHA01000094202賀疾妥注射液420毫克Perjeta與HerceptinåŠdocetaxel併用於治療轉移後未曾以抗HER2或化å¸ç™‚法治療之HER2陽性轉移性乳癌病患。注射液劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Pertuzumab ç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F. HOFFMANN-LA ROCHE LTD.WURMISWEG, CH-4303 KAISERAUGST, SWITZERLANDSWITZERLAND2014-05-06å°ç“¶;;ç›’è£Perjeta Vial 420mg詳見仿單
衛署èŒç–«è¼¸å—第000928號2017-06-192012-06-19èŒã€€ç–«DHA01000092805èŽ«é ˆç˜¤æ³¨å°„åŠ‘(å¾·åœ‹å» )éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ï¼šç”¨æ–¼å¾©ç™¼æˆ–å°åŒ–å¸ç™‚法有抗性之低惡度B-細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚併用CVP化å¸ç™‚法用於未經治療之和緩性(組織型態為濾泡型)B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤çš„病人。併用CHOP或其他化å¸ç™‚法用於CD20抗原陽性之瀰漫性大型B細胞éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€‚用於åšç‚ºæ¿¾æ³¡æ€§æ·‹å·´ç˜¤æ‚£è€…å°èª˜å°Žç™‚法產生å應之後的ç¶æŒæ²»ç™‚用藥。類風濕性關節炎:與methotrexate併用,é©ç”¨æ–¼æ²»ç™‚曾接å—一種(å«)以上之腫瘤壞æ»å› å(TNF)抑制療法治療但效果ä¸å½°ï¼Œæˆ–無法è€å—的活動性類風濕性關節炎æˆäººæ‚£è€…ã€‚èŽ«é ˆç˜¤(MabThera)與methotrexate併用,經X光檢查已è‰å¯¦å¯æ¸›ç·©é—œç¯€çµæ§‹å—æ的進展。慢性淋巴çƒæ€§ç™½è¡€ç—…ï¼šèŽ«é ˆç˜¤(MabThera)é©ç”¨æ–¼èˆ‡fludarabineåŠcyclophosphamide併用,åšç‚ºCD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…(CLL)æ‚£è€…çš„ç¬¬ä¸€ç·šç”¨è—¥ã€‚èŽ«é ˆç˜¤(MabThera)é©ç”¨æ–¼èˆ‡åŒ–å¸ç™‚法併用,åšç‚ºå¾©ç™¼/é ‘å›ºæ€§çš„CD20陽性慢性淋巴çƒæ€§ç™½è¡€ç—…病患的治療用藥。「肉芽腫性血管炎(Granulomatosis with Polyangiitis,GPA)(Wegener’s 肉芽腫症)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(Microscopic Polyangiitis ,MPA)ï¼šèŽ«é ˆç˜¤(MabThera)與葡è„ç³–çš®è³ªç´ (glucocorticoids)併用,é©ç”¨æ–¼æ²»ç™‚æˆäººä¹‹è‚‰èŠ½è…«æ€§è¡€ç®¡ç‚Ž(GPAï¼Œäº¦ç¨±ç‚ºéŸ‹æ ¼ç´è‚‰èŠ½è…«ç—‡)åŠé¡¯å¾®å¤šç™¼æ€§è¡€ç®¡ç‚Ž(MPA)。注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨Rituximabç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFERSTRASSE 116, D-68305, MANNHEIM, GERMANYGERMANY2014-05-06ç›’è£Mabthera solution for Infusion詳如仿單內容
衛署èŒç–«è¼¸å—第000929號2018-12-052013-12-05èŒã€€ç–«DHA01000092907ç®æ ¼è¥¿æ–½ é 充填注射ç†180微公克/0.5毫å‡æ²»ç™‚慢性Båž‹è‚ç‚Ž:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人,ç®æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性ã€æœ‰ç—…毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚ç‚Ž;治療慢性Cåž‹è‚ç‚Ž:å–®ç¨æˆ–åˆä½µribavirin使用的ç®æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467CATALENT BELGIUMFONT SAINT LANDRY 10, 1120 BRUSSELS, BELGIUMBELGIUM2014-05-06注射ç†;;ç›’è£Pegasys Pre-filled Pen 180mcg/0.5ml詳見仿單
衛署èŒç–«è¼¸å—第000929號2018-12-052013-12-05èŒã€€ç–«DHA01000092907ç®æ ¼è¥¿æ–½ é 充填注射ç†180微公克/0.5毫å‡æ²»ç™‚慢性Båž‹è‚ç‚Ž:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人,ç®æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性ã€æœ‰ç—…毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚ç‚Ž;治療慢性Cåž‹è‚ç‚Ž:å–®ç¨æˆ–åˆä½µribavirin使用的ç®æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F. HOFFMANN-LA ROCHE LTD.WURMISWEG CH-4303, KAISERAUGST, SWITZERLANDSWITZERLAND2014-05-06注射ç†;;ç›’è£Pegasys Pre-filled Pen 180mcg/0.5ml詳見仿單
衛署èŒç–«è¼¸å—第000929號2018-12-052013-12-05èŒã€€ç–«DHA01000092907ç®æ ¼è¥¿æ–½ é 充填注射ç†180微公克/0.5毫å‡æ²»ç™‚慢性Båž‹è‚ç‚Ž:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人,ç®æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性ã€æœ‰ç—…毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚ç‚Ž;治療慢性Cåž‹è‚ç‚Ž:å–®ç¨æˆ–åˆä½µribavirin使用的ç®æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射ç†;;ç›’è£Pegasys Pre-filled Pen 180mcg/0.5ml詳見仿單
衛署èŒç–«è¼¸å—第000942號2018-06-142013-06-14èŒã€€ç–«DHA01000094202賀疾妥注射液420毫克Perjeta與HerceptinåŠdocetaxel併用於治療轉移後未曾以抗HER2或化å¸ç™‚法治療之HER2陽性轉移性乳癌病患。注射液劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Pertuzumab ç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467GENENTECH, INC.1000 NEW HORIZONS WAY, VACAVILLE, CA 95688, USAUNITED STATES2014-05-06å°ç“¶;;ç›’è£Perjeta Vial 420mg詳見仿單
衛署èŒç–«è¼¸å—第000930號2018-12-052013-12-05èŒã€€ç–«DHA01000093005ç®æ ¼è¥¿æ–½ é å……å¡«æ³¨å°„ç† 135微公克/0.5毫å‡æ²»ç™‚慢性Båž‹è‚ç‚Ž:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人,ç®æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性ã€æœ‰ç—…毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚ç‚Ž;治療慢性Cåž‹è‚ç‚Ž:å–®ç¨æˆ–åˆä½µribavirin使用的ç®æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467CATALENT BELGIUMFONT SAINT LANDRY 10, 1120 BRUSSELS, BELGIUM.BELGIUM2014-05-06注射ç†;;ç›’è£Pegasys Pre-filled Pen 135mcg/0.5ml詳見仿單
衛署èŒç–«è¼¸å—第000930號2018-12-052013-12-05èŒã€€ç–«DHA01000093005ç®æ ¼è¥¿æ–½ é å……å¡«æ³¨å°„ç† 135微公克/0.5毫å‡æ²»ç™‚慢性Båž‹è‚ç‚Ž:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人,ç®æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性ã€æœ‰ç—…毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚ç‚Ž;治療慢性Cåž‹è‚ç‚Ž:å–®ç¨æˆ–åˆä½µribavirin使用的ç®æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467F. HOFFMANN-LA ROCHE LTD.WURMISWEG CH-4303, KAISERAUGST, SWITZERLAND.SWITZERLAND2014-05-06注射ç†;;ç›’è£Pegasys Pre-filled Pen 135mcg/0.5ml詳見仿單
衛署èŒç–«è¼¸å—第000930號2018-12-052013-12-05èŒã€€ç–«DHA01000093005ç®æ ¼è¥¿æ–½ é å……å¡«æ³¨å°„ç† 135微公克/0.5毫å‡æ²»ç™‚慢性Båž‹è‚ç‚Ž:å°æ–¼æ²’有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人,ç®æ ¼è¥¿æ–½é©åˆç”¨ä¾†æ²»ç™‚HBeAg陽性或HBeAg陰性ã€æœ‰ç—…毒複製和è‚臟發炎è‰æ“šä¹‹æ…¢æ€§Båž‹è‚ç‚Ž;治療慢性Cåž‹è‚ç‚Ž:å–®ç¨æˆ–åˆä½µribavirin使用的ç®æ ¼è¥¿æ–½ï¼Œé©åˆç”¨ä¾†æ²»ç™‚沒有è‚硬化的病人以åŠæœ‰ä»£å„ŸåŠŸèƒ½çš„è‚硬化病人之慢性Cåž‹è‚炎。注射劑注射ç†;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨PEGINTERFERON ALFA-2Aç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHNONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06注射ç†;;ç›’è£Pegasys Pre-filled Pen 135mcg/0.5ml詳見仿單
衛署èŒç–«è¼¸å—第000931號2017-08-092012-08-09èŒã€€ç–«DHA01000093107å¸¥å¥ æ³¨å°„åŠ‘ 6 æ¯«å…‹è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€å…¶ä»–GONADOL DYSGENESIS (TURNER'S SYNDROME)所導致之生長é²æ»¯ã€é’春期å‰å› 慢性腎臟衰ç«å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯åŠæˆäººç”Ÿé•·æ¿€ç´ åš´é‡åˆ†æ³Œä¸è¶³ä¹‹è£œå……療法。低出生體é‡å…’(Small for Gestational Age ; SGA)逾四æ²è€…之生長障礙。注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨SOMATROPIN (BIOSYNTHETIC HUMAN GROWTH HORMONE)臺ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-03-10ç›’è£Saizen 6 mg solution for injection詳如仿單
衛署èŒç–«è¼¸å—第000931號2017-08-092012-08-09èŒã€€ç–«DHA01000093107å¸¥å¥ æ³¨å°„åŠ‘ 6 æ¯«å…‹è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€å…¶ä»–GONADOL DYSGENESIS (TURNER'S SYNDROME)所導致之生長é²æ»¯ã€é’春期å‰å› 慢性腎臟衰ç«å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯åŠæˆäººç”Ÿé•·æ¿€ç´ åš´é‡åˆ†æ³Œä¸è¶³ä¹‹è£œå……療法。低出生體é‡å…’(Small for Gestational Age ; SGA)逾四æ²è€…之生長障礙。注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨SOMATROPIN (BIOSYNTHETIC HUMAN GROWTH HORMONE)臺ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2014-03-10ç›’è£Saizen 6 mg solution for injection詳如仿單
衛署èŒç–«è¼¸å—第000932號2017-08-092012-08-09èŒã€€ç–«DHA01000093209å¸¥å¥ æ³¨å°„åŠ‘ 12 æ¯«å…‹è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€å…¶ä»–GONADOL DYSGENESIS (TURNER'S SYNDROME)所導致之生長é²æ»¯ã€é’春期å‰å› 慢性腎臟衰ç«å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯åŠæˆäººç”Ÿé•·æ¿€ç´ åš´é‡åˆ†æ³Œä¸è¶³ä¹‹è£œå……療法。低出生體é‡å…’(Small for Gestational Age ; SGA)逾四æ²è€…之生長障礙。注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨SOMATROPIN (BIOSYNTHETIC HUMAN GROWTH HORMONE)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-11-13ç›’è£Saizen 12 mg solution for injection詳如仿單
衛署èŒç–«è¼¸å—第000932號2017-08-092012-08-09èŒã€€ç–«DHA01000093209å¸¥å¥ æ³¨å°„åŠ‘ 12 æ¯«å…‹è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€å…¶ä»–GONADOL DYSGENESIS (TURNER'S SYNDROME)所導致之生長é²æ»¯ã€é’春期å‰å› 慢性腎臟衰ç«å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯åŠæˆäººç”Ÿé•·æ¿€ç´ åš´é‡åˆ†æ³Œä¸è¶³ä¹‹è£œå……療法。低出生體é‡å…’(Small for Gestational Age ; SGA)逾四æ²è€…之生長障礙。注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨SOMATROPIN (BIOSYNTHETIC HUMAN GROWTH HORMONE)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2014-11-13ç›’è£Saizen 12 mg solution for injection詳如仿單
衛署èŒç–«è¼¸å—第000933號2017-08-092012-08-09èŒã€€ç–«DHA01000093301å¸¥å¥ æ³¨å°„åŠ‘ 20 æ¯«å…‹è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€å…¶ä»–GONADOL DYSGENESIS (TURNER'S SYNDROME)所導致之生長é²æ»¯ã€é’春期å‰å› 慢性腎臟衰ç«å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯åŠæˆäººç”Ÿé•·æ¿€ç´ åš´é‡åˆ†æ³Œä¸è¶³ä¹‹è£œå……療法。低出生體é‡å…’(Small for Gestational Age ; SGA)逾四æ²è€…之生長障礙。注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨SOMATROPIN (BIOSYNTHETIC HUMAN GROWTH HORMONE)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-11-13ç›’è£Saizen 20 mg solution for injection詳如仿單
衛署èŒç–«è¼¸å—第000933號2017-08-092012-08-09èŒã€€ç–«DHA01000093301å¸¥å¥ æ³¨å°„åŠ‘ 20 æ¯«å…‹è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€å…¶ä»–GONADOL DYSGENESIS (TURNER'S SYNDROME)所導致之生長é²æ»¯ã€é’春期å‰å› 慢性腎臟衰ç«å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯åŠæˆäººç”Ÿé•·æ¿€ç´ åš´é‡åˆ†æ³Œä¸è¶³ä¹‹è£œå……療法。低出生體é‡å…’(Small for Gestational Age ; SGA)逾四æ²è€…之生長障礙。注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨SOMATROPIN (BIOSYNTHETIC HUMAN GROWTH HORMONE)å°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK S.L.BATANES 1, 28760 TRES CANTOS, SPAINSPAIN2014-11-13ç›’è£Saizen 20 mg solution for injection詳如仿單
衛署èŒç–«è¼¸å—第000934號2017-10-012012-10-01èŒã€€ç–«DHA01000093400儷緻注射劑 300Uæˆäººä¸é¢¨å¾Œä¹‹æ‰‹è‡‚痙攣ã€çœ¼çž¼ç—™æ”£ã€åŠé‚Šé¡é¢ç—™æ”£ã€ç—™æ”£æ€§æ–œé ¸ã€å°å…’腦性麻痺引起之肌肉痙攣ã€çšºçœ‰ç´‹åŠæˆäººè…‹çª©å¤šæ±—症。å‡æ™¶æ³¨å°„劑å°ç“¶è£é™ç”±é†«å¸«ä½¿ç”¨BOTULINUM TOXIN TYPE A法商益普生股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市大åŒå€æ‰¿å¾·è·¯äºŒæ®µ81號4樓之427230363IPSEN BIOPHARM LTD.ASH ROAD, WREXHAM INDUSTRIAL ESTATE, WREXHAM, CLWYD, LL13 9UF, UKUNITED KINGDOM2014-11-07å°ç“¶è£Dysport, powder for solution for injection, 300Uè«‹åƒè€ƒä»¿å–®
衛署èŒç–«è¼¸å—第000935號2017-11-062012-11-06èŒã€€ç–«DHA01000093502奔麗生å‡æ™¶æ³¨å°„劑é©æ‡‰ç—‡:「與標準治療併用,é©ç”¨æ–¼åœ¨æ¨™æº–治療下ä»å˜æœ‰é«˜ç–¾ç—…活性的自體å…疫抗體陽性的全身性紅斑性狼瘡æˆå¹´æ‚£è€…。ã€é«˜ç–¾ç—…活性定義(下列3é»žçš†é ˆç¬¦åˆ):(1) anti-dsDNA 陽性(2) 低補體(3) SELENA SLEDAI >=10èªªæ˜Žé …:ç›®å‰å°šæœªæœ‰è‡¨åºŠè©¦é©—顯示本藥å“å°åš´é‡ç‹¼ç˜¡æ€§è…Žç‚ŽåŠåš´é‡ä¸æ¨žç¥žç¶“系統狼瘡之療效安全性。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨BELIMUMAB;;BELIMUMABè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE MANUFACTURING S.P.A.STRADA PROVINCIALE ASOLANA 90, 43056 SAN POLO DI TORRILE, PARMA, ITALYITALY2014-08-19å°ç“¶è£;;ç›’è£Benlysta Powder for Solution for Infusion請詳見仿單。
衛署èŒç–«è¼¸å—第000935號2017-11-062012-11-06èŒã€€ç–«DHA01000093502奔麗生å‡æ™¶æ³¨å°„劑é©æ‡‰ç—‡:「與標準治療併用,é©ç”¨æ–¼åœ¨æ¨™æº–治療下ä»å˜æœ‰é«˜ç–¾ç—…活性的自體å…疫抗體陽性的全身性紅斑性狼瘡æˆå¹´æ‚£è€…。ã€é«˜ç–¾ç—…活性定義(下列3é»žçš†é ˆç¬¦åˆ):(1) anti-dsDNA 陽性(2) 低補體(3) SELENA SLEDAI >=10èªªæ˜Žé …:ç›®å‰å°šæœªæœ‰è‡¨åºŠè©¦é©—顯示本藥å“å°åš´é‡ç‹¼ç˜¡æ€§è…Žç‚ŽåŠåš´é‡ä¸æ¨žç¥žç¶“系統狼瘡之療效安全性。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨BELIMUMAB;;BELIMUMABè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438HOSPIRA INC.1776 NORTH CENTENNIAL DRIVE, MCPHERSON, KS 67460, UNITED STATESUNITED STATES2014-08-19å°ç“¶è£;;ç›’è£Benlysta Powder for Solution for Infusion請詳見仿單。
衛署èŒç–«è¼¸å—第000935號2017-11-062012-11-06èŒã€€ç–«DHA01000093502奔麗生å‡æ™¶æ³¨å°„劑é©æ‡‰ç—‡:「與標準治療併用,é©ç”¨æ–¼åœ¨æ¨™æº–治療下ä»å˜æœ‰é«˜ç–¾ç—…活性的自體å…疫抗體陽性的全身性紅斑性狼瘡æˆå¹´æ‚£è€…。ã€é«˜ç–¾ç—…活性定義(下列3é»žçš†é ˆç¬¦åˆ):(1) anti-dsDNA 陽性(2) 低補體(3) SELENA SLEDAI >=10èªªæ˜Žé …:ç›®å‰å°šæœªæœ‰è‡¨åºŠè©¦é©—顯示本藥å“å°åš´é‡ç‹¼ç˜¡æ€§è…Žç‚ŽåŠåš´é‡ä¸æ¨žç¥žç¶“系統狼瘡之療效安全性。å‡æ™¶æ³¨å°„劑å°ç“¶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨BELIMUMAB;;BELIMUMABè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438HUMAN GENOME SCIENCES, INC.9911 BELWARD CAMPUS DRIVE, ROCKVILLE, MD 20850, UNITED STATESUNITED STATES2014-08-19å°ç“¶è£;;ç›’è£Benlysta Powder for Solution for Infusion請詳見仿單。
衛署èŒç–«è¼¸å—第000936號2017-12-282012-12-28èŒã€€ç–«DHA01000093604采視明瓶è£æ³¨å°„液é©ç”¨æ–¼æ²»ç™‚éžæ¯è‚‰ç‹€è„ˆçµ¡è†œè¡€ç®¡ç—…變(PCV)的血管新生型(濕性)年齡相關性黃斑部退化病變。注射劑瓶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184REGENERON PHARMACEUTICALS INC81 COLUMBIA TURNPIKE, RENSSELAER, NEW YORK 12144, USAUNITED STATES2014-09-25瓶è£;;ç›’è£Eylea aflibercept (rch) 40 mg/mL solution for intravitreal injection vial詳如仿單。
衛署èŒç–«è¼¸å—第000936號2017-12-282012-12-28èŒã€€ç–«DHA01000093604采視明瓶è£æ³¨å°„液é©ç”¨æ–¼æ²»ç™‚éžæ¯è‚‰ç‹€è„ˆçµ¡è†œè¡€ç®¡ç—…變(PCV)的血管新生型(濕性)年齡相關性黃斑部退化病變。注射劑瓶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184BAYER PHARMA AG(POSTAL ADDRESS) D-13342 BERLIN, GERMANY (STREET ADDRESS) MUELLERSTRASSE 170-178, D-13353 BERLIN, GERMANYGERMANY2014-09-25瓶è£;;ç›’è£Eylea aflibercept (rch) 40 mg/mL solution for intravitreal injection vial詳如仿單。
衛署èŒç–«è¼¸å—第000936號2017-12-282012-12-28èŒã€€ç–«DHA01000093604采視明瓶è£æ³¨å°„液é©ç”¨æ–¼æ²»ç™‚éžæ¯è‚‰ç‹€è„ˆçµ¡è†œè¡€ç®¡ç—…變(PCV)的血管新生型(濕性)年齡相關性黃斑部退化病變。注射劑瓶è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184VETTER PHARMA-FERTIGUNG GMBH & CO. KGEISENBAHNSTRASSE 2-4, 88085 LANGENARGEN, GERMANYGERMANY2014-09-25瓶è£;;ç›’è£Eylea aflibercept (rch) 40 mg/mL solution for intravitreal injection vial詳如仿單。
衛署èŒç–«è¼¸å—第000937號2018-01-032013-01-03èŒã€€ç–«DHA01000093706克得諾é å¡«å¼æ³¨å°„ç†250微克(1)實施人工生殖å”助技術(ART),如體外å—ç²¾(IVF)的超誘導排åµï¼šæŠ•èˆ‡Ovidrelå¯å¼•èµ·æœ€çµ‚濾泡æˆç†Ÿèˆ‡ç¶“刺激æˆé•·çš„濾泡黃體化。(2)無排åµæˆ–排åµéŽå°‘婦女的誘導排åµï¼šæŠ•èˆ‡Ovidrelå¯å¼•èµ·ç¶“刺激濾泡æˆé•·çš„無排åµæˆ–排åµéŽå°‘婦女的排åµåŠé»ƒé«”化。注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨CHORIOGONADOTROPIN ALFAå°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.P.A.VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALYITALY2014-11-13ç›’è£Ovidrel 250 micrograms solution for injection in pre-filled penOvidrel需由有治療ä¸å•ç—‡å•é¡Œç¶“驗的醫師使用。使用劑é‡æœ€å¤§åŠ‘é‡ç‚º250mcg。應採用以下劑é‡ï¼šï¼Žå¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF)的超誘導排åµï¼šç•¶æŠ•èˆ‡æœ€å¾Œä¸€åŠ‘çš„FSH或hMG製劑24至48å°æ™‚後,å³ç•¶æ¿¾æ³¡ç¶“刺激æˆé•·é”é©ç•¶æ™‚機時,投與一劑250mcg Ovidrel。.無排åµæˆ–排åµéŽå°‘婦女的誘導排åµï¼šç•¶æ¿¾æ³¡ç¶“刺激æˆé•·é”é©ç•¶æ™‚æ©Ÿ24至48å°æ™‚後投與一劑250mcg Ovidrel。建è°æ‚£è€…在使用Ovidrel當天åŠéš”天行房。特殊æ—群腎功能或è‚功能ä¸å…¨ï¼šå°æ–¼è…ŽåŠŸèƒ½æˆ–è‚功能ä¸å…¨çš„患者,Ovidrel的安全性ã€ç™‚效與藥物動力å¸æ•¸æ“šå°šæœªç¢ºç«‹ã€‚å…’ç«¥æ—群:Ovidrel並無é‡å°å°å…’æ—群的相關用途。使用方å¼ä»¥çš®ä¸‹æ³¨å°„使用。自行注射Ovidrel的患者,應經éŽå……分訓練並ä¾ç…§å°ˆå®¶çš„建è°ä¾†æ“作。Ovidrel僅é™å–®æ¬¡ä½¿ç”¨ã€‚
衛署èŒç–«è¼¸å—第000937號2018-01-032013-01-03èŒã€€ç–«DHA01000093706克得諾é å¡«å¼æ³¨å°„ç†250微克(1)實施人工生殖å”助技術(ART),如體外å—ç²¾(IVF)的超誘導排åµï¼šæŠ•èˆ‡Ovidrelå¯å¼•èµ·æœ€çµ‚濾泡æˆç†Ÿèˆ‡ç¶“刺激æˆé•·çš„濾泡黃體化。(2)無排åµæˆ–排åµéŽå°‘婦女的誘導排åµï¼šæŠ•èˆ‡Ovidrelå¯å¼•èµ·ç¶“刺激濾泡æˆé•·çš„無排åµæˆ–排åµéŽå°‘婦女的排åµåŠé»ƒé«”化。注射劑盒è£é™ç”±é†«å¸«ä½¿ç”¨CHORIOGONADOTROPIN ALFAå°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO S.AZONE INDUSTRIELLE DE L'OURIETTAZ 1170 AUBONNE, SWITZERLANDSWITZERLAND2014-11-13ç›’è£Ovidrel 250 micrograms solution for injection in pre-filled penOvidrel需由有治療ä¸å•ç—‡å•é¡Œç¶“驗的醫師使用。使用劑é‡æœ€å¤§åŠ‘é‡ç‚º250mcg。應採用以下劑é‡ï¼šï¼Žå¯¦æ–½äººå·¥ç”Ÿæ®–å”助技術(ART),如體外å—ç²¾(IVF)的超誘導排åµï¼šç•¶æŠ•èˆ‡æœ€å¾Œä¸€åŠ‘çš„FSH或hMG製劑24至48å°æ™‚後,å³ç•¶æ¿¾æ³¡ç¶“刺激æˆé•·é”é©ç•¶æ™‚機時,投與一劑250mcg Ovidrel。.無排åµæˆ–排åµéŽå°‘婦女的誘導排åµï¼šç•¶æ¿¾æ³¡ç¶“刺激æˆé•·é”é©ç•¶æ™‚æ©Ÿ24至48å°æ™‚後投與一劑250mcg Ovidrel。建è°æ‚£è€…在使用Ovidrel當天åŠéš”天行房。特殊æ—群腎功能或è‚功能ä¸å…¨ï¼šå°æ–¼è…ŽåŠŸèƒ½æˆ–è‚功能ä¸å…¨çš„患者,Ovidrel的安全性ã€ç™‚效與藥物動力å¸æ•¸æ“šå°šæœªç¢ºç«‹ã€‚å…’ç«¥æ—群:Ovidrel並無é‡å°å°å…’æ—群的相關用途。使用方å¼ä»¥çš®ä¸‹æ³¨å°„使用。自行注射Ovidrel的患者,應經éŽå……分訓練並ä¾ç…§å°ˆå®¶çš„建è°ä¾†æ“作。Ovidrel僅é™å–®æ¬¡ä½¿ç”¨ã€‚
衛署èŒç–«è¼¸å—第000938號2018-03-012013-03-01èŒã€€ç–«DHA01000093808采視明注射液(é å¡«é‡ç’,經H2O2æ»…èŒ)é©ç”¨æ–¼æ²»ç™‚éžæ¯è‚‰ç‹€è„ˆçµ¡è†œè¡€ç®¡ç—…變(PCV)的血管新生型(濕性)年齡相關性黃斑部退化病變。注射劑盒è£;;é å¡«é‡ç’é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184GP GRENZACH PRODUKTIONS GMBHEMIL-BARELL-STRASSE 7, 79639 GRENZACH-WYHLEN, GERMANYGERMANY2014-09-25ç›’è£;;é å¡«é‡ç’Eylea aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe (H2O2 sterilized)詳見仿單。
衛署èŒç–«è¼¸å—第000938號2018-03-012013-03-01èŒã€€ç–«DHA01000093808采視明注射液(é å¡«é‡ç’,經H2O2æ»…èŒ)é©ç”¨æ–¼æ²»ç™‚éžæ¯è‚‰ç‹€è„ˆçµ¡è†œè¡€ç®¡ç—…變(PCV)的血管新生型(濕性)年齡相關性黃斑部退化病變。注射劑盒è£;;é å¡«é‡ç’é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184REGENERON PHARMACEUTICALS INC81 COLUMBIA TURNPIKE, RENSSELAER, NEW YORK 12144, USAUNITED STATES2014-09-25ç›’è£;;é å¡«é‡ç’Eylea aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe (H2O2 sterilized)詳見仿單。
衛署èŒç–«è¼¸å—第000938號2018-03-012013-03-01èŒã€€ç–«DHA01000093808采視明注射液(é å¡«é‡ç’,經H2O2æ»…èŒ)é©ç”¨æ–¼æ²»ç™‚éžæ¯è‚‰ç‹€è„ˆçµ¡è†œè¡€ç®¡ç—…變(PCV)的血管新生型(濕性)年齡相關性黃斑部退化病變。注射劑盒è£;;é å¡«é‡ç’é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184VETTER PHARMA-FERTIGUNG GMBH & CO. KGSCHUTZENSTRASSE 87 AND 99-101, 88212 RAVENSBURG, GERMANYGERMANY2014-09-25ç›’è£;;é å¡«é‡ç’Eylea aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe (H2O2 sterilized)詳見仿單。
衛署èŒç–«è¼¸å—第000938號2018-03-012013-03-01èŒã€€ç–«DHA01000093808采視明注射液(é å¡«é‡ç’,經H2O2æ»…èŒ)é©ç”¨æ–¼æ²»ç™‚éžæ¯è‚‰ç‹€è„ˆçµ¡è†œè¡€ç®¡ç—…變(PCV)的血管新生型(濕性)年齡相關性黃斑部退化病變。注射劑盒è£;;é å¡«é‡ç’é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£æ‹œè€³è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段7號å°åŒ—101大樓之53至54樓23167184VETTER PHARMA-FERTIGUNG GMBH & CO. KGMOOSWIESEN 2, 88214 RAVENSBURG, GERMANYGERMANY2014-09-25ç›’è£;;é å¡«é‡ç’Eylea aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe (H2O2 sterilized)詳見仿單。
衛署èŒç–«è¼¸å—第000939號2018-04-242013-04-24èŒã€€ç–«DHA01000093900ä¼é©æµé 防æµæ„Ÿæ»…èŒæ‡¸æ¶²æ³¨å°„劑單劑é‡0.5mlé 充填注射é‡ç’或PRTC(Plastic Rigid Tip Cap)é 充填注射é‡ç’附或ä¸é™„é‡é (æ¯ç›’100支以下)é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨A/California/7/2009(H1N1)-like strain;;A/Victoria/361/2011(H3N2);;B/Massachusetts/02/2012;;B/Brisbane/60/2008-like virusè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS BRANCH OF SMITHKLINE BEECHAM PHARMA GMBH & CO. KGZIRKUSSTR 40, 01069 DRESDEN, GERMANYGERMANY2014-08-19單劑é‡0.5mlé 充填注射é‡ç’或PRTC(Plastic Rigid Tip Cap)é 充填注射é‡ç’附或ä¸é™„é‡é (æ¯ç›’100支以下)Fluarix Tetra如仿單
衛署èŒç–«è¼¸å—第000940號2018-05-022013-05-02èŒã€€ç–«DHA01000094008容å¯æ›¼é‡ç’è£æ³¨å°„劑10000國際單ä½"德國ç¶ç‰¹å» "治療慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。注射劑é‡ç’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116, 68305 MANNHEIM, GERMANYGERMANY2014-05-06é‡ç’è£;;ç›’è£Recormon solution for injection in pre-filled syringe 10000 IU "Vetter, Germany"完整用法用é‡æ•˜è¿°ï¼Œè©³å¦‚仿單。
衛署èŒç–«è¼¸å—第000940號2018-05-022013-05-02èŒã€€ç–«DHA01000094008容å¯æ›¼é‡ç’è£æ³¨å°„劑10000國際單ä½"德國ç¶ç‰¹å» "治療慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。注射劑é‡ç’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467VETTER PHARMA-FERTIGUNG GMBH & CO. KGSCHUTZENSTRASSE 87 AND 99/101, 88212 RAVENSBURG, GERMANYGERMANY2014-05-06é‡ç’è£;;ç›’è£Recormon solution for injection in pre-filled syringe 10000 IU "Vetter, Germany"完整用法用é‡æ•˜è¿°ï¼Œè©³å¦‚仿單。
衛署èŒç–«è¼¸å—第000940號2018-05-022013-05-02èŒã€€ç–«DHA01000094008容å¯æ›¼é‡ç’è£æ³¨å°„劑10000國際單ä½"德國ç¶ç‰¹å» "治療慢性腎衰ç«ä¸”伴隨症狀性貧血病人。治療與癌症化å¸æ²»ç™‚有關的症狀性貧血。治療æ£åœ¨æŽ¥å—抗腫瘤治療之多發性骨髓瘤(multiple myeloma)ã€ä½Žåº¦éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤(low grade non-Hodgkin's lymphoma)或慢性淋巴性白血病(chronic lymphocytic leukemia)æˆäººæ‚£è€…的症狀性貧血。注射劑é‡ç’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN BETAç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBH, GERMANY (Penzberg site)NONNENWALD 2, D-82377 PENZBERG, GERMANYGERMANY2014-05-06é‡ç’è£;;ç›’è£Recormon solution for injection in pre-filled syringe 10000 IU "Vetter, Germany"完整用法用é‡æ•˜è¿°ï¼Œè©³å¦‚仿單。
衛署èŒç–«è¼¸å—第000941號2018-06-072013-06-07èŒã€€ç–«DHA01000094100ç¶å¿…æ–½ 注射劑「Vectibix 單方療法,é©ç”¨æ–¼å·²ä½¿ç”¨å«æœ‰fluoropyrimidineã€oxaliplatin與irinotecan化å¸ç™‚æ³•å¤±æ•—çš„å…·è¡¨çš®ç”Ÿé•·å› åå—é«”(EGFR)表ç¾åž‹ä¸”KRAS野生型(wild type)之轉移性大腸直腸癌病患ã€ã€‚注射液å°ç“¶ç›’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Panitumumabè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438AMGEN MANUFACTURING,LIMITEDSTATE ROAD 31,KM 24.6 JUNCOS,PUERTO RICO 00777-4060PUERTO RICO2014-08-19å°ç“¶ç›’è£;;ç›’è£Vectibix solution for infusion詳見仿單
衛署èŒç–«è¼¸å—第000941號2018-06-072013-06-07èŒã€€ç–«DHA01000094100ç¶å¿…æ–½ 注射劑「Vectibix 單方療法,é©ç”¨æ–¼å·²ä½¿ç”¨å«æœ‰fluoropyrimidineã€oxaliplatin與irinotecan化å¸ç™‚æ³•å¤±æ•—çš„å…·è¡¨çš®ç”Ÿé•·å› åå—é«”(EGFR)表ç¾åž‹ä¸”KRAS野生型(wild type)之轉移性大腸直腸癌病患ã€ã€‚注射液å°ç“¶ç›’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Panitumumabè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438BOEHRINGER INGELHEIM FREMONT, INC6701 KAISER DRIVE, FREMONT, CALIFORNIA 94555. USAUNITED STATES2014-08-19å°ç“¶ç›’è£;;ç›’è£Vectibix solution for infusion詳見仿單
衛署èŒç–«è¼¸å—第000941號2018-06-072013-06-07èŒã€€ç–«DHA01000094100ç¶å¿…æ–½ 注射劑「Vectibix 單方療法,é©ç”¨æ–¼å·²ä½¿ç”¨å«æœ‰fluoropyrimidineã€oxaliplatin與irinotecan化å¸ç™‚æ³•å¤±æ•—çš„å…·è¡¨çš®ç”Ÿé•·å› åå—é«”(EGFR)表ç¾åž‹ä¸”KRAS野生型(wild type)之轉移性大腸直腸癌病患ã€ã€‚注射液å°ç“¶ç›’è£;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Panitumumabè·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438IMMUNEX RHODE ISLAND CORPORATION40 TECHNOLOGY WAY, WEST GREENWICH RHODE ISLAND 02817, USAUNITED STATES2014-08-19å°ç“¶ç›’è£;;ç›’è£Vectibix solution for infusion詳見仿單
衛署èŒç–«è¼¸å—第000942號2018-06-142013-06-14èŒã€€ç–«DHA01000094202賀疾妥注射液420毫克Perjeta與HerceptinåŠdocetaxel併用於治療轉移後未曾以抗HER2或化å¸ç™‚法治療之HER2陽性轉移性乳癌病患。注射液劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨Pertuzumab ç¾…æ°å¤§è—¥å» 股份有é™å…¬å¸å°åŒ—市æ¾å±±å€æ°‘生æ±è·¯ä¸‰æ®µï¼‘34號9樓23167467ROCHE DIAGNOSTICS GMBHSANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANYGERMANY2014-05-06å°ç“¶;;ç›’è£Perjeta Vial 420mg詳見仿單
衛署èŒç–«è¼¸å—第000943號2018-08-012013-08-01èŒã€€ç–«DHA01000094301柔癌æ•æ³¨å°„劑與5-fluorouracilã€leucovorinã€irinotecan-(FOLFIRI)åˆä½µä½¿ç”¨ï¼Œæ²»ç™‚已使用å«æœ‰oxaliplatin化å¸ç™‚法無效或惡化之轉移性大腸直腸癌病患。注射劑玻璃å°ç“¶è£;;玻璃å°ç“¶è£;;ç›’è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨Aflibercept賽諾è²è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市æ¾å±±å€å¾©èˆˆåŒ—è·¯337號12ã€13ã€14樓97168356SANOFI-AVENTIS DEUTSCHLAND GMBHINDUSTRIEPARK HOECHST, D-65926 FRANKFURT AM MAIN,GERMANYGERMANY2014-11-03玻璃å°ç“¶è£;;玻璃å°ç“¶è£;;ç›’è£ZALTRAP 25mg/ml concentrate for solution for infusion詳如仿單
衛署èŒç–«è¼¸å—第000944號2019-05-212014-05-21èŒã€€ç–«DHA01000094403派立克痘麻疹ã€è…®è…ºç‚Žã€å¾·åœ‹éº»ç–¹åŠæ°´ç—˜ä¹‹ä¸»å‹•å…疫,é©ç”¨æ–¼9個月至6æ²(72個月)çš„å©ç«¥ã€‚å‡æ™¶ä¹¾ç‡¥æ³¨å°„劑單劑é‡å°ç“¶è£ï¼Œé™„ç‰æ”¯æ•¸é 充填注射用水溶劑é‡ç’è£æˆ–注射用水溶劑0.5ml安瓶è£é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨Live attenuated measles virus (Schwarz strain) ;;Live attenuated mumps virus (RIT 4385 strain, derived from Jeryl Lynn strain) ;;Live attenuated rubella virus (Wistar RA 27/3 strain) ;;Live attenuated varicella virus (OKA strain) è·å•†è‘›è˜ç´ å²å…‹è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市ä¸æ£å€å¿ å西路一段66號23-24樓86927438GLAXOSMITHKLINE BIOLOGICALS S.A.89 RUE DE 1'INSTITUT 1330 RIXENSART-BELGIUMBELGIUM2014-08-19單劑é‡å°ç“¶è£ï¼Œé™„ç‰æ”¯æ•¸é 充填注射用水溶劑é‡ç’è£æˆ–注射用水溶劑0.5ml安瓶è£Priorix-tetra詳見仿單
衛署醫器製å—第001230號2015-12-042005-01-10èŒã€€ç–«DHY00500123004普生安è‚æ¯ï¼ï¼¡ï¼ï¼™ï¼–(Tï¼ï¼¢ï¼‰é…µç´ å…疫分æžæ³•å®šæ€§æ¸¬è©¦äººé¡žè¡€æ¸…或血漿ä¸ä¹‹ï¼¡åž‹è‚炎IGï¼æŠ—體(IGï¼ã€€ï¼¡ï¼®ï¼´ï¼©ï¼ï¼¨ï¼¡ï¼¶ï¼‰ã€‚檢驗試劑劑è£ç”±é†«å¸«æˆ–檢驗師使用普生股份有é™å…¬å¸æ–°ç«¹ç¸£å¯¶å±±é„‰æ–°ç«¹åœ’å€å‰µæ–°ä¸€è·¯ï¼–號47299918普生股份有é™å…¬å¸æ–°ç«¹å¸‚科å¸å·¥æ¥åœ’å€å‰µæ–°ä¸€è·¯ï¼–號TAIWAN2013-04-10劑è£HEPAVASE MA-96 (TMB)
衛署醫器製å—第001231號2016-04-062005-01-10èŒã€€ç–«DHY00500123106普生安è‚脢 Aï¼ï¼™ï¼–(Tï¼ï¼¢ï¼‰é…µç´ å…疫分æžæ³•å®šæ€§æ¸¬è©¦äººé¡žè¡€æ¸…或血漿ä¸ä¹‹ï¼¡åž‹è‚炎抗體(ANTIï¼ï¼¨ï¼¡ï¼¶ï¼‰æª¢é©—試劑劑è£ç”±é†«å¸«æˆ–檢驗師使用普生股份有é™å…¬å¸æ–°ç«¹ç¸£å¯¶å±±é„‰æ–°ç«¹åœ’å€å‰µæ–°ä¸€è·¯ï¼–號47299918普生股份有é™å…¬å¸æ–°ç«¹å¸‚科å¸å·¥æ¥åœ’å€å‰µæ–°ä¸€è·¯ï¼–號TAIWAN2013-04-10劑è£HEPAVASE A-96 (TMB)
衛署醫器製å—第001267號2012-05-132005-02-17èŒã€€ç–«DHY00500126701åˆå¯Œï¼¡ï½Žï½”ï½‰æª¢é©—è©¦åŠ‘é…µç´ å…疫法測定人類血清ä¸ï¼¢åž‹è‚炎表é¢æŠ—原之抗體(Antiï¼ï¼¨ï¼¢ï½“)試劑組由醫師或檢驗師使用臺富製藥股份有é™å…¬å¸æ¡ƒåœ’縣大園鄉溪海æ‘äº”é„°å´™é ‚ï¼“ï¼–è™Ÿ05084773臺富製藥股份有é™å…¬å¸å¤§åœ’å·¥å» æ¡ƒåœ’ç¸£å¤§åœ’é„‰æºªæµ·æ‘äº”é„°å´™é ‚ï¼“ï¼–è™ŸTAIWAN2013-10-17組FUJIREBIO TAIWAN ELISA-ANTI HBs
衛署èŒç–«è¼¸å—第000595號2020-04-052000-04-05èŒã€€ç–«DHA01000059504優泌樂ï¼æ··åˆåž‹ï¼’5 1ï¼ï¼å–®ä½/ 毫å‡ç³–尿病。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY FRANCE2 RUE DU COLONEL LILLY 67640 FEGERSHEIM, FRANCE.FRANCE2014-12-19å°ç“¶;;ç›’è£HUMALOG MIX25 100 IU/ML
衛署èŒç–«è¼¸å—第000595號2020-04-052000-04-05èŒã€€ç–«DHA01000059504優泌樂ï¼æ··åˆåž‹ï¼’5 1ï¼ï¼å–®ä½/ 毫å‡ç³–尿病。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY DEL CARIBE INC.12.3 KM, 65TH INFANTRY ROAD, CAROLINA 00985, PUERTO RICOPUERTO RICO2014-12-19å°ç“¶;;ç›’è£HUMALOG MIX25 100 IU/ML
衛署èŒç–«è¼¸å—第000581號2015-01-112000-01-11èŒã€€ç–«DHA01000058106ã€ç‘žå£«ã€žå®œä¿åˆ©è¡€æ³¨å°„液2ï¼ï¼ï¼å–®ä½/毫å‡æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€ä¹‹æ‚£è€…ã€æ²»ç™‚與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN ALFA嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854CILAG AGHOCHSTRASSE 201, CH-8200 SCHAFFHAUSEN, SWITZERLANDSWITZERLAND2014-12-11注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;ç›’è£EPREX INJECTION 2000IU/ML
衛署èŒç–«è¼¸å—第000582號2015-01-112000-01-11èŒã€€ç–«DHA01000058208ã€ç‘žå£«ã€žå®œä¿åˆ©è¡€æ³¨å°„液4ï¼ï¼ï¼å–®ä½/毫å‡æ²»ç™‚èˆ‡æ…¢æ€§è…Žè‡ŸåŠŸèƒ½å¤±èª¿æœ‰é—œçš„è²§è¡€ç—‡ç‹€æˆ–å› æ¤è€Œéœ€è¦è¼¸è¡€ä¹‹æ‚£è€…ã€æ²»ç™‚與癌症化å¸æ²»ç™‚有關的症狀性貧血。注射劑注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨EPOETIN ALFA嬌生股份有é™å…¬å¸å°åŒ—市大安å€æ•¦åŒ–å—路二段319號4ã€5樓30814854CILAG AGHOCHSTRASSE 201, CH-8200 SCHAFFHAUSEN, SWITZERLANDSWITZERLAND2014-12-11注射é‡ç’,å«é‡é 防刺/è·è£ç½® ( Passive Needle Guard );;ç›’è£EPREX INJECTION 4000IU/ML
衛署èŒç–«è¼¸å—第000584號2008-07-022000-01-18èŒã€€ç–«DHA01000058402安列露原房粉液1:1ï¼æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨è‡ºé³¥è²¿æ˜“有é™å…¬å¸å°åŒ—市å—京æ±è·¯ä¸€æ®µï¼‘ï¼è™Ÿï¼”F11823045TORII PHARMACEUTICAL CO.,LTD.2183-1 TERANOSAKU , OHTA, SAKURA CITY,CHIBA,JAPAN3-4-1,NIHONBASHI, HONCHO, CHUO-KU, TOKYO, JAPANJAPAN2014-05-29å°ç“¶ALLERGEN HOUSE DUST EXTRACT 1:10 "TORII"02003032
衛署èŒç–«è¼¸å—第000589號2015-03-132000-03-13èŒã€€ç–«DHA01000058909å› æ²»éš†ã€€å¤šåŠ‘é‡æ³¨å°„ç†ä¸€åƒäº”百è¬åœ‹éš›å–®ä½/毫å‡æ…¢æ€§ï¼¢åž‹è‚ç‚Žã€æ…¢æ€§ï¼£åž‹è‚ç‚Ž/éžï¼¡éžï¼¢åž‹è‚ç‚Žã€å¤šæ¯›ç‹€ç´°èƒžç™½è¡€çƒéŽå¤šç—…ã€æ…¢æ€§éª¨é«“性白血病ã€å¤šç™¼æ€§ç™½è¡€ç—…ã€éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€ï¼¡ï¼©ï¼¤ï¼³ç—…患之å¡æ³¢è¥¿æ°è‚‰ç˜¤ã€æƒ¡æ€§é»‘è‰²ç´ ç´°èƒžç˜¤ã€‚æ³¨å°„åŠ‘ç†è£é™ç”±é†«å¸«ä½¿ç”¨INTERFERON ALPHA- 2B美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH LABO N.V.INDUSTRIEPARK,30,B-2220 HEIST-OP-DEN-BERG BELGIUMBELGIUM2013-11-22ç†è£INTRON A MULTIDOSE PEN 15MIU/ML
衛署èŒç–«è¼¸å—第000589號2015-03-132000-03-13èŒã€€ç–«DHA01000058909å› æ²»éš†ã€€å¤šåŠ‘é‡æ³¨å°„ç†ä¸€åƒäº”百è¬åœ‹éš›å–®ä½/毫å‡æ…¢æ€§ï¼¢åž‹è‚ç‚Žã€æ…¢æ€§ï¼£åž‹è‚ç‚Ž/éžï¼¡éžï¼¢åž‹è‚ç‚Žã€å¤šæ¯›ç‹€ç´°èƒžç™½è¡€çƒéŽå¤šç—…ã€æ…¢æ€§éª¨é«“性白血病ã€å¤šç™¼æ€§ç™½è¡€ç—…ã€éžä½•æ°é‡‘æ°æ·‹å·´ç˜¤ã€ï¼¡ï¼©ï¼¤ï¼³ç—…患之å¡æ³¢è¥¿æ°è‚‰ç˜¤ã€æƒ¡æ€§é»‘è‰²ç´ ç´°èƒžç˜¤ã€‚æ³¨å°„åŠ‘ç†è£é™ç”±é†«å¸«ä½¿ç”¨INTERFERON ALPHA- 2B美商默沙æ±è—¥å» 股份有é™å…¬å¸å°ç£åˆ†å…¬å¸å°åŒ—市信義å€ä¿¡ç¾©è·¯äº”段106號12樓86683720SCHERING-PLOUGH (BRINNY) COMPANYINNISHANNON, CO. CORK,IRELAND2013-11-22ç†è£INTRON A MULTIDOSE PEN 15MIU/ML
衛署èŒç–«è¼¸å—第000595號2020-04-052000-04-05èŒã€€ç–«DHA01000059504優泌樂ï¼æ··åˆåž‹ï¼’5 1ï¼ï¼å–®ä½/ 毫å‡ç³–尿病。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803ELI LILLY AND COMPANYINDIANAPOLIS, INDIANA 46285, U.S.A.UNITED STATES2014-12-19å°ç“¶;;ç›’è£HUMALOG MIX25 100 IU/ML
衛署èŒç–«è¼¸å—第000596號2020-04-052000-04-05èŒã€€ç–«DHA01000059606優泌樂ï¼æ··åˆåž‹ï¼•ï¼ã€€ï¼‘ï¼ï¼å–®ä½/毫å‡ç³–尿病。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY FRANCE2 RUE DU COLONEL LILLY 67640 FEGERSHEIM, FRANCE.FRANCE2014-12-19å°ç“¶;;ç›’è£HUMALOG MIX50 100 IU/ML
衛署èŒç–«è¼¸å—第000596號2020-04-052000-04-05èŒã€€ç–«DHA01000059606優泌樂ï¼æ··åˆåž‹ï¼•ï¼ã€€ï¼‘ï¼ï¼å–®ä½/毫å‡ç³–尿病。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY DEL CARIBE INC.12.3 KM, 65TH INFANTRY ROAD, CAROLINA 00985, PUERTO RICOPUERTO RICO2014-12-19å°ç“¶;;ç›’è£HUMALOG MIX50 100 IU/ML
衛署èŒç–«è¼¸å—第000596號2020-04-052000-04-05èŒã€€ç–«DHA01000059606優泌樂ï¼æ··åˆåž‹ï¼•ï¼ã€€ï¼‘ï¼ï¼å–®ä½/毫å‡ç³–尿病。注射劑å°ç“¶;;ç›’è£é™ç”±é†«å¸«ä½¿ç”¨è‡ºç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803ELI LILLY AND COMPANYINDIANAPOLIS, INDIANA 46285, U.S.A.UNITED STATES2014-12-19å°ç“¶;;ç›’è£HUMALOG MIX50 100 IU/ML
衛署èŒç–«è¼¸å—第000792號2019-01-082004-04-05èŒã€€ç–«DHA01000079206å¸¥å¥ 1.33å…¬çµ²è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€å…¶ä»–GONADOL DYSGENESIS (TURNER'S SYNDROME)所導致之生長é²æ»¯ã€é’春期å‰å› 慢性腎臟衰ç«å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯åŠæˆäººç”Ÿé•·æ¿€ç´ åš´é‡åˆ†æ³Œä¸è¶³ä¹‹è£œå……療法。低出生體é‡å…’(Small for Gestational Ageï¼›SGA)逾四æ²è€…之生長障礙。å‡æ™¶æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨SOMATOTROPIN HUMANå°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO SA, AUBONNE BRANCHZONE INDUSTRIELLE DE L'OURIETTAZ, 1170 AUBONNE SWITZERLANDSWITZERLAND2014-11-13å°ç“¶SAIZEN 1.33MG
衛署èŒç–«è¼¸å—第000792號2019-01-082004-04-05èŒã€€ç–«DHA01000079206å¸¥å¥ 1.33å…¬çµ²è…¦ä¸‹åž‚é«”ç”Ÿé•·æ¿€ç´ åˆ†æ³Œä¸è¶³æ‰€å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯ã€å…¶ä»–GONADOL DYSGENESIS (TURNER'S SYNDROME)所導致之生長é²æ»¯ã€é’春期å‰å› 慢性腎臟衰ç«å°Žè‡´ä¹‹ç”Ÿé•·é²æ»¯åŠæˆäººç”Ÿé•·æ¿€ç´ åš´é‡åˆ†æ³Œä¸è¶³ä¹‹è£œå……療法。低出生體é‡å…’(Small for Gestational Ageï¼›SGA)逾四æ²è€…之生長障礙。å‡æ™¶æ³¨å°„劑å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨SOMATOTROPIN HUMANå°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610EVER PHARMA JENA GMBHD-07745 JENA OTTO SCHOTT-STRASSE 15 GERMANYGERMANY2014-11-13å°ç“¶SAIZEN 1.33MG
衛署èŒç–«è¼¸å—第000794號2014-05-032004-05-03èŒã€€ç–«DHA01000079400è·¯ç¦ç‘žå‡æ™¶æ³¨å°„劑75國際單ä½èˆ‡æ¿¾æ³¡åˆºæ¿€æ¿€ç´ (FSH)併用,用於嚴é‡ç¼ºä¹é»ƒé«”åˆºæ¿€æ¿€ç´ èˆ‡æ¿¾æ³¡åˆºæ¿€æ¿€ç´ æ‚£è€…çš„æ¿¾æ³¡åˆºæ¿€æˆé•·ã€‚æ¤é¡žæ‚£è€…臨床試驗ä¸å®šç¾©ç‚ºå…§ç”Ÿæ€§é»ƒé«”åˆºæ¿€æ¿€ç´ æ¿ƒåº¦å°‘æ–¼1?2 IU/L。å‡æ™¶æ³¨å°„劑瓶è£é™ç”±é†«å¸«ä½¿ç”¨RECOMBINANT HUMAN LUTENISING HORMONEå°ç£é»˜å…‹è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市內湖å€å ¤é ‚大é“2段89號6樓23526610MERCK SERONO SA, AUBONNE BRANCHZONE INDUSTRIELLE DE L'OURIETTAZ, 1170 AUBONNE SWITZERLANDSWITZERLAND2014-11-13瓶è£LUVERIS 75IU
衛署èŒç–«è¼¸å—第000795號2019-02-032004-05-20èŒã€€ç–«DHA01000079502優泌樂 注射劑100å–®ä½/毫å‡(法國禮來)糖尿病。注射劑管è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN LISPRO臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY FRANCE2 RUE DU COLONEL LILLY 67640 FEGERSHEIM, FRANCEFRANCE2014-10-08管è£HUMALOG U-100
衛署èŒç–«è¼¸å—第000795號2019-02-032004-05-20èŒã€€ç–«DHA01000079502優泌樂 注射劑100å–®ä½/毫å‡(法國禮來)糖尿病。注射劑管è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN LISPRO臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803LILLY DEL CARIBE INC.12.3 KM, 65TH INFANTRY ROAD, CAROLINA 00985, PUERTO RICOPUERTO RICO2014-10-08管è£HUMALOG U-100
衛署èŒç–«è¼¸å—第000795號2019-02-032004-05-20èŒã€€ç–«DHA01000079502優泌樂 注射劑100å–®ä½/毫å‡(法國禮來)糖尿病。注射劑管è£é™ç”±é†«å¸«ä½¿ç”¨INSULIN LISPRO臺ç£ç¦®ä¾†è‚¡ä»½æœ‰é™å…¬å¸å°åŒ—市復興北路365號11樓43430803ELI LILLY AND COMPANYINDIANAPOLIS, INDIANA 46285, U.S.A.UNITED STATES2014-10-08管è£HUMALOG U-100
衛署èŒç–«è¼¸å—第000796號2019-06-082004-06-08èŒã€€ç–«DHA01000079601凱銘斯å…ç–«çƒè›‹ç™½æ³¨å°„液 10%原發性體液性å…ç–«ä¸å…¨ã€åŽŸç™¼æ€§è¡€å°æ¿ç¼ºä¹ç´«æ–‘症。注射劑å°ç“¶;;å°ç“¶;;å°ç“¶é™ç”±é†«å¸«ä½¿ç”¨HUMAN IMMUNOGLOBULIN PROTEINS天行貿易股份有é™å…¬å¸å°åŒ—市ä¸å±±å€é•·å®‰æ±è·¯ä¸€æ®µ21號2樓11102308Grifols Therapeutics Inc.8368 US 70 BUS HWY WEST, CLAYTON, NC 27520, U.S.A.UNITED STATES2014-12-23å°ç“¶;;å°ç“¶;;å°ç“¶GAMUNEX-C仅能以静脉输注方å¼æŠ•药:ITP。静脉或皮下输注方å¼æŠ•药:PI。请勿以皮下输注方å¼æŠ•药æ–¼ITP病患。
PK
pÂXU¨`â< < xl/workbook.xml
PK
pÂX0ˆkÞ Þ xl/theme/theme1.xml
PK
pÂXUô”Z Z
xl/styles.xml
PK
pÂX6ë–ý’ ’ [Content_Types].xml
PK
pÂXJjùL L _rels/.rels
PK
pÂXÐ?dÝ- - xl/_rels/workbook.xml.rels
PK
pÂXÖ’|Z Z docProps/core.xmlPK
pÂXõ”¿w, , ‰ docProps/app.xmlPK
pÂXÏÄ_
Vs Vs ã xl/worksheets/sheet1.xmlPK
pÂXU¨`â< < ow xl/workbook.xmlPK
pÂX0ˆkÞ Þ Øx xl/theme/theme1.xmlPK
pÂXUô”Z Z
ç– xl/styles.xmlPK
pÂX6ë–ý’ ’ l› [Content_Types].xmlPK
pÂXJjùL L /£ _rels/.relsPK
pÂXÐ?dÝ- - ¤¥ xl/_rels/workbook.xml.relsPK > ¨